syndrome	score	normalized_score
DRAVET SYNDROME	2.6655186999999994	100.0
CHILDHOOD ABSENCE EPILEPSY	1.52874085	57.352471397030534
MYOCLONIC-ASTASTIC EPILEPSY	1.2192351540000002	45.74100920770132
EPILEPSY, FAMILIAL TEMPORAL LOBE, 3; ETL3	1.1936939999999998	44.78280343709463
MICROPHTHALMIA-BRAIN ATROPHY SYNDROME	1.1521162600000001	43.222966696875936
INFANTILE HYPOTONIA-OCULOMOTOR ANOMALIES-HYPERKINETIC MOVEMENTS-DEVELOPMENTAL DELAY SYNDROME	1.08630949	40.75415002715983
MICROPHTHALMIA, SYNDROMIC 2; MCOPS2	1.014284619	38.05205414615926
HEMIDYSTONIA-HEMIATROPHY SYNDROME	1.000541419	37.53646219026714
PAROXYSMAL KINESIGENIC DYSKINESIA	1.0	37.51615023372375
HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA	1.0	37.51615023372375
HYPERTRICHOSIS UNIVERSALIS	1.0	37.51615023372375
227210 EYEBROWS, DUPLICATION OF, WITH STRETCHABLE SKIN AND SYNDACTYLY	1.0	37.51615023372375
MYOCLONIC EPILEPSY OF LAFORA	0.93788904	35.18598612720294
LAFORA DISEASE	0.7715289599999999	28.944796373028638
EPILEPSY, LATERAL TEMPORAL LOBE, AUTOSOMAL DOMINANT	0.7706171	28.91058689627652
FEMALE RESTRICTED EPILEPSY WITH INTELLECTUAL DISABILITY	0.748578964	28.08380087522928
EARLY MYOCLONIC ENCEPHALOPATHY	0.7087289139999999	26.588780412607875
ALACRIMIA-CHOREOATHETOSIS-LIVER DYSFUNCTION SYNDROME	0.6760356139999999	25.362253658171674
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES-PLUS	0.59274141	22.237375787309247
ROLANDIC EPILEPSY	0.5906213	22.157837422037225
SPORADIC INFANTILE BILATERAL STRIATAL NECROSIS	0.5635556	21.142436554656328
BRAIN MALFORMATIONS-MUSCULOSKELETAL ABNORMALITIES-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROME	0.540186244	20.265708284094956
172500 PHOTOMYOCLONUS, DIABETES MELLITUS, DEAFNESS, NEPHROPATHY, AND CEREBRALDYSFUNCTION;;HERRMANN SYNDROME	0.5333330000000001	20.00860095260259
EPILEPSY, FAMILIAL TEMPORAL LOBE, 4	0.527027	19.772024109228727
DEVELOPMENTAL DELAY AND SEIZURES WITH OR WITHOUT MOVEMENT ABNORMALITIES; DEDSM	0.516847064	19.390112100883034
ISOLATED SUCCINATE-COQ REDUCTASE DEFICIENCY	0.50925926	19.10544690607498
EPILEPSY, BENIGN NEONATAL, 2	0.50704225	19.022273225845318
NON-PROGRESSIVE CEREBELLAR ATAXIA WITH INTELLECTUAL DISABILITY	0.504116984	18.912528507115713
MIDFACE HYPOPLASIA, OBESITY, DEVELOPMENTAL DELAY, AND NEONATAL HYPOTONIA	0.500545554	18.77854220268648
PAROXYSMAL HEMICRANIA	0.5	18.758075116861875
IDIOPATHIC INTRACRANIAL HYPERTENSION	0.5	18.758075116861875
INHALATIONAL ANTHRAX	0.5	18.758075116861875
EPILEPSY, FAMILIAL TEMPORAL LOBE, 7; ETL7	0.5	18.758075116861875
CREST SYNDROME	0.5	18.758075116861875
PRIMARY HYPERALDOSTERONISM-SEIZURES-NEUROLOGICAL ABNORMALITIES SYNDROME	0.4346148040000001	16.305074280664407
PROGRESSIVE MYOCLONIC EPILEPSY TYPE 3	0.42074085000000006	15.784576938064632
CLCN4-RELATED X-LINKED INTELLECTUAL DISABILITY SYNDROME	0.415131304	15.574128367585644
SPINOCEREBELLAR ATAXIA TYPE 10	0.4088913	15.34002744006261
3-PHOSPHOGLYCERATE DEHYDROGENASE DEFICIENCY, INFANTILE/JUVENILE FORM	0.3926433099999999	14.730465406226564
X-LINKED INTELLECTUAL DISABILITY, SNYDER TYPE	0.37313236	13.998489674823894
CLEFT PALATE, CARDIAC DEFECTS, AND MENTAL RETARDATION; CPCMR	0.368191344	13.813121776260662
PERIORAL MYOCLONIA WITH ABSENCES	0.36455991	13.676884352752808
EPILEPSY, JUVENILE ABSENCE	0.35751765999999996	13.412686243769368
EPILEPSY WITH GRAND MAL SEIZURES ON AWAKENING	0.35751765999999996	13.412686243769368
CORNELIA DE LANGE SYNDROME 3	0.35543885299999994	13.33469740805045
CENTRALOPATHIC EPILEPSY	0.35470090000000004	13.307012252437026
EARLY INFANTILE EPILEPTIC ENCEPHALOPATHY	0.348537004	13.075766604075975
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIC; CDG2C	0.347577154	13.039756727274135
MITOCHONDRIAL DNA DEPLETION SYNDROME 4A (ALPERS TYPE)	0.345372854	12.95705987731394
MITOCHONDRIAL DNA DEPLETION SYNDROME 7 (HEPATOCEREBRAL TYPE)	0.3448273	12.936592791489328
CEREBELLAR, OCULAR, CRANIOFACIAL, AND GENITAL SYNDROME; COFG	0.3418739	12.825792593389048
EPILEPSY, FAMILIAL ADULT MYOCLONIC, 5; FAME5	0.34037525	12.76956901484128
COG4-CDG	0.333878554	12.525837991682447
ROLANDIC EPILEPSY-PAROXYSMAL EXERCISE-INDUCED DYSTONIA-WRITER'S CRAMP SYNDROME	0.333333	12.505370905857838
EPILEPSY, ROLANDIC, WITH PAROXYSMAL EXERCISE-INDUCED DYSTONIA AND WRITER'S CRAMP; EPRPDC	0.333333	12.505370905857838
OROFACIODIGITAL SYNDROME TYPE 3	0.333333	12.505370905857838
MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIA; MEN2A	0.333333	12.505370905857838
THUMB AGENESIS, SHORT STATURE, AND IMMUNODEFICIENCY	0.333333	12.505370905857838
RECURRENT METABOLIC ENCEPHALOMYOPATHIC CRISES-RHABDOMYOLYSIS-CARDIAC ARRHYTHMIA-INTELLECTUAL DISABILITY SYNDROME	0.31566591	11.84256970322512
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 52; EIEE52	0.30128141399999997	11.30291879025272
INTELLECTUAL DISABILITY-CRANIOFACIAL DYSMORPHISM-CRYPTORCHIDISM SYNDROME	0.26993966399999997	10.12709698866491
PYCR2-RELATED MICROCEPHALY-PROGRESSIVE LEUKOENCEPHALOPATHY	0.26929041	10.102739478061064
WILLIAMS-BEUREN SYNDROME; WBS	0.26082112	9.78500432204809
PALLISTER-HALL SYNDROME	0.257795244	9.67148510344347
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 34; EIEE34	0.25562995400000005	9.590251758503893
WITTEVEEN-KOLK SYNDROME	0.254511633	9.548296659858364
HYPEREKPLEXIA 1; HKPX1	0.2542735	9.539362826454756
ATAXIA-OCULOMOTOR APRAXIA TYPE 1	0.25344828	9.508403748958884
MITOCHONDRIAL DNA DEPLETION SYNDROME 14	0.2526316	9.477765059386005
DYSTONIA 6, TORSION	0.25	9.379037558430937
BARDET-BIEDL SYNDROME	0.25	9.379037558430937
HYPERPARATHYROIDISM 2	0.25	9.379037558430937
METAPHYSEAL CHONDRODYSPLASIA, SPAHR TYPE	0.25	9.379037558430937
DERMOID CYSTS, FAMILIAL FRONTONASAL	0.25	9.379037558430937
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 19; EIEE19	0.243045154	9.118118511042525
SKELETAL DYSPLASIA-T-CELL IMMUNODEFICIENCY-DEVELOPMENTAL DELAY SYNDROME	0.237037	8.892715702951175
LENNOX-GASTAUT SYNDROME	0.23257131	8.725180206013938
EPILEPSY, FAMILIAL TEMPORAL LOBE, 2; ETL2	0.22592915	8.475991933577507
SPASTIC PARAPLEGIA-SEVERE DEVELOPMENTAL DELAY-EPILEPSY SYNDROME	0.224847064	8.435396232635698
WIEDEMANN-RAUTENSTRAUCH SYNDROME	0.212642793	7.977538968306621
MENTAL RETARDATION, X-LINKED, SYNDROMIC 33	0.210034743	7.879694972689558
HERPES SIMPLEX VIRUS ENCEPHALITIS	0.2051883	7.697875089002379
ATHEROSCLEROSIS-DEAFNESS-DIABETES-EPILEPSY-NEPHROPATHY SYNDROME	0.20344828	7.632596237272696
FAMILIAL HYPERALDOSTERONISM TYPE I	0.2	7.503230046744751
ATHEROSCLEROSIS, PREMATURE, WITH DEAFNESS, NEPHROPATHY, DIABETES MELLITUS,PHOTOMYOCLONUS, AND DEGENERATIVE NEUROLOGIC DISEASE	0.2	7.503230046744751
MAN1B1-CDG	0.189493073	7.109050594917981
EARLY-ONSET EPILEPTIC ENCEPHALOPATHY AND INTELLECTUAL DISABILITY DUE TO GRIN2A MUTATION	0.18939175000000003	7.1052493460278505
JUVENILE MYOCLONIC EPILEPSY	0.18297529999999998	6.864528843860672
MYOCLONIC EPILEPSY OF INFANCY	0.181285814	6.8011458332669
FAMILIAL INFANTILE MYOCLONIC EPILEPSY	0.181285814	6.8011458332669
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 25, WITH AMELOGENESIS IMPERFECTA; EIEE25	0.172753954	6.481063291733802
UNILATERAL POLYMICROGYRIA	0.17116626000000001	6.421499125104621
COMBINED MALONIC AND METHYLMALONIC ACIDEMIA	0.17042955399999998	6.393860752130534
NOONAN SYNDROME 6; NS6	0.167212554	6.273171296828646
ACROFRONTOFACIONASAL DYSOSTOSIS 1	0.167208419	6.273016167547428
MICROCEPHALY, CEREBELLAR HYPOPLASIA, AND CARDIAC CONDUCTION DEFECT SYNDROME; MCHCCD	0.166667	6.252704211004037
OLIVER-MCFARLANE SYNDROME	0.166667	6.252704211004037
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 27	0.16415611399999996	6.158505434608281
EARLY-ONSET EPILEPTIC ENCEPHALOPATHY-CORTICAL BLINDNESS-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.16346135	6.1324405640073
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM TYPES I AND III	0.160893854	6.036117998346815
SEIZURES, BENIGN FAMILIAL INFANTILE, 3; BFIS3	0.1595057	5.98403980433527
SEIZURES, BENIGN FAMILIAL INFANTILE, 1; BFIS1	0.1595057	5.98403980433527
TBCK-RELATED INTELLECTUAL DISABILITY SYNDROME	0.15815151	5.933235808850264
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHRISTIANSON TYPE	0.157896064	5.92365245833766
CONGENITAL MUSCULAR DYSTROPHY WITH INTELLECTUAL DISABILITY AND SEVERE EPILEPSY	0.15266181399999998	5.727283548976791
RIGIDITY AND MULTIFOCAL SEIZURE SYNDROME, LETHAL NEONATAL; RMFSL	0.15266181399999998	5.727283548976791
MENTAL RETARDATION, AUTOSOMAL DOMINANT 36; MRD36	0.14986335299999998	5.622296065677574
MULTICENTRIC OSTEOLYSIS-NODULOSIS-ARTHROPATHY SPECTRUM	0.14583318999999997	5.471099865103179
PHACE SYNDROME	0.14394397299999998	5.400223716307074
GANGLIONEUROMA	0.14285699999999998	5.359444673939073
223540 DWARFISM, MENTAL RETARDATION, AND EYE ABNORMALITY;;MOLLICA SYNDROME	0.14285699999999998	5.359444673939073
COMBINED SAPOSIN DEFICIENCY	0.14285699999999998	5.359444673939073
EPILEPSY, PHOTOGENIC, WITH SPASTIC DIPLEGIA AND MENTAL RETARDATION	0.14285699999999998	5.359444673939073
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 4	0.14089111	5.285692049356099
AUTOSOMAL RECESSIVE NON-SYNDROMIC INTELLECTUAL DISABILITY	0.13678895400000002	5.131794948577928
AICARDI SYNDROME; AIC	0.1359448	5.100125540293528
MICROCEPHALY-INTELLECTUAL DISABILITY-SENSORINEURAL HEARING LOSS-EPILEPSY-ABNORMAL MUSCLE TONE SYNDROME	0.135574524	5.086234210249587
CHROMOSOME 1P36 DELETION SYNDROME	0.134970183	5.063561662501187
ROLANDIC EPILEPSY-SPEECH DYSPRAXIA SYNDROME	0.1324787	4.970090811968419
X-LINKED INTELLECTUAL DISABILITY-CEREBELLAR HYPOPLASIA-SPONDYLO-EPIPHYSEAL DYSPLASIA SYNDROME	0.12093934	4.5371784486073965
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 57; EIEE57	0.120915814	4.536295843656997
%600176 PACHYGYRIA WITH MENTAL RETARDATION, SEIZURES, AND ARACHNOID CYSTS;;PACHYGYRIA WITH MENTAL RETARDATION AND SEIZURES	0.11869880399999999	4.453122163427329
POLYMICROGYRIA, BILATERAL PERISYLVIAN	0.11815324999999999	4.43265507760272
KCNQ2-RELATED EPILEPTIC ENCEPHALOPATHY	0.11309530000000001	4.242900265528058
KLEEFSTRA SYNDROME DUE TO 9Q34 MICRODELETION	0.10994303400000001	4.124639380695398
CDKL5-RELATED EPILEPTIC ENCEPHALOPATHY	0.10707893999999998	4.017189599907891
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 9; EIEE9	0.10675886400000001	4.005181580605682
BILATERAL POLYMICROGYRIA	0.10466076399999999	3.926468945800306
INTELLECTUAL DISABILITY-SPARSE HAIR-BRACHYDACTYLY SYNDROME	0.10456669400000002	3.92293980154782
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 9; GEFSP9	0.09895310400000001	3.712339515757291
INTELLECTUAL DISABILITY-OBESITY-BRAIN MALFORMATIONS-FACIAL DYSMORPHISM SYNDROME	0.09851445400000003	3.6958830564572684
FEBRILE SEIZURES, FAMILIAL, 2; FEB2	0.09812185000000001	3.681154065810907
%121210 FEBRILE SEIZURES, FAMILIAL, 1; FEB1;;CONVULSIONS, FAMILIAL FEBRILE;  1	0.09812185000000001	3.681154065810907
FEBRILE SEIZURES, FAMILIAL, 5; FEB5	0.09812185000000001	3.681154065810907
FEBRILE SEIZURES, FAMILIAL, 4; FEB4	0.09812185000000001	3.681154065810907
FEBRILE SEIZURES, FAMILIAL, 6; FEB6	0.09812185000000001	3.681154065810907
MACROCEPHALY-INTELLECTUAL DISABILITY-NEURODEVELOPMENTAL DISORDER-SMALL THORAX SYNDROME	0.096586434	3.6235511684836434
EARLY-ONSET PROGRESSIVE DIFFUSE BRAIN ATROPHY-MICROCEPHALY-MUSCLE WEAKNESS-OPTIC ATROPHY SYNDROME	0.096116864	3.605934709818394
FACIAL DYSMORPHISM, HYPERTRICHOSIS, EPILEPSY, INTELLECTUAL/DEVELOPMENTAL DELAY, AND GINGIVAL OVERGROWTH SYNDROME; FHEIG	0.095744569	3.59196763466713
TRICHORHINOPHALANGEAL SYNDROME, TYPE I	0.0947581	3.554959115462218
ACROFACIAL DYSOSTOSIS, PALAGONIA TYPE	0.0947581	3.554959115462218
1P36 DELETION SYNDROME	0.09460454300000001	3.549198247980779
STEROID-RESPONSIVE ENCEPHALOPATHY ASSOCIATED WITH AUTOIMMUNE THYROIDITIS	0.0941662	3.532753306138878
DEVELOPMENTAL DELAY-FACIAL DYSMORPHISM SYNDROME DUE TO MED13L DEFICIENCY	0.09157701400000001	3.4356170151798233
MEGALENCEPHALY-SEVERE KYPHOSCOLIOSIS-OVERGROWTH SYNDROME	0.09157506400000001	3.4355438586868683
OCULOCEREBROFACIAL SYNDROME, KAUFMAN TYPE	0.091470214	3.431610290334861
WILLIAMS-BEUREN REGION DUPLICATION SYNDROME	0.09062337300000002	3.399840076154785
7Q11.23 MICRODUPLICATION SYNDROME	0.08960572900000002	3.361661990966338
HYPOTONIA, ATAXIA, AND DELAYED DEVELOPMENT SYNDROME; HADDS	0.08925519400000001	3.3485112672441595
CONGENITAL LABIOSCROTAL AGENESIS-CEREBELLAR MALFORMATION-CORNEAL DYSTROPHY-FACIAL DYSMORPHISM SYNDROME	0.0891035	3.342820292350604
WAARDENBURG SYNDROME, TYPE 1; WS1	0.08879295	3.3311696518955207
WAARDENBURG SYNDROME TYPE 1	0.08879295	3.3311696518955207
ICHTHYOSIS FOLLICULARIS-ALOPECIA-PHOTOPHOBIA SYNDROME	0.08804141900000001	3.302975101994221
MENTAL RETARDATION, AUTOSOMAL DOMINANT 24; MRD24	0.08732713400000001	3.2761778786245257
WAARDENBURG-SHAH SYNDROME	0.08587087000000002	3.2215444596205622
122430 CORNEAL HYPESTHESIA WITH RETINAL ABNORMALITIES, SENSORINEURAL DEAFNESS,UNUSUAL FACIES, PERSISTENT DUCTUS ARTERIOSUS, AND MENTAL RETARDATION;;RAMOS-ARROYO SYNDROME	0.08541272000000001	3.2043564353909817
MONOSOMY 13Q34	0.08387885400000002	3.146811688096581
CHILDHOOD APRAXIA OF SPEECH	0.08333330000000001	3.1263446022719714
PIEBALDISM	0.08229944	3.0875581551913336
SEVERE GROWTH DEFICIENCY-STRABISMUS-EXTENSIVE DERMAL MELANOCYTOSIS-INTELLECTUAL DISABILITY SYNDROME	0.08063321400000001	3.0250477702519976
POLYHYDRAMNIOS-MEGALENCEPHALY-SYMPTOMATIC EPILEPSY SYNDROME	0.07992843	2.998606987825672
INTELLECTUAL DISABILITY-SEIZURES-HYPOPHOSPHATASIA-OPHTHALMIC-SKELETAL ANOMALIES SYNDROME	0.07929445999999998	2.974822874061998
GUANIDINOACETATE METHYLTRANSFERASE DEFICIENCY	0.07904281	2.965381934855682
SCHINZEL-GIEDION SYNDROME	0.07886666	2.9587734649920114
PERIPHERAL DEMYELINATING NEUROPATHY, CENTRAL DYSMYELINATION, WAARDENBURG SYNDROME, AND HIRSCHSPRUNG DISEASE; PCWH	0.07801007300000001	2.9266376184117573
WAARDENBURG SYNDROME, TYPE 2E; WS2E	0.07746865400000001	2.906325661868365
WAARDENBURG-SHAH SYNDROME	0.07746865400000001	2.906325661868365
CEREBELLAR ATROPHY, DEVELOPMENTAL DELAY, AND SEIZURES; CADEDS	0.07746865400000001	2.906325661868365
LEIGH SYNDROME WITH NEPHROTIC SYNDROME	0.07692310000000001	2.8858585760437556
TIETZ SYNDROME	0.07692310000000001	2.8858585760437556
TIETZ SYNDROME	0.07692310000000001	2.8858585760437556
SYSTEMIC PRIMARY CARNITINE DEFICIENCY	0.07692310000000001	2.8858585760437556
ERMINE PHENOTYPE	0.07692310000000001	2.8858585760437556
WAARDENBURG SYNDROME, TYPE 4B; WS4B	0.07692310000000001	2.8858585760437556
WIEDEMANN-RAUTENSTRAUCH SYNDROME; WDRTS	0.075449524	2.8305756774469457
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 15; EIEE15	0.07197415400000001	2.7001931744091694
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 13	0.07197415400000001	2.7001931744091694
TUBEROUS SCLEROSIS COMPLEX	0.0715302	2.6835377294483065
INTELLECTUAL DISABILITY-SEIZURES-ABNORMAL GAIT-FACIAL DYSMORPHISM SYNDROME	0.07149578	2.6822464235572614
EARLY-ONSET PROGRESSIVE ENCEPHALOPATHY-HEARING LOSS-PONS HYPOPLASIA-BRAIN ATROPHY SYNDROME	0.07142860000000001	2.6797260885845606
PHOSPHOSERINE AMINOTRANSFERASE DEFICIENCY	0.07142860000000001	2.6797260885845606
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 7; OPTB7	0.069967074	2.624895259598067
STAG1-RELATED INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM-GASTROESOPHAGEAL REFLUX SYNDROME	0.06896331300000001	2.5872380111233144
HYPEREKPLEXIA-EPILEPSY SYNDROME	0.0686937	2.577123169310349
INTELLECTUAL DISABILITY-BRACHYDACTYLY-PIERRE ROBIN SYNDROME	0.06842189400000001	2.566926054579922
AICARDI SYNDROME	0.06808763	2.554385756138196
HYPOPARATHYROIDISM-RETARDATION-DYSMORPHISM SYNDROME	0.067208119	2.5213898893299835
GITELMAN SYNDROME	0.06712703	2.5183477422236815
EHLERS-DANLOS SYNDROME, CLASSIC-LIKE, 2; EDSCLL2	0.0667735	2.505084657631553
VITAMIN D HYDROXYLATION-DEFICIENT RICKETS, TYPE 1A	0.0666667	2.5010779327865906
FAMILIAL HYPOCALCIURIC HYPERCALCEMIA	0.0666667	2.5010779327865906
PSEUDOHYPOPARATHYROIDISM TYPE 1B	0.0666667	2.5010779327865906
FAMILIAL ISOLATED HYPOPARATHYROIDISM DUE TO AGENESIS OF PARATHYROID GLAND	0.0666667	2.5010779327865906
HYPOPARATHYROIDISM-SENSORINEURAL DEAFNESS-RENAL DISEASE SYNDROME	0.0666667	2.5010779327865906
AUTOIMMUNE HYPOPARATHYROIDISM	0.0666667	2.5010779327865906
PSEUDOHYPOPARATHYROIDISM TYPE 2	0.0666667	2.5010779327865906
PSEUDOHYPOPARATHYROIDISM TYPE 1A	0.0666667	2.5010779327865906
VITAMIN D-DEPENDENT RICKETS, TYPE 2A	0.0666667	2.5010779327865906
AUTOSOMAL RECESSIVE KENNY-CAFFEY SYNDROME	0.0666667	2.5010779327865906
AUTOSOMAL DOMINANT KENNY-CAFFEY SYNDROME	0.0666667	2.5010779327865906
PSEUDOHYPOPARATHYROIDISM TYPE 1C	0.0666667	2.5010779327865906
HYPOCALCEMIC VITAMIN D-DEPENDENT RICKETS	0.0666667	2.5010779327865906
RENPENNING SYNDROME	0.066466079	2.493551405210551
EMANUEL SYNDROME	0.06644567300000001	2.4927858506488825
MEIER-GORLIN SYNDROME 7	0.06602174400000001	2.4768816665964497
MOWAT-WILSON SYNDROME; MOWS	0.065912539	2.472784715410176
PITT-HOPKINS-LIKE SYNDROME 1; PTHSL1	0.06590177300000001	2.47238081653676
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 68; MRT68	0.065286813	2.4493098847890287
BENIGN ADULT FAMILIAL MYOCLONIC EPILEPSY	0.0648148	2.431601774168758
INFANTILE CONVULSIONS AND CHOREOATHETOSIS	0.0648148	2.431601774168758
MENTAL RETARDATION, AUTOSOMAL DOMINANT 47; MRD47	0.063586973	2.385538431975736
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT ANOMALIES OF THE BRAIN, EYE, OR HEART; NEDBEH	0.063335133	2.376090364700875
PIGMENTARY DISORDER, RETICULATE, WITH SYSTEMIC MANIFESTATIONS, X-LINKED	0.063075033	2.366332414025083
INTELLECTUAL DEVELOPMENTAL DISORDER WITH HYPERTELORISM AND DISTINCTIVE FACIES; IDDHDF	0.063045554	2.365226475432343
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SPEECH DELAY, DYSMORPHIC FACIES, AND T-CELL ABNORMALITIES; IDDSFTA	0.063045554	2.365226475432343
612948 STARGARDT MACULAR DEGENERATION, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM,MENTAL RETARDATION, AND DYSMORPHIC FEATURES	0.062793714	2.355778408157482
AYME-GRIPP SYNDROME; AYGRP	0.062789579	2.355623278876266
FATTY ACID HYDROXYLASE-ASSOCIATED NEURODEGENERATION	0.06259785000000001	2.3484303449081043
HYPOTRICHOSIS 5; HYPT5	0.0625	2.3447593896077343
ECTODERMAL DYSPLASIA 13, HAIR/TOOTH TYPE; ECTD13	0.0625	2.3447593896077343
DEAFNESS-ENAMEL HYPOPLASIA-NAIL DEFECTS SYNDROME	0.0625	2.3447593896077343
SMITH-LEMLI-OPITZ SYNDROME; SLOS	0.062475459000000004	2.3438387057648487
TRISOMY 17P	0.062123873999999996	2.3306485900849245
PILAROWSKI-BJORNSSON SYNDROME; PILBOS	0.059910473	2.2476103056414503
RERE-RELATED NEURODEVELOPMENTAL SYNDROME	0.059910473	2.2476103056414503
WHITE-SUTTON SYNDROME; WHSUS	0.059672584	2.2386856261785
RENPENNING SYNDROME 1; RENS1	0.059200369	2.2209699372958824
FAMILIAL GLUCOCORTICOID DEFICIENCY	0.059127030000000004	2.218218540353891
MYOCLONIC EPILEPSY, FAMILIAL INFANTILE	0.05777791	2.1676047517505697
PEROXISOME BIOGENESIS DISORDER 1A (ZELLWEGER)	0.056597679	2.1233270282440717
TREMOR-ATAXIA-CENTRAL HYPOMYELINATION SYNDROME	0.056101154	2.104699321749272
15Q OVERGROWTH SYNDROME	0.055927839	2.0981972101715143
LETHAL KNIEST-LIKE DYSPLASIA	0.055607790000000004	2.0861902038053612
KNIEST-LIKE DYSPLASIA, LETHAL	0.055607790000000004	2.0861902038053612
HYPERINSULINISM DUE TO SHORT CHAIN 3-HYDROXYLACYL-COA DEHYDROGENASE DEFICIENCY	0.055555600000000004	2.0842322359246634
CONGENITAL ISOLATED ACTH DEFICIENCY	0.055555600000000004	2.0842322359246634
HYPOINSULINEMIC HYPOGLYCEMIA AND BODY HEMIHYPERTROPHY	0.055555600000000004	2.0842322359246634
CORTICAL DYSGENESIS WITH PONTOCEREBELLAR HYPOPLASIA DUE TO TUBB3 MUTATION	0.055555600000000004	2.0842322359246634
OBESITY DUE TO PROHORMONE CONVERTASE I DEFICIENCY	0.055555600000000004	2.0842322359246634
OBESITY, EARLY-ONSET, WITH ADRENAL INSUFFICIENCY AND RED HAIR; OBAIRH	0.055555600000000004	2.0842322359246634
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 3; HHF3	0.055555600000000004	2.0842322359246634
OBESITY DUE TO PRO-OPIOMELANOCORTIN DEFICIENCY	0.055555600000000004	2.0842322359246634
GLYCOGEN STORAGE DISEASE DUE TO LIVER PHOSPHORYLASE KINASE DEFICIENCY	0.055555600000000004	2.0842322359246634
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 5; HHF5	0.055555600000000004	2.0842322359246634
3-HYDROXYACYL-COA DEHYDROGENASE DEFICIENCY	0.055555600000000004	2.0842322359246634
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 7; HHF7	0.055555600000000004	2.0842322359246634
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 4; HHF4	0.055555600000000004	2.0842322359246634
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 6; HHF6	0.055555600000000004	2.0842322359246634
MECKEL SYNDROME, TYPE 1; MKS1	0.05538642	2.077885253628122
ARTHROGRYPOSIS, DISTAL, TYPE 2A	0.053173019	1.9948469691846475
SPASTIC TETRAPLEGIA-THIN CORPUS CALLOSUM-PROGRESSIVE POSTNATAL MICROCEPHALY SYNDROME	0.05267669	1.9762266158552935
SEVERE CONGENITAL NEMALINE MYOPATHY	0.0526316	1.9745350126412549
EHLERS-DANLOS SYNDROME, ARTHROCHALASIA TYPE, 1; EDSARTH1	0.0526316	1.9745350126412549
EHLERS-DANLOS SYNDROME, ARTHROCHALASIA TYPE, 2; EDSARTH2	0.0526316	1.9745350126412549
DOUBLE UTERUS-HEMIVAGINA-RENAL AGENESIS SYNDROME	0.0526316	1.9745350126412549
ISOLATED SEDOHEPTULOKINASE DEFICIENCY	0.0526316	1.9745350126412549
CHILDHOOD-ONSET NEMALINE MYOPATHY	0.0526316	1.9745350126412549
MEIER-GORLIN SYNDROME 1; MGORS1	0.0526316	1.9745350126412549
OKUR-CHUNG NEURODEVELOPMENTAL SYNDROME; OCNDS	0.051380464	1.9275972065024345
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 57; MRT57	0.051281214	1.9238737285917376
GLYCOSYLPHOSPHATIDYLINOSITOL DEFICIENCY	0.051181119000000004	1.920118549534093
SCHWARTZ-JAMPEL SYNDROME	0.05088634	1.9090595762843463
TRICHORHINOPHALANGEAL SYNDROME, TYPE III; TRPS3	0.0494995	1.8570306784942088
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 18	0.04942159399999999	1.8541079452940998
HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION 2; HOMGSMR2	0.049076854	1.8411746276625265
MITOCHONDRIAL DNA-ASSOCIATED LEIGH SYNDROME	0.048559609999999996	1.821769624051034
CENTRAL CONGENITAL HYPOTHYROIDISM	0.04784493	1.7949575818019963
WAC-RELATED FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY-BEHAVIORAL ABNORMALITIES SYNDROME	0.045159573999999994	1.6942133626749647
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 14	0.044925509999999995	1.6854321824866583
MENTAL RETARDATION, X-LINKED 98; MRX98	0.044765932999999994	1.6794454677808115
PERIPHERAL DEMYELINATING NEUROPATHY-CENTRAL DYSMYELINATING LEUKODYSTROPHY-WAARDENBURG SYNDROME-HIRSCHSPRUNG DISEASE	0.044658403	1.6754113561461794
ZLOTOGORA-OGUR SYNDROME	0.044348699	1.6637924543541942
INFANTILE SPASMS-PSYCHOMOTOR RETARDATION-PROGRESSIVE BRAIN ATROPHY-BASAL GANGLIA DISEASE SYNDROME	0.044297953999999994	1.6618886973105835
MESOMELIA-SYNOSTOSES SYNDROME	0.0442735	1.6609712773727685
MOWAT-WILSON SYNDROME	0.044112849	1.6549442703215704
GRISCELLI SYNDROME	0.043841793000000004	1.6447752927038186
CHRISTIANSON SYNDROME	0.04353051	1.633097152910614
SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.043266764	1.6232024183510705
VOGT-KOYANAGI-HARADA DISEASE	0.04316456	1.6193681177325825
ACRODERMATITIS ENTEROPATHICA	0.04316456	1.6193681177325825
CHROMOSOME 17Q12 DELETION SYNDROME	0.04310083	1.6169772134781875
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 5; OPTB5	0.042956379999999995	1.611558005576926
PSEUDOLEPRECHAUNISM SYNDROME, PATTERSON TYPE	0.042756550000000004	1.6040611532757214
X-LINKED INTELLECTUAL DISABILITY, HEDERA TYPE	0.042756550000000004	1.6040611532757214
H SYNDROME	0.04275482	1.603996250335817
MICROPHTHALMIA WITH LIMB ANOMALIES	0.04275482	1.603996250335817
LAMININ SUBUNIT ALPHA 2-RELATED CONGENITAL MUSCULAR DYSTROPHY	0.0427032	1.6020596666607516
COG2-CDG	0.04221225399999999	1.5836412627681058
DISTAL MONOSOMY 12Q	0.04221225399999999	1.5836412627681058
SPASTIC PARAPLEGIA 52, AUTOSOMAL RECESSIVE	0.04202195399999999	1.5765019393786284
TRICHOTHIODYSTROPHY	0.041856054	1.5702780100548537
KABUKI SYNDROME	0.041727178999999996	1.5654431161934828
INTELLECTUAL DISABILITY-MICROCEPHALY-STRABISMUS-BEHAVIORAL ABNORMALITIES SYNDROME	0.041271154	1.5483348137831487
16P13.11 MICRODELETION SYNDROME	0.040558743999999994	1.5216079331951415
DYSKERATOSIS CONGENITA	0.040545554	1.5211130951735587
MONILETHRIX	0.04	1.50064600934895
TRIOPIA	0.04	1.50064600934895
SPONDYLO-OCULAR SYNDROME	0.04	1.50064600934895
EPIDERMOLYSIS BULLOSA SIMPLEX DUE TO PLAKOPHILIN DEFICIENCY	0.04	1.50064600934895
BÖÖK SYNDROME	0.04	1.50064600934895
VAN DEN ENDE-GUPTA SYNDROME; VDEGS	0.04	1.50064600934895
ACROMICRIC DYSPLASIA	0.04	1.50064600934895
PILI TORTI	0.04	1.50064600934895
ROMBO SYNDROME	0.04	1.50064600934895
PIEBALD TRAIT-NEUROLOGIC DEFECTS SYNDROME	0.04	1.50064600934895
LEUKOMELANODERMA-INFANTILISM-INTELLECTUAL DISABILITY-HYPODONTIA-HYPOTRICHOSIS SYNDROME	0.04	1.50064600934895
MANDIBULOACRAL DYSPLASIA WITH TYPE A LIPODYSTROPHY	0.04	1.50064600934895
ACQUIRED HYPERTRICHOSIS LANUGINOSA	0.04	1.50064600934895
ULERYTHEMA OPHRYOGENESIS	0.04	1.50064600934895
POLYMICROGYRIA WITH OPTIC NERVE HYPOPLASIA	0.03930035	1.474397834837925
EPILEPSY, NOCTURNAL FRONTAL LOBE, 5; ENFL5	0.039272100000000004	1.4733380035938226
NON-DISTAL MONOSOMY 20Q	0.038972359	1.4620928752066158
MENINGIOMA	0.03853262	1.4455955608189883
POLYMICROGYRIA, BILATERAL TEMPOROOCCIPITAL; BTOP	0.038521299999999994	1.4451708779983423
14Q11.2 MICRODELETION SYNDROME	0.03843094	1.4417809186632233
FOCAL FACIAL DERMAL DYSPLASIA TYPE III	0.03843094	1.4417809186632233
EPILEPSY, JUVENILE MYOCLONIC, SUSCEPTIBILITY TO, 10; EJM10	0.037883259999999995	1.4212340735032174
MACROTHROMBOCYTOPENIA-LYMPHEDEMA-DEVELOPMENTAL DELAY-FACIAL DYSMORPHISM-CAMPTODACTYLY SYNDROME	0.037799913	1.4181072149296874
TAKENOUCHI-KOSAKI SYNDROME; TKS	0.037799913	1.4181072149296874
NEURODEVELOPMENTAL DISORDER WITH PROGRESSIVE MICROCEPHALY, SPASTICITY, AND BRAIN ANOMALIES; NDMSBA	0.037582554	1.4099527420310354
LISSENCEPHALY 2; LIS2	0.037582554	1.4099527420310354
MYOCLONUS AND ATAXIA	0.037037	1.3894856562064266
SEVERE ACHONDROPLASIA-DEVELOPMENTAL DELAY-ACANTHOSIS NIGRICANS SYNDROME	0.037037	1.3894856562064266
CORPUS CALLOSUM AGENESIS-MACROCEPHALY-HYPERTELORISM SYNDROME	0.037037	1.3894856562064266
EPILEPSY, PROGRESSIVE MYOCLONIC, 4, WITH OR WITHOUT RENAL FAILURE; EPM4	0.037037	1.3894856562064266
ADULT-ONSET AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA	0.037037	1.3894856562064266
MITOCHONDRIAL DNA DEPLETION SYNDROME, MYOPATHIC FORM	0.037037	1.3894856562064266
CANAVAN DISEASE	0.037037	1.3894856562064266
MCLEOD SYNDROME; MCLDS	0.037037	1.3894856562064266
SHORT STATURE WITH MICROCEPHALY AND DISTINCTIVE FACIES; SSMCF	0.03692799	1.3853960206694482
SKRABAN-DEARDORFF SYNDROME; SKDEAS	0.036916502999999996	1.3849650726517133
SEVERE INTELLECTUAL DISABILITY-POOR LANGUAGE-STRABISMUS-GRIMACING FACE-LONG FINGERS SYNDROME	0.036752714	1.378820339921082
AMISH INFANTILE EPILEPSY SYNDROME	0.03639365	1.3653496409535604
AU-KLINE SYNDROME; AUKS	0.036375083999999995	1.3646531161083209
MILLER-DIEKER LISSENCEPHALY SYNDROME; MDLS	0.03568276	1.3386797849139085
LELIS SYNDROME	0.03568276	1.3386797849139085
FEBRILE SEIZURES, FAMILIAL, 8; FEB8	0.03566625	1.3380603932735495
JUVENILE ABSENCE EPILEPSY	0.03566625	1.3380603932735495
EPILEPSY, CHILDHOOD ABSENCE, SUSCEPTIBILITY TO, 1; ECA1	0.03566625	1.3380603932735495
PEHO SYNDROME	0.03555847399999999	1.3340170526659596
DUBOWITZ SYNDROME	0.035554339	1.3338619233847433
XQ25 DUPLICATION SYNDROME	0.035492423	1.3315390734268722
HYPOTRICHOSIS-LYMPHEDEMA-TELANGIECTASIA-RENAL DEFECT SYNDROME; HLTRS	0.035446544	1.3298178699702992
ALPERS-HUTTENLOCHER SYNDROME	0.035365604	1.3267813127703816
HAMAMY SYNDROME; HMMS	0.03523429	1.3218549170185905
ECTODERMAL DYSPLASIA 1, HYPOHIDROTIC, X-LINKED; XHED	0.03490099	1.3093507841456902
PSEUDOPROGERIA SYNDROME	0.03490099	1.3093507841456902
CARDIOFACIOCUTANEOUS SYNDROME 1; CFC1	0.034843859000000005	1.3072074489666876
JUVENILE NEURONAL CEROID LIPOFUSCINOSIS	0.034820050000000005	1.3063142269457728
%613608 EPILEPSY, FAMILIAL ADULT MYOCLONIC, 3; FAME3;;CORTICAL MYOCLONIC TREMOR WITH EPILEPSY, FAMILIAL, 3; FCMTE3	0.034820050000000005	1.3063142269457728
GLOBAL DEVELOPMENTAL DELAY-NEURO-OPHTHALMOLOGICAL ABNORMALITIES-SEIZURES-INTELLECTUAL DISABILITY SYNDROME	0.034614804	1.2986141871749017
DOORS SYNDROME	0.034614804	1.2986141871749017
CRANIOFACIAL DYSMORPHISM, SKELETAL ANOMALIES, AND MENTAL RETARDATION SYNDROME	0.03434453	1.2884745471866323
3P25.3 MICRODELETION SYNDROME	0.0342031	1.2831686380590768
CEROID LIPOFUSCINOSIS, NEURONAL, 8, NORTHERN EPILEPSY VARIANT	0.034069249999999995	1.2781471013502927
PROGRESSIVE EPILEPSY-INTELLECTUAL DISABILITY SYNDROME, FINNISH TYPE	0.034069249999999995	1.2781471013502927
SEVERE FEEDING DIFFICULTIES-FAILURE TO THRIVE-MICROCEPHALY DUE TO ASXL3 DEFICIENCY SYNDROME	0.033917913	1.2724695197223719
COFFIN-LOWRY SYNDROME; CLS	0.033207769	1.2458276507307942
ABLEPHARON MACROSTOMIA SYNDROME	0.032983614	1.237418218075154
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SEVERE SPEECH AND AMBULATION DEFECTS; IDDSSAD	0.032803653999999995	1.2306668116790926
SLC35A2-CDG	0.032803653999999995	1.2306668116790926
OMPHALOCELE SYNDROME, SHPRINTZEN-GOLDBERG TYPE	0.032803653999999995	1.2306668116790926
TUBEROUS SCLEROSIS-1	0.032799519	1.2305116823978766
TUBEROUS SCLEROSIS 2; TSC2	0.032799519	1.2305116823978766
POTOCKI-SHAFFER SYNDROME	0.032799519	1.2305116823978766
212067 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE I/IIX;;CDG-X	0.032799519	1.2305116823978766
FBLN1-RELATED DEVELOPMENTAL DELAY-CENTRAL NERVOUS SYSTEM ANOMALY-SYNDACTYLY SYNDROME	0.0322581	1.2101997258544839
ALG13-CDG	0.0322581	1.2101997258544839
HYPOHIDROSIS-ENAMEL HYPOPLASIA-PALMOPLANTAR KERATODERMA-INTELLECTUAL DISABILITY SYNDROME	0.0322581	1.2101997258544839
WEST SYNDROME	0.0322581	1.2101997258544839
TRICHODERMODYSPLASIA-DENTAL ALTERATIONS SYNDROME	0.0322581	1.2101997258544839
19Q13.11 MICRODELETION SYNDROME	0.0322581	1.2101997258544839
ECTODERMAL DYSPLASIA 11B, HYPOHIDROTIC/HAIR/TOOTH TYPE, AUTOSOMAL RECESSIVE; ECTD11B	0.0322581	1.2101997258544839
FOCAL FACIAL DERMAL DYSPLASIA TYPE I	0.0322581	1.2101997258544839
257960 OCULOTRICHODYSPLASIA; OTD	0.0322581	1.2101997258544839
WOOLLY HAIR	0.0322581	1.2101997258544839
DUBOWITZ SYNDROME	0.0322581	1.2101997258544839
BLEPHARONASOFACIAL MALFORMATION SYNDROME	0.0322581	1.2101997258544839
NEURODEGENERATION DUE TO 3-HYDROXYISOBUTYRYL-COA HYDROLASE DEFICIENCY	0.0322581	1.2101997258544839
ICHTHYOSIS--CHEEK--EYEBROW SYNDROME	0.0322581	1.2101997258544839
ULNAR-MAMMARY SYNDROME; UMS	0.0322581	1.2101997258544839
AROMATIC L-AMINO ACID DECARBOXYLASE DEFICIENCY	0.031894783999999995	1.1965695082161685
SAY-BARBER-MILLER SYNDROME	0.031882153999999996	1.1960956792387165
YUNIS-VARON SYNDROME	0.031440324	1.1795199185809504
EPILEPSY, IDIOPATHIC GENERALIZED	0.031226909999999997	1.1715134468949704
MENTAL RETARDATION, AUTOSOMAL DOMINANT 13	0.031226080000000003	1.1714823084902766
CONTRACTURES-DEVELOPMENTAL DELAY-PIERRE ROBIN SYNDROME	0.030753990000000002	1.1537713091264379
LEUKODYSTROPHY, HYPOMYELINATING, 12	0.03059843	1.1479352967960799
FOCAL FACIAL DERMAL DYSPLASIA TYPE IV	0.030532620000000003	1.1454663589491985
EDINBURGH MALFORMATION SYNDROME	0.030532620000000003	1.1454663589491985
X-LINKED NON-SYNDROMIC INTELLECTUAL DISABILITY	0.030513204	1.1447379453762605
IFAP SYNDROME WITH OR WITHOUT BRESHECK SYNDROME	0.030360473000000002	1.1390080662349136
METACHROMATIC LEUKODYSTROPHY	0.029846799000000004	1.1197369952797558
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND THIN CORPUS CALLOSUM; PEBAT	0.029822163000000002	1.118812747402598
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 10; GEFSP10	0.029710972999999995	1.1146413266581099
CARDIOFACIOCUTANEOUS SYNDROME	0.029532364	1.1079406045810147
ECTODERMAL DYSPLASIA-INTELLECTUAL DISABILITY-CENTRAL NERVOUS SYSTEM MALFORMATION SYNDROME	0.0294589	1.1051845181202444
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, SEIZURES, AND ABSENT LANGUAGE; NDHSAL	0.029319583000000003	1.099957880618133
MACROCEPHALY, DYSMORPHIC FACIES, AND PSYCHOMOTOR RETARDATION; MDFPMR	0.029005553000000003	1.0881766839602367
XQ25 MICRODUPLICATION SYNDROME	0.028998913	1.0879275767226848
HOLOPROSENCEPHALY	0.028880573000000003	1.0834879155040258
15Q13.3 MICRODELETION SYNDROME	0.028864773000000003	1.0828951603303332
CONGENITAL CATARACT-MICROCEPHALY-NEVUS FLAMMEUS SIMPLEX-SEVERE INTELLECTUAL DISABILITY SYNDROME	0.028828139000000003	1.081520793682671
FEBRILE CONVULSIONS, FAMILIAL, 9	0.028623999999999997	1.0738622842901084
%614280 EPILEPSY, JUVENILE MYOCLONIC, SUSCEPTIBILITY TO, 9; EJM9	0.028623999999999997	1.0738622842901084
CRANIOFACIAL DYSPLASIA-SHORT STATURE-ECTODERMAL ANOMALIES-INTELLECTUAL DISABILITY SYNDROME	0.028557083	1.0713518160649185
CONGENITAL HYPOTHYROIDISM	0.028390484	1.0651016629521304
BEHAVIORAL VARIANT OF FRONTOTEMPORAL DEMENTIA	0.028347630000000002	1.0634939458500143
EPILEPSY, PYRIDOXINE-DEPENDENT	0.028341363999999997	1.0632588696526497
SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.028341363999999997	1.0632588696526497
RARS-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.028323354000000002	1.0625832037869405
POLYMICROGYRIA DUE TO TUBB2B MUTATION	0.028323354000000002	1.0625832037869405
BRACHMANN-DE LANGE-LIKE FACIAL CHANGES WITH MICROCEPHALY, METATARSUSADDUCTUS, AND DEVELOPMENTAL DELAY	0.028323354000000002	1.0625832037869405
MENKES DISEASE	0.028319219000000003	1.0624280745057242
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 67; EIEE67	0.028178494	1.0571486142640834
VASCULAR EHLERS-DANLOS SYNDROME	0.028074854	1.0532604404538601
JACOBSEN SYNDROME	0.027914203	1.0472334334026623
GONADAL DYSGENESIS, DYSMORPHIC FACIES, RETINAL DYSTROPHY, AND MYOPATHY; GDRM	0.02791194	1.0471485343546831
CHST3-RELATED SKELETAL DYSPLASIA	0.02791194	1.0471485343546831
NASAL GROOVE, FAMILIAL TRANSVERSE	0.027777800000000002	1.0421161179623317
EPILEPSY, NOCTURNAL FRONTAL LOBE, TYPE 1	0.027777800000000002	1.0421161179623317
CONGENITAL ICHTHYOSIS-MICROCEPHALUS-TETRAPLEGIA SYNDROME	0.027777800000000002	1.0421161179623317
212540 CATARACT, MICROCEPHALY, FAILURE TO THRIVE, KYPHOSCOLIOSIS SYNDROME;;CAMFAK SYNDROMECATARACT, MICROCEPHALY, ARTHROGRYPOSIS, KYPHOSIS SYNDROME, INCLUDED;;CAMAK SYNDROME, INCLUDED	0.027777800000000002	1.0421161179623317
PERIVENTRICULAR NODULAR HETEROTOPIA	0.027777800000000002	1.0421161179623317
FEBRILE INFECTION-RELATED EPILEPSY SYNDROME	0.027777800000000002	1.0421161179623317
208081 ARTHROGRYPOSIS, DISTAL, WITH MENTAL RETARDATION AND CHARACTERISTICFACIES	0.027777800000000002	1.0421161179623317
NASAL ALAR COLLAPSE, BILATERAL	0.027777800000000002	1.0421161179623317
FIBULAR DIMELIA-DIPLOPODIA SYNDROME	0.027777800000000002	1.0421161179623317
SPEECH-LANGUAGE DISORDER 1	0.027777800000000002	1.0421161179623317
TESTICULAR REGRESSION SYNDROME	0.027777800000000002	1.0421161179623317
211930 CAMPTODACTYLY WITH FIBROUS TISSUE HYPERPLASIA AND SKELETAL DYSPLASIA	0.027777800000000002	1.0421161179623317
WAARDENBURG SYNDROME, TYPE IIB	0.027777800000000002	1.0421161179623317
CYANIDE, INABILITY TO SMELL	0.027777800000000002	1.0421161179623317
NASAL BONES, ABSENCE OF	0.027777800000000002	1.0421161179623317
FALLOT COMPLEX WITH SEVERE MENTAL AND GROWTH RETARDATION	0.027777800000000002	1.0421161179623317
OPHTHALMOPLEGIA, FAMILIAL TOTAL, WITH IRIS TRANSILLUMINATION	0.027777800000000002	1.0421161179623317
OSTEOPENIA AND SPARSE HAIR	0.027777800000000002	1.0421161179623317
%135750 LAURIN-SANDROW SYNDROME;;LSS;;SANDROW SYNDROME;;MIRROR HANDS AND FEET WITH NASAL DEFECTS;;TETRAMELIC MIRROR-IMAGE POLYDACTYLY; TMIP;;MIRROR-IMAGE POLYDACTYLY; MIP;;FIBULA AND ULNA, DUPLICATION OF, WITH ABSENCE OF TIBIA AND RADIUSLAURIN-SANDROW SYNDROME, SEGMENTAL, INCLUDED	0.027777800000000002	1.0421161179623317
LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 7; FPLD7	0.027777800000000002	1.0421161179623317
CUTIS LAXA, AUTOSOMAL DOMINANT 1; ADCL1	0.027777800000000002	1.0421161179623317
22Q11.2 DISTAL DELETION SYNDROME	0.027777800000000002	1.0421161179623317
15Q24 RECURRENT MICRODELETION SYNDROME	0.027777800000000002	1.0421161179623317
GROWTH HORMONE DEFICIENCY, ISOLATED, TYPE IA	0.027777800000000002	1.0421161179623317
DIMPLES, FACIAL	0.027777800000000002	1.0421161179623317
GANGLIOCYTOMA	0.027777800000000002	1.0421161179623317
CLEFT CHIN	0.027777800000000002	1.0421161179623317
OROFACIAL CLEFT 3	0.027777800000000002	1.0421161179623317
SPONDYLOMETAPHYSEAL DYSPLASIA, KOZLOWSKI TYPE	0.027777800000000002	1.0421161179623317
DWARFISM, LEVI TYPE	0.027777800000000002	1.0421161179623317
PALATAL ANOMALIES-WIDELY SPACED TEETH-FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY SYNDROME	0.027660994	1.0377340065181313
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 47	0.027572554	1.0344160781914606
MITOCHONDRIAL MYOPATHY WITH LACTIC ACIDOSIS; MMLA	0.027568419	1.0342609489102443
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM TYPE II	0.027318963	1.0249023201375405
PILI TORTI-DEVELOPMENTAL DELAY-NEUROLOGICAL ABNORMALITIES SYNDROME	0.027249634000000002	1.0223013629579867
APNEA, OBSTRUCTIVE SLEEP	0.027027	1.0139489923668517
BENIGN OCCIPITAL EPILEPSY	0.027027	1.0139489923668517
FOCAL CORTICAL DYSPLASIA OF TAYLOR	0.027027	1.0139489923668517
EPILEPSY, FAMILIAL TEMPORAL LOBE, 8; ETL8	0.027027	1.0139489923668517
OCULOMAXILLOFACIAL DYSOSTOSIS	0.02668046	1.0009481456648572
AREDYLD SYNDROME	0.02668046	1.0009481456648572
INTELLECTUAL DISABILITY-POLYDACTYLY-UNCOMBABLE HAIR SYNDROME	0.02668046	1.0009481456648572
GAPO SYNDROME; GAPOS	0.026554019	0.996204566113155
3-METHYLGLUTACONIC ACIDURIA, TYPE IX; MGCA9	0.026402654	0.9905259340330274
ADRENOLEUKODYSTROPHY	0.026398519000000002	0.9903708047518109
RESTRICTIVE DERMOPATHY, LETHAL	0.02623199	0.9841232777695391
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR	0.026010619999999998	0.9758183275922996
JABERI-ELAHI SYNDROME; JABELS	0.025990633000000003	0.9750684922975783
AUTOSOMAL DOMINANT CEREBELLAR ATAXIA-DEAFNESS-NARCOLEPSY SYNDROME	0.0258571	0.9700588482084185
CRANIOECTODERMAL DYSPLASIA 2; CED2	0.025709314	0.9645144864299772
CHROMOSOME 18Q DELETION SYNDROME	0.025648209	0.9622220620699456
RECESSIVE INTELLECTUAL DISABILITY-MOTOR DYSFUNCTION-MULTIPLE JOINT CONTRACTURES SYNDROME	0.02556845	0.9592298114434539
BRACHYDACTYLY-SHORT STATURE-RETINITIS PIGMENTOSA SYNDROME	0.025545554	0.9583708416677028
CRANIOSYNOSTOSIS-ANAL ANOMALIES-POROKERATOSIS SYNDROME	0.025545554	0.9583708416677028
NICOLAIDES-BARAITSER SYNDROME; NCBRS	0.025541419000000003	0.9582157123864864
ECTODERMAL DYSPLASIA SYNDROME	0.025541419000000003	0.9582157123864864
MICROCEPHALIC PRIMORDIAL DWARFISM, ALAZAMI TYPE	0.025256709000000002	0.9475344892534429
OROFACIAL CLEFT 15	0.02516376	0.9440474006053683
COMBINED IMMUNODEFICIENCY-ENTEROPATHY SPECTRUM	0.025	0.9379037558430938
HIDROTIC ECTODERMAL DYSPLASIA, HALAL TYPE	0.025	0.9379037558430938
SPASTIC PARAPLEGIA WITH NEUROPATHY AND POIKILODERMA	0.025	0.9379037558430938
HIDROTIC ECTODERMAL DYSPLASIA, CHRISTIANSON-FOURIE TYPE	0.025	0.9379037558430938
ABLEPHARON-MACROSTOMIA SYNDROME	0.025	0.9379037558430938
ALOPECIA UNIVERSALIS	0.025	0.9379037558430938
ABSENT EYEBROWS AND EYELASHES WITH MENTAL RETARDATION	0.025	0.9379037558430938
ARTHROGRYPOSIS AND ECTODERMAL DYSPLASIA	0.025	0.9379037558430938
LMNA-RELATED CARDIOCUTANEOUS PROGERIA SYNDROME	0.025	0.9379037558430938
%147770 JOHNSON NEUROECTODERMAL SYNDROME;;JOHNSON-MCMILLIN SYNDROME; JMS;;ALOPECIA-ANOSMIA-DEAFNESS-HYPOGONADISM SYNDROME;;AADH SYNDROME	0.025	0.9379037558430938
PORPHYRIA, CONGENITAL ERYTHROPOIETIC; CEP	0.025	0.9379037558430938
KERATOSIS FOLLICULARIS-DWARFISM-CEREBRAL ATROPHY SYNDROME	0.025	0.9379037558430938
ROTHMUND-THOMSON SYNDROME TYPE 2	0.025	0.9379037558430938
HYPOTRICHOSIS-LYMPHEDEMA-TELANGIECTASIA-RENAL DEFECT SYNDROME	0.025	0.9379037558430938
HYPOTRICHOSIS-LYMPHEDEMA-TELANGIECTASIA SYNDROME; HLTS	0.025	0.9379037558430938
601375 ECTODERMAL DYSPLASIA, HIDROTIC, CHRISTIANSON-FOURIE TYPE	0.025	0.9379037558430938
ROTHMUND-THOMSON SYNDROME TYPE 1	0.025	0.9379037558430938
JOHNSON NEUROECTODERMAL SYNDROME	0.025	0.9379037558430938
KERATOSIS FOLLICULARIS, DWARFISM, AND CEREBRAL ATROPHY	0.025	0.9379037558430938
PARC SYNDROME	0.025	0.9379037558430938
EEM SYNDROME	0.025	0.9379037558430938
PILI TORTI-ONYCHODYSPLASIA SYNDROME	0.025	0.9379037558430938
BARTSOCAS-PAPAS SYNDROME; BPS	0.025	0.9379037558430938
2Q37 MICRODELETION SYNDROME	0.024858963	0.9326125905625802
RESTRICTIVE DERMOPATHY	0.02471529	0.9272225327100503
METHYLCOBALAMIN DEFICIENCY TYPE CBLE	0.024317899000000004	0.9123139522525205
CHROMOSOME 19Q13.11 DELETION SYNDROME, DISTAL	0.024145143999999997	0.9058328497188936
TRISOMY 20P	0.02381279	0.8933642071241146
DISTAL XQ28 MICRODUPLICATION SYNDROME	0.023801354	0.8929351724300417
BONE MARROW FAILURE SYNDROME 3; BMFS3	0.023801354	0.8929351724300417
OGDEN SYNDROME	0.023801354	0.8929351724300417
ALOPECIA-INTELLECTUAL DISABILITY SYNDROME	0.023797219	0.8927800431488253
CRONKHITE-CANADA SYNDROME	0.023797219	0.8927800431488253
AYMÉ-GRIPP SYNDROME	0.023588194	0.8849382298462211
KNOBLOCH SYNDROME	0.023296239	0.8739852022047343
INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME DUE TO SETD5 HAPLOINSUFFICIENCY	0.023296099999999997	0.8739799874598516
SCHÖPF-SCHULZ-PASSARGE SYNDROME	0.0232558	0.8724680866054327
X-LINKED MANDIBULOFACIAL DYSOSTOSIS	0.0232558	0.8724680866054327
SHORT-RIB THORACIC DYSPLASIA 7 WITH OR WITHOUT POLYDACTYLY; SRTD7	0.0232558	0.8724680866054327
FRONTOFACIONASAL DYSPLASIA	0.0232558	0.8724680866054327
HYPOTRICHOSIS 12; HYPT12	0.0232558	0.8724680866054327
ECTODERMAL DYSPLASIA 8, HAIR/TOOTH/NAIL TYPE	0.0232558	0.8724680866054327
HYPOHIDROTIC ECTODERMAL DYSPLASIA	0.0232558	0.8724680866054327
CRANDALL SYNDROME	0.0232558	0.8724680866054327
ECTODERMAL DYSPLASIA, TRICHOODONTOONYCHIAL TYPE	0.0232558	0.8724680866054327
WOODHOUSE-SAKATI SYNDROME	0.0232558	0.8724680866054327
ATYPICAL WERNER SYNDROME	0.0232558	0.8724680866054327
MARIE UNNA HEREDITARY HYPOTRICHOSIS	0.0232558	0.8724680866054327
NAGER SYNDROME	0.0232558	0.8724680866054327
HYPOTRICHOSIS 11; HYPT11	0.0232558	0.8724680866054327
HYPOTRICHOSIS AND RECURRENT SKIN VESICLES	0.0232558	0.8724680866054327
KID SYNDROME	0.0232558	0.8724680866054327
PSEUDOPELADE OF BROCQ	0.0232558	0.8724680866054327
OMENN SYNDROME	0.0232558	0.8724680866054327
ALOPECIA ANTIBODY DEFICIENCY	0.0232558	0.8724680866054327
ALPHA-THALASSEMIA-INTELLECTUAL DISABILITY SYNDROME LINKED TO CHROMOSOME 16	0.0232558	0.8724680866054327
X-LINKED HYPOHIDROTIC ECTODERMAL DYSPLASIA	0.0232558	0.8724680866054327
AGNATHIA-HOLOPROSENCEPHALY-SITUS INVERSUS SYNDROME	0.0232558	0.8724680866054327
BARTSOCAS-PAPAS SYNDROME	0.0232558	0.8724680866054327
LAMELLAR ICHTHYOSIS	0.0232558	0.8724680866054327
PATERNAL 20Q13.2Q13.3 MICRODELETION SYNDROME	0.0232558	0.8724680866054327
BARBER-SAY SYNDROME	0.0232558	0.8724680866054327
ACROFRONTOFACIONASAL DYSOSTOSIS	0.0232558	0.8724680866054327
VATER-LIKE DEFECTS WITH PULMONARY HYPERTENSION, LARYNGEAL WEBS, AND GROWTH DEFICIENCY	0.02297619	0.8619781958385814
PROXIMAL 16P11.2 MICRODUPLICATION SYNDROME	0.022826073000000002	0.8563463839139455
MONOSOMY 9P	0.022554323	0.846151370087931
MITOCHONDRIAL DNA DEPLETION SYNDROME 4B (MNGIE TYPE); MTDPS4B	0.022515503000000003	0.8446949931358579
GENERALIZED EPILEPSY-PAROXYSMAL DYSKINESIA SYNDROME	0.022513204	0.8446087435064704
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 15; EIG15	0.022513204	0.8446087435064704
PAROXYSMAL NONKINESIGENIC DYSKINESIA, 3, WITH OR WITHOUT GENERALIZED EPILEPSY; PNKD3	0.022513204	0.8446087435064704
INTELLECTUAL DISABILITY-STRABISMUS SYNDROME	0.022485283000000002	0.8435612550757946
CEREBELLAR-FACIAL-DENTAL SYNDROME	0.022284654	0.8360344273705529
ICHTHYOSIS-ALOPECIA-ECLABION-ECTROPION-INTELLECTUAL DISABILITY SYNDROME	0.022284654	0.8360344273705529
ABNORMAL HAIR, JOINT LAXITY, AND DEVELOPMENTAL DELAY; HJDD	0.022284654	0.8360344273705529
RETINITIS PIGMENTOSA WITH OR WITHOUT SKELETAL ANOMALIES	0.022284654	0.8360344273705529
DEVELOPMENTAL DELAY WITH SHORT STATURE, DYSMORPHIC FEATURES, AND SPARSE HAIR	0.022284654	0.8360344273705529
3-METHYLGLUTACONIC ACIDURIA, TYPE I; MGCA1	0.022244154	0.8345150232860871
PAGANINI-MIOZZO SYNDROME; MRXSPM	0.022244154	0.8345150232860871
COGNITIVE IMPAIRMENT-COARSE FACIES-HEART DEFECTS-OBESITY-PULMONARY INVOLVEMENT-SHORT STATURE-SKELETAL DYSPLASIA SYNDROME	0.022159674	0.8313456589143422
NEURODEVELOPMENTAL DISORDER WITH SPASTICITY AND POOR GROWTH; NEDSG	0.021969949000000003	0.824227907311249
MYOCLONIC EPILEPSY OF UNVERRICHT AND LUNDBORG	0.02196765	0.8241416576818615
RIDDLE SYNDROME	0.021850934000000002	0.8197629226911822
NEURODEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND DISTAL LIMB ANOMALIES; NEDDFL	0.021827314	0.8188767912226617
KERATOSIS PILARIS ATROPHICANS; KPA	0.0217391	0.815567341545944
GABRIELE-DE VRIES SYNDROME	0.0217391	0.815567341545944
MACROCEPHALY, ACQUIRED, WITH IMPAIRED INTELLECTUAL DEVELOPMENT; MACID	0.0217391	0.815567341545944
FRONTONASAL DYSPLASIA-SEVERE MICROPHTHALMIA-SEVERE FACIAL CLEFTING SYNDROME	0.0217391	0.815567341545944
ACROFACIAL DYSOSTOSIS, PALAGONIA TYPE	0.0217391	0.815567341545944
FOCAL FACIAL DERMAL DYSPLASIA TYPE II	0.0217391	0.815567341545944
CRANIOFRONTONASAL DYSPLASIA-POLAND ANOMALY SYNDROME	0.0217391	0.815567341545944
HYPOTRICHOSIS 1; HYPT1	0.0217391	0.815567341545944
HYPOTRICHOSIS 10; HYPT10	0.0217391	0.815567341545944
TOOTH AGENESIS, SELECTIVE, 8; STHAG8	0.0217391	0.815567341545944
NASOPALPEBRAL LIPOMA-COLOBOMA SYNDROME	0.0217391	0.815567341545944
LIMB-MAMMARY SYNDROME	0.0217391	0.815567341545944
TOOTH AGENESIS, SELECTIVE, 4	0.0217391	0.815567341545944
NEURODEVELOPMENTAL DELAY-SEIZURES-OPHTHALMIC ANOMALIES-OSTEOPENIA-CEREBELLAR ATROPHY SYNDROME	0.02170111	0.8141421029985647
PEROXISOME BIOGENESIS DISORDER 6B	0.021567214	0.8091188405468701
CORNELIA DE LANGE SYNDROME	0.021560299	0.808859416368004
NEPHROPATHIC INFANTILE CYSTINOSIS	0.02142853	0.8039159507678565
OCULODENTODIGITAL DYSPLASIA; ODDD	0.021374709000000002	0.8018967940461271
INTELLECTUAL DISABILITY-COARSE FACE-MACROCEPHALY-CEREBELLAR HYPOTROPHY SYNDROME	0.021374709000000002	0.8018967940461271
POLYGLUCOSAN BODY NEUROPATHY, ADULT FORM	0.021305380000000002	0.7992958368665734
SPASTIC PARAPLEGIA 64, AUTOSOMAL RECESSIVE; SPG64	0.021305380000000002	0.7992958368665734
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 64	0.021305380000000002	0.7992958368665734
%300660 LEUKOENCEPHALOPATHY WITH METAPHYSEAL CHONDRODYSPLASIA; LKMCD	0.021305380000000002	0.7992958368665734
PROGRESSIVE MYOCLONIC EPILEPSY WITH DYSTONIA	0.021299114	0.7990607606692087
INTELLECTUAL DISABILITY-DYSMORPHISM-HYPOGONADISM-DIABETES MELLITUS SYNDROME	0.021286404	0.7985839303997381
19P13.3 MICRODUPLICATION SYNDROME	0.021240244	0.7968521849049495
HYDROCEPHALUS, SKELETAL ANOMALIES, AND MENTAL DISTURBANCE	0.021157474000000003	0.7937469731501043
LISSENCEPHALY 5; LIS5	0.021153339	0.7935918438688877
PALLISTER-KILLIAN SYNDROME	0.021116759	0.7922195030933381
AUTOSOMAL RECESSIVE PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA	0.02102166	0.7886517547222612
INTELLECTUAL DISABILITY-FEEDING DIFFICULTIES-DEVELOPMENTAL DELAY-MICROCEPHALY SYNDROME	0.02101888	0.7885474598246114
ERYTHERMALGIA, PRIMARY	0.02081283	0.7808172570689528
FEBRILE SEIZURES, FAMILIAL, 11; FEB11	0.020740849999999998	0.7781168445751292
MEDIUM CHAIN ACYL-COA DEHYDROGENASE DEFICIENCY	0.020740849999999998	0.7781168445751292
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 4; GEFSP4	0.020740849999999998	0.7781168445751292
HYPERPHOSPHATASIA-INTELLECTUAL DISABILITY SYNDROME	0.020633584	0.7740926372041587
NEONATAL LUPUS ERYTHEMATOSUS	0.02061192	0.7732798873254951
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 5; MDDGA5	0.02061192	0.7732798873254951
MICROPHTHALMIA WITH CYST, BILATERAL FACIAL CLEFTS, AND LIMB ANOMALIES	0.020545554	0.770790090499084
NEVUS COMEDONICUS SYNDROME	0.020541419	0.7706349612178676
GYRATE ATROPHY OF CHOROID AND RETINA	0.020541419	0.7706349612178676
KABUKI SYNDROME 1	0.020136993000000002	0.7554624546434436
ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 2	0.02	0.750323004674475
HAIR WHORL	0.02	0.750323004674475
CHONDROECTODERMAL DYSPLASIA WITH NIGHT BLINDNESS	0.02	0.750323004674475
HAIRY NOSE TIP	0.02	0.750323004674475
MANITOBA OCULOTRICHOANAL SYNDROME	0.02	0.750323004674475
SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 6	0.02	0.750323004674475
DISSECTING CELLULITIS OF THE SCALP	0.02	0.750323004674475
ICHTHYOSIS, SPLIT HAIRS, AND AMINO ACIDURIA	0.02	0.750323004674475
ANTERIOR CHAMBER CLEAVAGE DISORDER, CEREBELLAR HYPOPLASIA, HYPOTHYROIDISM, AND TRACHEAL STENOSIS	0.02	0.750323004674475
ALPORT SYNDROME-INTELLECTUAL DISABILITY-MIDFACE HYPOPLASIA-ELLIPTOCYTOSIS SYNDROME	0.02	0.750323004674475
138920 GRANDDAD SYNDROME;;GROWTH RETARDATION, AGED FACIES, NORMAL DEVELOPMENT, DECREASED SUBCUTANEOUSFAT, AUTOSOMAL DOMINANT INHERITANCE	0.02	0.750323004674475
EPIDERMOLYSIS BULLOSA ACQUISITA	0.02	0.750323004674475
VAN BOGAERT-HOZAY SYNDROME	0.02	0.750323004674475
INFANTILE MYOFIBROMATOSIS	0.02	0.750323004674475
AUTOSOMAL DOMINANT HYPER-IGE SYNDROME	0.02	0.750323004674475
MIDPHALANGEAL HAIR	0.02	0.750323004674475
STRIATE PALMOPLANTAR KERATODERMA	0.02	0.750323004674475
WERNER SYNDROME; WRN	0.02	0.750323004674475
JUVENILE HYALINE FIBROMATOSIS	0.02	0.750323004674475
PREMATURE AGING SYNDROME, OKAMOTO TYPE	0.02	0.750323004674475
FAMILIAL MELANOMA	0.02	0.750323004674475
%152800 LYMPHANGIECTASIA, INTESTINAL	0.02	0.750323004674475
AMELOONYCHOHYPOHIDROTIC SYNDROME	0.02	0.750323004674475
611426 TENTED EYEBROWS	0.02	0.750323004674475
HERMANSKY-PUDLAK SYNDROME 1; HPS1	0.02	0.750323004674475
BLEPHAROPHIMOSIS, PTOSIS, AND EPICANTHUS INVERSUS	0.02	0.750323004674475
DARIER DISEASE	0.02	0.750323004674475
TRICHODISCOMAS, FAMILIAL MULTIPLE	0.02	0.750323004674475
FAMILIAL MALE-LIMITED PRECOCIOUS PUBERTY	0.02	0.750323004674475
RED SKIN PIGMENT ANOMALY OF NEW GUINEA	0.02	0.750323004674475
RINGED HAIR	0.02	0.750323004674475
ALBINISM, OCULOCUTANEOUS, TYPE VI; OCA6	0.02	0.750323004674475
CATATRICHY	0.02	0.750323004674475
SCALP-EAR-NIPPLE SYNDROME; SENS	0.02	0.750323004674475
TRICHODENTOOSSEOUS SYNDROME	0.02	0.750323004674475
PSEUDOVAGINAL PERINEOSCROTAL HYPOSPADIAS; PPSH	0.02	0.750323004674475
INHERITED EPIDERMOLYSIS BULLOSA	0.02	0.750323004674475
HYPERTELORISM, TEEBI TYPE	0.01991604	0.7471731487008515
KAUFMAN OCULOCEREBROFACIAL SYNDROME; KOS	0.01987327	0.7455685829553551
RUBINSTEIN-TAYBI SYNDROME 1; RSTS1	0.019755389	0.7411461416496536
KLEEFSTRA SYNDROME	0.019632243	0.7365261778129715
3-METHYLGLUTACONIC ACIDURIA TYPE 9	0.0194943	0.7313510875012809
1Q44 MICRODELETION SYNDROME	0.019143623999999998	0.7181950740019195
CORNELIA DE LANGE SYNDROME 2; CDLS2	0.019129662999999998	0.7176713110285066
MARSHALL-SMITH SYNDROME; MRSHSS	0.01911954	0.7172915350396906
SALT-AND-PEPPER SYNDROME	0.019082104	0.7158870804395409
X-LINKED INTELLECTUAL DISABILITY DUE TO GRIA3 MUTATIONS	0.019082104	0.7158870804395409
SALT AND PEPPER DEVELOPMENTAL REGRESSION SYNDROME; SPDRS	0.019082104	0.7158870804395409
GAUCHER DISEASE	0.01905633	0.7149201391834169
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIK	0.018944073000000002	0.7107086887066298
LISSENCEPHALY 1; LIS1	0.018944073000000002	0.7107086887066298
ACYL-COA DEHYDROGENASE, SHORT-CHAIN, DEFICIENCY OF	0.018944073000000002	0.7107086887066298
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 15; COXPD15	0.018944073000000002	0.7107086887066298
3-HYDROXY-3-METHYLGLUTARYL-COA LYASE DEFICIENCY; HMGCLD	0.018944073000000002	0.7107086887066298
ACROOSTEOLYSIS DOMINANT TYPE	0.01889817	0.708986584862451
HAREL-YOON SYNDROME; HAYOS	0.018895613999999998	0.7088906935824537
ALAZAMI-YUAN SYNDROME	0.018588244	0.6973593544851141
GOLDBERG-SHPRINTZEN SYNDROME	0.018588244	0.6973593544851141
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 61; MRT61	0.018588244	0.6973593544851141
ACROMEGALOID FACIAL APPEARANCE SYNDROME	0.018584108999999998	0.6972042252038976
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 18; GPIBD18	0.018553023000000002	0.6960379981577323
EPILEPSY, NOCTURNAL FRONTAL LOBE, 2; ENFL2	0.01853655	0.6954199946149319
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 6	0.018490529999999998	0.6936935013811759
MICROCEPHALY-LYMPHEDEMA-CHORIORETINOPATHY SYNDROME	0.018440704	0.6918242216796304
GABRIELE-DE VRIES SYNDROME; GADEVS	0.018402654	0.6903967321632373
AUTOSOMAL SPASTIC PARAPLEGIA TYPE 58	0.018402654	0.6903967321632373
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 33; MC1DN33	0.018402654	0.6903967321632373
LIPOYLTRANSFERASE 1 DEFICIENCY; LIPT1D	0.018402654	0.6903967321632373
JUVENILE HUNTINGTON DISEASE	0.018398519000000002	0.6902416028820209
PRADER-WILLI SYNDROME	0.018398519000000002	0.6902416028820209
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 2; PEBEL2	0.018398519000000002	0.6902416028820209
MERCURY POISONING	0.018398519000000002	0.6902416028820209
MEGALENCEPHALY WITH DYSMYELINATION	0.018398519000000002	0.6902416028820209
DEVELOPMENTAL DELAY WITH OR WITHOUT DYSMORPHIC FACIES AND AUTISM; DEDDFA	0.018122532999999996	0.6798876706436162
22Q11.2 DELETION SYNDROME	0.018087573	0.6785761060314454
BLEPHAROPHIMOSIS-PTOSIS-ESOTROPIA-SYNDACTYLY-SHORT STATURE SYNDROME	0.01804269	0.6768922686605051
COFFIN-SIRIS SYNDROME 1; CSS1	0.017994733000000002	0.6750931066437466
AUTISM SPECTRUM DISORDER DUE TO AUTS2 DEFICIENCY	0.017934163	0.6728207534240898
49,XYYYY SYNDROME	0.0178571	0.6699296463386284
MITOCHONDRIAL NEUROGASTROINTESTINAL ENCEPHALOMYOPATHY	0.0178571	0.6699296463386284
49,XXXYY SYNDROME	0.0178571	0.6699296463386284
CONGENITAL MUSCULAR DYSTROPHY WITHOUT INTELLECTUAL DISABILITY	0.0178571	0.6699296463386284
PROGRESSIVE NON-FLUENT APHASIA	0.0178571	0.6699296463386284
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 5A	0.0178571	0.6699296463386284
ATAXIA-PANCYTOPENIA SYNDROME	0.0178571	0.6699296463386284
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 4; SCAR4	0.0178571	0.6699296463386284
SPASTIC PARAPLEGIA TYPE 7	0.0178571	0.6699296463386284
VPS11-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.017815584	0.6683721258455251
DYRK1A-RELATED INTELLECTUAL DISABILITY SYNDROME	0.017692434	0.663752011944242
MENTAL RETARDATION, AUTOSOMAL DOMINANT 7	0.017688299	0.6635968826630256
GAPO SYNDROME	0.01733905	0.6504944047100478
EPILEPSY, PROGRESSIVE MYOCLONIC, 10	0.01725926	0.6475009910828989
DISCRIMINATION, TWO-POINT, REDUCTION IN	0.0172414	0.6468309526397247
SICKLE CELL ANEMIA	0.0172414	0.6468309526397247
141405 HEMIFACIAL SPASM, FAMILIAL	0.0172414	0.6468309526397247
THUMBS, CONGENITAL CLASPED	0.0172414	0.6468309526397247
SPATIAL VISUALIZATION, APTITUDE FOR	0.0172414	0.6468309526397247
CONGENITAL TRACHEAL STENOSIS	0.0172414	0.6468309526397247
MODIFIER, X-LINKED, FOR NEUROFUNCTIONAL DEFECTS	0.0172414	0.6468309526397247
ASPARAGUS, SPECIFIC SMELL HYPERSENSITIVITY	0.0172414	0.6468309526397247
304950 DYGGVE-MELCHIOR-CLAUSEN SYNDROME, X-LINKED	0.0172414	0.6468309526397247
ALCOHOL DEPENDENCE	0.0172414	0.6468309526397247
COCHLEOSACCULAR DEGENERATION OF THE INNER EAR WITH PROGRESSIVE CATARACTS	0.0172414	0.6468309526397247
CERVICAL RIB	0.0172414	0.6468309526397247
CARDIAC ARRHYTHMIA	0.0172414	0.6468309526397247
600416 MUSCULAR DYSTROPHY, SCAPULOHUMERAL	0.0172414	0.6468309526397247
ANDROSTENONE, ABILITY TO SMELL	0.0172414	0.6468309526397247
GRANULOMAS, CONGENITAL CEREBRAL	0.0172414	0.6468309526397247
ANKYLOBLEPHARON-ECTODERMAL DEFECTS-CLEFT LIP/PALATE	0.0172414	0.6468309526397247
%600511 SCHIZOPHRENIA 3; SCZD3;;SCHIZOPHRENIA SUSCEPTIBILITY LOCUS, CHROMOSOME 6-RELATED	0.0172414	0.6468309526397247
TRANSSEXUALITY	0.0172414	0.6468309526397247
ENDOCARDIAL FIBROELASTOSIS	0.0172414	0.6468309526397247
VESTIBULOCOCHLEAR DYSFUNCTION, PROGRESSIVE	0.0172414	0.6468309526397247
MOTION SICKNESS	0.0172414	0.6468309526397247
%160700 MYOPIA 2, AUTOSOMAL DOMINANT; MYP2	0.0172414	0.6468309526397247
SPASTIC PSEUDOSCLEROSIS	0.0172414	0.6468309526397247
PALMOMENTAL REFLEX	0.0172414	0.6468309526397247
PERONEAL NERVE, ACCESSORY DEEP	0.0172414	0.6468309526397247
POLYCYSTIC LIVER DISEASE 1 WITH OR WITHOUT KIDNEY CYSTS; PCLD1	0.0172414	0.6468309526397247
THROMBOPHILIA, HEREDITARY, DUE TO PROTEIN C DEFICIENCY, AUTOSOMALDOMINANT	0.0172414	0.6468309526397247
RHEUMATOID ARTHRITIS	0.0172414	0.6468309526397247
190400 TRIGEMINAL NEURALGIA;;TIC DOULOUREUX	0.0172414	0.6468309526397247
NEUROVISCERAL STORAGE DISEASE WITH CURVILINEAR BODIES	0.0172414	0.6468309526397247
MYOPATHY, CONGENITAL	0.0172414	0.6468309526397247
%609939 SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 6; SLEB6	0.0172414	0.6468309526397247
206600 ANHIDROSIS, FAMILIAL GENERALIZED, WITH ABNORMAL OR ABSENT SWEAT GLANDS	0.0172414	0.6468309526397247
ARTHROGRYPOSIS MULTIPLEX CONGENITA WITH WHISTLING FACE	0.0172414	0.6468309526397247
GLUTATHIONE SYNTHETASE DEFICIENCY	0.0172414	0.6468309526397247
CEREBRAL ANGIOPATHY, DYSPHORIC	0.0172414	0.6468309526397247
PANCREATIC TRIACYLGLYCEROL LIPASE DEFICIENCY	0.0172414	0.6468309526397247
CEREBRAL SCLEROSIS SIMILAR TO PELIZAEUS-MERZBACHER DISEASE	0.0172414	0.6468309526397247
JUMPING FRENCHMAN OF MAINE	0.0172414	0.6468309526397247
MOSAIC TRISOMY 15	0.0172414	0.6468309526397247
INTRINSIC FACTOR AND R BINDER, COMBINED CONGENITAL DEFICIENCY OF	0.0172414	0.6468309526397247
HYPEREOSINOPHILIC SYNDROME, IDIOPATHIC	0.0172414	0.6468309526397247
DIASTEMATOMYELIA	0.0172414	0.6468309526397247
223300 DISSEMINATED SCLEROSIS WITH NARCOLEPSY	0.0172414	0.6468309526397247
TRICARBOXYLIC ACID CYCLE, DEFECT OF	0.0172414	0.6468309526397247
269800 SENILE PLAQUE FORMATION	0.0172414	0.6468309526397247
NOVELTY SEEKING PERSONALITY TRAIT	0.0172414	0.6468309526397247
MEDIAN-ULNAR NERVE COMMUNICATIONS	0.0172414	0.6468309526397247
COGNITIVE FUNCTION 1, SOCIAL	0.0172414	0.6468309526397247
601668 SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH ABNORMAL DENTITION; SEMDAD	0.0172414	0.6468309526397247
MERALGIA PARAESTHETICA, FAMILIAL	0.0172414	0.6468309526397247
8Q24.3 MICRODELETION SYNDROME	0.017177983	0.6444517909403525
15Q24 MICRODELETION SYNDROME	0.017160803000000002	0.6438072634793373
MITOCHONDRIAL DNA-RELATED CARDIOMYOPATHY AND HEARING LOSS	0.01714688	0.6432849261196331
FANCONI ANEMIA	0.017139284	0.6429999534424578
2P15P16.1 MICRODELETION SYNDROME	0.017059384	0.6400024130387832
HALLERMANN-STREIFF SYNDROME; HSS	0.01694324	0.6356451372860376
9P13 MICRODELETION SYNDROME	0.01693985	0.6355179575367452
SMITH-MAGENIS SYNDROME	0.016907683000000003	0.6343111755321772
PERMANENT NEONATAL DIABETES MELLITUS	0.016847064000000002	0.632036984021159
TRANSIENT NEONATAL DIABETES MELLITUS	0.016847064000000002	0.632036984021159
ZIMMERMANN-LABAND SYNDROME 1	0.016684769	0.6259483004189768
8Q22.1 MICRODELETION SYNDROME	0.016619384	0.6234953069359448
NABLUS MASK-LIKE FACIAL SYNDROME; NMLFS	0.016619384	0.6234953069359448
WIEDEMANN-STEINER SYNDROME; WDSTS	0.016528253	0.6200764226489953
DESANTO-SHINAWI SYNDROME	0.016528253	0.6200764226489953
HYPERPHOSPHATASIA WITH MENTAL RETARDATION	0.016465169	0.6177097538276511
KRABBE DISEASE	0.016417654	0.6159271739492956
EEC SYNDROME	0.0163945	0.6150585250067839
BRANCHIOSKELETOGENITAL SYNDROME	0.016364099	0.6139179965235285
WRINKLY SKIN SYNDROME	0.016313354	0.6120142394799183
SPASTIC ATAXIA 5, AUTOSOMAL RECESSIVE	0.016301509999999998	0.6115698981965499
MYOCLONIC EPILEPSY, JUVENILE, SUSCEPTIBILITY TO, 4; EJM4	0.016301509999999998	0.6115698981965499
HERMANSKY-PUDLAK SYNDROME 10; HPS10	0.016301509999999998	0.6115698981965499
EARLY-ONSET SPASTIC ATAXIA-MYOCLONIC EPILEPSY-NEUROPATHY SYNDROME	0.016301509999999998	0.6115698981965499
EPILEPSY, FAMILIAL ADULT MYOCLONIC, 1; FAME1	0.016301509999999998	0.6115698981965499
SCHUURS-HOEIJMAKERS SYNDROME; SHMS	0.016207583	0.6080461187535471
JOUBERT SYNDROME WITH HEPATIC DEFECT	0.016081919	0.6033316892505765
SIMOSA CRANIOFACIAL SYNDROME	0.01607383	0.6030282211113358
FLAT FACE-MICROSTOMIA-EAR ANOMALY SYNDROME	0.01607383	0.6030282211113358
SPONDYLOEPIPHYSEAL DYSPLASIA WITH CONGENITAL JOINT DISLOCATIONS	0.01607383	0.6030282211113358
CHROMOSOME 3PTER-P25 DELETION SYNDROME	0.016060813	0.6025398733837435
MACROCEPHALY-SPASTIC PARAPLEGIA-DYSMORPHISM SYNDROME	0.015859549	0.5949892229231033
DEVELOPMENTAL DELAY, INTELLECTUAL DISABILITY, OBESITY, AND DYSMORPHIC FEATURES; DIDOD	0.015840064	0.5942582207357991
MENTAL RETARDATION, AUTOSOMAL DOMINANT 44; MRD44	0.015835929	0.5941030914545826
CLEFT PALATE, PSYCHOMOTOR RETARDATION, AND DISTINCTIVE FACIAL FEATURES	0.015666164	0.5877341622101546
2Q23.1 MICRODELETION SYNDROME	0.015662029	0.5875790329289382
AUTOSOMAL RECESSIVE FRONTOTEMPORAL PACHYGYRIA	0.015587804	0.58479439667784
FOUNTAIN SYNDROME	0.015575829	0.5843451407787912
INSULIN-LIKE GROWTH FACTOR I, RESISTANCE TO; IGF1RES	0.015519393999999999	0.5822279168403509
HYPERINSULINISM-HYPERAMMONEMIA SYNDROME	0.015470953999999999	0.5804106345230293
MEGALOBLASTIC ANEMIA DUE TO DIHYDROFOLATE REDUCTASE DEFICIENCY	0.015470953999999999	0.5804106345230293
DEFICIENCY IN ANTERIOR PITUITARY FUNCTION-VARIABLE IMMUNODEFICIENCY SYNDROME	0.015470953999999999	0.5804106345230293
MENTAL RETARDATION, X-LINKED 41	0.015470953999999999	0.5804106345230293
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 21; MC1DN21	0.015470953999999999	0.5804106345230293
FONTAINE PROGEROID SYNDROME; FPS	0.01538085	0.5770302793223699
MICROTRIPLICATION 11Q24.1	0.01529451	0.5737911349111903
PARTIAL DELETION OF THE SHORT ARM OF CHROMOSOME 7	0.01529451	0.5737911349111903
AMYLOIDOSIS, HEREDITARY, TRANSTHYRETIN-RELATED	0.015277409	0.5731495712260434
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 27; COXPD27	0.015204414	0.5704110798397327
FUMARASE DEFICIENCY; FMRD	0.015204414	0.5704110798397327
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IAA	0.015204414	0.5704110798397327
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 58; EIEE58	0.015204414	0.5704110798397327
EVEN-PLUS SYNDROME	0.015070924	0.5654030489450328
INTELLECTUAL DISABILITY-EPILEPSY-EXTRAPYRAMIDAL SYNDROME	0.01506573	0.5652081900607189
AMAUROSIS CONGENITA, CONE-ROD TYPE, WITH CONGENITAL HYPERTRICHOSIS	0.01503441	0.5640331842353987
AMAUROSIS-HYPERTRICHOSIS SYNDROME	0.01503441	0.5640331842353987
MYOCLONIC-ATONIC EPILEPSY	0.014925399999999998	0.5599435486984203
NIEMANN-PICK DISEASE TYPE B	0.014925399999999998	0.5599435486984203
PAROXYSMAL EXERTION-INDUCED DYSKINESIA	0.014925399999999998	0.5599435486984203
AUTISM SPECTRUM DISORDER-EPILEPSY-ARTHROGRYPOSIS SYNDROME	0.014925399999999998	0.5599435486984203
CHROMOSOME XP11.23-P11.22 DUPLICATION SYNDROME	0.014925399999999998	0.5599435486984203
OCULODENTODIGITAL DYSPLASIA	0.014852418999999999	0.557205582538213
MICROPHTHALMIA WITH LINEAR SKIN DEFECTS SYNDROME	0.014794673999999999	0.5550392124429666
FG SYNDROME TYPE 1	0.014662913	0.550096046972021
ALPHA-METHYLACYL-COA RACEMASE DEFICIENCY; AMACRD	0.01465886	0.5499439940151237
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 53; EIEE53	0.01465886	0.5499439940151237
PETERS-PLUS SYNDROME; PTRPLS	0.014516142999999999	0.5445898016022174
HIRSCHSPRUNG DISEASE, CARDIAC DEFECTS, AND AUTONOMIC DYSFUNCTION	0.014470489999999999	0.5428770767955972
MICROGNATHIA-RECURRENT INFECTIONS-BEHAVIORAL ABNORMALITIES-MILD INTELLECTUAL DISABILITY SYNDROME	0.014463313	0.5426078233853697
TALL STATURE-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.014284619	0.5359039124355047
DESMOSTEROLOSIS	0.014249119999999999	0.5345721266183577
GLOBAL DEVELOPMENTAL DELAY, PROGRESSIVE ATAXIA, AND ELEVATED GLUTAMINE; GDPAG	0.014244153999999998	0.534385821416297
POSTNATAL MICROCEPHALY-INFANTILE HYPOTONIA-SPASTIC DIPLEGIA-DYSARTHRIA-INTELLECTUAL DISABILITY SYNDROME	0.014244153999999998	0.534385821416297
MENTAL RETARDATION, AUTOSOMAL DOMINANT 51; MRD51	0.014244153999999998	0.534385821416297
MACS SYNDROME	0.01417449	0.531772296326415
PETERS PLUS SYNDROME	0.014163094	0.5313447622783514
ROIFMAN-CHITAYAT SYNDROME	0.014078314	0.5281641430615363
VISCERAL NEUROPATHY-BRAIN ANOMALIES-FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY SYNDROME	0.014017974	0.5259004185564335
WILLIAMS SYNDROME	0.01398568	0.5246888720007856
BRACHYMORPHISM-ONYCHODYSPLASIA-DYSPHALANGISM SYNDROME	0.0137432	0.5155919558921123
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 24; EIEE24	0.013698599999999998	0.5139187355916881
CONGENITAL CEREBELLAR ATAXIA DUE TO RNU12 MUTATION	0.013698599999999998	0.5139187355916881
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 70; MRT70	0.013698599999999998	0.5139187355916881
ABETA AMYLOIDOSIS, ARCTIC TYPE	0.013698599999999998	0.5139187355916881
MENTAL RETARDATION, X-LINKED 77	0.013698599999999998	0.5139187355916881
EPILEPSY, HOT WATER, 1	0.013698599999999998	0.5139187355916881
609438 MENTAL RETARDATION, KERATOCONUS, FEBRILE SEIZURES, AND SINOATRIALBLOCK	0.013698599999999998	0.5139187355916881
KEPPEN-LUBINSKY SYNDROME; KPLBS	0.013698599999999998	0.5139187355916881
EPILEPSY, FAMILIAL TEMPORAL LOBE, 6; ETL6	0.013698599999999998	0.5139187355916881
OLIVER SYNDROME	0.01353576	0.5078096056876287
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 6	0.01353276	0.5076970572369274
MUCOPOLYSACCHARIDOSIS, TYPE VII; MPS7	0.013521829999999999	0.5072870057148727
MULTIPLE SULFATASE DEFICIENCY	0.013499863	0.5064628884426886
JOUBERT SYNDROME	0.013462913	0.5050766666915525
JOUBERT SYNDROME WITH RENAL DEFECT	0.013462913	0.5050766666915525
JOUBERT SYNDROME WITH OCULAR DEFECT	0.013462913	0.5050766666915525
OGDEN SYNDROME; OGDNS	0.013422734	0.5035693052913117
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE I	0.013418599	0.5034141760100952
FRONTONASAL DYSPLASIA 2; FND2	0.01332565	0.49992708736202085
YUNIS-VARON SYNDROME	0.01332565	0.49992708736202085
TETRASOMY 12P	0.01332565	0.49992708736202085
CEREBROOCULONASAL SYNDROME	0.01332565	0.49992708736202085
16Q24.3 MICRODELETION SYNDROME	0.013303478999999998	0.499095316795189
TENORIO SYNDROME; TNORS	0.013238028999999998	0.4966398847623917
SEVERE INTELLECTUAL DISABILITY-CORPUS CALLOSUM AGENESIS-FACIAL DYSMORPHISM-CEREBELLAR ATAXIA SYNDROME	0.013211904	0.4956597753375357
MENTAL RETARDATION, AUTOSOMAL DOMINANT 26	0.013211904	0.4956597753375357
CHAR SYNDROME	0.013211904	0.4956597753375357
CHROMOSOME 9P DELETION SYNDROME	0.013119244	0.4921835288568789
20Q13.33 MICRODELETION SYNDROME	0.013115109	0.4920283995756624
MICROCEPHALY, FACIAL DYSMORPHISM, RENAL AGENESIS, AND AMBIGUOUS GENITALIA SYNDROME; MFRG	0.013115109	0.4920283995756624
CARTILAGE-HAIR HYPOPLASIA	0.01306555	0.49016913668622936
HALLERMANN-STREIFF SYNDROME	0.01306555	0.49016913668622936
MICROCEPHALY, SEIZURES, SPASTICITY, AND BRAIN CALCIFICATIONS; MISSBC	0.012969374	0.48656098342135073
X-LINKED INTELLECTUAL DISABILITY-GLOBAL DEVELOPMENT DELAY-FACIAL DYSMORPHISM-SACRAL CAUDAL REMNANT SYNDROME	0.012956823	0.48609011821976716
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 5	0.012956823	0.48609011821976716
KBG SYNDROME	0.012956823	0.48609011821976716
LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 2; LSDMCA2	0.012859144	0.48242557818108733
ADNP SYNDROME	0.012814919	0.4807664264370009
GAUCHER DISEASE TYPE 3	0.01270754	0.4767379797410539
SPINAL MUSCULAR ATROPHY-PROGRESSIVE MYOCLONIC EPILEPSY SYNDROME	0.01270754	0.4767379797410539
BRACHYCEPHALY, TRICHOMEGALY, AND DEVELOPMENTAL DELAY; BTDD	0.01266635	0.47519268951292676
PTOSIS-UPPER OCULAR MOVEMENT LIMITATION-ABSENCE OF LACRIMAL PUNCTUM SYNDROME	0.01266635	0.47519268951292676
CEREBROOCULONASAL SYNDROME	0.01265581	0.47479726928946336
11P15.4 MICRODUPLICATION SYNDROME	0.012636153	0.4740598143243191
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC DEFECTS AND DYSMORPHIC FACIES; IDDCDF	0.012636152999999999	0.47405981432431904
CORNELIA DE LANGE SYNDROME 5; CDLS5	0.012636152999999999	0.47405981432431904
CAMPTODACTYLY SYNDROME, GUADALAJARA TYPE 1	0.012636152999999999	0.47405981432431904
HYPERPROLINEMIA, TYPE I	0.012581272999999999	0.4720009279994922
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 24; COXPD24	0.012581272999999999	0.4720009279994922
HYPERTELORISM, TEEBI TYPE; TBHS	0.01257369	0.47171644303226995
17Q21.31 MICRODUPLICATION SYNDROME	0.012415404000000001	0.4657781616763748
12Q14 MICRODELETION SYNDROME	0.012415404000000001	0.4657781616763748
HOLOPROSENCEPHALY 11	0.012415404000000001	0.4657781616763748
ELSAHY-WATERS SYNDROME; ESWS	0.012415404000000001	0.4657781616763748
RADIOULNAR SYNOSTOSIS-MICROCEPHALY-SCOLIOSIS SYNDROME	0.012415404000000001	0.4657781616763748
GINGIVAL FIBROMATOSIS-HYPERTRICHOSIS SYNDROME	0.012411269	0.46562303239515834
WIEDEMANN-STEINER SYNDROME	0.012411268999999999	0.46562303239515823
FACIAL DYSMORPHISM-MACROCEPHALY-MYOPIA-DANDY-WALKER MALFORMATION SYNDROME	0.012411268999999999	0.46562303239515823
17Q24.2 MICRODELETION SYNDROME	0.012411268999999999	0.46562303239515823
NON-DISTAL MONOSOMY 10Q	0.01224928	0.4595458287349476
INTELLECTUAL DISABILITY-CATARACTS-CALCIFIED PINNAE-MYOPATHY SYNDROME	0.012120859	0.45472796720578257
SPASTIC PARAPLEGIA 44, AUTOSOMAL RECESSIVE; SPG44	0.012112849	0.4544274628424104
HOLOPROSENCEPHALY 5; HPE5	0.012101374	0.45399696501847847
TEMTAMY PREAXIAL BRACHYDACTYLY SYNDROME	0.012094734	0.4537478577809266
CORNELIA DE LANGE SYNDROME 1	0.012090598999999999	0.4535927284997101
20P13 MICRODELETION SYNDROME	0.012090598999999999	0.4535927284997101
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 64; EIEE64	0.012039854	0.45168897145609976
UNDETERMINED EARLY-ONSET EPILEPTIC ENCEPHALOPATHY	0.012039854	0.45168897145609976
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 38; EIEE38	0.012039854	0.45168897145609976
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 1	0.012039854	0.45168897145609976
RING CHROMOSOME 14 SYNDROME	0.012039854	0.45168897145609976
BETA-UREIDOPROPIONASE DEFICIENCY	0.012039854	0.45168897145609976
ALTERNATING HEMIPLEGIA OF CHILDHOOD 2	0.012039854	0.45168897145609976
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 68; EIEE68	0.012039854	0.45168897145609976
CLASSIC GLUCOSE TRANSPORTER TYPE 1 DEFICIENCY SYNDROME	0.012039854	0.45168897145609976
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIH	0.012039854	0.45168897145609976
PYRIDOXINE-DEPENDENT EPILEPSY	0.012039854	0.45168897145609976
PERLMAN SYNDROME	0.012039854	0.45168897145609976
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT SEIZURES AND GAIT ABNORMALITIES; NEDSGA	0.012039854	0.45168897145609976
MICROCEPHALY, PROGRESSIVE, WITH SEIZURES AND CEREBRAL AND CEREBELLAR ATROPHY	0.012039854	0.45168897145609976
PYRIDOXAL PHOSPHATE-RESPONSIVE SEIZURES	0.012039854	0.45168897145609976
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 56; EIEE56	0.012039854	0.45168897145609976
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 16; EIEE16	0.012039854	0.45168897145609976
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 48	0.012039854	0.45168897145609976
PEHO-LIKE SYNDROME; PEHOL	0.012039854	0.45168897145609976
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 50; EIEE50	0.012039854	0.45168897145609976
EPILEPSY, PROGRESSIVE MYOCLONIC, 9; EPM9	0.012039854	0.45168897145609976
DYSKINESIA, SEIZURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER	0.012039854	0.45168897145609976
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 35	0.012039854	0.45168897145609976
HYDROCEPHALUS, NORMAL-PRESSURE	0.011993834	0.44996247822234386
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 1; NBIA1	0.011993834	0.44996247822234386
POLYCYSTIC LIPOMEMBRANOUS OSTEODYSPLASIA WITH SCLEROSING LEUKOENCEPHALOPATHY; PLOSL	0.011989699	0.4498073489411274
INCONTINENTIA PIGMENTI	0.011973313	0.44919260930339755
BRACHYDACTYLY-PREAXIAL HALLUX VARUS SYNDROME	0.011869850000000001	0.4453110758517659
CEREBROFACIOTHORACIC DYSPLASIA	0.011869850000000001	0.4453110758517659
GLOBAL DEVELOPMENTAL DELAY-OSTEOPENIA-ECTODERMAL DEFECT SYNDROME	0.011869850000000001	0.4453110758517659
MANDIBULOFACIAL DYSOSTOSIS WITH MACROBLEPHARON AND MACROSTOMIA	0.011869850000000001	0.4453110758517659
BLEPHAROPHIMOSIS WITH PTOSIS, SYNDACTYLY, AND SHORT STATURE	0.011869850000000001	0.4453110758517659
MÜLLERIAN APLASIA AND HYPERANDROGENISM	0.011869850000000001	0.4453110758517659
NON-DISTAL TRISOMY 13Q	0.011869850000000001	0.4453110758517659
MICROCEPHALY 4, PRIMARY, AUTOSOMAL RECESSIVE; MCPH4	0.011869850000000001	0.4453110758517659
GINGIVAL FIBROMATOSIS-FACIAL DYSMORPHISM SYNDROME	0.011869850000000001	0.4453110758517659
ZIMMERMANN-LABAND SYNDROME 2; ZLS2	0.011869850000000001	0.4453110758517659
228560 FIBROMATOSIS, GINGIVAL, WITH DISTINCTIVE FACIES	0.011869850000000001	0.4453110758517659
PELGER-HUET ANOMALY; PHA	0.011861304	0.44499046283186844
MONOSOMY 22Q13.3	0.011853982999999998	0.4447158070960073
DISTAL MONOSOMY 19P13.3	0.011853982999999998	0.4447158070960073
OCULOCEREBRORENAL SYNDROME OF LOWE	0.011811008999999999	0.44310358805586325
MCDONOUGH SYNDROME	0.01177719	0.441834829371109
PURE AUTONOMIC FAILURE	0.01157143	0.434115506299018
SPINAL MUSCULAR ATROPHY, DISTAL, AUTOSOMAL RECESSIVE, 1; DSMA1	0.01157143	0.434115506299018
OCHOA SYNDROME	0.01157143	0.434115506299018
MICROCEPHALY-CORPUS CALLOSUM AND CEREBELLAR VERMIS HYPOPLASIA-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROM	0.011533313	0.4326855032005592
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 47	0.011494299999999999	0.43122188563149083
X-LINKED SPASTICITY-INTELLECTUAL DISABILITY-EPILEPSY SYNDROME	0.011494299999999999	0.43122188563149083
SEVERE NEURODEGENERATIVE SYNDROME WITH LIPODYSTROPHY	0.011494299999999999	0.43122188563149083
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH EPISODIC RHABDOMYOLYSIS; PEERB	0.011494299999999999	0.43122188563149083
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 14; EIEE14	0.011494299999999999	0.43122188563149083
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 69; EIEE69	0.011494299999999999	0.43122188563149083
ADULT POLYGLUCOSAN BODY DISEASE	0.01144828	0.42949539239773493
FRONTOTEMPORAL DEMENTIA, CHROMOSOME 3-LINKED; FTD3	0.01144828	0.42949539239773493
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4B3; CMT4B3	0.01144828	0.42949539239773493
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 1; IBGC1	0.01144828	0.42949539239773493
CEREBRAL ARTERIOPATHY, AUTOSOMAL RECESSIVE, WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY; CARASIL	0.01144828	0.42949539239773493
SPASTIC PARAPLEGIA 9A, AUTOSOMAL DOMINANT; SPG9A	0.01144828	0.42949539239773493
OROFACIODIGITAL SYNDROME XVIII; OFD18	0.01142466	0.42860926092921436
ALLAN-HERNDON-DUDLEY SYNDROME	0.01142466	0.42860926092921436
EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE, 1; EDSMC1	0.011366674	0.42643384944176166
MUSCULAR PSEUDOHYPERTROPHY-HYPOTHYROIDISM SYNDROME	0.01129321	0.4236777629809914
TETRA-AMELIA WITH ECTODERMAL DYSPLASIA AND LACRIMAL DUCT ABNORMALITIES	0.01126959	0.42279163151247084
SPASTIC PARAPLEGIA 16, X-LINKED	0.01116456	0.4188513102534228
SCHAAF-YANG SYNDROME; SHFYNG	0.011151913	0.4183768435014169
INTELLECTUAL DISABILITY-SEIZURES-MACROCEPHALY-OBESITY SYNDROME	0.011151913	0.4183768435014169
DOWN SYNDROME	0.01114644	0.41817151761118776
EMANUEL SYNDROME	0.011059253	0.4149005970207601
%600325 AMINOPTERIN SYNDROME SINE AMINOPTERIN; ASSA;;PSEUDOAMINOPTERIN SYNDROME	0.010991893999999999	0.41237354665716663
NETHERTON SYNDROME	0.010987963	0.4122260706705979
17Q11.2 MICRODUPLICATION SYNDROME	0.010987963	0.4122260706705979
OSTEOGENESIS IMPERFECTA	0.01088634	0.4084135669353962
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 18	0.010831242999999999	0.4063465396059687
RUBINSTEIN-TAYBI SYNDROME	0.010831242999999999	0.4063465396059687
CRANIOFACIOFRONTODIGITAL SYNDROME	0.01076701	0.403936764728006
HYPERTRICHOTIC OSTEOCHONDRODYSPLASIA, CANTU TYPE	0.01076701	0.403936764728006
PROGEROID SYNDROME, PETTY TYPE	0.01076701	0.403936764728006
NEURAL TUBE DEFECTS, SUSCEPTIBILITY TO; NTD	0.01075482	0.4034794428566569
COFFIN-SIRIS SYNDROME 2; CSS2	0.010745043	0.4031126474558217
COFFIN-SIRIS SYNDROME 3; CSS3	0.010745043	0.4031126474558217
COFFIN-SIRIS SYNDROME 4; CSS4	0.010745043	0.4031126474558217
PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION	0.010725689	0.40238655988419825
OROFACIODIGITAL SYNDROME TYPE 6	0.010708093	0.40172642570468564
AUTOSOMAL RECESSIVE ROBINOW SYNDROME	0.010674349999999999	0.4004605182473491
MELAS	0.01061368	0.3981844134126691
MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIB; MEN2B	0.010610494	0.39806488695802444
NEURODEVELOPMENTAL DISORDER WITH MOVEMENT ABNORMALITIES, ABNORMAL GAIT, AND AUTISTIC FEATURES; NEDMAGA	0.010610494	0.39806488695802444
COFFIN-SIRIS SYNDROME 7; CSS7	0.010610494	0.39806488695802444
TEMPLE-BARAITSER SYNDROME	0.010606359	0.397909757676808
COFFIN-SIRIS SYNDROME 5	0.010556673	0.3960457302362952
MYHRE SYNDROME	0.010556673	0.3960457302362952
CARDIAC-VALVULAR EHLERS-DANLOS SYNDROME	0.010556672999999999	0.39604573023629513
TARP SYNDROME	0.010556672999999999	0.39604573023629513
X-LINKED INTELLECTUAL DISABILITY-SHORT STATURE-OVERWEIGHT SYNDROME	0.01049053	0.393564299511386
MENTAL RETARDATION, X-LINKED, SYNDROMIC, HEDERA TYPE; MRXSH	0.01049053	0.393564299511386
HYDROCEPHALY-TALL STATURE-JOINT LAXITY SYNDROME	0.010476599999999999	0.3930416995386302
5Q14.3 MICRODELETION SYNDROME	0.010459589	0.3924035123070044
CONGENITAL MUSCULAR DYSTROPHY, FUKUYAMA TYPE	0.010454633	0.392217582266446
CEREBELLOFACIODENTAL SYNDROME	0.010446544	0.3919141141272054
CDAGS SYNDROME	0.010446544	0.3919141141272054
ROTHMUND-THOMSON SYNDROME	0.010446544	0.3919141141272054
NETHERTON SYNDROME; NETH	0.010446544	0.3919141141272054
ROSSELLI-GULIENETTI SYNDROME	0.010446544	0.3919141141272054
B4GALT7-RELATED SPONDYLODYSPLASTIC EHLERS-DANLOS SYNDROME	0.010446544	0.3919141141272054
DIAMOND-BLACKFAN ANEMIA 15 WITH MANDIBULOFACIAL DYSOSTOSIS; DBA15	0.010446544	0.3919141141272054
NOONAN SYNDROME 9; NS9	0.010446544	0.3919141141272054
3MC SYNDROME	0.010446339999999998	0.39190646083255776
GOLDBERG-SHPRINTZEN MEGACOLON SYNDROME	0.010442409	0.391758984845989
OHDO SYNDROME	0.010442409	0.391758984845989
PONTOCEREBELLAR HYPOPLASIA TYPE 10	0.010424372999999999	0.3910823435603735
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, KRAKOW TYPE; SEMDK	0.010389413	0.38977077894820256
SPASTIC PARAPLEGIA AND PSYCHOMOTOR RETARDATION WITH OR WITHOUT SEIZURES	0.010346233	0.38815083158111036
ALEXANDER DISEASE	0.010315949	0.38701469248743225
TRISOMY 8P	0.010292329	0.3861285610189117
9Q33.3Q34.11 MICRODELETION SYNDROME	0.010285688999999999	0.38587945378135974
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES, SEIZURES, AND DISTAL LIMB ANOMALIES	0.010236003	0.384015426340847
DISTAL 22Q11.2 MICRODELETION SYNDROME	0.010236003	0.384015426340847
WOLF-HIRSCHHORN SYNDROME	0.010236003	0.384015426340847
SHASHI-PENA SYNDROME; SHAPNS	0.010236003	0.384015426340847
EARLY-ONSET SEIZURES-DISTAL LIMB ANOMALIES-FACIAL DYSMORPHISM-GLOBAL DEVELOPMENTAL DELAY SYNDROME	0.010236003	0.384015426340847
COHEN SYNDROME	0.010199488999999999	0.38264556163121277
BAINBRIDGE-ROPERS SYNDROME; BRPS	0.010138919	0.38037320841155614
SMITH-MAGENIS SYNDROME; SMS	0.010034743	0.3764649259448078
JOUBERT SYNDROME WITH OCULORENAL DEFECT	0.010014633	0.3757104761636076
HYPERTELORISM AND OTHER FACIAL DYSMORPHISM, BRACHYDACTYLY, GENITAL ABNORMALITIES, MENTAL RETARDATION, AND RECURRENT INFLAMMATORY EPISODES	0.00991817	0.3720915557636119
SPONDYLOEPIPHYSEAL DYSPLASIA, CANTU TYPE	0.00991817	0.3720915557636119
MUSCLE-EYE-BRAIN DISEASE	0.009909079	0.37175049644183705
PRIMARY HYPERGONADOTROPIC HYPOGONADISM-PARTIAL ALOPECIA SYNDROME	0.00990099	0.3714470283025965
ECTODERMAL DYSPLASIA, SENSORINEURAL HEARING LOSS, AND DISTINCTIVE FACIAL FEATURES	0.00990099	0.3714470283025965
ECTODERMAL DYSPLASIA 10B, HYPOHIDROTIC/HAIR/TOOTH TYPE, AUTOSOMAL RECESSIVE; ECTD10B	0.00990099	0.3714470283025965
190360 TRICHODYSPLASIA-XERODERMA	0.00990099	0.3714470283025965
ANKYLOBLEPHARON-ECTODERMAL DEFECTS-CLEFT LIP/PALATE SYNDROME	0.00990099	0.3714470283025965
STORM SYNDROME	0.00990099	0.3714470283025965
PALMOPLANTAR KERATODERMA AND WOOLLY HAIR; PPKWH	0.00990099	0.3714470283025965
ECTODERMAL DYSPLASIA, HYPOHIDROTIC, WITH HYPOTHYROIDISM AND CILIARYDYSKINESIA	0.00990099	0.3714470283025965
CLEFT LIP/PALATE-ECTODERMAL DYSPLASIA SYNDROME; CLPED1	0.00990099	0.3714470283025965
ECTODERMAL DYSPLASIA, ECTRODACTYLY, AND MACULAR DYSTROPHY SYNDROME	0.00990099	0.3714470283025965
BAZEX-DUPRÉ-CHRISTOL SYNDROME	0.00990099	0.3714470283025965
HAIR DEFECT WITH PHOTOSENSITIVITY AND MENTAL RETARDATION	0.00990099	0.3714470283025965
HUTCHINSON-GILFORD PROGERIA SYNDROME	0.00990099	0.3714470283025965
NOONAN SYNDROME 4; NS4	0.00990099	0.3714470283025965
ECTODERMAL DYSPLASIA 7, HAIR/NAIL TYPE; ECTD7	0.00990099	0.3714470283025965
ECTODERMAL DYSPLASIA-SYNDACTYLY SYNDROME 1	0.00990099	0.3714470283025965
SKIN FRAGILITY-WOOLLY HAIR SYNDROME; SFWHS	0.00990099	0.3714470283025965
PACHYONYCHIA CONGENITA 2	0.00990099	0.3714470283025965
%129900 ECTRODACTYLY, ECTODERMAL DYSPLASIA, AND CLEFT LIP/PALATE SYNDROME1; EEC1;;EEC;;EEC SYNDROME 1	0.00990099	0.3714470283025965
BARBER-SAY SYNDROME; BBRSAY	0.00990099	0.3714470283025965
NAXOS DISEASE; NXD	0.00990099	0.3714470283025965
ODONTOONYCHODERMAL DYSPLASIA; OODD	0.00990099	0.3714470283025965
HAIR DEFECT-PHOTOSENSITIVITY-INTELLECTUAL DISABILITY SYNDROME	0.00990099	0.3714470283025965
ECTODERMAL DYSPLASIA WITH MENTAL RETARDATION AND SYNDACTYLY	0.00990099	0.3714470283025965
HYPOTRICHOSIS SIMPLEX	0.00990099	0.3714470283025965
MARSHALL SYNDROME	0.00990099	0.3714470283025965
129540 ECTODERMAL DYSPLASIA SYNDROME WITH DISTINCTIVE FACIAL APPEARANCE ANDPREAXIAL POLYDACTYLY OF FEET	0.00990099	0.3714470283025965
ECTRODACTYLY, ECTODERMAL DYSPLASIA, AND CLEFT LIP/PALATE SYNDROME 3; EEC3	0.00990099	0.3714470283025965
NEONATAL ICHTHYOSIS-SCLEROSING CHOLANGITIS SYNDROME	0.00990099	0.3714470283025965
NESTOR-GUILLERMO PROGERIA SYNDROME; NGPS	0.00990099	0.3714470283025965
CHONDRODYSPLASIA PUNCTATA 2, X-LINKED DOMINANT; CDPX2	0.00990099	0.3714470283025965
ECTODERMAL DYSPLASIA WITH NATAL TEETH, TURNPENNY TYPE	0.00990099	0.3714470283025965
HYPOHIDROTIC ECTODERMAL DYSPLASIA-HYPOTHYROIDISM-CILIARY DYSKINESIA SYNDROME	0.00990099	0.3714470283025965
KERATOSIS FOLLICULARIS SPINULOSA DECALVANS, AUTOSOMAL DOMINANT; KFSD	0.00990099	0.3714470283025965
HYPOTRICHOSIS 7; HYPT7	0.00990099	0.3714470283025965
ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 11; ARCI11	0.00990099	0.3714470283025965
MANDIBULOFACIAL DYSOSTOSIS WITH ALOPECIA; MFDA	0.00990099	0.3714470283025965
INTERSTITIAL LUNG DISEASE, NEPHROTIC SYNDROME, AND EPIDERMOLYSIS BULLOSA, CONGENITAL; ILNEB	0.00990099	0.3714470283025965
TRICHODYSPLASIA-XERODERMA SYNDROME	0.00990099	0.3714470283025965
KERATOSIS FOLLICULARIS SPINULOSA DECALVANS, X-LINKED; KFSDX	0.00990099	0.3714470283025965
HIDROTIC ECTODERMAL DYSPLASIA	0.00990099	0.3714470283025965
ODONTO-ONYCHO DYSPLASIA-ALOPECIA SYNDROME	0.00990099	0.3714470283025965
HYPOTRICHOSIS 8; HYPT8	0.00990099	0.3714470283025965
NOONAN SYNDROME 10; NS10	0.00990099	0.3714470283025965
TRICHORHINOPHALANGEAL SYNDROME TYPE 1 AND 3	0.00990099	0.3714470283025965
MARIE UNNA HEREDITARY HYPOTRICHOSIS 1	0.00990099	0.3714470283025965
CARTILAGE-HAIR HYPOPLASIA; CHH	0.00990099	0.3714470283025965
BOHRING-OPITZ SYNDROME	0.009887973	0.3709586805750041
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 7; MC3DN7	0.009887973	0.3709586805750041
2Q23.1 MICRODUPLICATION SYNDROME	0.009882954	0.37077038701698106
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY AND HYPOPLASIA OF THE CORPUS CALLOSUM; NEDEHCC	0.009804814	0.3678388750377179
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 63; MRT63	0.009804814	0.3678388750377179
MENTAL RETARDATION, AUTOSOMAL DOMINANT 55, WITH SEIZURES; MRD55	0.009804814	0.3678388750377179
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 35; COXPD35	0.009804814	0.3678388750377179
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 12; MC1DN12	0.009804814	0.3678388750377179
MICROCEPHALY, EPILEPSY, AND DIABETES SYNDROME	0.009804814	0.3678388750377179
X-LINKED NEURODEGENERATIVE SYNDROME, BERTINI TYPE	0.009804814	0.3678388750377179
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 63; EIEE63	0.009804814	0.3678388750377179
BIOTINIDASE DEFICIENCY	0.009804814	0.3678388750377179
MACROCEPHALY AND EPILEPTIC ENCEPHALOPATHY	0.009804814	0.3678388750377179
HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME	0.009804814	0.3678388750377179
MYOCLONIC EPILEPSY ASSOCIATED WITH RAGGED-RED FIBERS	0.009800679	0.3676837457565014
ATAXIA WITH MYOCLONIC EPILEPSY AND PRESENILE DEMENTIA	0.009800679	0.3676837457565014
HURLER SYNDROME	0.009793884	0.36742882351566325
CHROMOSOME 15Q14 DELETION SYNDROME	0.009694584	0.3637034697974545
8Q12 MICRODUPLICATION SYNDROME	0.009694584	0.3637034697974545
KYPHOSCOLIOTIC EHLERS-DANLOS SYNDROME	0.00964984	0.36202484717139677
PTERYGIUM COLLI-INTELLECTUAL DISABILITY-DIGITAL ANOMALIES SYNDROME	0.0095975	0.3600612518681637
TRISOMY 18P	0.0095975	0.3600612518681637
CHROMOSOME 17P13.1 DELETION SYNDROME	0.009473214	0.3553985196202151
RAINE SYNDROME	0.009473214	0.3553985196202151
JOUBERT SYNDROME 14	0.009473214	0.3553985196202151
PSEUDOAMINOPTERIN SYNDROME	0.009473214	0.3553985196202151
16P12.1P12.3 TRIPLICATION SYNDROME	0.009469700000000001	0.35526668786829385
WAARDENBURG SYNDROME TYPE 3	0.009469700000000001	0.35526668786829385
2Q31.1 MICRODELETION SYNDROME	0.009439503	0.3541338126796861
AL KAISSI SYNDROME; ALKAS	0.009439503	0.3541338126796861
19P13.12 MICRODELETION SYNDROME	0.009439503	0.3541338126796861
X-LINKED INTELLECTUAL DISABILITY-HYPOGAMMAGLOBULINEMIA-PROGRESSIVE NEUROLOGICAL DETERIORATION SYNDROME	0.009366039	0.3513777262189157
MENTAL RETARDATION, AUTOSOMAL DOMINANT 23; MRD23	0.009346554	0.3506467240316116
MENTAL RETARDATION, X-LINKED 21	0.009342419000000001	0.35049159475039526
211910 CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE I; GCS1;;FACIOTHORACOSKELETAL SYNDROME; FTSS	0.009342419	0.35049159475039515
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME	0.009342419	0.35049159475039515
X-LINKED INTELLECTUAL DISABILITY, NASCIMENTO TYPE	0.009342419	0.35049159475039515
KLEEFSTRA SYNDROME	0.009342419	0.35049159475039515
JOUBERT SYNDROME 3; JBTS3	0.0093374	0.35030330119237213
GLYCINE ENCEPHALOPATHY	0.00925926	0.34737178921310896
HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME	0.00925926	0.34737178921310896
XQ12-Q13.3 DUPLICATION SYNDROME	0.00925926	0.34737178921310896
SPINAL MUSCULAR ATROPHY WITH PROGRESSIVE MYOCLONIC EPILEPSY	0.00925926	0.34737178921310896
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 1; EIEE1	0.00925926	0.34737178921310896
PAINE SYNDROME	0.00925926	0.34737178921310896
MYOCLONIC EPILEPSY, HARTUNG TYPE	0.00925926	0.34737178921310896
MICROHYDRANENCEPHALY; MHAC	0.00925926	0.34737178921310896
CARNOSINEMIA	0.00925926	0.34737178921310896
CARNOSINASE DEFICIENCY	0.00925926	0.34737178921310896
310370 MYOCLONIC EPILEPSY, PROGRESSIVE	0.00925926	0.34737178921310896
HYDROXYLYSINURIA	0.00925926	0.34737178921310896
DEAFNESS, CONGENITAL, AND FAMILIAL MYOCLONIC EPILEPSY	0.00925926	0.34737178921310896
%235830 HISTIDINURIA DUE TO A RENAL TUBULAR DEFECT	0.00925926	0.34737178921310896
EPILEPSY, PROGRESSIVE MYOCLONIC, 3, WITH OR WITHOUT INTRACELLULAR INCLUSIONS	0.00925926	0.34737178921310896
SEIZURES-INTELLECTUAL DISABILITY DUE TO HYDROXYLYSINURIA SYNDROME	0.00925926	0.34737178921310896
GAUCHER DISEASE TYPE 2	0.00925926	0.34737178921310896
MERRF	0.00925926	0.34737178921310896
ADULT NEURONAL CEROID LIPOFUSCINOSIS	0.00925926	0.34737178921310896
MULTIPLE JOINT DISLOCATIONS, SHORT STATURE, AND CRANIOFACIAL DYSMORPHISM WITH OR WITHOUT CONGENITAL HEART DEFECTS	0.009248329999999999	0.3469617376910543
X-LINKED INTELLECTUAL DISABILITY-CRANIOFACIOSKELETAL SYNDROME	0.00915567	0.3434854912103975
PSEUDOTRISOMY 13 SYNDROME	0.00915567	0.3434854912103975
17Q23.1Q23.2 MICRODELETION SYNDROME	0.009149029999999999	0.34323638397284556
CATEL-MANZKE SYNDROME	0.009149029999999999	0.34323638397284556
3MC SYNDROME 1	0.009149029999999999	0.34323638397284556
METACHROMATIC LEUKODYSTROPHY DUE TO SAPOSIN B DEFICIENCY	0.009086973	0.3409082442377914
AUTOSOMAL DOMINANT CHARCOT-MARIE-TOOTH DISEASE TYPE 2Z	0.009086973	0.3409082442377914
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 77	0.009086973	0.3409082442377914
SPINOCEREBELLAR ATAXIA TYPE 13	0.009086973	0.3409082442377914
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, X-LINKED; ATRX	0.008931903	0.33509061482104785
FETAL TRIMETHADIONE SYNDROME	0.008898084	0.33382185613629356
17Q12 MICRODUPLICATION SYNDROME	0.008893949	0.33366672685507714
NON-RHIZOMELIC CHONDRODYSPLASIA PUNCTATA	0.008801	0.3301796382070027
SIDERIUS X-LINKED MENTAL RETARDATION SYNDROME; MRXSSD	0.008801	0.3301796382070027
GASTROCUTANEOUS SYNDROME	0.008801	0.3301796382070027
IMMUNODEFICIENCY 49; IMD49	0.008785132999999999	0.32958436945124414
EDINBURGH MALFORMATION SYNDROME	0.008672579	0.32536177667783767
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2Z; CMT2Z	0.008545554	0.32059628769439896
SPASTIC PARAPLEGIA 48, AUTOSOMAL RECESSIVE; SPG48	0.008545554	0.32059628769439896
CURRARINO SYNDROME	0.008545554	0.32059628769439896
OKAMOTO SYNDROME	0.008545554	0.32059628769439896
SPASTIC PARAPLEGIA 35, AUTOSOMAL RECESSIVE	0.008541419	0.3204411584131825
HUNTINGTON DISEASE-LIKE 3	0.008541419	0.3204411584131825
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 9A	0.008541419	0.3204411584131825
ENCEPHALITIS LETHARGICA	0.008541419	0.3204411584131825
METACHROMATIC LEUKODYSTROPHY, LATE INFANTILE FORM	0.008541419	0.3204411584131825
CHILDHOOD DISINTEGRATIVE DISORDER	0.008541419	0.3204411584131825
%604802 HUNTINGTON DISEASE-LIKE 3; HDL3;;HUNTINGTON DISEASE-LIKE NEURODEGENERATIVE DISORDER, AUTOSOMAL RECESSIVE	0.008541419	0.3204411584131825
METACHROMATIC LEUKODYSTROPHY, ADULT FORM	0.008541419	0.3204411584131825
METACHROMATIC LEUKODYSTROPHY, JUVENILE FORM	0.008541419	0.3204411584131825
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 35	0.008541419	0.3204411584131825
SPASTIC PARAPLEGIA 6, AUTOSOMAL DOMINANT	0.008541419	0.3204411584131825
COG5-CDG	0.008541419	0.3204411584131825
NEURODEVELOPMENTAL DISORDER AND LANGUAGE DELAY WITH OR WITHOUT STRUCTURAL BRAIN ABNORMALITIES; NEDLBA	0.008525033	0.31982641877545265
CONGENITAL HYPOTHYROIDISM DUE TO MATERNAL INTAKE OF ANTITHYROID DRUGS	0.008390484	0.3147786582776554
CONGENITAL HYPOTHYROIDISM DUE TO TRANSPLACENTAL PASSAGE OF TSH-BINDING INHIBITORY ANTIBODIES	0.008390484	0.3147786582776554
PRIMARY CONGENITAL HYPOTHYROIDISM WITHOUT THYROID DEVELOPMENTAL ANOMALY	0.008390484	0.3147786582776554
RESISTANCE TO THYROTROPIN-RELEASING HORMONE SYNDROME	0.008390484	0.3147786582776554
PERMANENT CONGENITAL HYPOTHYROIDISM	0.008390484	0.3147786582776554
FAMILIAL THYROID DYSHORMONOGENESIS	0.008390484	0.3147786582776554
THYROID HEMIAGENESIS	0.008390484	0.3147786582776554
THYROID ECTOPIA	0.008390484	0.3147786582776554
PERIPHERAL HYPOTHYROIDISM	0.008390484	0.3147786582776554
HYPOTHYROIDISM DUE TO DEFICIENT TRANSCRIPTION FACTORS INVOLVED IN PITUITARY DEVELOPMENT OR FUNCTION	0.008390484	0.3147786582776554
14Q24.1Q24.3 MICRODELETION SYNDROME	0.00835253	0.3133547703116846
SIMPSON-GOLABI-BEHMEL SYNDROME	0.008336663	0.31275950155592613
HEART DEFECTS, CONGENITAL, AND OTHER CONGENITAL ANOMALIES; HDCA	0.008336663	0.31275950155592613
COHEN-GIBSON SYNDROME; COGIS	0.008267334	0.3101585443763723
HEREDITARY HYPEREKPLEXIA	0.008263198999999999	0.3100034150951558
AUTOSOMAL DOMINANT ROBINOW SYNDROME	0.008243714	0.30927241290785173
CHROMOSOME 6Q11-Q14 DELETION SYNDROME	0.008243714	0.30927241290785173
TETRASOMY 9P	0.008115292999999999	0.3044545513786867
MONOSOMY 9Q22.3	0.008115292999999999	0.3044545513786867
MENTAL RETARDATION, X-LINKED, SYNDROMIC, BAIN TYPE; MRXSB	0.008106683	0.30413153732517434
CREATINE DEFICIENCY SYNDROME, X-LINKED	0.008106683	0.30413153732517434
48,XXYY SYNDROME	0.008083063	0.30324540585665377
49,XXXXY SYNDROME	0.008083063	0.30324540585665377
48,XXXY SYNDROME	0.008083063	0.30324540585665377
MENTAL RETARDATION, AUTOSOMAL DOMINANT 57; MRD57	0.008083063	0.30324540585665377
PITT-HOPKINS SYNDROME	0.008083063	0.30324540585665377
MULTIPLE SYSTEM ATROPHY 1, SUSCEPTIBILITY TO; MSA1	0.008	0.30012920186979
ARNOLD-CHIARI MALFORMATION TYPE I	0.008	0.30012920186979
SPASTIC PARAPLEGIA 12, AUTOSOMAL DOMINANT	0.008	0.30012920186979
MULTIPLE SCLEROSIS, SUSCEPTIBILITY TO	0.008	0.30012920186979
SPASTIC PARAPLEGIA 13, AUTOSOMAL DOMINANT	0.008	0.30012920186979
CAMPTOBRACHYDACTYLY	0.008	0.30012920186979
SANDHOFF DISEASE	0.008	0.30012920186979
SPASTIC PARAPLEGIA 5A, AUTOSOMAL RECESSIVE; SPG5A	0.008	0.30012920186979
FOWLER URETHRAL SPHINCTER DYSFUNCTION SYNDROME	0.008	0.30012920186979
POSTERIOR URETHRAL VALVE	0.008	0.30012920186979
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA WITH LATE-ONSET SPASTICITY	0.008	0.30012920186979
SPINOCEREBELLAR ATAXIA 42	0.008	0.30012920186979
FRAGILE X TREMOR/ATAXIA SYNDROME; FXTAS	0.008	0.30012920186979
ISOLATED EPISPADIAS	0.008	0.30012920186979
SPASTIC PARAPLEGIA 46, AUTOSOMAL RECESSIVE; SPG46	0.008	0.30012920186979
AMYOTROPHIC DYSTONIC PARAPLEGIA	0.008	0.30012920186979
MITOCHONDRIAL MEMBRANE PROTEIN-ASSOCIATED NEURODEGENERATION	0.008	0.30012920186979
NEUROLEPTIC MALIGNANT SYNDROME	0.008	0.30012920186979
%611945 SPASTIC PARAPLEGIA 37, AUTOSOMAL DOMINANT; SPG37	0.008	0.30012920186979
ADULT-ONSET DISTAL MYOPATHY DUE TO VCP MUTATION	0.008	0.30012920186979
HEREDITARY MOTOR AND SENSORY NEUROPATHY, TYPE IIC; HMSN2C	0.008	0.30012920186979
SPINOCEREBELLAR ATAXIA 48; SCA48	0.008	0.30012920186979
CHIARI MALFORMATION TYPE I	0.008	0.30012920186979
SPINOCEREBELLAR ATAXIA TYPE 19/22	0.008	0.30012920186979
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 13	0.008	0.30012920186979
POSTERIOR COLUMN ATAXIA WITH RETINITIS PIGMENTOSA; AXPC1	0.008	0.30012920186979
PRIMARY PROGRESSIVE FREEZING GAIT	0.008	0.30012920186979
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 46	0.008	0.30012920186979
NORMAL PRESSURE HYDROCEPHALUS	0.008	0.30012920186979
NEURODEGENERATION WITH ATAXIA, DYSTONIA, AND GAZE PALSY, CHILDHOOD-ONSET	0.008	0.30012920186979
SPASTIC PARAPLEGIA, ATAXIA, AND MENTAL RETARDATION	0.008	0.30012920186979
AUTOSOMAL RECESSIVE SPASTIC ATAXIA OF CHARLEVOIX-SAGUENAY	0.008	0.30012920186979
SYRINGOMYELIA, ISOLATED	0.008	0.30012920186979
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE IIB; HSAN2B	0.008	0.30012920186979
INDIFFERENCE TO PAIN, CONGENITAL, AUTOSOMAL RECESSIVE; CIP	0.008	0.30012920186979
SPINOCEREBELLAR ATAXIA TYPE 42	0.008	0.30012920186979
207720 APNEA, CENTRAL SLEEP;;SLEEP APNEA, LETHAL CENTRAL	0.008	0.30012920186979
SPASTIC PARAPLEGIA 76, AUTOSOMAL RECESSIVE	0.008	0.30012920186979
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 73	0.008	0.30012920186979
SPASTIC PARAPLEGIA 29, AUTOSOMAL DOMINANT	0.008	0.30012920186979
SPINOCEREBELLAR ATAXIA TYPE 8	0.008	0.30012920186979
KUFOR-RAKEB SYNDROME	0.008	0.30012920186979
SPASTIC PARALYSIS, INFANTILE-ONSET ASCENDING; IAHSP	0.008	0.30012920186979
SPASTIC PARAPLEGIA 36, AUTOSOMAL DOMINANT; SPG36	0.008	0.30012920186979
SPASTIC PARAPLEGIA 19, AUTOSOMAL DOMINANT	0.008	0.30012920186979
PEROXISOME BIOGENESIS DISORDER 14B	0.008	0.30012920186979
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 8	0.008	0.30012920186979
SPORADIC ADULT-ONSET ATAXIA OF UNKNOWN ETIOLOGY	0.008	0.30012920186979
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 48	0.008	0.30012920186979
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 12	0.008	0.30012920186979
METACHROMATIC LEUKODYSTROPHY, ADULT-ONSET, WITH NORMAL ARYLSULFATASEA	0.008	0.30012920186979
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 36	0.008	0.30012920186979
AUTOSOMAL DOMINANT CENTRONUCLEAR MYOPATHY	0.008	0.30012920186979
ANTERIOR SEGMENT DEVELOPMENTAL ANOMALY	0.007983614	0.2995144622320602
PYRUVATE DEHYDROGENASE DEFICIENCY	0.007959913	0.29862529195537074
THYROID HORMONOGENESIS, GENETIC DEFECT IN, 1	0.00784493	0.29431157245304645
HYPERMOBILE EHLERS-DANLOS SYNDROME	0.00784493	0.29431157245304645
HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 2	0.00784493	0.29431157245304645
HYPOTHYROIDISM DUE TO TSH RECEPTOR MUTATIONS	0.00784493	0.29431157245304645
ISOLATED THYROID-STIMULATING HORMONE DEFICIENCY	0.00784493	0.29431157245304645
SEPTO-OPTIC DYSPLASIA SPECTRUM	0.007822963	0.2934874551808623
PRADER-WILLI-LIKE SYNDROME	0.007822963	0.2934874551808623
OPITZ GBBB SYNDROME, TYPE II; GBBB2	0.007795244	0.29244754501253367
BETA-MERCAPTOLACTATE CYSTEINE DISULFIDURIA	0.007791108999999999	0.2922924157313172
HENNEKAM LYMPHANGIECTASIA-LYMPHEDEMA SYNDROME	0.007791108999999999	0.2922924157313172
TATTON-BROWN-RAHMAN SYNDROME; TBRS	0.007791108999999999	0.2922924157313172
AUTOSOMAL RECESSIVE MULTIPLE PTERYGIUM SYNDROME	0.007721779999999999	0.28969145855176337
BRITTLE CORNEA SYNDROME 2; BCS2	0.007721779999999999	0.28969145855176337
PEROXISOME BIOGENESIS DISORDER 4B; PBD4B	0.007699813	0.28886734127957914
HUNTER-MACDONALD SYNDROME	0.007698159999999999	0.2888053270832428
CRANIOSYNOSTOSIS-MENTAL RETARDATION SYNDROME OF LIN AND GETTIG	0.007698159999999999	0.2888053270832428
D-BIFUNCTIONAL PROTEIN DEFICIENCY	0.0076761929999999996	0.28798120981105857
NEURODEVELOPMENTAL DISORDER WITH ATAXIC GAIT, ABSENT SPEECH, AND DECREASED CORTICAL WHITE MATTER; NDAGSCW	0.0076761929999999996	0.28798120981105857
611961 STEVENSON-CAREY SYNDROME	0.007634593	0.2864205379613357
SEIZURES-SCOLIOSIS-MACROCEPHALY SYNDROME	0.007634593	0.2864205379613357
PRIMARY ALDOSTERONISM, SEIZURES, AND NEUROLOGIC ABNORMALITIES	0.007587804	0.28466519480804997
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 49; MRT49	0.007587804	0.28466519480804997
CORTICAL MALFORMATIONS, OCCIPITAL; OCCM	0.007587804	0.28466519480804997
RARE NON-SYNDROMIC INTELLECTUAL DISABILITY	0.007587804	0.28466519480804997
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP C; MOCODC	0.007587804	0.28466519480804997
W SYNDROME	0.007587804	0.28466519480804997
SARCOSINEMIA	0.007587804	0.28466519480804997
OROFACIODIGITAL SYNDROME TYPE 2	0.007587804	0.28466519480804997
X SMALL RINGS	0.007587804	0.28466519480804997
NEURODEVELOPMENTAL DISORDER WITH IMPAIRED SPEECH AND HYPERKINETIC MOVEMENTS; NEDISHM	0.007587804	0.28466519480804997
3-PHOSPHOSERINE PHOSPHATASE DEFICIENCY	0.007587804	0.28466519480804997
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 3; EIG3	0.0075836689999999995	0.28451006552683356
EPILEPSY, FAMILIAL ADULT MYOCLONIC, 4; FAME4	0.0075836689999999995	0.28451006552683356
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 23; EIEE23	0.007580483	0.2843905390721889
MITOCHONDRIAL DNA DEPLETION SYNDROME 13 (ENCEPHALOMYOPATHIC TYPE); MTDPS13	0.007580483	0.2843905390721889
RING CHROMOSOME 22 SYNDROME	0.007580483	0.2843905390721889
11Q22.2Q22.3 MICRODELETION SYNDROME	0.007580483	0.2843905390721889
WILSON-TURNER X-LINKED MENTAL RETARDATION SYNDROME; WTS	0.007580483	0.2843905390721889
INTELLECTUAL DISABILITY-AUTISM-SPEECH APRAXIA-CRANIOFACIAL DYSMORPHISM SYNDROME	0.007580483	0.2843905390721889
KBG SYNDROME	0.007580483	0.2843905390721889
KLEEFSTRA SYNDROME 2; KLEFS2	0.007580483	0.2843905390721889
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIM; CDG2M	0.007580483	0.2843905390721889
COHEN SYNDROME	0.007580483	0.2843905390721889
COFFIN-SIRIS SYNDROME	0.007580483	0.2843905390721889
PHELAN-MCDERMID SYNDROME	0.007580483	0.2843905390721889
WILSON-TURNER SYNDROME	0.007580483	0.2843905390721889
HURLER SYNDROME	0.0075738739999999995	0.2841425948352942
SHPRINTZEN-GOLDBERG CRANIOSYNOSTOSIS SYNDROME; SGS	0.0075738739999999995	0.2841425948352942
GREIG CEPHALOPOLYSYNDACTYLY SYNDROME	0.007569738999999999	0.2839874655540778
MUCOPOLYSACCHARIDOSIS, TYPE II	0.007569738999999999	0.2839874655540778
CRANIOSYNOSTOSIS-HYDROCEPHALUS-ARNOLD-CHIARI MALFORMATION TYPE I-RADIOULNAR SYNOSTOSIS SYNDROME	0.007569738999999999	0.2839874655540778
GREIG CEPHALOPOLYSYNDACTYLY SYNDROME	0.007569738999999999	0.2839874655540778
ADULT-ONSET AUTOSOMAL DOMINANT LEUKODYSTROPHY	0.007565264	0.2838195807817819
LYNCH SYNDROME	0.007561129	0.2836644515005654
FAMILIAL COLORECTAL CANCER TYPE X	0.007561129	0.2836644515005654
C SYNDROME	0.0075375089999999995	0.28277832003204484
PITT-HOPKINS SYNDROME	0.0075375089999999995	0.28277832003204484
MENTAL RETARDATION-HYPOTONIC FACIES SYNDROME, X-LINKED, 1; MRXHF1	0.0075375089999999995	0.28277832003204484
BOHRING-OPITZ SYNDROME	0.007487822999999999	0.280914292591532
VAN ESCH-O'DRISCOLL SYNDROME; VEODS	0.007487822999999999	0.280914292591532
KOOLEN-DE VRIES SYNDROME; KDVS	0.007487822999999999	0.280914292591532
CONGENITAL HEART DEFECTS, DYSMORPHIC FACIAL FEATURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER; CHDFIDD	0.007487822999999999	0.280914292591532
MANDIBULOFACIAL DYSOSTOSIS, GUION-ALMEIDA TYPE; MFDGA	0.007487822999999999	0.280914292591532
X-LINKED FEMALE RESTRICTED FACIAL DYSMORPHISM-SHORT STATURE-CHOANAL ATRESIA-INTELLECTUAL DISABILITY	0.007487822999999999	0.280914292591532
DISTAL MONOSOMY 10Q	0.007487822999999999	0.280914292591532
CHROMOSOME 10Q26 DELETION SYNDROME	0.007487822999999999	0.280914292591532
SMITH-LEMLI-OPITZ SYNDROME	0.007487822999999999	0.280914292591532
8P11.2 DELETION SYNDROME	0.007487822999999999	0.280914292591532
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA	0.007290073	0.2734954738828132
L1 SYNDROME	0.007290073	0.2734954738828132
16P13.2 MICRODELETION SYNDROME	0.007290072999999999	0.2734954738828132
PEROXISOME BIOGENESIS DISORDER 8B; PBD8B	0.007281544	0.27317549863746976
LOWE OCULOCEREBRORENAL SYNDROME	0.007277409	0.27302036935625335
MENTAL RETARDATION, AUTOSOMAL DOMINANT 54; MRD54	0.007277409	0.27302036935625335
ALKURAYA-KUCINSKAS SYNDROME; ALKKUCS	0.007266452999999999	0.27260934241429263
MEND SYNDROME	0.007266452999999999	0.27260934241429263
DISTAL 22Q11.2 MICRODUPLICATION SYNDROME	0.007266452999999999	0.27260934241429263
HOLOPROSENCEPHALY 7	0.007266452999999999	0.27260934241429263
TETRASOMY 5P	0.007266452999999999	0.27260934241429263
PROMINENT GLABELLA-MICROCEPHALY-HYPOGENITALISM SYNDROME	0.007259813	0.27236023517674074
TEMTAMY SYNDROME; TEMTYS	0.007259813	0.27236023517674074
6Q TERMINAL DELETION SYNDROME	0.007259813	0.27236023517674074
CHROMOSOME 2Q37 DELETION SYNDROME	0.007259813	0.27236023517674074
LEIGH SYNDROME, FRENCH CANADIAN TYPE; LSFC	0.007259813	0.27236023517674074
MACDERMOT-WINTER SYNDROME	0.007259813	0.27236023517674074
BARAITSER-WINTER SYNDROME 1; BRWS1	0.007259813	0.27236023517674074
PONTOCEREBELLAR HYPOPLASIA, TYPE 10; PCH10	0.007259813	0.27236023517674074
FATTY ACYL-COA REDUCTASE 1 DEFICIENCY	0.007259813	0.27236023517674074
BARAITSER-WINTER CEREBROFRONTOFACIAL SYNDROME	0.007259813	0.27236023517674074
INTELLECTUAL DEVELOPMENTAL DISORDER WITH NEUROPSYCHIATRIC FEATURES; IDDNPF	0.0072598129999999995	0.2723602351767407
PEROXISOMAL FATTY ACYL-COA REDUCTASE 1 DISORDER	0.0072598129999999995	0.2723602351767407
FLOATING-HARBOR SYNDROME	0.00724969	0.27198045918792474
OMODYSPLASIA 1; OMOD1	0.00724969	0.27198045918792474
CLASSICAL EHLERS-DANLOS SYNDROME	0.00724969	0.27198045918792474
DYSSEGMENTAL DYSPLASIA, SILVERMAN-HANDMAKER TYPE	0.00724969	0.27198045918792474
CHARGE SYNDROME	0.00724969	0.27198045918792474
KALLMANN SYNDROME	0.007154259	0.2684002554549702
CADASIL	0.007154259	0.2684002554549702
X-LINKED INTELLECTUAL DISABILITY, NAJM TYPE	0.007154259	0.2684002554549702
PELIZAEUS-MERZBACHER DISEASE	0.007154259	0.2684002554549702
SPASTICITY, CHILDHOOD-ONSET, WITH HYPERGLYCINEMIA	0.007154259	0.2684002554549702
ZELLWEGER SYNDROME	0.007130638999999999	0.26751412398644964
COFFIN-SIRIS SYNDROME 6; CSS6	0.007093174	0.26610858141794325
CONGENITAL HEART DEFECTS AND SKELETAL MALFORMATIONS SYNDROME; CHDSKM	0.007093174	0.26610858141794325
KAPUR-TORIELLO SYNDROME	0.007089039	0.2659534521367268
NEURODEVELOPMENTAL DISORDER-CRANIOFACIAL DYSMORPHISM-CARDIAC DEFECT-SKELETAL ANOMALIES SYNDROME	0.007089039	0.2659534521367268
AMISH LETHAL MICROCEPHALY	0.00704225	0.26419810898344104
MYOCLONIC EPILEPSY, JUVENILE, 2	0.00704225	0.26419810898344104
269720 SEIZURES, BENIGN FAMILIAL NEONATAL, AUTOSOMAL RECESSIVE;;BFNS, AUTOSOMAL RECESSIVE;;CONVULSIONS, BENIGN FAMILIAL NEONATAL, AUTOSOMAL RECESSIVE;;EPILEPSY, BENIGN FAMILIAL NEONATAL, AUTOSOMAL RECESSIVE	0.00704225	0.26419810898344104
X-LINKED INTELLECTUAL DISABILITY-LIMB SPASTICITY-RETINAL DYSTROPHY-DIABETES INSIPIDUS SYNDROME	0.00704225	0.26419810898344104
ALOPECIA-MENTAL RETARDATION SYNDROME WITH CONVULSIONS AND HYPERGONADOTROPICHYPOGONADISM	0.00704225	0.26419810898344104
HEPATIC VENO-OCCLUSIVE DISEASE-IMMUNODEFICIENCY SYNDROME	0.00704225	0.26419810898344104
TUBULAR RENAL DISEASE-CARDIOMYOPATHY SYNDROME	0.00704225	0.26419810898344104
LEUKOENCEPHALOPATHY, ARTHRITIS, COLITIS, AND HYPOGAMMAGLOBULINEMA	0.00704225	0.26419810898344104
608278 GROWTH FAILURE, MICROCEPHALY, MENTAL RETARDATION, CATARACTS, LARGEJOINT CONTRACTURES, OSTEOPOROSIS, CORTICAL DYSPLASIA, AND CEREBELLARATROPHY	0.00704225	0.26419810898344104
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 12	0.00704225	0.26419810898344104
%249650 MERCAPTOLACTATE-CYSTEINE DISULFIDURIA; MCDU;;DISULFIDURIA, MIXED	0.00704225	0.26419810898344104
MITOCHONDRIAL MYOPATHY, ENCEPHALOPATHY, LACTIC ACIDOSIS, AND STROKE-LIKE EPISODES; MELAS	0.00704225	0.26419810898344104
TRAPPC11-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R18	0.00704225	0.26419810898344104
PAROXYSMAL DYSTONIC CHOREATHETOSIS WITH EPISODIC ATAXIA AND SPASTICITY	0.00704225	0.26419810898344104
EPILEPSY, BENIGN NEONATAL, 3	0.00704225	0.26419810898344104
GLYCOGEN STORAGE DISEASE 0, MUSCLE; GSD0B	0.00704225	0.26419810898344104
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 29	0.00704225	0.26419810898344104
INFANTILE-ONSET AXONAL MOTOR AND SENSORY NEUROPATHY-OPTIC ATROPHY-NEURODEGENERATIVE SYNDROME	0.00704225	0.26419810898344104
CONGENITAL INSENSITIVITY TO PAIN WITH SEVERE INTELLECTUAL DISABILITY	0.00704225	0.26419810898344104
EARLY-ONSET EPILEPSY-INTELLECTUAL DISABILITY-BRAIN ANOMALIES SYNDROME	0.00704225	0.26419810898344104
EPILEPSY, PROGRESSIVE MYOCLONIC, 8; EPM8	0.00704225	0.26419810898344104
ENCEPHALOPATHY DUE TO PROSAPOSIN DEFICIENCY	0.00704225	0.26419810898344104
SEIZURES, BENIGN FAMILIAL INFANTILE, 5	0.00704225	0.26419810898344104
CHOPS SYNDROME; CHOPS	0.007039064	0.26407858252879646
PROGRESSIVE ESSENTIAL TREMOR-SPEECH IMPAIRMENT-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY-ABNORMAL BEHAVIOR SYNDROME	0.007039064	0.26407858252879646
TRISOMY 12P	0.007039064	0.26407858252879646
MANNOSIDOSIS, ALPHA B, LYSOSOMAL	0.007039064	0.26407858252879646
X-LINKED INTELLECTUAL DISABILITY, STEVENSON TYPE	0.007039064	0.26407858252879646
CATARACTS, GROWTH HORMONE DEFICIENCY, SENSORY NEUROPATHY, SENSORINEURAL HEARING LOSS, AND SKELETAL DYSPLASIA; CAGSSS	0.007039064	0.26407858252879646
HYPERTRICHOSIS CUBITI	0.007039064	0.26407858252879646
CORPUS CALLOSUM, AGENESIS OF, WITH FACIAL ANOMALIES AND CEREBELLAR ATAXIA; CCAFCA	0.007039064	0.26407858252879646
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIA; CDG2A	0.0070349290000000005	0.26392345324758
COFFIN-SIRIS SYNDROME 8; CSS8	0.0070349290000000005	0.26392345324758
ZIMMERMANN-LABAND SYNDROME	0.0070349290000000005	0.26392345324758
FAMILIAL OSTEODYSPLASIA, ANDERSON TYPE	0.0070349290000000005	0.26392345324758
BORJESON-FORSSMAN-LEHMANN SYNDROME	0.0070349290000000005	0.26392345324758
300232 SPONDYLOEPIMETAPHYSEAL DYSPLASIA, X-LINKED, WITH MENTAL DETERIORATION;;SEMD, X-LINKED, WITH MENTAL DETERIORATION	0.0070349290000000005	0.26392345324758
%601499 AXENFELD-RIEGER SYNDROME, TYPE 2; RIEG2;;RIEGER SYNDROME, TYPE 2	0.007028319999999999	0.26367550901068526
MUCOPOLYSACCHARIDOSIS, TYPE VI; MPS6	0.007028319999999999	0.26367550901068526
CUTIS GYRATA-ACANTHOSIS NIGRICANS-CRANIOSYNOSTOSIS SYNDROME	0.007028319999999999	0.26367550901068526
SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 1	0.007028319999999999	0.26367550901068526
FOCAL DERMAL HYPOPLASIA; FDH	0.007028319999999999	0.26367550901068526
HOLOPROSENCEPHALY-POSTAXIAL POLYDACTYLY SYNDROME	0.007028319999999999	0.26367550901068526
CRANIOFACIAL DYSSYNOSTOSIS	0.007028319999999999	0.26367550901068526
AMASTIA, BILATERAL, WITH URETERAL TRIPLICATION AND DYSMORPHISM	0.007028319999999999	0.26367550901068526
RHEUMATIC FEVER	0.00701971	0.26335249495717294
PARKINSON DISEASE 22, AUTOSOMAL DOMINANT; PARK22	0.00701971	0.26335249495717294
POLYMYOSITIS	0.00701971	0.26335249495717294
NEUROFERRITINOPATHY	0.00701971	0.26335249495717294
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLC TYPE; MAHCC	0.007006353	0.2628513917385011
CONGENITAL TOXOPLASMOSIS	0.007006353	0.2628513917385011
BRAIN ABNORMALITIES, NEURODEGENERATION, AND DYSOSTEOSCLEROSIS; BANDDOS	0.007006353	0.2628513917385011
RITSCHER-SCHINZEL SYNDROME 2; RTSC2	0.006946404	0.2606023360481396
MOSAIC TRISOMY 9	0.006946404	0.2606023360481396
600123 ATRIOVENTRICULAR SEPTAL DEFECT WITH BLEPHAROPHIMOSIS AND ANAL ANDRADIAL DEFECTS	0.006946404	0.2606023360481396
CHROMOSOME 16P13.3 DUPLICATION SYNDROME	0.006946404	0.2606023360481396
FRONTOOCULAR SYNDROME	0.006946404	0.2606023360481396
OROFACIODIGITAL SYNDROME XIV; OFD14	0.006946404	0.2606023360481396
MANDIBULOFACIAL DYSOSTOSIS-MICROCEPHALY SYNDROME	0.006942269	0.2604472067669231
X-LINKED INTELLECTUAL DISABILITY, GOLABI-ITO-HALL TYPE	0.006942269	0.2604472067669231
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 2; HPMRS2	0.006942269	0.2604472067669231
LERI PLEONOSTEOSIS	0.00687294	0.2578462495873693
PEROXISOME BIOGENESIS DISORDER 12A (ZELLWEGER)	0.006817983	0.25578447451897457
ENCEPHALOCRANIOCUTANEOUS LIPOMATOSIS; ECCL	0.006817983	0.25578447451897457
FRIED SYNDROME	0.006748654	0.2531835173394207
MALT LYMPHOMA	0.00673599	0.2527084128128608
MATERNALLY-INHERITED DIABETES AND DEAFNESS	0.00673599	0.2527084128128608
INTELLECTUAL DEVELOPMENTAL DISORDER 59; MRD59	0.006718394	0.2520482786333482
JOUBERT SYNDROME 1	0.006718394	0.2520482786333482
OCULOFACIOCARDIODENTAL SYNDROME	0.006718394	0.2520482786333482
CHARGE SYNDROME	0.006718394	0.2520482786333482
3MC SYNDROME 2	0.006718394	0.2520482786333482
JOUBERT SYNDROME 35; JBTS35	0.006718394	0.2520482786333482
INTELLECTUAL DISABILITY, BIRK-BAREL TYPE	0.006718394	0.2520482786333482
CHROMOSOME 22Q11.2 DELETION SYNDROME, DISTAL	0.006718394	0.2520482786333482
INTELLECTUAL DEVELOPMENTAL DISORDER WITH ABNORMAL BEHAVIOR, MICROCEPHALY, AND SHORT STATURE; IDDABS	0.006718394	0.2520482786333482
8P23.1 DUPLICATION SYNDROME	0.006718394	0.2520482786333482
SEVERE INTELLECTUAL DISABILITY-EPILEPSY-ANAL ANOMALIES-DISTAL PHALANGEAL HYPOPLASIA	0.006714259	0.2518931493521318
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 3; IHPRF3	0.006714259	0.2518931493521318
MENTAL RETARDATION, AUTOSOMAL DOMINANT 48; MRD48	0.006714259	0.2518931493521318
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 65; EIEE65	0.006714259	0.2518931493521318
MICROCEPHALY 5, PRIMARY, AUTOSOMAL RECESSIVE	0.006714259	0.2518931493521318
BARAITSER-WINTER SYNDROME 2; BRWS2	0.006714259	0.2518931493521318
HYPOGONADOTROPIC HYPOGONADISM-SEVERE MICROCEPHALY-SENSORINEURAL HEARING LOSS-DYSMORPHISM SYNDROME	0.006714259	0.2518931493521318
CONGENITAL RUBELLA SYNDROME	0.006682169	0.2506892560911316
ATAXIA WITH VITAMIN E DEFICIENCY	0.00661284	0.24808829891157777
MANGANESE POISONING	0.00661284	0.24808829891157777
3-METHYLGLUTACONIC ACIDURIA TYPE 3	0.00661284	0.24808829891157777
ATAXIA-TAPETORETINAL DEGENERATION SYNDROME	0.00661284	0.24808829891157777
KYPHOSCOLIOTIC EHLERS-DANLOS SYNDROME DUE TO LYSYL HYDROXYLASE 1 DEFICIENCY	0.00661284	0.24808829891157777
SPASTIC PARAPARESIS-DEAFNESS SYNDROME	0.00661284	0.24808829891157777
DYSTONIA, CHILDHOOD-ONSET, WITH OPTIC ATROPHY AND BASAL GANGLIA ABNORMALITIES; DYTOABG	0.00661284	0.24808829891157777
NEUROFIBROMATOSIS TYPE 2	0.00661284	0.24808829891157777
CYSTINOSIS	0.00661284	0.24808829891157777
BETA-THALASSEMIA MAJOR	0.00658922	0.24720216744305717
PRUNE BELLY SYNDROME	0.0065476200000000005	0.24564149559333429
TOWNES-BROCKS SYNDROME	0.0065476200000000005	0.24564149559333429
CAMPTODACTYLY SYNDROME, GUADALAJARA TYPE 3	0.00649351	0.2436114967041875
DEAFNESS, X-LINKED 7; DFNX7	0.00649351	0.2436114967041875
3M SYNDROME	0.00649351	0.2436114967041875
%606242 MENTAL RETARDATION, MICROCEPHALY, GROWTH RETARDATION, JOINT CONTRACTURES,AND FACIAL DYSMORPHISM;;KONDOH SYNDROME	0.00649351	0.2436114967041875
SHORT STATURE, OPTIC NERVE ATROPHY, AND PELGER-HUET ANOMALY; SOPH	0.00649351	0.2436114967041875
CRANIODIGITAL-INTELLECTUAL DISABILITY SYNDROME	0.00649351	0.2436114967041875
FRONTOMETAPHYSEAL DYSPLASIA 2; FMD2	0.00649351	0.2436114967041875
LEUKODYSTROPHY, PROGRESSIVE, EARLY CHILDHOOD-ONSET; PLDECO	0.00649351	0.2436114967041875
APHONIA-DEAFNESS-RETINAL DYSTROPHY-BIFID HALLUCES-INTELLECTUAL DISABILITY SYNDROME	0.00649351	0.2436114967041875
TRICHORHINOPHALANGEAL SYNDROME TYPE 2	0.00649351	0.2436114967041875
TRISOMY 4P	0.00649351	0.2436114967041875
CATARACT-GROWTH HORMONE DEFICIENCY-SENSORY NEUROPATHY-SENSORINEURAL HEARING LOSS-SKELETAL DYSPLASIA SYNDROME	0.00649351	0.2436114967041875
CARPENTER-WAZIRI SYNDROME	0.00649351	0.2436114967041875
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 45; MRT45	0.00649351	0.2436114967041875
HYPERTRICHOSIS LANUGINOSA CONGENITA	0.00649351	0.2436114967041875
JOUBERT SYNDROME 2	0.0064649339999999994	0.2425394351951086
CRANIOTELENCEPHALIC DYSPLASIA	0.0064649339999999994	0.2425394351951086
%300861 MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHUDLEY-SCHWARTZ TYPE; MRXSCS;;MENTAL RETARDATION, X-LINKED, WITH SEIZURES, HYPOGAMMAGLOBULINEMIA,AND GAIT DISTURBANCE	0.006463313	0.24247862151557975
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 66; EIEE66	0.006463313	0.24247862151557975
PRIMARY MICROCEPHALY-MILD INTELLECTUAL DISABILITY-YOUNG-ONSET DIABETES SYNDROME	0.006463313	0.24247862151557975
NEURODEVELOPMENTAL DISORDER WITH SEVERE MOTOR IMPAIRMENT AND ABSENT LANGUAGE; NEDMIAL	0.006463313	0.24247862151557975
VITAMIN K ANTAGONIST EMBRYOFETOPATHY	0.006460799	0.24238430591389215
PAPILLOMA OF CHOROID PLEXUS	0.006460799	0.24238430591389215
NEUROFIBROMATOSIS TYPE 1	0.006460799	0.24238430591389215
BRAIN MALFORMATION-CONGENITAL HEART DISEASE-POSTAXIAL POLYDACTYLY SYNDROME	0.00640085	0.24013525022353066
RAMOS-ARROYO SYNDROME	0.00640085	0.24013525022353066
%601927 LYMPHEDEMA, CARDIAC SEPTAL DEFECTS, AND CHARACTERISTIC FACIES;;IRONS-BIANCHI SYNDROME;;LYMPHEDEMA, ATRIAL SEPTAL DEFECT, AND CHARACTERISTIC FACIES	0.00640085	0.24013525022353066
ALAGILLE SYNDROME 1; ALGS1	0.00640085	0.24013525022353066
HYPOMANDIBULAR FACIOCRANIAL DYSOSTOSIS	0.00640085	0.24013525022353066
SIFRIM-HITZ-WEISS SYNDROME	0.00640085	0.24013525022353066
AXIAL MESODERMAL DYSPLASIA SPECTRUM	0.00632625	0.2373365454160949
CUTIS LAXA	0.006276564	0.23547251797558208
3C SYNDROME	0.006276564	0.23547251797558208
RITSCHER-SCHINZEL SYNDROME 1	0.006276564	0.23547251797558208
LOEYS-DIETZ SYNDROME, TYPE 1A LOEYS-DIETZ AORTIC ANEURYSM SYNDROME	0.006276564	0.23547251797558208
COSTELLO SYNDROME; CSTLO	0.006276564	0.23547251797558208
OSTEOPATHIA STRIATA WITH CRANIAL SCLEROSIS	0.0062724289999999995	0.2353173886943656
THANATOPHORIC DYSPLASIA TYPE 2	0.0062724289999999995	0.2353173886943656
THANATOPHORIC DYSPLASIA TYPE 1	0.0062724289999999995	0.2353173886943656
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 4; MDDGA4	0.0062724289999999995	0.2353173886943656
THANATOPHORIC DYSPLASIA	0.0062724289999999995	0.2353173886943656
VON HIPPEL-LINDAU DISEASE	0.0062031	0.23271643151481178
ISOTRETINOIN-LIKE SYNDROME	0.006179479999999999	0.2318303000462912
CZEIZEL-LOSONCI SYNDROME	0.006179479999999999	0.2318303000462912
RING CHROMOSOME 7 SYNDROME	0.00617284	0.23158119280873932
DYSMORPHISM-SHORT STATURE-DEAFNESS-DISORDER OF SEX DEVELOPMENT SYNDROME	0.00617284	0.23158119280873932
3MC SYNDROME 3	0.00617284	0.23158119280873932
JUBERG-HAYWARD SYNDROME	0.00617284	0.23158119280873932
CLEFT LIP/PALATE WITH ABNORMAL THUMBS AND MICROCEPHALY	0.00617284	0.23158119280873932
ACROMEGALOID FACIAL APPEARANCE SYNDROME	0.00617284	0.23158119280873932
INTELLECTUAL DISABILITY-MUSCLE WEAKNESS-SHORT STATURE-FACIAL DYSMORPHISM SYNDROME	0.00617284	0.23158119280873932
ARTHROGRYPOSIS, DISTAL, TYPE 5D; DA5D	0.00617284	0.23158119280873932
FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, 3B	0.00617284	0.23158119280873932
9Q31.1Q31.3 MICRODELETION SYNDROME	0.00617284	0.23158119280873932
MENTAL RETARDATION, AUTOSOMAL DOMINANT 27	0.00617284	0.23158119280873932
TEEBI-SHALTOUT SYNDROME; TBSH	0.00617284	0.23158119280873932
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA DUE TO CWF19L1 DEFICIENCY	0.0059218940000000005	0.2221666649721873
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 35	0.0059218940000000005	0.2221666649721873
DESBUQUOIS DYSPLASIA 2; DBQD2	0.0059218940000000005	0.2221666649721873
BARATELA-SCOTT SYNDROME	0.0059218940000000005	0.2221666649721873
GERMAN SYNDROME	0.0059218940000000005	0.2221666649721873
SHORT ULNA-DYSMORPHISM-HYPOTONIA-INTELLECTUAL DISABILITY SYNDROME	0.0059218940000000005	0.2221666649721873
MUCOPOLYSACCHARIDOSIS-PLUS SYNDROME; MPSPS	0.0059218940000000005	0.2221666649721873
SEVERE INTELLECTUAL DISABILITY-SHORT STATURE-BEHAVIORAL ABNORMALITIES-FACIAL DYSMORPHISM SYNDROME	0.0059218940000000005	0.2221666649721873
MARFANOID HABITUS-AUTOSOMAL RECESSIVE INTELLECTUAL DISABILITY SYNDROME	0.0059218940000000005	0.2221666649721873
APERT SYNDROME	0.00591938	0.2220723493704997
GÓMEZ-LÓPEZ-HERNÁNDEZ SYNDROME	0.00591938	0.2220723493704997
AUTOSOMAL RECESSIVE MALIGNANT OSTEOPETROSIS	0.00591938	0.2220723493704997
CROUZON SYNDROME-ACANTHOSIS NIGRICANS SYNDROME	0.00591938	0.2220723493704997
MUCOPOLYSACCHARIDOSIS TYPE 1	0.00591938	0.2220723493704997
CHROMOSOME 15Q13.3 MICRODELETION SYNDROME	0.005917759	0.22201153569097082
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, GENEVIEVE TYPE; SEMDG	0.005917759	0.22201153569097082
MENTAL RETARDATION, AUTOSOMAL DOMINANT 29; MRD29	0.005917759	0.22201153569097082
X-LINKED INTELLECTUAL DISABILITY, CABEZAS TYPE	0.005917759	0.22201153569097082
MUCOPOLYSACCHARIDOSIS TYPE IIIA	0.005917759	0.22201153569097082
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 13; MRT13	0.005917759	0.22201153569097082
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 16	0.005917759	0.22201153569097082
4Q21 MICRODELETION SYNDROME	0.005917759	0.22201153569097082
DUPLICATION/INVERSION 15Q11	0.005917759	0.22201153569097082
8P INVERTED DUPLICATION/DELETION SYNDROME	0.005917759	0.22201153569097082
EPILEPSY-TELANGIECTASIA	0.005917759	0.22201153569097082
MUCOPOLYSACCHARIDOSIS TYPE IIIB	0.005917759	0.22201153569097082
MECKEL SYNDROME, TYPE 4; MKS4	0.00573101	0.21500543215097315
MENTAL RETARDATION, BUENOS AIRES TYPE	0.00573101	0.21500543215097315
PENTALOGY OF CANTRELL	0.00573101	0.21500543215097315
ANTLEY-BIXLER SYNDROME WITHOUT GENITAL ANOMALIES OR DISORDERED STEROIDOGENESIS; ABS2	0.00573101	0.21500543215097315
SHORT-RIB THORACIC DYSPLASIA 14 WITH POLYDACTYLY	0.00573101	0.21500543215097315
JACOBSEN SYNDROME	0.00573101	0.21500543215097315
ROBERTS SYNDROME; RBS	0.00573101	0.21500543215097315
BRACHYTELEPHALANGY-DYSMORPHISM-KALLMANN SYNDROME	0.00537634	0.20169957914757836
BOSMA ARHINIA MICROPHTHALMIA SYNDROME	0.00537634	0.20169957914757836
ISOLATED TRIGONOCEPHALY	0.00537634	0.20169957914757836
TRANSALDOLASE DEFICIENCY	0.00537634	0.20169957914757836
WHITE MATTER HYPOPLASIA-CORPUS CALLOSUM AGENESIS-INTELLECTUAL DISABILITY SYNDROME	0.00537634	0.20169957914757836
BLEPHAROPHIMOSIS-EPICANTHUS INVERSUS-PTOSIS SYNDROME	0.00537634	0.20169957914757836
WAARDENBURG SYNDROME	0.00537634	0.20169957914757836
X-LINKED INTELLECTUAL DISABILITY, SIDERIUS TYPE	0.00537634	0.20169957914757836
SHORT STATURE, FACIAL DYSMORPHISM, AND SKELETAL ANOMALIES WITH OR WITHOUT CARDIAC ANOMALIES; SSFSC	0.00537634	0.20169957914757836
LICHTENSTEIN SYNDROME	0.00537634	0.20169957914757836
MENTAL RETARDATION, X-LINKED 97; MRX97	0.00537634	0.20169957914757836
SOMATOMAMMOTROPINOMA	0.00537634	0.20169957914757836
MONOSOMY 22	0.00537634	0.20169957914757836
MCDONOUGH SYNDROME	0.00537634	0.20169957914757836
ACROMEGALY	0.00537634	0.20169957914757836
DISORDER OF SEX DEVELOPMENT-INTELLECTUAL DISABILITY SYNDROME	0.00537634	0.20169957914757836
TRICHOHEPATONEURODEVELOPMENTAL SYNDROME; THNS	0.00537634	0.20169957914757836
9Q SUBTELOMERIC DELETION SYNDROME	0.00537634	0.20169957914757836
PRIMROSE SYNDROME; PRIMS	0.00537634	0.20169957914757836
HYPOSPADIAS-INTELLECTUAL DISABILITY, GOLDBLATT TYPE SYNDROME	0.00537634	0.20169957914757836
NIGHT BLINDNESS-SKELETAL ANOMALIES-DYSMORPHISM SYNDROME	0.00537634	0.20169957914757836
DEAFNESS WITH LABYRINTHINE APLASIA, MICROTIA, AND MICRODONTIA	0.00537634	0.20169957914757836
URUGUAY FACIOCARDIOMUSCULOSKELETAL SYNDROME; FCMSU	0.00537634	0.20169957914757836
MENTAL RETARDATION, X-LINKED 73	0.00537634	0.20169957914757836
XYLT1-CDG	0.00537634	0.20169957914757836
DONNAI-BARROW SYNDROME	0.005360472999999999	0.20110431039181983
SIALIDOSIS TYPE 2	0.005360472999999999	0.20110431039181983
AUTOSOMAL RECESSIVE CUTIS LAXA TYPE 2	0.005360472999999999	0.20110431039181983
HYPEREKPLEXIA 4; HKPX4	0.005360472999999999	0.20110431039181983
MUCOPOLYSACCHARIDOSIS TYPE 2	0.005360472999999999	0.20110431039181983
DIGEORGE SYNDROME; DGS	0.005360472999999999	0.20110431039181983
ENCEPHALOMYOPATHY, MITOCHONDRIAL, DUE TO VOLTAGE-DEPENDENT ANION CHANNEL DEFICIENCY	0.005360472999999999	0.20110431039181983
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIIA	0.005360472999999999	0.20110431039181983
CARDIAC, FACIAL, AND DIGITAL ANOMALIES WITH DEVELOPMENTAL DELAY; CAFDADD	0.005360472999999999	0.20110431039181983
WEAVER SYNDROME	0.005360472999999999	0.20110431039181983
PSYCHOMOTOR RETARDATION, EPILEPSY, AND CRANIOFACIAL DYSMORPHISM	0.005360472999999999	0.20110431039181983
CATEL-MANZKE SYNDROME; CATMANS	0.005360472999999999	0.20110431039181983
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 2; MC5DN2	0.005360472999999999	0.20110431039181983
CLASSICAL-LIKE EHLERS-DANLOS SYNDROME TYPE 2	0.004819054	0.18079235384842735
ICF SYNDROME	0.004819054	0.18079235384842735
PRIMARY CONGENITAL HYPOTHYROIDISM	0.004819054	0.18079235384842735
TOWNES-BROCKS SYNDROME 1; TBS1	0.004819054	0.18079235384842735
DIABETES MELLITUS, NEONATAL, WITH CONGENITAL HYPOTHYROIDISM; NDH	0.004819054	0.18079235384842735
CONGENITAL CONTRACTURES OF THE LIMBS AND FACE, HYPOTONIA, AND DEVELOPMENTAL DELAY	0.004819054	0.18079235384842735
DE BARSY SYNDROME	0.004819054	0.18079235384842735
CARDIOCRANIAL SYNDROME, PFEIFFER TYPE	0.004819054	0.18079235384842735
LATERAL MENINGOCELE SYNDROME	0.004819054	0.18079235384842735
MULTIPLE BENIGN CIRCUMFERENTIAL SKIN CREASES ON LIMBS	0.004819054	0.18079235384842735
AARSKOG-SCOTT SYNDROME	0.004819054	0.18079235384842735
606156 SENER SYNDROME;;FRONTONASAL DYSPLASIA AND DILATED VIRCHOW-ROBIN SPACES	0.004819054	0.18079235384842735
CRANIOFRONTONASAL SYNDROME; CFNS	0.004819054	0.18079235384842735
DEAFNESS-EPIPHYSEAL DYSPLASIA-SHORT STATURE SYNDROME	0.004819054	0.18079235384842735
DISTAL MONOSOMY 3P	0.004814918999999999	0.18063722456721087
SMITH-KINGSMORE SYNDROME; SKS	0.004814918999999999	0.18063722456721087
XP22.13P22.2 DUPLICATION SYNDROME	0.004814918999999999	0.18063722456721087
ADAMS-OLIVER SYNDROME 5; AOS5	0.004814918999999999	0.18063722456721087
MUCOPOLYSACCHARIDOSIS TYPE 3	0.004814918999999999	0.18063722456721087
PANCREATIC HYPOPLASIA-DIABETES-CONGENITAL HEART DISEASE SYNDROME	0.004814918999999999	0.18063722456721087
ACROCALLOSAL SYNDROME; ACLS	0.004814918999999999	0.18063722456721087
MENKES DISEASE	0.004814918999999999	0.18063722456721087
ASPARTYLGLUCOSAMINURIA	0.004814918999999999	0.18063722456721087
SEIZURES, SCOLIOSIS, AND MACROCEPHALY/MICROCEPHALY SYNDROME; SSMS	0.004658403	0.1747653467972294
HYPOTONIA, HYPERVENTILATION, IMPAIRED INTELLECTUAL DEVELOPMENT, DYSAUTONOMIA, EPILEPSY, AND EYE ABNORMALITIES; HIDEA	0.004658403	0.1747653467972294
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND SPEECH AND WALKING IMPAIRMENT; NEDSSWI	0.004658403	0.1747653467972294
CONGENITAL HYPOTONIA, EPILEPSY, DEVELOPMENTAL DELAY, AND DIGITAL ANOMALIES; CHEDDA	0.004658403	0.1747653467972294
MENTAL RETARDATION, AUTOSOMAL DOMINANT 43; MRD43	0.004658403	0.1747653467972294
NEPHROGENIC DIABETES INSIPIDUS	0.004658403	0.1747653467972294
DEVELOPMENTAL DELAY WITH VARIABLE INTELLECTUAL IMPAIRMENT AND BEHAVIORAL ABNORMALITIES; DDVIBA	0.004658403	0.1747653467972294
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 51; EIEE51	0.004658403	0.1747653467972294
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 4; PEOA4	0.004658403	0.1747653467972294
ANGELMAN SYNDROME	0.004658403	0.1747653467972294
PUERTO RICAN INFANT HYPOTONIA SYNDROME	0.004658403	0.1747653467972294
CHROMOSOME 19P13.13 DELETION SYNDROME	0.004658403	0.1747653467972294
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY	0.004658403	0.1747653467972294
PROPIONIC ACIDEMIA	0.004658403	0.1747653467972294
X-LINKED CREATINE TRANSPORTER DEFICIENCY	0.004658403	0.1747653467972294
XQ28 (MECP2) DUPLICATION	0.004658403	0.1747653467972294
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 1; IHPRF1	0.004658403	0.1747653467972294
HOLOPROSENCEPHALY 2; HPE2	0.004658403	0.1747653467972294
MALONYL-COA DECARBOXYLASE DEFICIENCY	0.004658403	0.1747653467972294
HYPOTONIA-SPEECH IMPAIRMENT-SEVERE COGNITIVE DELAY SYNDROME	0.004658403	0.1747653467972294
BARTTER SYNDROME, TYPE 1, ANTENATAL	0.004658403	0.1747653467972294
KAGAMI-OGATA SYNDROME	0.004658403	0.1747653467972294
BARTTER SYNDROME, ANTENATAL, TYPE 2	0.004658403	0.1747653467972294
CEREBELLAR ATAXIA, NONPROGRESSIVE, WITH MENTAL RETARDATION; CANPMR	0.004658403	0.1747653467972294
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 17; MC1DN17	0.004535253	0.17014523289594635
LEUKOENCEPHALOPATHY, BRAIN CALCIFICATIONS, AND CYSTS	0.004535253	0.17014523289594635
X-LINKED INTELLECTUAL DISABILITY, PAI TYPE	0.004535253	0.17014523289594635
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLE COMPLEMENTATION TYPE	0.004535253	0.17014523289594635
NIEMANN-PICK DISEASE TYPE C	0.004535253	0.17014523289594635
FOIX-CHAVANY-MARIE SYNDROME	0.004535253	0.17014523289594635
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 37; EIEE37	0.004535253	0.17014523289594635
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLG COMPLEMENTATION TYPE	0.004535253	0.17014523289594635
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA, TYPE CBLD	0.004535253	0.17014523289594635
FREE SIALIC ACID STORAGE DISEASE	0.0045352529999999995	0.17014523289594632
HSD10 DISEASE	0.0045352529999999995	0.17014523289594632
AUTOSOMAL DOMINANT OPTIC ATROPHY, CLASSIC FORM	0.0045352529999999995	0.17014523289594632
PEROXISOMAL ACYL-COA OXIDASE DEFICIENCY	0.0045352529999999995	0.17014523289594632
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 3; PEOA3	0.0045352529999999995	0.17014523289594632
NON-PROGRESSIVE PREDOMINANTLY POSTERIOR CAVITATING LEUKOENCEPHALOPATHY WITH PERIPHERAL NEUROPATHY	0.0045352529999999995	0.17014523289594632
METABOLIC ENCEPHALOMYOPATHIC CRISES, RECURRENT, WITH RHABDOMYOLYSIS, CARDIAC ARRHYTHMIAS, AND NEURODEGENERATION; MECRCN	0.0045352529999999995	0.17014523289594632
CHROMOSOME 22Q13 DUPLICATION SYNDROME	0.004511633	0.16925910142742578
MICROCEPHALY 15, PRIMARY, AUTOSOMAL RECESSIVE	0.004511633	0.16925910142742578
MENTAL RETARDATION, X-LINKED 90	0.004511633	0.16925910142742578
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 4	0.004511633	0.16925910142742578
MENTAL RETARDATION, AUTOSOMAL DOMINANT 56; MRD56	0.004511633	0.16925910142742578
OPTIC ATROPHY-INTELLECTUAL DISABILITY SYNDROME	0.004511632999999999	0.16925910142742576
CHROMOSOME 1Q41-Q42 DELETION SYNDROME	0.004511632999999999	0.16925910142742576
CHROMOSOME 5P13 DUPLICATION SYNDROME	0.004511632999999999	0.16925910142742576
MENTAL RETARDATION, AUTOSOMAL DOMINANT 49; MRD49	0.004511632999999999	0.16925910142742576
DISTAL MONOSOMY 15Q	0.004511632999999999	0.16925910142742576
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 75; EIEE75	0.004511632999999999	0.16925910142742576
LEUKODYSTROPHY, HYPOMYELINATING, 10; HLD10	0.004511632999999999	0.16925910142742576
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT VARIABLE BRAIN ABNORMALITIES; NEDBA	0.004511632999999999	0.16925910142742576
10Q22.3Q23.3 MICRODELETION SYNDROME	0.004511632999999999	0.16925910142742576
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY AND STRUCTURAL BRAIN ANOMALIES; NEDMIBA	0.004511632999999999	0.16925910142742576
PMM2-CDG	0.004511632999999999	0.16925910142742576
TRISOMY X	0.004511632999999999	0.16925910142742576
MENTAL RETARDATION, X-LINKED, SYNDROMIC, TURNER TYPE; MRXST	0.004511632999999999	0.16925910142742576
PONTOCEREBELLAR HYPOPLASIA TYPE 7	0.004511632999999999	0.16925910142742576
AHDC1-RELATED INTELLECTUAL DISABILITY-OBSTRUCTIVE SLEEP APNEA-MILD DYSMORPHISM SYNDROME	0.004511632999999999	0.16925910142742576
8P23.1 MICRODELETION SYNDROME	0.004511632999999999	0.16925910142742576
OCULAR ANOMALIES-AXONAL NEUROPATHY-DEVELOPMENTAL DELAY SYNDROME	0.004511632999999999	0.16925910142742576
PRADER-WILLI SYNDROME; PWS	0.004511632999999999	0.16925910142742576
WIEACKER-WOLFF SYNDROME	0.004511632999999999	0.16925910142742576
CK SYNDROME	0.004511632999999999	0.16925910142742576
KOOLEN-DE VRIES SYNDROME	0.004511632999999999	0.16925910142742576
C SYNDROME	0.004511632999999999	0.16925910142742576
6Q25 MICRODELETION SYNDROME	0.004511632999999999	0.16925910142742576
FAMILIAL VISCERAL MYOPATHY	0.0042734999999999995	0.1603252680238184
XY TYPE GONADAL DYSGENESIS-ASSOCIATED ANOMALIES SYNDROME	0.0042734999999999995	0.1603252680238184
FACIAL DYSMORPHISM-SHAWL SCROTUM-JOINT LAXITY SYNDROME	0.0042734999999999995	0.1603252680238184
FETAL MINOXIDIL SYNDROME	0.0042734999999999995	0.1603252680238184
BECKWITH-WIEDEMANN SYNDROME	0.0042734999999999995	0.1603252680238184
HYPERTRICHOTIC OSTEOCHONDRODYSPLASIA	0.0042734999999999995	0.1603252680238184
FRASER SYNDROME	0.0042734999999999995	0.1603252680238184
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IC; ARCL1C	0.0042734999999999995	0.1603252680238184
MENTAL RETARDATION, X-LINKED, SYNDROMIC, MARTIN-PROBST TYPE	0.0042734999999999995	0.1603252680238184
CATARACT-ABERRANT ORAL FRENULA-GROWTH DELAY SYNDROME	0.0042734999999999995	0.1603252680238184
OSTEOGENESIS IMPERFECTA, TYPE XVIII; OI18	0.0042734999999999995	0.1603252680238184
AUTOSOMAL DOMINANT CUTIS LAXA	0.0042734999999999995	0.1603252680238184
BLADDER EXSTROPHY	0.0042734999999999995	0.1603252680238184
EHLERS-DANLOS SYNDROME, PERIODONTAL TYPE, 2; EDSPD2	0.0042734999999999995	0.1603252680238184
ARTERIAL TORTUOSITY SYNDROME	0.0042734999999999995	0.1603252680238184
SCHWARTZ-JAMPEL SYNDROME, TYPE 1; SJS1	0.0042734999999999995	0.1603252680238184
VASCULAR MALFORMATION, PRIMARY INTRAOSSEOUS	0.0042734999999999995	0.1603252680238184
GORLIN-CHAUDHRY-MOSS SYNDROME	0.0042734999999999995	0.1603252680238184
LEPRECHAUNISM	0.0042734999999999995	0.1603252680238184
MEGACYSTIS-MICROCOLON-INTESTINAL HYPOPERISTALSIS SYNDROME	0.0042734999999999995	0.1603252680238184
AUTOSOMAL RECESSIVE SPONDYLOCOSTAL DYSOSTOSIS	0.0042734999999999995	0.1603252680238184
HURLER-SCHEIE SYNDROME	0.0042734999999999995	0.1603252680238184
GROWTH RETARDATION, DEAFNESS, FEMORAL EPIPHYSEAL DYSPLASIA, AND LACRIMAL DUCT OBSTRUCTION	0.0042734999999999995	0.1603252680238184
LOEYS-DIETZ SYNDROME 3; LDS3	0.0042734999999999995	0.1603252680238184
INTELLECTUAL DISABILITY, BUENOS-AIRES TYPE	0.0042734999999999995	0.1603252680238184
CONGENITAL HEMIDYSPLASIA WITH ICHTHYOSIFORM ERYTHRODERMA AND LIMB DEFECTS	0.0042734999999999995	0.1603252680238184
FAMILIAL PRIMARY HYPOMAGNESEMIA WITH HYPERCALCIURIA AND NEPHROCALCINOSIS WITH SEVERE OCULAR INVOLVEMENT	0.0042734999999999995	0.1603252680238184
ACHONDROGENESIS	0.0042734999999999995	0.1603252680238184
LATERAL MENINGOCELE SYNDROME	0.0042734999999999995	0.1603252680238184
EHLERS-DANLOS SYNDROME, TYPE I	0.0042734999999999995	0.1603252680238184
MUSCULAR HYPERTONIA, LETHAL	0.0042734999999999995	0.1603252680238184
ANEURYSM-OSTEOARTHRITIS SYNDROME	0.0042734999999999995	0.1603252680238184
FOCAL DERMAL HYPOPLASIA	0.0042734999999999995	0.1603252680238184
EHLERS-DANLOS SYNDROME, KYPHOSCOLIOTIC TYPE, 2; EDSKSCL2	0.0042734999999999995	0.1603252680238184
CARPENTER SYNDROME	0.0042734999999999995	0.1603252680238184
ANOPHTHALMIA-MEGALOCORNEA-CARDIOPATHY-SKELETAL ANOMALIES SYNDROME	0.0042734999999999995	0.1603252680238184
LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 2	0.0042734999999999995	0.1603252680238184
DEAFNESS-INTELLECTUAL DISABILITY SYNDROME, MARTIN-PROBST TYPE	0.0042734999999999995	0.1603252680238184
LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 1	0.0042734999999999995	0.1603252680238184
FRANK-TER HAAR SYNDROME	0.0042734999999999995	0.1603252680238184
SCARF SYNDROME	0.0042734999999999995	0.1603252680238184
ISOLATED CLEFT LIP	0.0042734999999999995	0.1603252680238184
SHPRINTZEN-GOLDBERG SYNDROME	0.0042734999999999995	0.1603252680238184
VELOCARDIOFACIAL SYNDROME	0.0042734999999999995	0.1603252680238184
OSTEOGENESIS IMPERFECTA, TYPE XIII	0.0042734999999999995	0.1603252680238184
HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 4	0.0042734999999999995	0.1603252680238184
ACHONDROGENESIS TYPE 2	0.0042734999999999995	0.1603252680238184
ACHONDROGENESIS TYPE 1A	0.0042734999999999995	0.1603252680238184
SCARF SYNDROME	0.0042734999999999995	0.1603252680238184
ACHONDROGENESIS TYPE 1B	0.0042734999999999995	0.1603252680238184
X-LINKED EHLERS-DANLOS SYNDROME	0.0042734999999999995	0.1603252680238184
RIN2 SYNDROME	0.0042734999999999995	0.1603252680238184
COOPER-JABS SYNDROME	0.0042734999999999995	0.1603252680238184
MEIER-GORLIN SYNDROME 6; MGORS6	0.0042734999999999995	0.1603252680238184
ROBINOW SYNDROME, AUTOSOMAL DOMINANT 2; DRS2	0.0042734999999999995	0.1603252680238184
MUCOPOLYSACCHARIDOSIS TYPE 7	0.0042734999999999995	0.1603252680238184
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 15; GPIBD15	0.004251533	0.15950115075163424
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 2; MCCRP2	0.004251533	0.15950115075163424
LEUKODYSTROPHY, HYPOMYELINATING, 3; HLD3	0.004251533	0.15950115075163424
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 12; COXPD12	0.004251533	0.15950115075163424
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 1; MCCRP1	0.004251533	0.15950115075163424
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 23	0.004251533	0.15950115075163424
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 14; COXPD14	0.004251533	0.15950115075163424
GALACTOSEMIA	0.004251533	0.15950115075163424
HOMOCYSTINURIA WITHOUT METHYLMALONIC ACIDURIA	0.004251533	0.15950115075163424
MITOCHONDRIAL DNA DEPLETION SYNDROME, ENCEPHALOMYOPATHIC FORM WITH METHYLMALONIC ACIDURIA	0.004251533	0.15950115075163424
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE II; CDG1I	0.004251533	0.15950115075163424
GALLOWAY-MOWAT SYNDROME 3; GAMOS3	0.004251533	0.15950115075163424
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 23	0.004251533	0.15950115075163424
RFT1-CDG	0.004251533	0.15950115075163424
GALLOWAY-MOWAT SYNDROME 4; GAMOS4	0.004251533	0.15950115075163424
X-LINKED INTELLECTUAL DISABILITY-HYPOTONIA-MOVEMENT DISORDER SYNDROME	0.004251533	0.15950115075163424
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 3; MCAHS3	0.004251533	0.15950115075163424
LEIGH SYNDROME WITH CARDIOMYOPATHY	0.004251533	0.15950115075163424
NEURODEVELOPMENTAL DISORDER WITH CEREBELLAR ATROPHY AND WITH OR WITHOUT SEIZURES; NEDCAS	0.004251533	0.15950115075163424
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 3	0.004251533	0.15950115075163424
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 37; COXPD37	0.004251533	0.15950115075163424
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 2 WITH HYPERGLYCINEMIA; MMDS2	0.004251533	0.15950115075163424
HELSMOORTEL-VAN DER AA SYNDROME	0.004251533	0.15950115075163424
HOMOCYSTINURIA DUE TO CYSTATHIONINE BETA-SYNTHASE DEFICIENCY	0.004251533	0.15950115075163424
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 2	0.004251533	0.15950115075163424
HEART AND BRAIN MALFORMATION SYNDROME	0.004251533	0.15950115075163424
PROPIONIC ACIDEMIA	0.004116984	0.15445339025383692
PARKINSONISM-DYSTONIA, INFANTILE, 1; PKDYS1	0.004116984	0.15445339025383692
FLOATING-HARBOR SYNDROME	0.004116984	0.15445339025383692
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 32; COXPD32	0.004116984	0.15445339025383692
INTELLECTUAL DEVELOPMENTAL DISORDER WITH GASTROINTESTINAL DIFFICULTIES AND HIGH PAIN THRESHOLD	0.004116984	0.15445339025383692
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 20	0.004116984	0.15445339025383692
300270 ADRENOMYODYSTROPHY	0.004116984	0.15445339025383692
NIEMANN-PICK DISEASE, TYPE A	0.004116984	0.15445339025383692
ATHYREOSIS	0.004116984	0.15445339025383692
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IR	0.004116984	0.15445339025383692
THYROID HYPOPLASIA	0.004116984	0.15445339025383692
IDIOPATHIC CONGENITAL HYPOTHYROIDISM	0.004116984	0.15445339025383692
INFANTILE DYSTONIA-PARKINSONISM	0.004116984	0.15445339025383692
HYPOPHOSPHATASIA, INFANTILE	0.004112849	0.15429826097262048
ALPHA-THALASSEMIA-X-LINKED INTELLECTUAL DISABILITY SYNDROME	0.004112849	0.15429826097262048
PORPHYRIA	0.004112849	0.15429826097262048
GITELMAN SYNDROME	0.004112849	0.15429826097262048
PORPHYRIA DUE TO ALA DEHYDRATASE DEFICIENCY	0.004112849	0.15429826097262048
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 2; IHPRF2	0.004112849	0.15429826097262048
PAROXYSMAL EXTREME PAIN DISORDER	0.004112849	0.15429826097262048
RETT SYNDROME; RTT	0.004112849	0.15429826097262048
ACUTE ADRENAL INSUFFICIENCY	0.004112849	0.15429826097262048
HEREDITARY FRUCTOSE INTOLERANCE	0.004112849	0.15429826097262048
WOLFRAM SYNDROME	0.004112849	0.15429826097262048
PORPHYRIA VARIEGATA	0.004112849	0.15429826097262048
ACUTE INTERMITTENT PORPHYRIA	0.004112849	0.15429826097262048
AUTOSOMAL DOMINANT PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA	0.004112849	0.15429826097262048
HEREDITARY COPROPORPHYRIA	0.004112849	0.15429826097262048
DDOST-CDG	0.004112849	0.15429826097262048
AUTISM, SUSCEPTIBILITY TO, 18	0.004112849	0.15429826097262048
COMBINED PITUITARY HORMONE DEFICIENCIES, GENETIC FORMS	0.004112849	0.15429826097262048
LUBS X-LINKED MENTAL RETARDATION SYNDROME; MRXSL	0.004112849	0.15429826097262048
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL DOMINANT; NDHMSD	0.004112849	0.15429826097262048
RETT SYNDROME, CONGENITAL VARIANT	0.004112849	0.15429826097262048
LATE-ONSET ISOLATED ACTH DEFICIENCY	0.004112849	0.15429826097262048
DIABETES INSIPIDUS, NEPHROGENIC, X-LINKED	0.004112849	0.15429826097262048
ADIPOSIS DOLOROSA	0.004112849	0.15429826097262048
INTELLECTUAL DISABILITY-SEVERE SPEECH DELAY-MILD DYSMORPHISM SYNDROME	0.004112849	0.15429826097262048
FAMILIAL MEDITERRANEAN FEVER	0.004112849	0.15429826097262048
ADDISON DISEASE	0.004112849	0.15429826097262048
DIABETES INSIPIDUS, NEPHROGENIC, AUTOSOMAL	0.004112849	0.15429826097262048
KAGAMI-OGATA SYNDROME	0.004063163	0.1524342335321077
CHÉDIAK-HIGASHI SYNDROME	0.004063163	0.1524342335321077
MICROCEPHALY-SEIZURES-INTELLECTUAL DISABILITY-HEART DISEASE SYNDROME	0.004063163	0.1524342335321077
RECOMBINANT CHROMOSOME 8 SYNDROME	0.004063163	0.1524342335321077
MENTAL RETARDATION, X-LINKED 99, SYNDROMIC, FEMALE-RESTRICTED	0.004063163	0.1524342335321077
PRIMARY NON-ESSENTIAL CUTIS VERTICIS GYRATA	0.004063163	0.1524342335321077
OCULOECTODERMAL SYNDROME; OES	0.004063163	0.1524342335321077
15Q14 MICRODELETION SYNDROME	0.004063163	0.1524342335321077
POLYHYDRAMNIOS, MEGALENCEPHALY, AND SYMPTOMATIC EPILEPSY; PMSE	0.004063163	0.1524342335321077
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 1; MCAHS1	0.004063163	0.1524342335321077
PROXIMAL 16P11.2 MICRODELETION SYNDROME	0.004063163	0.1524342335321077
GENITOPATELLAR SYNDROME	0.004063163	0.1524342335321077
RECOMBINANT 8 SYNDROME	0.004063163	0.1524342335321077
CODAS SYNDROME	0.004063163	0.1524342335321077
ADAMS-OLIVER SYNDROME 1; AOS1	0.004063163	0.1524342335321077
HYPERMETHIONINEMIA DUE TO ADENOSINE KINASE DEFICIENCY	0.004063163	0.1524342335321077
20P12.3 MICRODELETION SYNDROME	0.004063163	0.1524342335321077
AUTOSOMAL DOMINANT INTELLECTUAL DISABILITY-CRANIOFACIAL ANOMALIES-CARDIAC DEFECTS SYNDROME	0.004063163	0.1524342335321077
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME	0.004063163	0.1524342335321077
MENTAL RETARDATION, AUTOSOMAL DOMINANT 32; MRD32	0.004063163	0.1524342335321077
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, SBBYS TYPE	0.004063163	0.1524342335321077
HYPERMANGANESEMIA WITH DYSTONIA 2	0.003993834	0.14983327635255386
RADIOULNAR SYNOSTOSIS-DEVELOPMENTAL DELAY-HYPOTONIA SYNDROME	0.003993834	0.14983327635255386
SHWACHMAN-DIAMOND SYNDROME	0.003993834	0.14983327635255386
JOUBERT SYNDROME 24	0.003993834	0.14983327635255386
SPASTIC PARAPLEGIA 9B, AUTOSOMAL RECESSIVE; SPG9B	0.003993834	0.14983327635255386
3Q29 MICRODELETION SYNDROME	0.003993834	0.14983327635255386
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 8; MC3DN8	0.003993834	0.14983327635255386
CONGENITAL MUSCULAR DYSTROPHY DUE TO LMNA MUTATION	0.003993834	0.14983327635255386
ALACRIMA, ACHALASIA, AND MENTAL RETARDATION SYNDROME	0.003993834	0.14983327635255386
X-LINKED INTELLECTUAL DISABILITY-HYPOTONIA-FACIAL DYSMORPHISM-AGGRESSIVE BEHAVIOR SYNDROME	0.003993834	0.14983327635255386
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 4; NBIA4	0.003993834	0.14983327635255386
SPASTIC PARAPLEGIA 53, AUTOSOMAL RECESSIVE	0.003993834	0.14983327635255386
PARTINGTON SYNDROME	0.003989699	0.14967814707133742
CHOREOACANTHOCYTOSIS	0.003989699	0.14967814707133742
CHOREOATHETOSIS, FAMILIAL INVERTED	0.003989699	0.14967814707133742
WOLCOTT-RALLISON SYNDROME	0.003989699	0.14967814707133742
RECESSIVE MITOCHONDRIAL ATAXIA SYNDROME	0.003989699	0.14967814707133742
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 23; LGMDR23	0.003989699	0.14967814707133742
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 15	0.003989699	0.14967814707133742
GLUTARYL-COA DEHYDROGENASE DEFICIENCY	0.003989699	0.14967814707133742
EPENDYMOMA	0.003989699	0.14967814707133742
INFANTILE-ONSET X-LINKED SPINAL MUSCULAR ATROPHY	0.003989699	0.14967814707133742
DYSEQUILIBRIUM SYNDROME	0.003989699	0.14967814707133742
FAMILIAL DYSAUTONOMIA	0.003989699	0.14967814707133742
SUBEPENDYMOMA	0.003989699	0.14967814707133742
ALZHEIMER DISEASE 3; AD	0.003989699	0.14967814707133742
KUFOR-RAKEB SYNDROME	0.003989699	0.14967814707133742
LEUKOENCEPHALOPATHY WITH VANISHING WHITE MATTER; VWM	0.003989699	0.14967814707133742
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 2	0.003989699	0.14967814707133742
METACHROMATIC LEUKODYSTROPHY	0.003989699	0.14967814707133742
CENTRONUCLEAR MYOPATHY	0.003989699	0.14967814707133742
SPASTIC PARAPLEGIA 18, AUTOSOMAL RECESSIVE; SPG18	0.003989699	0.14967814707133742
SPONTANEOUS PERIODIC HYPOTHERMIA	0.003989699	0.14967814707133742
CEREBRAL ARTERIOPATHY, AUTOSOMAL DOMINANT, WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY, TYPE 2; CADASIL2	0.003989699	0.14967814707133742
FAMILIAL ACUTE NECROTIZING ENCEPHALOPATHY	0.003989699	0.14967814707133742
ATAXIA-TELANGIECTASIA	0.003989699	0.14967814707133742
COCKAYNE SYNDROME A; CSA	0.003989699	0.14967814707133742
BEHÇET DISEASE	0.003989699	0.14967814707133742
X-LINKED CENTRONUCLEAR MYOPATHY	0.003989699	0.14967814707133742
SEVERE INTELLECTUAL DISABILITY-HYPOTONIA-STRABISMUS-COARSE FACE-PLANOVALGUS SYNDROME	0.003989699	0.14967814707133742
TETRASOMY 18P	0.003989699	0.14967814707133742
COFFIN-LOWRY SYNDROME	0.003989699	0.14967814707133742
SIALIDOSIS TYPE 1	0.003989699	0.14967814707133742
NEURODEVELOPMENTAL DISORDER WITH POOR LANGUAGE AND LOSS OF HAND SKILLS; NDPLHS	0.003989699	0.14967814707133742
GLYCOGEN STORAGE DISEASE DUE TO ACID MALTASE DEFICIENCY	0.003989699	0.14967814707133742
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 11	0.003989699	0.14967814707133742
GLOBAL DEVELOPMENTAL DELAY, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM, AND DYSMORPHIC FACIES; GDACCF	0.003970214	0.1489471448840333
RETINITIS PIGMENTOSA-JUVENILE CATARACT-SHORT STATURE-INTELLECTUAL DISABILITY SYNDROME	0.003970214	0.1489471448840333
TRISOMY 8Q	0.003970214	0.1489471448840333
MICROCEPHALY, SHORT STATURE, AND LIMB ABNORMALITIES; MISSLA	0.003970214	0.1489471448840333
FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS	0.003970214	0.1489471448840333
OROFACIODIGITAL SYNDROME TYPE 14	0.003970214	0.1489471448840333
EPIPHYSEAL DYSPLASIA, MULTIPLE, WITH EARLY-ONSET DIABETES MELLITUS	0.003970214	0.1489471448840333
DISTAL MONOSOMY 9P	0.003970214	0.1489471448840333
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE II; MOPD2	0.003970214	0.1489471448840333
SPINOCEREBELLAR ATAXIA 42, EARLY-ONSET, SEVERE, WITH NEURODEVELOPMENTAL DEFICITS; SCA42ND	0.003970214	0.1489471448840333
MENTAL RETARDATION, X-LINKED 107; MRX107	0.003970214	0.1489471448840333
PENTASOMY X	0.003970214	0.1489471448840333
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 4	0.003970214	0.1489471448840333
LIG4 SYNDROME	0.003970214	0.1489471448840333
XIA-GIBBS SYNDROME	0.003970214	0.1489471448840333
CHROMOSOME 16Q22 DELETION SYNDROME	0.003970214	0.1489471448840333
MENTAL RETARDATION AND DISTINCTIVE FACIAL FEATURES WITH OR WITHOUT CARDIAC DEFECTS	0.003970214	0.1489471448840333
CHROMOSOME 10Q22.3-Q23.2 DELETION SYNDROME	0.003970214	0.1489471448840333
TETRASOMY X	0.003970214	0.1489471448840333
MENTAL RETARDATION, ENTEROPATHY, DEAFNESS, PERIPHERAL NEUROPATHY, ICHTHYOSIS, AND KERATODERMA	0.003970214	0.1489471448840333
RETINAL DYSTROPHY, JUVENILE CATARACTS, AND SHORT STATURE SYNDROME; RDJCSS	0.003970214	0.1489471448840333
ZELLWEGER-LIKE SYNDROME WITHOUT PEROXISOMAL ANOMALIES	0.003970214	0.1489471448840333
10Q22.3Q23.3 MICRODUPLICATION SYNDROME	0.003970214	0.1489471448840333
MENTAL RETARDATION, AUTOSOMAL DOMINANT 40; MRD40	0.003970214	0.1489471448840333
BEAULIEU-BOYCOTT-INNES SYNDROME; BBIS	0.003970214	0.1489471448840333
AUTOSOMAL RECESSIVE PRIMARY MICROCEPHALY	0.003970214	0.1489471448840333
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIG; CDG2G	0.003970214	0.1489471448840333
YUAN-HAREL-LUPSKI SYNDROME; YUHAL	0.003970214	0.1489471448840333
1P21.3 MICRODELETION SYNDROME	0.003970214	0.1489471448840333
INTELLECTUAL DISABILITY, WOLFF TYPE	0.003966079	0.14879201560281685
HENNEKAM-BEEMER SYNDROME	0.003966079	0.14879201560281685
CHIME SYNDROME	0.003966079	0.14879201560281685
BRANCHIOOCULOFACIAL SYNDROME	0.003966079	0.14879201560281685
PEROXISOME BIOGENESIS DISORDER 4A (ZELLWEGER)	0.003966079	0.14879201560281685
INTELLECTUAL DISABILITY-BALDING-PATELLA LUXATION-ACROMICRIA SYNDROME	0.003966079	0.14879201560281685
TELO2-RELATED INTELLECTUAL DISABILITY-NEURODEVELOPMENTAL DISORDER	0.003966079	0.14879201560281685
1Q41Q42 MICRODELETION SYNDROME	0.003966079	0.14879201560281685
MICROCEPHALY WITH OR WITHOUT CHORIORETINOPATHY, LYMPHEDEMA, OR MENTAL RETARDATION; MCLMR	0.003966079	0.14879201560281685
SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 2; CSCSC2	0.003966079	0.14879201560281685
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIE; CDG2E	0.003966079	0.14879201560281685
MENTAL RETARDATION, AUTOSOMAL DOMINANT 20	0.003966079	0.14879201560281685
DISTAL MONOSOMY 7Q36	0.003966079	0.14879201560281685
MACROCEPHALY-INTELLECTUAL DISABILITY-LEFT VENTRICULAR NON COMPACTION SYNDROME	0.003966079	0.14879201560281685
MICROCEPHALIC PRIMORDIAL DWARFISM DUE TO RTTN DEFICIENCY	0.003966079	0.14879201560281685
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 36; MRT36	0.003966079	0.14879201560281685
PEROXISOME BIOGENESIS DISORDER 2A (ZELLWEGER); PBD2A	0.003966079	0.14879201560281685
MENTAL RETARDATION, X-LINKED, SYNDROMIC 34; MRXS34	0.003966079	0.14879201560281685
MIRAGE SYNDROME; MIRAGE	0.003841793	0.14412928335486827
OPTIC PATHWAY GLIOMA	0.003841793	0.14412928335486827
WALKER-WARBURG SYNDROME	0.003841793	0.14412928335486827
MONOSOMY 18Q	0.003841793	0.14412928335486827
CRANIOPHARYNGIOMA	0.003841793	0.14412928335486827
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 12; MDDGA12	0.003841793	0.14412928335486827
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME, PREUS TYPE	0.003841793	0.14412928335486827
X-LINKED CEREBRAL-CEREBELLAR-COLOBOMA SYNDROME	0.003841793	0.14412928335486827
CONGENITAL MUSCULAR DYSTROPHY WITH CEREBELLAR INVOLVEMENT	0.003841793	0.14412928335486827
PFEIFFER SYNDROME TYPE 2	0.003841793	0.14412928335486827
PETTIGREW SYNDROME	0.003841793	0.14412928335486827
1Q21.1 MICRODUPLICATION SYNDROME	0.003841793	0.14412928335486827
ACHONDROPLASIA, SEVERE, WITH DEVELOPMENTAL DELAY AND ACANTHOSIS NIGRICANS; SADDAN	0.003841793	0.14412928335486827
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE	0.003841793	0.14412928335486827
MICROCEPHALY-CORPUS CALLOSUM HYPOPLASIA-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.003841793	0.14412928335486827
INFANTILE SIALIC ACID STORAGE DISEASE	0.003841793	0.14412928335486827
1Q21.1 MICRODELETION SYNDROME	0.003841793	0.14412928335486827
MUENKE SYNDROME	0.003841793	0.14412928335486827
MEGALENCEPHALY-CAPILLARY MALFORMATION-POLYMICROGYRIA SYNDROME	0.003841793	0.14412928335486827
MEND SYNDROME; MEND	0.003841793	0.14412928335486827
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 13; MDDGA13	0.003841793	0.14412928335486827
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 36; EIEE36	0.003841793	0.14412928335486827
MENTAL RETARDATION, AUTOSOMAL DOMINANT 35; MRD35	0.003841793	0.14412928335486827
CEREBRAL-CEREBELLAR-COLOBOMA SYNDROME, X-LINKED	0.0038417929999999996	0.14412928335486824
BAND HETEROTOPIA; BH	0.0038417929999999996	0.14412928335486824
GRACILE BONE DYSPLASIA; GCLEB	0.0038417929999999996	0.14412928335486824
MELANOSIS, NEUROCUTANEOUS; NCMS	0.0038417929999999996	0.14412928335486824
PROLIFERATIVE VASCULOPATHY AND HYDRANENCEPHALY-HYDROCEPHALY SYNDROME; PVHH	0.0038417929999999996	0.14412928335486824
EPIDERMAL NEVUS SYNDROME	0.0037101139999999996	0.13918919420824175
OSTEOPETROSIS WITH RENAL TUBULAR ACIDOSIS	0.0037101139999999996	0.13918919420824175
LETHAL ATAXIA WITH DEAFNESS AND OPTIC ATROPHY	0.0037101139999999996	0.13918919420824175
LEUKODYSTROPHY, HYPOMYELINATING, 13; HLD13	0.0037101139999999996	0.13918919420824175
KHAN-KHAN-KATSANIS SYNDROME; 3KS	0.0037101139999999996	0.13918919420824175
N SYNDROME	0.0037101139999999996	0.13918919420824175
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 7; COXPD7	0.0037101139999999996	0.13918919420824175
COENZYME Q10 DEFICIENCY, PRIMARY, 8; COQ10D8	0.0037101139999999996	0.13918919420824175
PONTOCEREBELLAR HYPOPLASIA, TYPE 1C; PCH1C	0.0037101139999999996	0.13918919420824175
TREACHER-COLLINS SYNDROME	0.0037101139999999996	0.13918919420824175
HYPERTRYPTOPHANEMIA; HYPTRP	0.0037101139999999996	0.13918919420824175
BAKER-GORDON SYNDROME; BAGOS	0.0037101139999999996	0.13918919420824175
PEROXISOME BIOGENESIS DISORDER 5B	0.0037101139999999996	0.13918919420824175
MUCOLIPIDOSIS IV; ML4	0.0037101139999999996	0.13918919420824175
CROUZON SYNDROME	0.003705979	0.1390340649270253
RIBOFLAVIN TRANSPORTER DEFICIENCY	0.003705979	0.1390340649270253
COFS SYNDROME	0.003705979	0.1390340649270253
NEUROPATHY, CONGENITAL HYPOMYELINATING, 3; CHN3	0.003705979	0.1390340649270253
BORJESON-FORSSMAN-LEHMANN SYNDROME; BFLS	0.003705979	0.1390340649270253
MICROPHTHALMIA, LENZ TYPE	0.003705979	0.1390340649270253
PONTOCEREBELLAR HYPOPLASIA, TYPE 2B; PCH2B	0.003705979	0.1390340649270253
PONTOCEREBELLAR HYPOPLASIA, TYPE 2A; PCH2A	0.003705979	0.1390340649270253
VASCULOPATHY, RETINAL, WITH CEREBRAL LEUKODYSTROPHY; RVCL	0.003705979	0.1390340649270253
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 3; MMDS3	0.003705979	0.1390340649270253
TRIPLE A SYNDROME	0.003705979	0.1390340649270253
FILIPPI SYNDROME; FLPIS	0.003705979	0.1390340649270253
GRANULOMATOSIS WITH POLYANGIITIS	0.003705979	0.1390340649270253
AUTOSOMAL RECESSIVE CHORIORETINOPATHY-MICROCEPHALY SYNDROME	0.003705979	0.1390340649270253
NEONATAL ADRENOLEUKODYSTROPHY	0.003705979	0.1390340649270253
FLYNN-AIRD SYNDROME	0.003705979	0.1390340649270253
IMMUNODEFICIENCY 26 WITH OR WITHOUT NEUROLOGIC ABNORMALITIES; IMD26	0.003705979	0.1390340649270253
HEPATIC FIBROSIS-RENAL CYSTS-INTELLECTUAL DISABILITY SYNDROME	0.003705979	0.1390340649270253
INFANTILE NEUROAXONAL DYSTROPHY	0.003705979	0.1390340649270253
PDE4D HAPLOINSUFFICIENCY SYNDROME	0.003705979	0.1390340649270253
HYPERPARATHYROIDISM-JAW TUMOR SYNDROME	0.00357143	0.13398630442922801
HYPERPARATHYROIDISM, NEONATAL SEVERE	0.00357143	0.13398630442922801
PRIMARY PERITONEAL CARCINOMA	0.00357143	0.13398630442922801
UROFACIAL SYNDROME	0.00357143	0.13398630442922801
WOUND BOTULISM	0.00357143	0.13398630442922801
INFANT BOTULISM	0.00357143	0.13398630442922801
NK-CELL ENTEROPATHY	0.00357143	0.13398630442922801
GASTROINTESTINAL STROMAL TUMOR	0.00357143	0.13398630442922801
13Q12.3 MICRODELETION SYNDROME	0.00357143	0.13398630442922801
TOXIN-MEDIATED INFECTIOUS BOTULISM	0.00357143	0.13398630442922801
UROFACIAL SYNDROME 2	0.00357143	0.13398630442922801
SECONDARY SHORT BOWEL SYNDROME	0.00357143	0.13398630442922801
PERITONEAL CYSTIC MESOTHELIOMA	0.00357143	0.13398630442922801
GRFOMA	0.00357143	0.13398630442922801
HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 1; HSCR1	0.00357143	0.13398630442922801
HIRSCHSPRUNG DISEASE	0.00357143	0.13398630442922801
THYROTOXIC PERIODIC PARALYSIS	0.00357143	0.13398630442922801
KAPUR-TORIELLO SYNDROME	0.00357143	0.13398630442922801
PITT-HOPKINS-LIKE SYNDROME 2; PTHSL2	0.00357143	0.13398630442922801
TURCOT SYNDROME WITH POLYPOSIS	0.00357143	0.13398630442922801
ATTRV30M AMYLOIDOSIS	0.00357143	0.13398630442922801
FG SYNDROME 2; FGS2	0.00357143	0.13398630442922801
HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 6; CHNG6	0.00357143	0.13398630442922801
TYPHOID	0.00357143	0.13398630442922801
SILVER-RUSSELL SYNDROME	0.00357143	0.13398630442922801
ADIPOSIS DOLOROSA	0.00357143	0.13398630442922801
LIDDLE SYNDROME	0.00357143	0.13398630442922801
PSEUDOMYXOMA PERITONEI	0.00357143	0.13398630442922801
ANAL SPHINCTER MYOPATHY, INTERNAL	0.00357143	0.13398630442922801
JUVENILE DERMATOMYOSITIS	0.00357143	0.13398630442922801
ANAL SPHINCTER DYSPLASIA; ASDP	0.00357143	0.13398630442922801
PRIMARY PARATHYROID HYPERPLASIA	0.00357143	0.13398630442922801
PPOMA	0.00357143	0.13398630442922801
YOUNG-ONSET PARKINSON DISEASE	0.00357143	0.13398630442922801
THYROTROPIN-RELEASING HORMONE DEFICIENCY	0.00357143	0.13398630442922801
GLUCAGONOMA	0.00357143	0.13398630442922801
PUDENDAL NEURALGIA	0.00357143	0.13398630442922801
TUMOR NECROSIS FACTOR RECEPTOR 1 ASSOCIATED PERIODIC SYNDROME	0.00357143	0.13398630442922801
DIASTASIS RECTI AND WEAKNESS OF THE LINEA ALBA	0.00357143	0.13398630442922801
PARATHYROID CARCINOMA	0.00357143	0.13398630442922801
CAP POLYPOSIS	0.00357143	0.13398630442922801
HINMAN SYNDROME	0.00357143	0.13398630442922801
SACRAL DEFECT WITH ANTERIOR MENINGOCELE	0.00357143	0.13398630442922801
LAMBERT-EATON MYASTHENIC SYNDROME	0.00357143	0.13398630442922801
MITOCHONDRIAL DNA DEPLETION SYNDROME 1 (MNGIE TYPE); MTDPS1	0.00357143	0.13398630442922801
PARKINSON DISEASE, LATE-ONSET; PD	0.00357143	0.13398630442922801
SEVERE GENERALIZED RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA	0.00357143	0.13398630442922801
IATROGENIC BOTULISM	0.00357143	0.13398630442922801
RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA INVERSA	0.00357143	0.13398630442922801
INHALATIONAL BOTULISM	0.00357143	0.13398630442922801
CENTRAL HYPOVENTILATION SYNDROME, CONGENITAL; CCHS	0.00357143	0.13398630442922801
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE VII; HSAN7	0.00357143	0.13398630442922801
IGG4-RELATED RETROPERITONEAL FIBROSIS	0.00357143	0.13398630442922801
RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA, GENERALIZED INTERMEDIATE	0.00357143	0.13398630442922801
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE III	0.00357143	0.13398630442922801
SHEEHAN SYNDROME	0.00357143	0.13398630442922801
SOLITARY FIBROUS TUMOUR/HEMANGIOPERICYTOMA	0.00357143	0.13398630442922801
EPIDERMOLYSIS BULLOSA SIMPLEX, GENERALIZED SEVERE	0.00357143	0.13398630442922801
MULTIPLE SYSTEM ATROPHY, CEREBELLAR TYPE	0.00357143	0.13398630442922801
AUTOSOMAL RECESSIVE DOPA-RESPONSIVE DYSTONIA	0.00357143	0.13398630442922801
MUSCULOCONTRACTURAL EHLERS-DANLOS SYNDROME	0.00357143	0.13398630442922801
MYXEDEMA	0.00357143	0.13398630442922801
MULTIPLE ENDOCRINE NEOPLASIA TYPE 2	0.00357143	0.13398630442922801
SOMATOSTATINOMA	0.00357143	0.13398630442922801
VISCERAL MYOPATHY; VSCM	0.00357143	0.13398630442922801
PORPHYRIA VARIEGATA	0.00357143	0.13398630442922801
LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 4; CGL4	0.00357143	0.13398630442922801
%193250 VOLVULUS OF MIDGUT;;INTESTINAL MALROTATION, FAMILIAL	0.00357143	0.13398630442922801
MULTIPLE SYSTEM ATROPHY, PARKINSONIAN TYPE	0.00357143	0.13398630442922801
BOTULISM	0.00357143	0.13398630442922801
PANHYPOPITUITARISM	0.00357143	0.13398630442922801
NEUROENDOCRINE NEOPLASM OF APPENDIX	0.00357143	0.13398630442922801
MYOPATHY, MYOFIBRILLAR, 1; MFM1	0.00357143	0.13398630442922801
NEUROENDOCRINE TUMOR OF THE RECTUM	0.00357143	0.13398630442922801
MULTIPLE SYSTEM ATROPHY	0.00357143	0.13398630442922801
NEUROENDOCRINE TUMOR OF ANAL CANAL	0.00357143	0.13398630442922801
FOODBORNE BOTULISM	0.00357143	0.13398630442922801
TURNPENNY-FRY SYNDROME; TPFS	0.0035217440000000003	0.13212227698871523
ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 1	0.0035217440000000003	0.13212227698871523
NOONAN SYNDROME 3; NS3	0.0035217440000000003	0.13212227698871523
TRANSALDOLASE DEFICIENCY	0.0035217440000000003	0.13212227698871523
OROTIC ACIDURIA	0.0035217440000000003	0.13212227698871523
RABSON-MENDENHALL SYNDROME	0.0035217440000000003	0.13212227698871523
MCKUSICK-KAUFMAN SYNDROME	0.0035217440000000003	0.13212227698871523
SYNDROMIC DIARRHEA	0.0035217440000000003	0.13212227698871523
GENITOPATELLAR SYNDROME; GTPTS	0.0035217440000000003	0.13212227698871523
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLJ TYPE	0.0035217440000000003	0.13212227698871523
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 65; MRT65	0.0035217440000000003	0.13212227698871523
ZECHI-CEIDE SYNDROME	0.0035217440000000003	0.13212227698871523
DISTAL MONOSOMY 6P	0.0035217440000000003	0.13212227698871523
HAMEL CEREBRO-PALATO-CARDIAC SYNDROME	0.0035217440000000003	0.13212227698871523
609945 BRACHYPHALANGY, POLYDACTYLY, AND TIBIAL APLASIA/HYPOPLASIA	0.0035217440000000003	0.13212227698871523
MYELODYSPLASIA, IMMUNODEFICIENCY, FACIAL DYSMORPHISM, SHORT STATURE,	0.0035217440000000003	0.13212227698871523
NOONAN SYNDROME 11; NS11	0.0035217440000000003	0.13212227698871523
CHROMOSOME 17Q23.1-Q23.2 DELETION SYNDROME	0.0035217440000000003	0.13212227698871523
THOC6-RELATED DEVELOPMENTAL DELAY-MICROCEPHALY-FACIAL DYSMORPHISM SYNDROME	0.0035217440000000003	0.13212227698871523
HADZISELIMOVIC SYNDROME	0.0035217440000000003	0.13212227698871523
IMMUNODEFICIENCY, DEVELOPMENTAL DELAY, AND HYPOHOMOCYSTEINEMIA; IMDDHH	0.0035217440000000003	0.13212227698871523
NEUTROPENIA, SEVERE CONGENITAL, 4, AUTOSOMAL RECESSIVE; SCN4	0.0035217440000000003	0.13212227698871523
SECKEL SYNDROME 9; SCKL9	0.0035217440000000003	0.13212227698871523
BARDET-BIEDL SYNDROME 2	0.0035217440000000003	0.13212227698871523
16P13.11 MICRODUPLICATION SYNDROME	0.0035217440000000003	0.13212227698871523
VERTEBRAL, CARDIAC, RENAL, AND LIMB DEFECTS SYNDROME 1; VCRL1	0.0035217440000000003	0.13212227698871523
SPONDYLODYSPLASTIC EHLERS-DANLOS SYNDROME	0.0035217440000000003	0.13212227698871523
LYMPHEDEMA, HEREDITARY, III	0.0035217440000000003	0.13212227698871523
NOONAN SYNDROME 5; NS5	0.0035217440000000003	0.13212227698871523
VERTEBRAL ANOMALIES AND VARIABLE ENDOCRINE AND T-CELL DYSFUNCTION; VETD	0.0035217440000000003	0.13212227698871523
%300712 CRANIOFACIOSKELETAL SYNDROME	0.0035217440000000003	0.13212227698871523
FETAL ALCOHOL SYNDROME	0.0035217440000000003	0.13212227698871523
CHOREOATHETOSIS, HYPOTHYROIDISM, AND NEONATAL RESPIRATORY DISTRESSCHOREOATHETOSIS AND CONGENITAL HYPOTHYROIDISM, INCLUDED	0.0035217440000000003	0.13212227698871523
MENTAL RETARDATION, AUTOSOMAL DOMINANT 21	0.0035217440000000003	0.13212227698871523
TRISOMY 18	0.0035217440000000003	0.13212227698871523
TYSHCHENKO SYNDROME	0.0035217440000000003	0.13212227698871523
608227 CRANIOFACIAL ABNORMALITIES, CATARACTS, CONGENITAL HEART DISEASE, SACRALNEURAL TUBE DEFECTS, AND GROWTH AND DEVELOPMENTAL RETARDATION	0.0035217440000000003	0.13212227698871523
LUNG AGENESIS-HEART DEFECT-THUMB ANOMALIES SYNDROME	0.003517609	0.13196714770749876
21Q22.11Q22.12 MICRODELETION SYNDROME	0.003517609	0.13196714770749876
SCHINZEL-GIEDION MIDFACE-RETRACTION SYNDROME	0.003517609	0.13196714770749876
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IID; ARCL2D	0.003517609	0.13196714770749876
AICAR TRANSFORMYLASE/IMP CYCLOHYDROLASE DEFICIENCY	0.003517609	0.13196714770749876
TRISOMY 13	0.003517609	0.13196714770749876
CHROMOSOME 17Q12 DUPLICATION SYNDROME	0.003517609	0.13196714770749876
FRYNS SYNDROME; FRNS	0.003517609	0.13196714770749876
X-LINKED INTELLECTUAL DISABILITY WITH MARFANOID HABITUS	0.003517609	0.13196714770749876
ACROCARDIOFACIAL SYNDROME	0.003517609	0.13196714770749876
NOONAN SYNDROME 7; NS7	0.003517609	0.13196714770749876
DISTAL 7Q11.23 MICRODELETION SYNDROME	0.003517609	0.13196714770749876
BENIGN HEREDITARY CHOREA	0.00344828	0.12936619052794493
AUTOSOMAL DOMINANT CHARCOT-MARIE-TOOTH DISEASE TYPE 2K	0.00344828	0.12936619052794493
MAST SYNDROME	0.00344828	0.12936619052794493
HUNTINGTON DISEASE-LIKE 2	0.00344828	0.12936619052794493
RICHARDS-RUNDLE SYNDROME	0.00344828	0.12936619052794493
PARALYSIS AGITANS, JUVENILE, OF HUNT	0.00344828	0.12936619052794493
SPINOCEREBELLAR ATAXIA TYPE 5	0.00344828	0.12936619052794493
ATAXIA-PHOTOSENSITIVITY-SHORT STATURE SYNDROME	0.00344828	0.12936619052794493
BEHR SYNDROME	0.00344828	0.12936619052794493
CEREBELLAR ATAXIA-ECTODERMAL DYSPLASIA SYNDROME	0.00344828	0.12936619052794493
AUTOSOMAL RECESSIVE CEREBELLOPARENCHYMAL DISORDER TYPE 3	0.00344828	0.12936619052794493
PRIMARY DYSTONIA, DYT4 TYPE	0.00344828	0.12936619052794493
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 26	0.00344828	0.12936619052794493
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 1	0.00344828	0.12936619052794493
PROGRESSIVE PSEUDORHEUMATOID ARTHROPATHY OF CHILDHOOD	0.00344828	0.12936619052794493
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 3	0.00344828	0.12936619052794493
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 4	0.00344828	0.12936619052794493
KENNEDY DISEASE	0.00344828	0.12936619052794493
LATE-ONSET DISTAL MYOPATHY, MARKESBERY-GRIGGS TYPE	0.00344828	0.12936619052794493
KUSKOKWIM SYNDROME	0.00344828	0.12936619052794493
AUTOSOMAL DOMINANT CEREBELLAR ATAXIA	0.00344828	0.12936619052794493
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 5	0.00344828	0.12936619052794493
INCLUSION BODY MYOPATHY WITH EARLY-ONSET PAGET DISEASE WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA 1	0.00344828	0.12936619052794493
MUTILATING HEREDITARY SENSORY NEUROPATHY WITH SPASTIC PARAPLEGIA	0.00344828	0.12936619052794493
SPINOCEREBELLAR ATAXIA TYPE 4	0.00344828	0.12936619052794493
CORTICOBASAL SYNDROME	0.00344828	0.12936619052794493
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2EE; CMT2EE	0.00344828	0.12936619052794493
SPASTIC ATAXIA 1, AUTOSOMAL DOMINANT; SPAX1	0.00344828	0.12936619052794493
SPASTIC PARAPLEGIA 80, AUTOSOMAL DOMINANT; SPG80	0.00344828	0.12936619052794493
OPTIC ATROPHY WITH OR WITHOUT DEAFNESS, OPHTHALMOPLEGIA, MYOPATHY, ATAXIA, AND NEUROPATHY	0.00344828	0.12936619052794493
CLASSIC GALACTOSEMIA	0.00344828	0.12936619052794493
ACETAZOLAMIDE-RESPONSIVE MYOTONIA	0.00344828	0.12936619052794493
MYOTONIA PERMANENS	0.00344828	0.12936619052794493
224550 DYSTONIA WITH RINGBINDEN	0.00344828	0.12936619052794493
MYOTONIA FLUCTUANS	0.00344828	0.12936619052794493
MULTIPLE EPIPHYSEAL DYSPLASIA DUE TO COLLAGEN 9 ANOMALY	0.00344828	0.12936619052794493
CHARCOT-MARIE-TOOTH DISEASE/HEREDITARY MOTOR AND SENSORY NEUROPATHY	0.00344828	0.12936619052794493
MOEBIUS SYNDROME; MBS	0.00344828	0.12936619052794493
MYOPATHY, DISTAL, 1; MPD1	0.00344828	0.12936619052794493
SPINOCEREBELLAR ATAXIA TYPE 17	0.00344828	0.12936619052794493
SPONDYLOMETAPHYSEAL DYSPLASIA	0.00344828	0.12936619052794493
SPONDYLOMETAPHYSEAL DYSPLASIA, KOZLOWSKI TYPE	0.00344828	0.12936619052794493
DEAF BLIND HYPOPIGMENTATION SYNDROME, YEMENITE TYPE	0.00344828	0.12936619052794493
SPONDYLOEPIMETAPHYSEAL DYSPLASIA CONGENITA, STRUDWICK TYPE	0.00344828	0.12936619052794493
MULTICENTRIC CARPO-TARSAL OSTEOLYSIS WITH OR WITHOUT NEPHROPATHY	0.00344828	0.12936619052794493
EMERY-DREIFUSS MUSCULAR DYSTROPHY 3, AUTOSOMAL RECESSIVE; EDMD3	0.00344828	0.12936619052794493
GLYCOGEN STORAGE DISEASE DUE TO LAMP-2 DEFICIENCY	0.00344828	0.12936619052794493
HYPOCALCEMIC VITAMIN D-RESISTANT RICKETS	0.00344828	0.12936619052794493
POTASSIUM-AGGRAVATED MYOTONIA	0.00344828	0.12936619052794493
PSEUDOACHONDROPLASIA	0.00344828	0.12936619052794493
CHARCOT-MARIE-TOOTH DISEASE, X-LINKED RECESSIVE, 5	0.00344828	0.12936619052794493
MULTIPLE EPIPHYSEAL DYSPLASIA TYPE 1	0.00344828	0.12936619052794493
MELNICK-NEEDLES SYNDROME	0.00344828	0.12936619052794493
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, IRAPA TYPE	0.00344828	0.12936619052794493
SPASTIC PARAPLEGIA-NEPHRITIS-DEAFNESS SYNDROME	0.00344828	0.12936619052794493
MYASTHENIC SYNDROME, CONGENITAL, 16; CMS16	0.00344828	0.12936619052794493
SPINOCEREBELLAR ATAXIA TYPE 34	0.00344828	0.12936619052794493
OSTEOCHONDRITIS DISSECANS	0.00344828	0.12936619052794493
IDIOPATHIC JUVENILE OSTEOPOROSIS	0.00344828	0.12936619052794493
BARTH SYNDROME; BTHS	0.00344828	0.12936619052794493
MULTIPLE SYMMETRIC LIPOMATOSIS	0.00344828	0.12936619052794493
AMYOTROPHIC LATERAL SCLEROSIS TYPE 4	0.00344828	0.12936619052794493
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, SHOHAT TYPE	0.00344828	0.12936619052794493
SPONASTRIME DYSPLASIA	0.00344828	0.12936619052794493
SPASTIC PARAPLEGIA-FACIAL-CUTANEOUS LESIONS SYNDROME	0.00344828	0.12936619052794493
HEREDITARY SPASTIC PARAPLEGIA	0.00344828	0.12936619052794493
MULTIPLE METAPHYSEAL DYSPLASIA	0.00344828	0.12936619052794493
ATP13A2-RELATED JUVENILE NEURONAL CEROID LIPOFUSCINOSIS	0.00344828	0.12936619052794493
ICHTHYOSIS-HEPATOSPLENOMEGALY-CEREBELLAR DEGENERATION SYNDROME	0.00344828	0.12936619052794493
DYSTONIA 16; DYT16	0.00344828	0.12936619052794493
TREMOR, HEREDITARY ESSENTIAL, AND IDIOPATHIC NORMAL PRESSURE HYDROCEPHALUS	0.00344828	0.12936619052794493
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4J	0.00344828	0.12936619052794493
JUVENILE AMYOTROPHIC LATERAL SCLEROSIS	0.00344828	0.12936619052794493
NEMALINE MYOPATHY 7; NEM7	0.00344828	0.12936619052794493
NEMALINE MYOPATHY 6	0.00344828	0.12936619052794493
POLYNEUROPATHY-INTELLECTUAL DISABILITY-ACROMICRIA-PREMATURE MENOPAUSE SYNDROME	0.00344828	0.12936619052794493
ROUSSY-LÉVY SYNDROME	0.00344828	0.12936619052794493
CATARACT, CONGENITAL, WITH MENTAL IMPAIRMENT AND DENTATE GYRUS ATROPHY	0.00344828	0.12936619052794493
ATYPICAL PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION	0.00344828	0.12936619052794493
BRITTLE CORNEA SYNDROME	0.00344828	0.12936619052794493
PALMOPLANTAR KERATODERMA-SPASTIC PARALYSIS SYNDROME	0.00344828	0.12936619052794493
MULTIPLE SCLEROSIS-ICHTHYOSIS-FACTOR VIII DEFICIENCY SYNDROME	0.00344828	0.12936619052794493
PELVIC DYSPLASIA-ARTHROGRYPOSIS OF LOWER LIMBS SYNDROME	0.00344828	0.12936619052794493
NONAKA MYOPATHY	0.00344828	0.12936619052794493
HYPERKALEMIC PERIODIC PARALYSIS	0.00344828	0.12936619052794493
SPASTIC PARAPLEGIA 78, AUTOSOMAL RECESSIVE	0.00344828	0.12936619052794493
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, OKINAWA TYPE; HMSNO	0.00344828	0.12936619052794493
ABETA AMYLOIDOSIS, IOWA TYPE	0.00344828	0.12936619052794493
MENTAL RETARDATION, X-LINKED 12; MRX12	0.00344828	0.12936619052794493
MULTIPLE EPIPHYSEAL DYSPLASIA TYPE 5	0.00344828	0.12936619052794493
AUTOSOMAL DOMINANT STRIATAL NEURODEGENERATION	0.00344828	0.12936619052794493
THORACOMELIC DYSPLASIA	0.00344828	0.12936619052794493
DOPA-RESPONSIVE DYSTONIA	0.00344828	0.12936619052794493
MYASTHENIC SYNDROME, CONGENITAL, 7, PRESYNAPTIC; CMS7	0.00344828	0.12936619052794493
TRYPTOPHANURIA WITH DWARFISM	0.00344828	0.12936619052794493
SPASTIC PARAPLEGIA 43, AUTOSOMAL RECESSIVE; SPG43	0.00344828	0.12936619052794493
MUCOPOLYSACCHARIDOSIS TYPE 4	0.00344828	0.12936619052794493
EARLY-ONSET GENERALIZED LIMB-ONSET DYSTONIA	0.00344828	0.12936619052794493
DUCHENNE AND BECKER MUSCULAR DYSTROPHY	0.00344828	0.12936619052794493
SPASTIC ATAXIA-CORNEAL DYSTROPHY SYNDROME	0.00344828	0.12936619052794493
SPINAL MUSCULAR ATROPHY, DISTAL, AUTOSOMAL RECESSIVE, 5	0.00344828	0.12936619052794493
%271630 BRACHYOLMIA TYPE 1, TOLEDO TYPE;;SPONDYLOEPIPHYSEAL DYSPLASIA TARDA, TOLEDO TYPE;;SED, CHONDROITIN SULFATE TYPE;;PAPS-CHONDROITIN SULFATE SULFOTRANSFERASE DEFICIENCY	0.00344828	0.12936619052794493
EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS	0.00344828	0.12936619052794493
MULTICENTRIC OSTEOLYSIS, NODULOSIS, AND ARTHROPATHY; MONA	0.00344828	0.12936619052794493
271322 SPINOCEREBELLAR DEGENERATION WITH SLOW EYE MOVEMENTS; SDSEM	0.00344828	0.12936619052794493
METAPHYSEAL CHONDRODYSPLASIA, SPAHR TYPE	0.00344828	0.12936619052794493
PSYCHOGENIC MOVEMENT DISORDERS	0.00344828	0.12936619052794493
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL DOMINANT 4; LGMDD4	0.00344828	0.12936619052794493
X-LINKED ADRENOLEUKODYSTROPHY	0.00344828	0.12936619052794493
CONGENITAL MYOPATHY WITH MYASTHENIC-LIKE ONSET	0.00344828	0.12936619052794493
MUCOLIPIDOSIS TYPE IV	0.00344828	0.12936619052794493
LAING EARLY-ONSET DISTAL MYOPATHY	0.00344828	0.12936619052794493
MASA SYNDROME	0.00344828	0.12936619052794493
CONGENITAL MUSCULAR DYSTROPHY-INFANTILE CATARACT-HYPOGONADISM SYNDROME	0.00344828	0.12936619052794493
TRISOMY XQ28	0.00344828	0.12936619052794493
DYSTONIA 23; DYT23	0.00344828	0.12936619052794493
%300158 ARTHROGRYPOSIS, CONGENITAL, LOWER LIMB, X-LINKED; ACLLX;;ARTHROGRYPOSIS, X-LINKED, TYPE V, FORMERLY; AMCX5, FORMERLY	0.00344828	0.12936619052794493
BENCZE SYNDROME	0.00342466	0.12848005905942436
ACROCEPHALOPOLYDACTYLOUS DYSPLASIA	0.00342466	0.12848005905942436
SPONDYLOEPIPHYSEAL DYSPLASIA-BRACHYDACTYLY AND DISTINCTIVE SPEECH	0.00342466	0.12848005905942436
NIJMEGEN BREAKAGE SYNDROME	0.00342466	0.12848005905942436
DEAFNESS-CRANIOFACIAL SYNDROME	0.00342466	0.12848005905942436
260150 PALANT CLEFT PALATE SYNDROME	0.00342466	0.12848005905942436
613627 BRACHYDACTYLY, TYPE A1, WITH SHORT STATURE, SCOLIOSIS, MICROCEPHALY,PTOSIS, HEARING LOSS, AND MENTAL RETARDATION;;TSUKAHARA SYNDROME	0.00342466	0.12848005905942436
BRANCHIO-OCULO-FACIAL SYNDROME	0.00342466	0.12848005905942436
FEINGOLD SYNDROME 1; FGLDS1	0.00342466	0.12848005905942436
%164220 SCHILBACH-ROTT SYNDROME;;OCULAR HYPOTELORISM, SUBMUCOSAL CLEFT PALATE, AND HYPOSPADIAS;;CLEFT PALATE, HYPOTELORISM, AND HYPOSPADIAS;;BLEPHAROFACIOSKELETAL SYNDROME; BRSS	0.00342466	0.12848005905942436
NIJMEGEN BREAKAGE SYNDROME	0.00342466	0.12848005905942436
ROBINOW SYNDROME, AUTOSOMAL DOMINANT 3; DRS3	0.00342466	0.12848005905942436
CHROMOSOME 8Q22.1 DUPLICATION SYNDROME	0.00342466	0.12848005905942436
CUTANEOUS MASTOCYTOSIS, CONDUCTIVE HEARING LOSS AND MICROTIA	0.00342466	0.12848005905942436
GROWTH DELAY-HYDROCEPHALY-LUNG HYPOPLASIA SYNDROME	0.00342466	0.12848005905942436
MICROCEPHALY-MICROCORNEA SYNDROME, SEEMANOVA TYPE	0.00342466	0.12848005905942436
DISTAL MONOSOMY 17Q	0.00342466	0.12848005905942436
AUTOSOMAL DOMINANT SPONDYLOCOSTAL DYSOSTOSIS	0.00342466	0.12848005905942436
DELAYED MEMBRANOUS CRANIAL OSSIFICATION	0.00342466	0.12848005905942436
MICROCEPHALY, AUTOSOMAL DOMINANT	0.00342466	0.12848005905942436
SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 1; CSCSC1	0.00342466	0.12848005905942436
THAKKER-DONNAI SYNDROME	0.00342466	0.12848005905942436
FRONTONASAL DYSPLASIA-ALOPECIA-GENITAL ANOMALIES SYNDROME	0.00342466	0.12848005905942436
CARDIOSPONDYLOCARPOFACIAL SYNDROME; CSCF	0.00342466	0.12848005905942436
CROSSED POLYSYNDACTYLY	0.00342466	0.12848005905942436
HENNEKAM LYMPHANGIECTASIA-LYMPHEDEMA SYNDROME 3; HKLLS3	0.00342466	0.12848005905942436
PROGEROID FACIAL APPEARANCE WITH HAND ANOMALIES	0.00342466	0.12848005905942436
OSTEOPENIA-MYOPIA-HEARING LOSS-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.00342466	0.12848005905942436
PTERYGIUM COLLI AND MENTAL RETARDATION WITH FACIAL AND DIGITAL ANOMALIES	0.00342466	0.12848005905942436
115645 CATARACT, ABERRANT ORAL FRENULA, AND GROWTH RETARDATION	0.00342466	0.12848005905942436
SCHOLTE SYNDROME; SHLTS	0.00342466	0.12848005905942436
VERVERI-BRADY SYNDROME; VERBRAS	0.00342466	0.12848005905942436
MULTIPLE EPIPHYSEAL DYSPLASIA, LOWRY TYPE	0.00342466	0.12848005905942436
SHORT STATURE, HEARING LOSS, RETINITIS PIGMENTOSA, AND DISTINCTIVE FACIES; SHRF	0.00342466	0.12848005905942436
AUTOSOMAL RECESSIVE FACIODIGITOGENITAL SYNDROME	0.00342466	0.12848005905942436
FEMORAL-FACIAL SYNDROME	0.00342466	0.12848005905942436
HOLOPROSENCEPHALY-CRANIOSYNOSTOSIS SYNDROME	0.00342466	0.12848005905942436
ALOPECIA-CONTRACTURES-DWARFISM-INTELLECTUAL DISABILITY SYNDROME	0.00342466	0.12848005905942436
ATRIOVENTRICULAR DEFECT-BLEPHAROPHIMOSIS-RADIAL AND ANAL DEFECT SYNDROME	0.00342466	0.12848005905942436
CLEFT LIP/PALATE-INTESTINAL MALROTATION-CARDIOPATHY SYNDROME	0.00342466	0.12848005905942436
OTOONYCHOPERONEAL SYNDROME	0.00342466	0.12848005905942436
134780 FEMORAL-FACIAL SYNDROME; FFS;;FEMORAL HYPOPLASIA-UNUSUAL FACIES SYNDROME; FHUFS	0.00342466	0.12848005905942436
FAMILIAL SCAPHOCEPHALY SYNDROME, MCGILLIVRAY TYPE	0.00342466	0.12848005905942436
MULTIPLE EPIPHYSEAL DYSPLASIA WITH ROBIN PHENOTYPE	0.00342466	0.12848005905942436
URBAN-ROGERS-MEYER SYNDROME	0.00342466	0.12848005905942436
MEGALENCEPHALY-POLYMICROGYRIA-POLYDACTYLY-HYDROCEPHALUS SYNDROME 3; MPPH3	0.003300374	0.12381732681147578
LIGNEOUS CONJUNCTIVITIS	0.003300374	0.12381732681147578
LENZ-MAJEWSKI HYPEROSTOTIC DWARFISM	0.003300374	0.12381732681147578
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 8	0.003300374	0.12381732681147578
MARDEN-WALKER SYNDROME	0.003300374	0.12381732681147578
POPOV-CHANG SYNDROME; POPCHAS	0.003300374	0.12381732681147578
MEGALENCEPHALY-CAPILLARY MALFORMATION-POLYMICROGYRIA SYNDROME	0.003300374	0.12381732681147578
DEXTROCARDIA	0.003300374	0.12381732681147578
BEARE-STEVENSON CUTIS GYRATA SYNDROME; BSTVS	0.003300374	0.12381732681147578
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 11; MDDGA11	0.003300374	0.12381732681147578
THANATOPHORIC DYSPLASIA, TYPE I	0.003300374	0.12381732681147578
BRESEK SYNDROME	0.003300374	0.12381732681147578
ANOPHTHALMIA/MICROPHTHALMIA-ESOPHAGEAL ATRESIA SYNDROME	0.003300374	0.12381732681147578
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIB; ARCL2B	0.003300374	0.12381732681147578
OTOPALATODIGITAL SYNDROME TYPE 2	0.003300374	0.12381732681147578
MEDULLOBLASTOMA	0.003300374	0.12381732681147578
XERODERMA PIGMENTOSUM-COCKAYNE SYNDROME COMPLEX	0.003300374	0.12381732681147578
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 9; MDDGA9	0.003300374	0.12381732681147578
MICROCEPHALY-THIN CORPUS CALLOSUM-INTELLECTUAL DISABILITY SYNDROME	0.003300374	0.12381732681147578
FANCONI ANEMIA, COMPLEMENTATION GROUP L	0.003300374	0.12381732681147578
OXOGLUTARIC ACIDURIA	0.003300374	0.12381732681147578
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA, TYPE CBLC	0.003296239	0.12366219753025932
HISTIOCYTOID CARDIOMYOPATHY	0.003296239	0.12366219753025932
LOWRY-MACLEAN SYNDROME	0.003296239	0.12366219753025932
CRYPTOCOCCOSIS	0.003296239	0.12366219753025932
LYMPHANGIOLEIOMYOMATOSIS	0.003296239	0.12366219753025932
NEUROFIBROMATOSIS, TYPE I	0.003296239	0.12366219753025932
NASU-HAKOLA DISEASE	0.003296239	0.12366219753025932
PORT-WINE NEVI-MEGA CISTERNA MAGNA-HYDROCEPHALUS SYNDROME	0.003296239	0.12366219753025932
ATYPICAL TERATOID RHABDOID TUMOR	0.003296239	0.12366219753025932
CORPUS CALLOSUM, PARTIAL AGENESIS OF, X-LINKED	0.003296239	0.12366219753025932
PAPILLOMA OF CHOROID PLEXUS	0.003296239	0.12366219753025932
GAUCHER DISEASE, TYPE IIIC	0.003296239	0.12366219753025932
FRONTAL ENCEPHALOCELE	0.003296239	0.12366219753025932
AMELOCEREBROHYPOHIDROTIC SYNDROME	0.003296239	0.12366219753025932
OCULOCEREBROCUTANEOUS SYNDROME	0.003296239	0.12366219753025932
AICARDI-GOUTIERES SYNDROME 4; AGS4	0.003296239	0.12366219753025932
VENTRICULOMEGALY WITH CYSTIC KIDNEY DISEASE; VMCKD	0.003296239	0.12366219753025932
ADAMS-OLIVER SYNDROME	0.003296239	0.12366219753025932
CRANIOFACIAL DYSSYNOSTOSIS WITH SHORT STATURE	0.003296239	0.12366219753025932
OROFACIODIGITAL SYNDROME I; OFD1	0.003296239	0.12366219753025932
ALOPECIA-EPILEPSY-PYORRHEA-INTELLECTUAL DISABILITY SYNDROME	0.003296239	0.12366219753025932
WHIPPLE DISEASE	0.003296239	0.12366219753025932
GAUCHER DISEASE-OPHTHALMOPLEGIA-CARDIOVASCULAR CALCIFICATION SYNDROME	0.003296239	0.12366219753025932
LARGE CONGENITAL MELANOCYTIC NEVUS	0.003296239	0.12366219753025932
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 49; EIEE49	0.003296239	0.12366219753025932
ISOLATED SPINA BIFIDA	0.003296239	0.12366219753025932
KRABBE DISEASE	0.003296239	0.12366219753025932
MEGALENCEPHALY-POLYMICROGYRIA-POSTAXIAL POLYDACTYLY-HYDROCEPHALUS SYNDROME	0.003296239	0.12366219753025932
BRAIN SMALL VESSEL DISEASE 1 WITH OR WITHOUT OCULAR ANOMALIES; BSVD1	0.003296239	0.12366219753025932
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 3; MDDGA3	0.003296239	0.12366219753025932
LHERMITTE-DUCLOS DISEASE	0.003296239	0.12366219753025932
CONGENITAL HYDROCEPHALUS	0.003296239	0.12366219753025932
HYDROCEPHALUS WITH STENOSIS OF THE AQUEDUCT OF SYLVIUS	0.003296239	0.12366219753025932
STURGE-WEBER SYNDROME	0.003296239	0.12366219753025932
47,XYY SYNDROME	0.003296239	0.12366219753025932
ALEXANDER DISEASE	0.003296239	0.12366219753025932
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 1; OPTB1	0.003296239	0.12366219753025932
LOWRY-WOOD SYNDROME	0.00316456	0.11872210838363283
45,X/46,XY MIXED GONADAL DYSGENESIS	0.00316456	0.11872210838363283
GOLDENHAR SYNDROME	0.00316456	0.11872210838363283
CORNEAL DYSTROPHY-PERCEPTIVE DEAFNESS SYNDROME	0.00316456	0.11872210838363283
MICROCORNEA-GLAUCOMA-ABSENT FRONTAL SINUSES SYNDROME	0.00316456	0.11872210838363283
JALILI SYNDROME	0.00316456	0.11872210838363283
CONE ROD DYSTROPHY	0.00316456	0.11872210838363283
CHYLOMICRON RETENTION DISEASE	0.00316456	0.11872210838363283
UVEAL COLOBOMA-CLEFT LIP AND PALATE-INTELLECTUAL DISABILITY	0.00316456	0.11872210838363283
PSEUDOHYPOPARATHYROIDISM WITH ALBRIGHT HEREDITARY OSTEODYSTROPHY	0.00316456	0.11872210838363283
RENAL COLOBOMA SYNDROME	0.00316456	0.11872210838363283
PROGRESSIVE CONE DYSTROPHY	0.00316456	0.11872210838363283
OSTEOSCLEROSIS-DEVELOPMENTAL DELAY-CRANIOSYNOSTOSIS SYNDROME	0.00316456	0.11872210838363283
CHILDHOOD-ONSET SPASTICITY WITH HYPERGLYCINEMIA	0.00316456	0.11872210838363283
X-LINKED RETINAL DYSPLASIA	0.00316456	0.11872210838363283
MOEBIUS SYNDROME	0.00316456	0.11872210838363283
FETAL METHYLMERCURY SYNDROME	0.00316456	0.11872210838363283
AXIAL SPONDYLOMETAPHYSEAL DYSPLASIA	0.00316456	0.11872210838363283
MUCOPOLYSACCHARIDOSIS TYPE 6	0.00316456	0.11872210838363283
BLUE CONE MONOCHROMATISM	0.00316456	0.11872210838363283
STEVENS-JOHNSON SYNDROME	0.00316456	0.11872210838363283
INTERMEDIATE OSTEOPETROSIS	0.00316456	0.11872210838363283
CEREBELLAR HYPOPLASIA-TAPETORETINAL DEGENERATION SYNDROME	0.00316456	0.11872210838363283
RETINITIS PIGMENTOSA-INTELLECTUAL DISABILITY-DEAFNESS-HYPOGONADISM SYNDROME	0.00316456	0.11872210838363283
PSEUDOXANTHOMA ELASTICUM	0.00316456	0.11872210838363283
BRADYOPSIA	0.00316456	0.11872210838363283
OCULAR ALBINISM	0.00316456	0.11872210838363283
SPINOCEREBELLAR DEGENERATION-CORNEAL DYSTROPHY SYNDROME	0.00316456	0.11872210838363283
DUANE ANOMALY-MYOPATHY-SCOLIOSIS SYNDROME	0.00316456	0.11872210838363283
ABSENCE DEFORMITY OF LEG-CATARACT SYNDROME	0.00316456	0.11872210838363283
RETINAL DEGENERATION-NANOPHTHALMOS-GLAUCOMA SYNDROME	0.00316456	0.11872210838363283
PROGRESSIVE BIFOCAL CHORIORETINAL ATROPHY	0.00316456	0.11872210838363283
MMEP SYNDROME	0.00316456	0.11872210838363283
OCULOCUTANEOUS ALBINISM	0.00316456	0.11872210838363283
OSTEOPOROSIS-OCULOCUTANEOUS HYPOPIGMENTATION SYNDROME	0.00316456	0.11872210838363283
AUTOIMMUNE POLYENDOCRINOPATHY TYPE 1	0.00316456	0.11872210838363283
SPORADIC CREUTZFELDT-JAKOB DISEASE	0.00316456	0.11872210838363283
CLEFT LIP-RETINOPATHY SYNDROME	0.00316456	0.11872210838363283
CRANIOMETAPHYSEAL DYSPLASIA	0.00316456	0.11872210838363283
ERDHEIM-CHESTER DISEASE	0.00316456	0.11872210838363283
PROLIDASE DEFICIENCY	0.00316456	0.11872210838363283
INTESTINAL LYMPHANGIECTASIA	0.00316456	0.11872210838363283
MARFAN SYNDROME	0.00316456	0.11872210838363283
SEVERE OCULO-RENAL-CEREBELLAR SYNDROME	0.00316456	0.11872210838363283
MUCOLIPIDOSIS TYPE III	0.00316456	0.11872210838363283
X-LINKED RECESSIVE OCULAR ALBINISM	0.00316456	0.11872210838363283
PANCREATITIS, SCLEROSING CHOLANGITIS, AND SICCA COMPLEX	0.00316456	0.11872210838363283
OCULOCUTANEOUS ALBINISM TYPE 1B	0.00316456	0.11872210838363283
BLUE CONE MONOCHROMACY; BCM	0.00316456	0.11872210838363283
CONE-ROD DYSTROPHY, X-LINKED, 1; CORDX1	0.00316456	0.11872210838363283
ANIRIDIA-PTOSIS-INTELLECTUAL DISABILITY-FAMILIAL OBESITY SYNDROME	0.00316456	0.11872210838363283
HERMANSKY-PUDLAK SYNDROME 8; HPS8	0.00316456	0.11872210838363283
MACULAR DYSTROPHY, VITELLIFORM, 2; VMD2	0.00316456	0.11872210838363283
N SYNDROME	0.00316456	0.11872210838363283
ARTHROGRYPOSIS-OCULOMOTOR LIMITATION-ELECTRORETINAL ANOMALIES SYNDROME	0.00316456	0.11872210838363283
NEURODEVELOPMENTAL DISORDER WITH SPASTIC QUADRIPLEGIA AND BRAIN ABNORMALITIES WITH OR WITHOUT SEIZURES; NEDSBAS	0.00316456	0.11872210838363283
CHORIORETINAL ATROPHY, PROGRESSIVE BIFOCAL	0.00316456	0.11872210838363283
OCULOCUTANEOUS ALBINISM TYPE 2	0.00316456	0.11872210838363283
FOVEAL HYPOPLASIA AND PRESENILE CATARACT SYNDROMEFOVEAL HYPOPLASIA, ISOLATED, INCLUDED	0.00316456	0.11872210838363283
DYSKERATOSIS, HEREDITARY BENIGN INTRAEPITHELIAL; HBID	0.00316456	0.11872210838363283
AUTOSOMAL DOMINANT OPTIC ATROPHY PLUS SYNDROME	0.00316456	0.11872210838363283
CONE-ROD DYSTROPHY 17; CORD17	0.00316456	0.11872210838363283
AUDITORY NEUROPATHY AND OPTIC ATROPHY; ANOA	0.00316456	0.11872210838363283
DOYNE HONEYCOMB RETINAL DYSTROPHY	0.00316456	0.11872210838363283
ASCHER SYNDROME	0.00316456	0.11872210838363283
CONE DYSTROPHY 4	0.00316456	0.11872210838363283
HERMANSKY-PUDLAK SYNDROME 3; HPS3	0.00316456	0.11872210838363283
OCULOCUTANEOUS ALBINISM TYPE 1A	0.00316456	0.11872210838363283
ALBINISM, OCULAR, WITH LATE-ONSET SENSORINEURAL DEAFNESS	0.00316456	0.11872210838363283
LEBER CONGENITAL AMAUROSIS 8; LCA8	0.00316456	0.11872210838363283
GILLESPIE SYNDROME; GLSP	0.00316456	0.11872210838363283
TANGIER DISEASE; TGD	0.00316456	0.11872210838363283
ALBINISM, OCULAR, TYPE I	0.00316456	0.11872210838363283
CHROMOSOME XP11.3 DELETION SYNDROME	0.00316456	0.11872210838363283
RETINITIS PIGMENTOSA 20	0.00316456	0.11872210838363283
PSEUDOXANTHOMA ELASTICUM, FORME FRUSTE	0.00316456	0.11872210838363283
RETINITIS PIGMENTOSA 27; RP27	0.00316456	0.11872210838363283
OCULAR ALBINISM WITH LATE-ONSET SENSORINEURAL DEAFNESS	0.00316456	0.11872210838363283
OPTIC ATROPHY, HEARING LOSS, AND PERIPHERAL NEUROPATHY, AUTOSOMALDOMINANT	0.00316456	0.11872210838363283
MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 6	0.00316456	0.11872210838363283
CORPUS CALLOSUM, AGENESIS OF, WITH MENTAL RETARDATION, OCULAR COLOBOMA,AND MICROGNATHIA	0.00316456	0.11872210838363283
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 18	0.00316456	0.11872210838363283
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, TYPE VIC, WITH OPTIC ATROPHY; HMSN6C	0.00316456	0.11872210838363283
NYSTAGMUS 2, CONGENITAL, AUTOSOMAL DOMINANT; NYS2	0.00316456	0.11872210838363283
LEBER CONGENITAL AMAUROSIS 19; LCA19	0.00316456	0.11872210838363283
BONNEMANN-MEINECKE-REICH SYNDROME	0.00316456	0.11872210838363283
LEBER CONGENITAL AMAUROSIS 11; LCA11	0.00316456	0.11872210838363283
CREUTZFELDT-JAKOB DISEASE; CJD	0.00316456	0.11872210838363283
LEUKOENCEPHALOPATHY-SPONDYLOMETAPHYSEAL DYSPLASIA SYNDROME	0.00316456	0.11872210838363283
OSTEOPETROSIS,  AUTOSOMAL RECESSIVE 4; OPTB4	0.00316456	0.11872210838363283
LEBER CONGENITAL AMAUROSIS 5; LCA5	0.00316456	0.11872210838363283
BUSCHKE-OLLENDORFF SYNDROME	0.00316456	0.11872210838363283
XFE PROGEROID SYNDROME; XFEPS	0.00316456	0.11872210838363283
BIRDSHOT CHORIORETINOPATHY	0.00316456	0.11872210838363283
%606772 MENTAL RETARDATION, OBESITY, MANDIBULAR PROGNATHISM, AND EYE AND SKINANOMALIES;;MOMES SYNDROME	0.00316456	0.11872210838363283
ACRO-RENAL-OCULAR SYNDROME	0.00316456	0.11872210838363283
RETINAL CONE DYSTROPHY 4	0.00316456	0.11872210838363283
ABETALIPOPROTEINEMIA	0.00316456	0.11872210838363283
610319 RHIZOMELIC DYSPLASIA, SCOLIOSIS, AND RETINITIS PIGMENTOSA	0.00316456	0.11872210838363283
MITOCHONDRIAL MYOPATHY, EPISODIC, WITH OR WITHOUT OPTIC ATROPHY AND REVERSIBLE LEUKOENCEPHALOPATHY; MEOAL	0.00316456	0.11872210838363283
BROOKE-SPIEGLER SYNDROME	0.00316456	0.11872210838363283
LEG, ABSENCE DEFORMITY OF, WITH CONGENITAL CATARACT	0.00316456	0.11872210838363283
%608703 SPINOCEREBELLAR ATAXIA 25; SCA25	0.00316456	0.11872210838363283
CHOROIDAL ATROPHY-ALOPECIA SYNDROME	0.00316456	0.11872210838363283
WAGR SYNDROME	0.00316456	0.11872210838363283
FISH-EYE DISEASE	0.00316456	0.11872210838363283
CORNEA GUTTATA WITH ANTERIOR POLAR CATARACTS	0.00316456	0.11872210838363283
EPITHELIAL RECURRENT EROSION DYSTROPHY	0.00316456	0.11872210838363283
CATARACT-ATAXIA-DEAFNESS SYNDROME	0.00316456	0.11872210838363283
AUTOSOMAL RECESSIVE PALMOPLANTAR KERATODERMA AND CONGENITAL ALOPECIA	0.00316456	0.11872210838363283
OCULOCUTANEOUS ALBINISM TYPE 4	0.00316456	0.11872210838363283
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 3; OPTB3	0.00316456	0.11872210838363283
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 4; MMDS4	0.00316456	0.11872210838363283
258650 OPTIC ATROPHY, HEARING LOSS, AND PERIPHERAL NEUROPATHY, AUTOSOMALRECESSIVE	0.00316456	0.11872210838363283
FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, 2; CFEOM2	0.00316456	0.11872210838363283
AGEL AMYLOIDOSIS	0.00316456	0.11872210838363283
%258500 OPTIC ATROPHY 6; OPA6;;OPTIC ATROPHY, CONGENITAL OR EARLY INFANTILE, AUTOSOMAL RECESSIVE	0.00316456	0.11872210838363283
MICROGASTRIA-LIMB REDUCTION DEFECT SYNDROME	0.00297619	0.11165519116410628
EBSTEIN MALFORMATION	0.00297619	0.11165519116410628
MESOAXIAL HEXADACTYLY AND CARDIAC MALFORMATION	0.00297619	0.11165519116410628
SPONDYLOMETAPHYSEAL DYSPLASIA, SEDAGHATIAN TYPE; SMDS	0.00297619	0.11165519116410628
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, OHDO TYPE	0.00297619	0.11165519116410628
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY, TYPE 1, WITH OR WITHOUT FRACTURES; SEMDJL1	0.00297619	0.11165519116410628
JUVENILE POLYPOSIS OF INFANCY	0.00297619	0.11165519116410628
614262 ARTHROGRYPOSIS, PERTHES DISEASE, AND UPWARD GAZE PALSY; APUG	0.00297619	0.11165519116410628
WHITE FORELOCK WITH MALFORMATIONS	0.00297619	0.11165519116410628
BONE DYSPLASIA, LETHAL HOLMGREN TYPE	0.00297619	0.11165519116410628
INDOMETHACIN EMBRYOFETOPATHY	0.00297619	0.11165519116410628
HOLT-ORAM SYNDROME	0.00297619	0.11165519116410628
SCIMITAR SYNDROME	0.00297619	0.11165519116410628
SHORT-RIB THORACIC DYSPLASIA 6 WITH OR WITHOUT POLYDACTYLY; SRTD6	0.00297619	0.11165519116410628
%263630 POLYSYNDACTYLY WITH CARDIAC MALFORMATION;;BONNEAU SYNDROME	0.00297619	0.11165519116410628
ALVEOLAR CAPILLARY DYSPLASIA WITH MISALIGNMENT OF PULMONARY VEINS; ACDMPV	0.00297619	0.11165519116410628
CONGENITAL HEART DEFECTS, MULTIPLE TYPES, 5; CHTD5	0.00297619	0.11165519116410628
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 2; MVA2	0.00297619	0.11165519116410628
HETEROTAXY, VISCERAL, 1, X-LINKED; HTX1	0.00297619	0.11165519116410628
MEGALENCEPHALY	0.00297619	0.11165519116410628
DUANE-RADIAL RAY SYNDROME; DRRS	0.00297619	0.11165519116410628
CONGENITALLY CORRECTED TRANSPOSITION OF THE GREAT ARTERIES	0.00297619	0.11165519116410628
FALLOT COMPLEX-INTELLECTUAL DISABILITY-GROWTH DELAY SYNDROME	0.00297619	0.11165519116410628
HISTIOCYTOSIS-LYMPHADENOPATHY PLUS SYNDROME	0.00297619	0.11165519116410628
SPONDYLOOCULAR SYNDROME; SOS	0.00297619	0.11165519116410628
HYPOPLASTIC LEFT HEART SYNDROME	0.00297619	0.11165519116410628
CONGENITAL PULMONARY VALVE STENOSIS	0.00297619	0.11165519116410628
ALAGILLE SYNDROME 2	0.00297619	0.11165519116410628
WHITE FORELOCK WITH MALFORMATIONS	0.00297619	0.11165519116410628
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 1; NSLH1	0.00297619	0.11165519116410628
KLIPPEL-TRÉNAUNAY SYNDROME	0.00297619	0.11165519116410628
DIPHALLIA	0.00297619	0.11165519116410628
ULNAR/FIBULAR RAY DEFECT AND BRACHYDACTYLY	0.00297619	0.11165519116410628
%608572 BURN-MCKEOWN SYNDROME	0.00297619	0.11165519116410628
HETEROTAXY, VISCERAL, 7, AUTOSOMAL; HTX7	0.00297619	0.11165519116410628
PORENCEPHALY, CEREBELLAR HYPOPLASIA, AND INTERNAL MALFORMATIONS	0.00297619	0.11165519116410628
LYMPHATIC MALFORMATION 7; LMPHM7	0.00297619	0.11165519116410628
ABRUZZO-ERICKSON SYNDROME	0.00297619	0.11165519116410628
DIAMOND-BLACKFAN ANEMIA 4	0.00297619	0.11165519116410628
MICROPHTHALMIA, SYNDROMIC 9; MCOPS9	0.00297619	0.11165519116410628
DIAMOND-BLACKFAN ANEMIA 6; DBA6	0.00297619	0.11165519116410628
CONGENITAL ALVEOLAR CAPILLARY DYSPLASIA	0.00297619	0.11165519116410628
POLAND SYNDROME	0.00297619	0.11165519116410628
XK APROSENCEPHALY SYNDROME	0.00297619	0.11165519116410628
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIC; ARCL2C	0.00297619	0.11165519116410628
DIAMOND-BLACKFAN ANEMIA 16	0.00297619	0.11165519116410628
ATRIAL SEPTAL DEFECT 5	0.00297619	0.11165519116410628
STRUCTURAL HEART DEFECTS AND RENAL ANOMALIES SYNDROME	0.00297619	0.11165519116410628
%241310 HYPOMANDIBULAR FACIOCRANIAL DYSOSTOSIS	0.00297619	0.11165519116410628
ELLIS VAN CREVELD SYNDROME	0.00297619	0.11165519116410628
TURNER SYNDROME	0.00297619	0.11165519116410628
PERICARDIAL AND DIAPHRAGMATIC DEFECT	0.00297619	0.11165519116410628
JOHANSON-BLIZZARD SYNDROME; JBS	0.00297619	0.11165519116410628
MEACHAM SYNDROME	0.00297619	0.11165519116410628
PENILE AGENESIS	0.00297619	0.11165519116410628
EISENMENGER SYNDROME	0.00297619	0.11165519116410628
MOSAIC MONOSOMY X	0.00297619	0.11165519116410628
CONTRACTURAL ARACHNODACTYLY, CONGENITAL	0.00297619	0.11165519116410628
TURNER SYNDROME DUE TO STRUCTURAL X CHROMOSOME ANOMALIES	0.00297619	0.11165519116410628
EBSTEIN ANOMALY	0.00297619	0.11165519116410628
ELLIS-VAN CREVELD SYNDROME	0.00297619	0.11165519116410628
HEART DEFECTS-LIMB SHORTENING SYNDROME	0.00297619	0.11165519116410628
CEREBROCOSTOMANDIBULAR SYNDROME; CCMS	0.00297619	0.11165519116410628
CARDIAC-UROGENITAL SYNDROME; CUGS	0.00297619	0.11165519116410628
ASPLENIA WITH CARDIOVASCULAR ANOMALIES	0.00297619	0.11165519116410628
MONOSOMY X	0.00297619	0.11165519116410628
BRACHYDACTYLY, TYPE E, WITH ATRIAL SEPTAL DEFECT, TYPE II	0.00297619	0.11165519116410628
FRONTONASAL DYSPLASIA-BIFID NOSE-UPPER LIMB ANOMALIES SYNDROME	0.00297619	0.11165519116410628
CONGENITAL TOTAL PULMONARY VENOUS RETURN ANOMALY	0.00297619	0.11165519116410628
FAMILIAL CUTANEOUS COLLAGENOMA	0.00297619	0.11165519116410628
AORTIC VALVE DISEASE 3; AOVD3	0.00297619	0.11165519116410628
NOONAN SYNDROME 8; NS8	0.00297619	0.11165519116410628
ALAGILLE SYNDROME	0.00297619	0.11165519116410628
ULNAR/FIBULA RAY DEFECT-BRACHYDACTYLY SYNDROME	0.00297619	0.11165519116410628
8P23.1 DELETION SYNDROME	0.00297619	0.11165519116410628
DIAMOND-BLACKFAN ANEMIA 1	0.00297619	0.11165519116410628
CONGENITAL HEART DEFECTS, MULTIPLE TYPES, 3; CHTD3	0.00297619	0.11165519116410628
THIAMINE-RESPONSIVE MEGALOBLASTIC ANEMIA SYNDROME	0.00297619	0.11165519116410628
COLE-CARPENTER SYNDROME 2; CLCRP2	0.00275482	0.10335024098686685
AASE-SMITH SYNDROME I	0.00275482	0.10335024098686685
VACTERL ASSOCIATION, X-LINKED, WITH OR WITHOUT HYDROCEPHALUS; VACTERLX	0.00275482	0.10335024098686685
RADIAL APLASIA, X-LINKED	0.00275482	0.10335024098686685
MUCOPOLYSACCHARIDOSIS-LIKE SYNDROME WITH CONGENITAL HEART DEFECTS AND HEMATOPOIETIC DISORDERS	0.00275482	0.10335024098686685
BOR-DUANE HYDROCEPHALUS CONTIGUOUS GENE SYNDROME	0.00275482	0.10335024098686685
KLEEBLATTSCHAEDEL SYNDROME	0.00275482	0.10335024098686685
MECKEL SYNDROME	0.00275482	0.10335024098686685
B4GALT1-CDG	0.00275482	0.10335024098686685
PRIMARY CILIARY DYSKINESIA	0.00275482	0.10335024098686685
THORACOABDOMINAL SYNDROME	0.00275482	0.10335024098686685
CROUZON DISEASE	0.00275482	0.10335024098686685
MYOPATHY, CENTRONUCLEAR, X-LINKED; CNMX	0.00275482	0.10335024098686685
GENITOPALATOCARDIAC SYNDROME	0.00275482	0.10335024098686685
HB BART'S HYDROPS FETALIS	0.00275482	0.10335024098686685
VACTERL WITH HYDROCEPHALUS	0.00275482	0.10335024098686685
307010 HYDROCEPHALUS WITH CEREBELLAR AGENESIS	0.00275482	0.10335024098686685
HYDROCEPHALUS DUE TO CONGENITAL STENOSIS OF AQUEDUCT OF SYLVIUS	0.00275482	0.10335024098686685
ACROFACIAL DYSOSTOSIS 1, NAGER TYPE; AFD1	0.00275482	0.10335024098686685
MASA SYNDROME	0.00275482	0.10335024098686685
TEMPLE SYNDROME	0.00275482	0.10335024098686685
MEGALENCEPHALY	0.00275482	0.10335024098686685
X-LINKED DOMINANT CHONDRODYSPLASIA, CHASSAING-LACOMBE TYPE	0.00275482	0.10335024098686685
PELVIS-SHOULDER DYSPLASIA	0.00275482	0.10335024098686685
HEMIFACIAL MICROSOMIA	0.00275482	0.10335024098686685
CHONDRODYSPLASIA WITH PLATYSPONDYLY, DISTINCTIVE BRACHYDACTYLY, HYDROCEPHALY, AND MICROPHTHALMIA	0.00275482	0.10335024098686685
RHOMBENCEPHALOSYNAPSIS	0.00275482	0.10335024098686685
ENDOCRINE-CEREBROOSTEODYSPLASIA; ECO	0.00275482	0.10335024098686685
HYDROCEPHALUS, TALL STATURE, JOINT LAXITY, AND KYPHOSCOLIOSIS	0.00275482	0.10335024098686685
TRISOMY 1Q	0.00275482	0.10335024098686685
TRIPLOIDY	0.00275482	0.10335024098686685
CENTRAL PRECOCIOUS PUBERTY	0.00275482	0.10335024098686685
MUSCULAR HYPERTROPHY-HEPATOMEGALY-POLYHYDRAMNIOS SYNDROME	0.00275482	0.10335024098686685
CAMPOMELIC DYSPLASIA	0.00275482	0.10335024098686685
SHORT RIB-POLYDACTYLY SYNDROME	0.00275482	0.10335024098686685
ACHONDROPLASIA	0.00275482	0.10335024098686685
ABSENT RADIUS-ANOGENITAL ANOMALIES SYNDROME	0.00275482	0.10335024098686685
CRANIOFACIAL CONODYSPLASIA	0.00275482	0.10335024098686685
ALBERS-SCHÖNBERG OSTEOPETROSIS	0.00275482	0.10335024098686685
COLE-CARPENTER SYNDROME 1; CLCRP1	0.00275482	0.10335024098686685
MARFAN LIPODYSTROPHY SYNDROME; MFLS	0.00275482	0.10335024098686685
BASAL CELL NEVUS SYNDROME	0.00275482	0.10335024098686685
AXENFELD-RIEGER ANOMALY WITH PARTIALLY ABSENT EYE MUSCLES, DISTINCTIVE FACE, HYDROCEPHALY, AND SKELETAL ABNORMALITIES	0.00275482	0.10335024098686685
OTOMANDIBULAR SYNDROME	0.00275482	0.10335024098686685
BIEMOND SYNDROME TYPE 2	0.00275482	0.10335024098686685
AUTOSOMAL DOMINANT CHARCOT-MARIE-TOOTH DISEASE TYPE 2A2	0.00275482	0.10335024098686685
ARACHNOIDITIS	0.00275482	0.10335024098686685
FAMILIAL LAMBDOID SYNOSTOSIS	0.00275482	0.10335024098686685
INIENCEPHALY	0.00275482	0.10335024098686685
CRANIOSYNOSTOSIS-DANDY-WALKER MALFORMATION-HYDROCEPHALUS SYNDROME	0.00275482	0.10335024098686685
PYCNODYSOSTOSIS	0.00275482	0.10335024098686685
CRANIOSYNOSTOSIS, SAGITTAL, WITH DANDY-WALKER MALFORMATION AND HYDROCEPHALUS	0.00275482	0.10335024098686685
OSTEOCHONDRODYSPLASIA, RHIZOMELIC, WITH CALLOSAL AGENESIS, THROMBOCYTOPENIA,HYDROCEPHALUS, AND HYPERTENSION	0.00275482	0.10335024098686685
FANCONI ANEMIA, COMPLEMENTATION GROUP R	0.00275482	0.10335024098686685
COLOBOMA-OBESITY-HYPOGENITALISM-MENTAL RETARDATION SYNDROME	0.00275482	0.10335024098686685
PITUITARY DEFICIENCY DUE TO RATHKE CLEFT CYSTS	0.00275482	0.10335024098686685
TETRAAMELIA-MULTIPLE MALFORMATIONS SYNDROME	0.00275482	0.10335024098686685
HYDROLETHALUS	0.00275482	0.10335024098686685
VENTRICULOMEGALY WITH DEFECTS OF THE RADIUS AND KIDNEY	0.00275482	0.10335024098686685
CROUZON SYNDROME WITH ACANTHOSIS NIGRICANS	0.00275482	0.10335024098686685
HYDROCEPHALUS-COSTOVERTEBRAL DYSPLASIA-SPRENGEL ANOMALY SYNDROME	0.00275482	0.10335024098686685
FUNCTIONING GONADOTROPIC ADENOMA	0.00275482	0.10335024098686685
LAURIN-SANDROW SYNDROME	0.00275482	0.10335024098686685
HYDROCEPHALUS-OBESITY-HYPOGONADISM SYNDROME	0.00275482	0.10335024098686685
MECKEL SYNDROME, TYPE 6; MKS6	0.00275482	0.10335024098686685
DISTAL 7Q11.23 MICRODUPLICATION SYNDROME	0.00275482	0.10335024098686685
183802 SPLIT-HAND WITH OBSTRUCTIVE UROPATHY, SPINA BIFIDA, AND DIAPHRAGMATICDEFECTS	0.00275482	0.10335024098686685
LETHAL OMPHALOCELE-CLEFT PALATE SYNDROME	0.00275482	0.10335024098686685
ACALVARIA	0.00275482	0.10335024098686685
TEMPLE SYNDROME	0.00275482	0.10335024098686685
SHORT-RIB THORACIC DYSPLASIA 18 WITH POLYDACTYLY; SRTD18	0.00275482	0.10335024098686685
DYSSEGMENTAL DYSPLASIA, ROLLAND-DESBUQUOIS TYPE	0.00275482	0.10335024098686685
DIABETIC EMBRYOPATHY	0.00275482	0.10335024098686685
SHORT-RIB THORACIC DYSPLASIA 12; SRTD12	0.00275482	0.10335024098686685
6P22 MICRODELETION SYNDROME	0.00275482	0.10335024098686685
SHORT-RIB THORACIC DYSPLASIA 10 WITH OR WITHOUT POLYDACTYLY; SRTD10	0.00275482	0.10335024098686685
HYPOPLASMINOGENEMIA	0.00275482	0.10335024098686685
HEMANGIOBLASTOMA	0.00275482	0.10335024098686685
STEINERT MYOTONIC DYSTROPHY	0.00275482	0.10335024098686685
%252100 MOHR SYNDROME;;OROFACIODIGITAL SYNDROME II; OFD2;;OFDS II;;ORAL-FACIAL-DIGITAL SYNDROME, TYPE II	0.00275482	0.10335024098686685
PLASMINOGEN DEFICIENCY, TYPE ILIGNEOUS CONJUNCTIVITIS, INCLUDED	0.00275482	0.10335024098686685
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 7; MDDGA7	0.00275482	0.10335024098686685
AMINOPTERIN/METHOTREXATE EMBRYOFETOPATHY	0.00275482	0.10335024098686685
PAPILLARY TUMOR OF THE PINEAL REGION	0.00275482	0.10335024098686685
FACIAL DYSMORPHISM WITH MULTIPLE MALFORMATIONS	0.00275482	0.10335024098686685
PINEOCYTOMA	0.00275482	0.10335024098686685
HYDROCEPHALUS, CONGENITAL, 3, WITH BRAIN ANOMALIES; HYC3	0.00275482	0.10335024098686685
DANDY-WALKER SYNDROME	0.00275482	0.10335024098686685
DANDY-WALKER MALFORMATION WITH MENTAL RETARDATION, MACROCEPHALY, MYOPIA, AND BRACHYTELEPHALANGY	0.00275482	0.10335024098686685
DANDY-WALKER MALFORMATION WITH POSTAXIAL POLYDACTYLY	0.00275482	0.10335024098686685
POSTERIOR MENINGOCELE	0.00275482	0.10335024098686685
MYCOPHENOLATE MOFETIL EMBRYOPATHY	0.00275482	0.10335024098686685
OMPHALOCELE-CLEFT PALATE SYNDROME, LETHAL	0.00275482	0.10335024098686685
258040 OEIS COMPLEX;;OMPHALOCELE-EXSTROPHY-IMPERFORATE ANUS-SPINAL DEFECTS	0.00275482	0.10335024098686685
VACTERL ASSOCIATION WITH HYDROCEPHALUS	0.00275482	0.10335024098686685
BIEMOND SYNDROME II	0.00275482	0.10335024098686685
FETAL AKINESIA DEFORMATION SEQUENCE; FADS	0.00275482	0.10335024098686685
STROMME SYNDROME; STROMS	0.00275482	0.10335024098686685
236640 HYDROCEPHALUS WITH ASSOCIATED MALFORMATIONS	0.00275482	0.10335024098686685
METATROPIC DYSPLASIA	0.00275482	0.10335024098686685
DIENCEPHALIC SYNDROME	0.00275482	0.10335024098686685
241800 HYPOTHALAMIC HAMARTOMASCONGENITAL HYPOTHALAMIC HAMARTOMA SYNDROME, INCLUDED; CHHS, INCLUDED	0.00275482	0.10335024098686685
CHIARI MALFORMATION TYPE II	0.00275482	0.10335024098686685
FRONTONASAL DYSPLASIA	0.00275482	0.10335024098686685
243440 ISOTRETINOIN EMBRYOPATHY-LIKE SYNDROME;;MICROTIA-AORTIC ARCH SYNDROME	0.00275482	0.10335024098686685
CENTRAL NEUROCYTOMA	0.00275482	0.10335024098686685
NEPHRONOPHTHISIS 18; NPHP18	0.00275482	0.10335024098686685
GORLIN SYNDROME	0.00275482	0.10335024098686685
BEEMER LETHAL MALFORMATION SYNDROME	0.00275482	0.10335024098686685
DISTAL 16P11.2 MICRODELETION SYNDROME	0.001086973	0.0407790423680014
SCHINDLER DISEASE, TYPE I	0.001086973	0.0407790423680014
X-LINKED INTELLECTUAL DISABILITY-HYPOGONADISM-ICHTHYOSIS-OBESITY-SHORT STATURE SYNDROME	0.001086973	0.0407790423680014
AMINOACYLASE 1 DEFICIENCY; ACY1D	0.001086973	0.0407790423680014
17Q12 MICRODELETION SYNDROME	0.001086973	0.0407790423680014
TEMPLE-BARAITSER SYNDROME; TMBTS	0.001086973	0.0407790423680014
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA	0.001086973	0.0407790423680014
CHROMOSOME 16P11.2 DELETION SYNDROME, 593-KB	0.001086973	0.0407790423680014
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIL; CDG2L	0.001086973	0.0407790423680014
PONTOCEREBELLAR HYPOPLASIA, TYPE 6	0.001086973	0.0407790423680014
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IN	0.001086973	0.0407790423680014
THIAMINE METABOLISM DYSFUNCTION SYNDROME 5 (EPISODIC ENCEPHALOPATHY TYPE)	0.001086973	0.0407790423680014
COENZYME Q10 DEFICIENCY, PRIMARY, 4	0.001086973	0.0407790423680014
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IF	0.001086973	0.0407790423680014
HEREDITARY FOLATE MALABSORPTION	0.001086973	0.0407790423680014
LEUKODYSTROPHY, HYPOMYELINATING, 5; HLD5	0.001086973	0.0407790423680014
MITOCHONDRIAL DNA DEPLETION SYNDROME 5 (ENCEPHALOMYOPATHIC WITH OR WITHOUT METHYLMALONIC ACIDURIA); MTDPS5	0.001086973	0.0407790423680014
CHROMOSOME 16P13.3 DELETION SYNDROME	0.001086973	0.0407790423680014
2-METHYLBUTYRYL-COA DEHYDROGENASE DEFICIENCY	0.001086973	0.0407790423680014
PONTINE TEGMENTAL CAP DYSPLASIA	0.001086973	0.0407790423680014
3-METHYLGLUTACONIC ACIDURIA TYPE 1	0.001086973	0.0407790423680014
X-LINKED NEURODEGENERATIVE SYNDROME, HAMEL TYPE	0.001086973	0.0407790423680014
3-METHYLGLUTACONIC ACIDURIA WITH DEAFNESS, ENCEPHALOPATHY, AND LEIGH-LIKE SYNDROME; MEGDEL	0.001086973	0.0407790423680014
ARGININEMIA	0.001086973	0.0407790423680014
MICROPHTHALMIA, SYNDROMIC 5; MCOPS5	0.001086973	0.0407790423680014
CONGENITAL CATARACTS, HEARING LOSS, AND NEURODEGENERATION; CCHLND	0.001086973	0.0407790423680014
MITOCHONDRIAL PYRUVATE CARRIER DEFICIENCY	0.001086973	0.0407790423680014
16P11.2P12.2 MICRODUPLICATION SYNDROME	0.001086973	0.0407790423680014
POTOCKI-LUPSKI SYNDROME	0.001086973	0.0407790423680014
COENZYME Q10 DEFICIENCY, PRIMARY, 5; COQ10D5	0.001086973	0.0407790423680014
NEUTROPENIA, SEVERE CONGENITAL, 3, AUTOSOMAL RECESSIVE; SCN3	0.001086973	0.0407790423680014
PYRIDOXAMINE 5-PRIME-PHOSPHATE OXIDASE DEFICIENCY	0.001086973	0.0407790423680014
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 14; MDDGB14	0.001086973	0.0407790423680014
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 10	0.001086973	0.0407790423680014
PHOSPHOSERINE AMINOTRANSFERASE DEFICIENCY; PSATD	0.001086973	0.0407790423680014
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 7	0.001086973	0.0407790423680014
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 6; MRT6	0.001086973	0.0407790423680014
CEDNIK SYNDROME	0.001086973	0.0407790423680014
AUTOSOMAL DOMINANT HYPERINSULINISM DUE TO SUR1 DEFICIENCY	0.001086973	0.0407790423680014
MENTAL RETARDATION, AUTOSOMAL DOMINANT 9; MRD9	0.001086973	0.0407790423680014
CEREBRAL CREATINE DEFICIENCY SYNDROME 2	0.001086973	0.0407790423680014
MEVALONIC ACIDURIA	0.001086973	0.0407790423680014
SEIZURES, SENSORINEURAL DEAFNESS, ATAXIA, MENTAL RETARDATION, AND ELECTROLYTE IMBALANCE	0.001086973	0.0407790423680014
N-ACETYLASPARTATE DEFICIENCY; NACED	0.001086973	0.0407790423680014
PACHYGYRIA-INTELLECTUAL DISABILITY-EPILEPSY SYNDROME	0.001086973	0.0407790423680014
MICROCEPHALY, GROWTH RETARDATION, CATARACT, HEARING LOSS, AND UNUSUAL APPEARANCE	0.001086973	0.0407790423680014
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 1	0.001086973	0.0407790423680014
ALG11-CDG	0.001086973	0.0407790423680014
PHOSPHOSERINE PHOSPHATASE DEFICIENCY; PSPHD	0.001086973	0.0407790423680014
PONTOCEREBELLAR HYPOPLASIA, TYPE 1B	0.001086973	0.0407790423680014
XQ21 MICRODELETION SYNDROME	0.001086973	0.0407790423680014
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IU; CDG1U	0.001086973	0.0407790423680014
MENTAL RETARDATION, AUTOSOMAL DOMINANT 6, WITH OR WITHOUT SEIZURES; MRD6	0.001086973	0.0407790423680014
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 39	0.001086973	0.0407790423680014
SEVERE INTELLECTUAL DISABILITY AND PROGRESSIVE SPASTIC PARAPLEGIA	0.001086973	0.0407790423680014
GABA-TRANSAMINASE DEFICIENCY	0.001086973	0.0407790423680014
SYNDROMIC RECESSIVE X-LINKED ICHTHYOSIS	0.001086973	0.0407790423680014
CHROMOSOME 14Q11-Q22 DELETION SYNDROME	0.001086973	0.0407790423680014
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IP; CDG1P	0.001086973	0.0407790423680014
CHROMOSOME 17Q11.2 DELETION SYNDROME, 1.4-MB	0.001086973	0.0407790423680014
PONTOCEREBELLAR HYPOPLASIA, TYPE 7; PCH7	0.001086973	0.0407790423680014
SPASTIC PARAPLEGIA 49, AUTOSOMAL RECESSIVE	0.001086973	0.0407790423680014
PONTOCEREBELLAR HYPOPLASIA, TYPE 2D	0.001086973	0.0407790423680014
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 7	0.001086973	0.0407790423680014
SPASTIC PARAPLEGIA 47, AUTOSOMAL RECESSIVE; SPG47	0.001086973	0.0407790423680014
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 11; COXPD11	0.001086973	0.0407790423680014
LEUKODYSTROPHY, HYPOMYELINATING, 4	0.001086973	0.0407790423680014
PEROXISOME BIOGENESIS DISORDER 11A (ZELLWEGER)	0.001086973	0.0407790423680014
3-METHYLGLUTACONIC ACIDURIA TYPE 4	0.001086973	0.0407790423680014
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 13	0.001086973	0.0407790423680014
ADAMS-OLIVER SYNDROME 2; AOS2	0.001086973	0.0407790423680014
HYPERINSULINISM DUE TO UCP2 DEFICIENCY	0.001086973	0.0407790423680014
BRAIN MALFORMATIONS WITH OR WITHOUT URINARY TRACT DEFECTS; BRMUTD	0.001086973	0.0407790423680014
X-LINKED INTELLECTUAL DISABILITY, TURNER TYPE	0.001086973	0.0407790423680014
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 2; CDCBM2	0.001086973	0.0407790423680014
RAPID-ONSET CHILDHOOD OBESITY-HYPOTHALAMIC DYSFUNCTION-HYPOVENTILATION-AUTONOMIC DYSREGULATION SYNDROME	0.001086973	0.0407790423680014
AUTOSOMAL DOMINANT HYPERINSULINISM DUE TO KIR6.2 DEFICIENCY	0.001086973	0.0407790423680014
THROMBOPHILIA DUE TO PROTEIN C DEFICIENCY, AUTOSOMAL RECESSIVE; THPH4	0.001086973	0.0407790423680014
GLASS SYNDROME	0.001086973	0.0407790423680014
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 3; HPMRS3	0.001086973	0.0407790423680014
DPAGT1-CDG	0.001086973	0.0407790423680014
MENTAL RETARDATION WITH OPTIC ATROPHY, FACIAL DYSMORPHISM, MICROCEPHALY, AND SHORT STATURE	0.001086973	0.0407790423680014
MENTAL RETARDATION, AUTOSOMAL DOMINANT 22; MRD22	0.001086973	0.0407790423680014
CONGENITAL DISORDER OF DEGLYCOSYLATION; CDDG	0.001086973	0.0407790423680014
OSTEOSCLEROTIC METAPHYSEAL DYSPLASIA	0.001086973	0.0407790423680014
PEROXISOME BIOGENESIS DISORDER 5A (ZELLWEGER)	0.001086973	0.0407790423680014
CHROMOSOME 6PTER-P24 DELETION SYNDROME	0.001086973	0.0407790423680014
XP21 MICRODELETION SYNDROME	0.001086973	0.0407790423680014
MENTAL RETARDATION, AUTOSOMAL DOMINANT 5	0.001086973	0.0407790423680014
MENTAL RETARDATION, AUTOSOMAL DOMINANT 2	0.001086973	0.0407790423680014
X-LINKED INTELLECTUAL DISABILITY-EPILEPSY-PROGRESSIVE JOINT CONTRACTURES-DYSMORPHISM SYNDROME	0.001086973	0.0407790423680014
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME X	0.001086973	0.0407790423680014
LISSENCEPHALY 4	0.001086973	0.0407790423680014
STOMATIN-DEFICIENT CRYOHYDROCYTOSIS WITH NEUROLOGIC DEFECTS; SDCHCN	0.001086973	0.0407790423680014
PROGRESSIVE ENCEPHALOPATHY WITH LEUKODYSTROPHY DUE TO DECR DEFICIENCY	0.001086973	0.0407790423680014
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA DUE TO STUB1 DEFICIENCY	0.001086973	0.0407790423680014
DYSTONIA-APHONIA SYNDROME	0.001086973	0.0407790423680014
NIEMANN-PICK DISEASE, TYPE C1; NPC1	0.001086973	0.0407790423680014
CEROID LIPOFUSCINOSIS, NEURONAL, 1	0.001086973	0.0407790423680014
ELEJALDE DISEASE	0.001086973	0.0407790423680014
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2A	0.001086973	0.0407790423680014
LEIGH SYNDROME; LS	0.001086973	0.0407790423680014
HOLOCARBOXYLASE SYNTHETASE DEFICIENCY	0.001086973	0.0407790423680014
PYRUVATE DEHYDROGENASE PHOSPHATASE DEFICIENCY	0.001086973	0.0407790423680014
BIOTINIDASE DEFICIENCYMULTIPLE CARBOXYLASE DEFICIENCY, LATE-ONSET	0.001086973	0.0407790423680014
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 1; MC1DN1	0.001086973	0.0407790423680014
GALLOWAY-MOWAT SYNDROME 1; GAMOS1	0.001086973	0.0407790423680014
METHYLMALONIC ACIDURIA, CBLA TYPE	0.001086973	0.0407790423680014
3-HYDROXYISOBUTYRYL-COA HYDROLASE DEFICIENCY	0.001086973	0.0407790423680014
DIHYDROLIPOAMIDE DEHYDROGENASE DEFICIENCY	0.001086973	0.0407790423680014
LANDAU-KLEFFNER SYNDROME	0.001086973	0.0407790423680014
PEHO SYNDROME; PEHO	0.001086973	0.0407790423680014
ISOLATED GLYCEROL KINASE DEFICIENCY	0.001086973	0.0407790423680014
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, C; HPABH4C	0.001086973	0.0407790423680014
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, A; HPABH4A	0.001086973	0.0407790423680014
SSR4-CDG	0.001086973	0.0407790423680014
HSD10 MITOCHONDRIAL DISEASE; HSD10MD	0.001086973	0.0407790423680014
STOCCO DOS SANTOS X-LINKED MENTAL RETARDATION SYNDROME; SDSX	0.001086973	0.0407790423680014
MENTAL RETARDATION, X-LINKED 72	0.001086973	0.0407790423680014
MEHMO SYNDROME; MEHMO	0.001086973	0.0407790423680014
RAYNAUD-CLAES SYNDROME; MRXSRC	0.001086973	0.0407790423680014
MENTAL RETARDATION, X-LINKED, SYNDROMIC 13	0.001086973	0.0407790423680014
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLD TYPE	0.001086973	0.0407790423680014
SEVERE INTELLECTUAL DISABILITY-PROGRESSIVE POSTNATAL MICROCEPHALY-MIDLINE STEREOTYPIC HAND MOVEMENTS SYNDROME	0.001086973	0.0407790423680014
GM2-GANGLIOSIDOSIS, AB VARIANT	0.001086973	0.0407790423680014
SULFOCYSTEINURIA	0.001086973	0.0407790423680014
PITUITARY STALK INTERRUPTION SYNDROME	0.001086973	0.0407790423680014
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 1	0.001086973	0.0407790423680014
PYRUVATE CARBOXYLASE DEFICIENCY	0.001086973	0.0407790423680014
PHOSPHOENOLPYRUVATE CARBOXYKINASE DEFICIENCY, CYTOSOLIC; PCKDC	0.001086973	0.0407790423680014
PYRUVATE DEHYDROGENASE E3-BINDING PROTEIN DEFICIENCY	0.001086973	0.0407790423680014
KETOADIPICACIDURIA	0.001086973	0.0407790423680014
VICI SYNDROME; VICIS	0.001086973	0.0407790423680014
ARGININOSUCCINIC ACIDURIA	0.001086973	0.0407790423680014
EARLY-ONSET PROGRESSIVE ENCEPHALOPATHY-SPASTIC ATAXIA-DISTAL SPINAL MUSCULAR ATROPHY SYNDROME	0.001086973	0.0407790423680014
LONG CHAIN 3-HYDROXYACYL-COA DEHYDROGENASE DEFICIENCY	0.001086973	0.0407790423680014
CHILDHOOD-ONSET MOTOR AND COGNITIVE REGRESSION SYNDROME WITH EXTRAPYRAMIDAL MOVEMENT DISORDER	0.001086973	0.0407790423680014
SEVERE NEURODEVELOPMENTAL DISORDER WITH FEEDING DIFFICULTIES-STEREOTYPIC HAND MOVEMENT-BILATERAL CATARACT	0.001086973	0.0407790423680014
PALLISTER-HALL SYNDROME	0.001086973	0.0407790423680014
MICROLISSENCEPHALY-MICROMELIA SYNDROME	0.001086973	0.0407790423680014
AICARDI-GOUTIÈRES SYNDROME	0.001086973	0.0407790423680014
MAPLE SYRUP URINE DISEASE	0.001086973	0.0407790423680014
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 1	0.001086973	0.0407790423680014
PLAA-ASSOCIATED NEURODEVELOPMENTAL DISORDER	0.001086973	0.0407790423680014
NKX6-2-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.001086973	0.0407790423680014
%114100 BASAL GANGLIA CALCIFICATION, IDIOPATHIC, CHILDHOOD-ONSET;;IBGC, CHILDHOOD-ONSET;;STRIOPALLIDODENTATE CALCINOSIS, BILATERAL, CHILDHOOD-ONSET;;CEREBRAL CALCIFICATION, NONARTERIOSCLEROTIC, IDIOPATHIC, CHILDHOOD-ONSET	0.001086973	0.0407790423680014
ADENYLOSUCCINASE DEFICIENCY	0.001086973	0.0407790423680014
POTOCKI-SHAFFER SYNDROME	0.001086973	0.0407790423680014
WYBURN-MASON SYNDROME	0.001086973	0.0407790423680014
ACYL-COA DEHYDROGENASE, MEDIUM-CHAIN, DEFICIENCY OF	0.001086973	0.0407790423680014
BERRY ANEURYSM, CIRRHOSIS, PULMONARY EMPHYSEMA, AND CEREBRAL CALCIFICATION	0.001086973	0.0407790423680014
X-LINKED LISSENCEPHALY WITH ABNORMAL GENITALIA	0.001086973	0.0407790423680014
3-METHYLCROTONYL-COA CARBOXYLASE 1 DEFICIENCY; MCC1D	0.001086973	0.0407790423680014
HOLOPROSENCEPHALY 1; HPE1	0.001086973	0.0407790423680014
HARTNUP DISORDER	0.001086973	0.0407790423680014
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, B; HPABH4B	0.001086973	0.0407790423680014
INTELLECTUAL DISABILITY-MACROCEPHALY-HYPOTONIA-BEHAVIORAL ABNORMALITIES SYNDROME	0.001086973	0.0407790423680014
GAUCHER DISEASE, TYPE II	0.001086973	0.0407790423680014
FOLATE MALABSORPTION, HEREDITARY	0.001086973	0.0407790423680014
LATHOSTEROLOSIS	0.001086973	0.0407790423680014
CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME 1; CAMRQ1	0.001086973	0.0407790423680014
SHORT STATURE-BRACHYDACTYLY-OBESITY-GLOBAL DEVELOPMENTAL DELAY SYNDROME	0.001086973	0.0407790423680014
MITOCHONDRIAL COMPLEX IV DEFICIENCY	0.001086973	0.0407790423680014
COACH SYNDROME	0.001086973	0.0407790423680014
CITRULLINEMIA, CLASSIC	0.001086973	0.0407790423680014
GRISCELLI SYNDROME, TYPE 1	0.001086973	0.0407790423680014
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IA; CDG1A	0.001086973	0.0407790423680014
3-METHYLCROTONYL-COA CARBOXYLASE 2 DEFICIENCY; MCC2D	0.001086973	0.0407790423680014
STT3B-CDG	0.001086973	0.0407790423680014
STT3A-CDG	0.001086973	0.0407790423680014
DEAFNESS, DYSTONIA, AND CEREBRAL HYPOMYELINATION; DDCH	0.001086973	0.0407790423680014
DIABETES MELLITUS, PERMANENT NEONATAL; PNDM	0.001086973	0.0407790423680014
NARP SYNDROME	0.001086973	0.0407790423680014
X-LINKED INTELLECTUAL DISABILITY-CARDIOMEGALY-CONGESTIVE HEART FAILURE SYNDROME	0.001086973	0.0407790423680014
SALLA DISEASE	0.001086973	0.0407790423680014
ALSTRÖM SYNDROME	0.001086973	0.0407790423680014
SRD5A3-CDG	0.001086973	0.0407790423680014
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIF; CDG2F	0.001086973	0.0407790423680014
FILIPPI SYNDROME	0.001086973	0.0407790423680014
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 2	0.001086973	0.0407790423680014
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 4	0.001086973	0.0407790423680014
CEREBRAL PALSY, SPASTIC, SYMMETRIC, AUTOSOMAL RECESSIVE	0.001086973	0.0407790423680014
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IC; CDG1C	0.001086973	0.0407790423680014
BETA-PROPELLER PROTEIN-ASSOCIATED NEURODEGENERATION	0.001086973	0.0407790423680014
ENCEPHALOPATHY, ETHYLMALONIC; EE	0.001086973	0.0407790423680014
PIERPONT SYNDROME	0.001086973	0.0407790423680014
ISOVALERIC ACIDEMIA	0.001086973	0.0407790423680014
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIB	0.001086973	0.0407790423680014
HEREDITARY SENSORY AND AUTONOMIC NEUROPATHY DUE TO TECPR2 MUTATION	0.001086973	0.0407790423680014
NEUROECTODERMAL MELANOLYSOSOMAL DISEASE	0.001086973	0.0407790423680014
PHACE ASSOCIATION	0.001086973	0.0407790423680014
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IL; CDG1L	0.001086973	0.0407790423680014
RUVALCABA SYNDROME	0.001086973	0.0407790423680014
RIBOSE 5-PHOSPHATE ISOMERASE DEFICIENCY; RPIAD	0.001086973	0.0407790423680014
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IK; CDG1K	0.001086973	0.0407790423680014
MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 6	0.001086973	0.0407790423680014
PERIVENTRICULAR HETEROTOPIA WITH MICROCEPHALY, AUTOSOMAL RECESSIVE; ARPHM	0.001086973	0.0407790423680014
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IJ; CDG1J	0.001086973	0.0407790423680014
SEVERE CANAVAN DISEASE	0.001086973	0.0407790423680014
NIEMANN-PICK DISEASE, TYPE C2	0.001086973	0.0407790423680014
THIAMINE METABOLISM DYSFUNCTION SYNDROME 2 (BIOTIN- OR THIAMINE-RESPONSIVE TYPE); THMD2	0.001086973	0.0407790423680014
SIALURIA	0.001086973	0.0407790423680014
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 2; MRT2	0.001086973	0.0407790423680014
LEBER CONGENITAL AMAUROSIS	0.001086973	0.0407790423680014
POLYMICROGYRIA, BILATERAL FRONTOPARIETAL	0.001086973	0.0407790423680014
MICROCEPHALIC PRIMORDIAL DWARFISM, DAUBER TYPE	0.001086973	0.0407790423680014
PEROXISOME BIOGENESIS DISORDER 1B; PBD1B	0.001086973	0.0407790423680014
MICROCEPHALY, CORPUS CALLOSUM DYSGENESIS, AND CLEFT LIP/PALATE	0.001086973	0.0407790423680014
MENTAL RETARDATION, X-LINKED, WITH CEREBELLAR HYPOPLASIA AND DISTINCTIVE FACIAL APPEARANCE	0.001086973	0.0407790423680014
AUTOSOMAL RECESSIVE CUTIS LAXA TYPE 2, CLASSIC TYPE	0.001086973	0.0407790423680014
MENTAL RETARDATION, X-LINKED, SYNDROMIC, HOUGE TYPE; MRXSHG	0.001086973	0.0407790423680014
GALLOWAY-MOWAT SYNDROME 2, X-LINKED; GAMOS2	0.001086973	0.0407790423680014
MENTAL RETARDATION, X-LINKED, SYNDROMIC, 35; MRXS35	0.001086973	0.0407790423680014
MENTAL RETARDATION, X-LINKED 104; MRX104	0.001086973	0.0407790423680014
MENTAL RETARDATION, X-LINKED 103	0.001086973	0.0407790423680014
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IY; CDG1Y	0.001086973	0.0407790423680014
GMPPB-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R19	0.001086973	0.0407790423680014
MENTAL RETARDATION, X-LINKED 101; MRX101	0.001086973	0.0407790423680014
20Q11.2 MICRODUPLICATION SYNDROME	0.001086973	0.0407790423680014
DISTAL MONOSOMY 1Q	0.001086973	0.0407790423680014
MENTAL RETARDATION, X-LINKED 88	0.001086973	0.0407790423680014
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 6; COXPD6	0.001086973	0.0407790423680014
MENTAL RETARDATION AND MICROCEPHALY WITH PONTINE AND CEREBELLAR HYPOPLASIA; MICPCH	0.001086973	0.0407790423680014
INTELLECTUAL DISABILITY-HYPERKINETIC MOVEMENT-TRUNCAL ATAXIA SYNDROME	0.001086973	0.0407790423680014
MENTAL RETARDATION, X-LINKED 91; MRX91	0.001086973	0.0407790423680014
SHUKLA-VERNON SYNDROME; SHUVER	0.001086973	0.0407790423680014
SPINOCEREBELLAR ATAXIA, X-LINKED 3	0.001086973	0.0407790423680014
BRACHYCEPHALY, DEAFNESS, CATARACT, MICROSTOMIA, AND MENTAL RETARDATION	0.001086973	0.0407790423680014
19P13.13 MICRODELETION SYNDROME	0.001086973	0.0407790423680014
TRIGONOCEPHALY-SHORT STATURE-DEVELOPMENTAL DELAY SYNDROME	0.001086973	0.0407790423680014
DISTAL TRISOMY 17Q	0.001086973	0.0407790423680014
HYPERAMMONEMIA DUE TO N-ACETYLGLUTAMATE SYNTHASE DEFICIENCY	0.001086973	0.0407790423680014
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE ID; CDG1D	0.001086973	0.0407790423680014
TIMOTHY SYNDROME; TS	0.001086973	0.0407790423680014
HYPERIMMUNOGLOBULINEMIA D WITH PERIODIC FEVER	0.001086973	0.0407790423680014
D-2-HYDROXYGLUTARIC ACIDURIA 1	0.001086973	0.0407790423680014
NEUROPATHY, ATAXIA, AND RETINITIS PIGMENTOSA	0.001086973	0.0407790423680014
TRIGONOCEPHALY WITH SHORT STATURE AND DEVELOPMENTAL DELAY	0.001086973	0.0407790423680014
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 18; LGMDR18	0.001086973	0.0407790423680014
PYRUVATE DEHYDROGENASE E1-ALPHA DEFICIENCY; PDHAD	0.001086973	0.0407790423680014
PELIZAEUS-MERZBACHER DISEASE	0.001086973	0.0407790423680014
WAISMAN SYNDROME; WSMN	0.001086973	0.0407790423680014
MENTAL RETARDATION, X-LINKED 9	0.001086973	0.0407790423680014
GLYCEROL KINASE DEFICIENCY; GKD	0.001086973	0.0407790423680014
FUCOSIDOSIS	0.001086973	0.0407790423680014
LUSCAN-LUMISH SYNDROME; LLS	0.001086973	0.0407790423680014
GLYCOGEN STORAGE DISEASE DUE TO HEPATIC GLYCOGEN SYNTHASE DEFICIENCY	0.001086973	0.0407790423680014
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 33; EIEE33	0.001086973	0.0407790423680014
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 31; MC1DN31	0.001086973	0.0407790423680014
EAST SYNDROME	0.001086973	0.0407790423680014
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 28; EIEE28	0.001086973	0.0407790423680014
NEURODEVELOPMENTAL DISORDER, MITOCHONDRIAL, WITH ABNORMAL MOVEMENTS AND LACTIC ACIDOSIS, WITH OR WITHOUT SEIZURES; NEMMLAS	0.001086973	0.0407790423680014
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 42; EIEE42	0.001086973	0.0407790423680014
LISSENCEPHALY 6 WITH MICROCEPHALY; LIS6	0.001086973	0.0407790423680014
NEUROLOGIC, ENDOCRINE, AND PANCREATIC DISEASE, MULTISYSTEM, INFANTILE-ONSET; IMNEPD	0.001086973	0.0407790423680014
3-METHYLGLUTACONIC ACIDURIA WITH CATARACTS, NEUROLOGIC INVOLVEMENT, AND NEUTROPENIA; MEGCANN	0.001086973	0.0407790423680014
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 41; EIEE41	0.001086973	0.0407790423680014
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 1; IECEE1	0.001086973	0.0407790423680014
CENTRAL BILATERAL MACROGYRIA	0.001086973	0.0407790423680014
GROWTH RETARDATION, IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND HEPATOPATHY; GRIDHH	0.001086973	0.0407790423680014
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 19; MC1DN19	0.001086973	0.0407790423680014
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 29; EIEE29	0.001086973	0.0407790423680014
ENCEPHALOCRANIOCUTANEOUS LIPOMATOSIS	0.001086973	0.0407790423680014
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 18; MC1DN18	0.001086973	0.0407790423680014
LISSENCEPHALY 7 WITH CEREBELLAR HYPOPLASIA; LIS7	0.001086973	0.0407790423680014
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 16; MC1DN16	0.001086973	0.0407790423680014
GRISCELLI SYNDROME TYPE 1	0.001086973	0.0407790423680014
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 13; MC1DN13	0.001086973	0.0407790423680014
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 31; EIEE31	0.001086973	0.0407790423680014
MICROCEPHALY 17, PRIMARY, AUTOSOMAL RECESSIVE; MCPH17	0.001086973	0.0407790423680014
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 20; SCAR20	0.001086973	0.0407790423680014
MENTAL RETARDATION, AUTOSOMAL DOMINANT 38; MRD38	0.001086973	0.0407790423680014
MICROCEPHALY 14, PRIMARY, AUTOSOMAL RECESSIVE; MCPH14	0.001086973	0.0407790423680014
MENTAL RETARDATION, AUTOSOMAL DOMINANT 31; MRD31	0.001086973	0.0407790423680014
ADULT-ONSET DYSTONIA-PARKINSONISM	0.001086973	0.0407790423680014
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, ATAXIA, AND SEIZURES; NEDMAS	0.001086973	0.0407790423680014
CITRULLINEMIA TYPE II	0.001086973	0.0407790423680014
MOSAIC TRISOMY 14	0.001086973	0.0407790423680014
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 26; EIEE26	0.001086973	0.0407790423680014
HYDRANENCEPHALY	0.001086973	0.0407790423680014
SIDEROBLASTIC ANEMIA WITH B-CELL IMMUNODEFICIENCY, PERIODIC FEVERS, AND DEVELOPMENTAL DELAY; SIFD	0.001086973	0.0407790423680014
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC ARRHYTHMIA	0.001086973	0.0407790423680014
X-LINKED INTELLECTUAL DISABILITY, ARMFIELD TYPE	0.001086973	0.0407790423680014
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 46; EIEE46	0.001086973	0.0407790423680014
SHORT STATURE, BRACHYDACTYLY, INTELLECTUAL DEVELOPMENTAL DISABILITY, AND SEIZURES; SBIDDS	0.001086973	0.0407790423680014
MEGALOCORNEA-INTELLECTUAL DISABILITY SYNDROME	0.001086973	0.0407790423680014
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 46	0.001086973	0.0407790423680014
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 45	0.001086973	0.0407790423680014
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 2; CDGF2	0.001086973	0.0407790423680014
MEGA-CORPUS-CALLOSUM SYNDROME WITH CEREBELLAR HYPOPLASIA AND CORTICAL MALFORMATIONS; MCCCHCM	0.001086973	0.0407790423680014
COWDEN SYNDROME	0.001086973	0.0407790423680014
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 70; EIEE70	0.001086973	0.0407790423680014
22Q11.2 MICRODUPLICATION SYNDROME	0.001086973	0.0407790423680014
KEUTEL SYNDROME	0.001086973	0.0407790423680014
ZTTK SYNDROME; ZTTKS	0.001086973	0.0407790423680014
FIBROSIS, NEURODEGENERATION, AND CEREBRAL ANGIOMATOSIS; FINCA	0.001086973	0.0407790423680014
NEURODEGENERATION, CHILDHOOD-ONSET, WITH BRAIN ATROPHY; CONDBA	0.001086973	0.0407790423680014
PONTOCEREBELLAR HYPOPLASIA, TYPE 11; PCH11	0.001086973	0.0407790423680014
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 27; EIEE27	0.001086973	0.0407790423680014
MATERNAL PHENYLKETONURIA	0.001086973	0.0407790423680014
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 43	0.001086973	0.0407790423680014
15Q11Q13 MICRODUPLICATION SYNDROME	0.001086973	0.0407790423680014
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 10; MC1DN10	0.001086973	0.0407790423680014
JOUBERT SYNDROME 30; JBTS30	0.001086973	0.0407790423680014
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 5; MC1DN5	0.001086973	0.0407790423680014
PONTOCEREBELLAR HYPOPLASIA, TYPE 1D; PCH1D	0.001086973	0.0407790423680014
INTELLECTUAL DEVELOPMENTAL DISORDER WITH OR WITHOUT EPILEPSY OR CEREBELLAR ATAXIA; IDDECA	0.001086973	0.0407790423680014
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 5; RCDP5	0.001086973	0.0407790423680014
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIN	0.001086973	0.0407790423680014
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL RECESSIVE; NDHMSR	0.001086973	0.0407790423680014
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 3; IECEE3	0.001086973	0.0407790423680014
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 17; GPIBD17	0.001086973	0.0407790423680014
SCHIZENCEPHALY	0.001086973	0.0407790423680014
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 2; IECEE2	0.001086973	0.0407790423680014
LEUKODYSTROPHY AND ACQUIRED MICROCEPHALY WITH OR WITHOUT DYSTONIA; LDAMD	0.001086973	0.0407790423680014
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 1; CDGF1	0.001086973	0.0407790423680014
SOTOS SYNDROME	0.001086973	0.0407790423680014
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND BRAIN ATROPHY; NEDMEBA	0.001086973	0.0407790423680014
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 6; MMDS6	0.001086973	0.0407790423680014
LEUKODYSTROPHY, HYPOMYELINATING, 15; HLD15	0.001086973	0.0407790423680014
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 6	0.001086973	0.0407790423680014
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 29; COXPD29	0.001086973	0.0407790423680014
CHROMOSOME 11P13 DELETION SYNDROME, DISTAL	0.001086973	0.0407790423680014
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 52	0.001086973	0.0407790423680014
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIO	0.001086973	0.0407790423680014
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 62; EIEE62	0.001086973	0.0407790423680014
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 4; FFEVF4	0.001086973	0.0407790423680014
CEREBELLAR ATROPHY, VISUAL IMPAIRMENT, AND PSYCHOMOTOR RETARDATION; CAVIPMR	0.001086973	0.0407790423680014
CHROMOSOME 1P35 DELETION SYNDROME	0.001086973	0.0407790423680014
CHROMOSOME 16P13.2 DELETION SYNDROME	0.001086973	0.0407790423680014
THORACIC DYSPLASIA-HYDROCEPHALUS SYNDROME	0.001086973	0.0407790423680014
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 16; GPIBD16	0.001086973	0.0407790423680014
NEURODEVELOPMENTAL DISORDER WITH REGRESSION, ABNORMAL MOVEMENTS, LOSS OF SPEECH, AND SEIZURES; NEDAMSS	0.001086973	0.0407790423680014
MENTAL RETARDATION, AUTOSOMAL DOMINANT 53; MRD53	0.001086973	0.0407790423680014
HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION; HOMGSMR	0.001086973	0.0407790423680014
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 4; MC1DN4	0.001086973	0.0407790423680014
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 2; MC1DN2	0.001086973	0.0407790423680014
BASEL-VANAGAITE-SMIRIN-YOSEF SYNDROME; BVSYS	0.001086973	0.0407790423680014
TAY-SACHS DISEASE	0.001086973	0.0407790423680014
CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 3; CPSQ3	0.001086973	0.0407790423680014
MENTAL RETARDATION, AUTOSOMAL DOMINANT 42	0.001086973	0.0407790423680014
INFANTILE OSTEOPETROSIS WITH NEUROAXONAL DYSPLASIA	0.001086973	0.0407790423680014
DUANE RETRACTION SYNDROME	0.001086973	0.0407790423680014
INFLAMMATORY BOWEL DISEASE, IMMUNODEFICIENCY, AND ENCEPHALOPATHY; IBDIMDE	0.001086973	0.0407790423680014
MENTAL RETARDATION, AUTOSOMAL DOMINANT 52; MRD52	0.001086973	0.0407790423680014
MENTAL RETARDATION, AUTOSOMAL DOMINANT 41	0.001086973	0.0407790423680014
MICROCEPHALY 16, PRIMARY, AUTOSOMAL RECESSIVE	0.001086973	0.0407790423680014
BONE MARROW FAILURE SYNDROME 5; BMFS5	0.001086973	0.0407790423680014
INTELLECTUAL DEVELOPMENTAL DISORDER WITH MACROCEPHALY, SEIZURES, AND SPEECH DELAY; IDDMSSD	0.001086973	0.0407790423680014
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 5; MC5DN5	0.001086973	0.0407790423680014
MENTAL RETARDATION, AUTOSOMAL DOMINANT 58; MRD58	0.001086973	0.0407790423680014
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, SEIZURES, AND CORTICAL ATROPHY; NDMSCA	0.001086973	0.0407790423680014
EPILEPSY, HEARING LOSS, AND MENTAL RETARDATION SYNDROME; EHLMRS	0.001086973	0.0407790423680014
ACROMELIC FRONTONASAL DYSPLASIA	0.001086973	0.0407790423680014
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 64; MRT64	0.001086973	0.0407790423680014
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND BEHAVIORAL ABNORMALITIES; IDDFBA	0.001086973	0.0407790423680014
SPASTIC TETRAPLEGIA, THIN CORPUS CALLOSUM, AND PROGRESSIVE MICROCEPHALY; SPATCCM	0.001086973	0.0407790423680014
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 53; MRT53	0.001086973	0.0407790423680014
2,4-DIENOYL-COA REDUCTASE DEFICIENCY; DECRD	0.001086973	0.0407790423680014
LISSENCEPHALY 9 WITH COMPLEX BRAINSTEM MALFORMATION; LIS9	0.001086973	0.0407790423680014
GALLOWAY-MOWAT SYNDROME 8; GAMOS8	0.001086973	0.0407790423680014
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA TYPE MUT-	0.001086973	0.0407790423680014
CLASSIC PHENYLKETONURIA	0.001086973	0.0407790423680014
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 5; CDCBM5	0.001086973	0.0407790423680014
CONGENITAL DISORDER OF GLYCOSYLATION	0.001086973	0.0407790423680014
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 42; MRT42	0.001086973	0.0407790423680014
O'DONNELL-LURIA-RODAN SYNDROME; ODLURO	0.001086973	0.0407790423680014
NEURODEVELOPMENTAL DISORDER WITH COARSE FACIES AND MILD DISTAL SKELETAL ABNORMALITIES; NEDCFSA	0.001086973	0.0407790423680014
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 71; MRT71	0.001086973	0.0407790423680014
NEUROLOGICAL CONDITIONS ASSOCIATED WITH AMINOACYLASE 1 DEFICIENCY	0.001086973	0.0407790423680014
PONTOCEREBELLAR HYPOPLASIA, TYPE 9	0.001086973	0.0407790423680014
X-LINKED INTELLECTUAL DISABILITY-CEREBELLAR HYPOPLASIA SYNDROME	0.001086973	0.0407790423680014
HOLOPROSENCEPHALY 12 WITH OR WITHOUT PANCREATIC AGENESIS; HPE12	0.001086973	0.0407790423680014
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND NONEPILEPTIC HYPERKINETIC MOVEMENTS; NEDNEH	0.001086973	0.0407790423680014
HERNÁNDEZ-AGUIRRE NEGRETE SYNDROME	0.001086973	0.0407790423680014
NEURODEGENERATION, EARLY-ONSET, WITH CHOREOATHETOID MOVEMENTS AND MICROCYTIC ANEMIA; NDCAMA	0.001086973	0.0407790423680014
GRUBBEN-DE COCK-BORGHGRAEF SYNDROME	0.001086973	0.0407790423680014
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY, CATARACTS, FEEDING DIFFICULTIES, AND DELAYED BRAIN MYELINATION	0.001086973	0.0407790423680014
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIQ; CDG2Q	0.001086973	0.0407790423680014
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 21; EIEE21	0.001086973	0.0407790423680014
VICI SYNDROME	0.001086973	0.0407790423680014
PERIVENTRICULAR NODULAR HETEROTOPIA 6; PVNH6	0.001086973	0.0407790423680014
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 54; EIEE54	0.001086973	0.0407790423680014
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 9; IIAE9	0.001086973	0.0407790423680014
ARTHROGRYPOSIS, MENTAL RETARDATION, AND SEIZURES	0.001086973	0.0407790423680014
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IW; CDG1W	0.001086973	0.0407790423680014
NEURODEVELOPMENTAL DISORDER WITH INVOLUNTARY MOVEMENTS; NEDIM	0.001086973	0.0407790423680014
CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY	0.001086973	0.0407790423680014
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IX; CDG1X	0.001086973	0.0407790423680014
ALG1-CDG	0.001086973	0.0407790423680014
ALG3-CDG	0.001086973	0.0407790423680014
HYPOXANTHINE GUANINE PHOSPHORIBOSYLTRANSFERASE PARTIAL DEFICIENCY	0.001086973	0.0407790423680014
LOPES-MACIEL-RODAN SYNDROME; LOMARS	0.001086973	0.0407790423680014
LEIGH SYNDROME WITH LEUKODYSTROPHY	0.001086973	0.0407790423680014
GALLOWAY-MOWAT SYNDROME	0.001086973	0.0407790423680014
STANKIEWICZ-ISIDOR SYNDROME; STISS	0.001086973	0.0407790423680014
6-PYRUVOYL-TETRAHYDROPTERIN SYNTHASE DEFICIENCY	0.001086973	0.0407790423680014
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 41; MRT41	0.001086973	0.0407790423680014
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, NEUROPATHY, AND DEAFNESS; NEDHND	0.001086973	0.0407790423680014
HARTNUP DISEASE	0.001086973	0.0407790423680014
CHROMOSOME 15Q11.2 DELETION SYNDROME	0.001086973	0.0407790423680014
2P21 MICRODELETION SYNDROME	0.001086973	0.0407790423680014
CHROMOSOME 5Q12 DELETION SYNDROME	0.001086973	0.0407790423680014
INFANTILE REFSUM DISEASE	0.001086973	0.0407790423680014
MICROPHTHALMIA WITH BRAIN AND DIGIT ANOMALIES	0.001086973	0.0407790423680014
CORPUS CALLOSUM AGENESIS-NEURONOPATHY SYNDROME	0.001086973	0.0407790423680014
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 55; EIEE55	0.001086973	0.0407790423680014
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 5; MMDS5	0.001086973	0.0407790423680014
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 44	0.001086973	0.0407790423680014
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 3; MVA3	0.001086973	0.0407790423680014
ENCEPHALOPATHY, PROGRESSIVE, WITH AMYOTROPHY AND OPTIC ATROPHY; PEAMO	0.001086973	0.0407790423680014
3Q29 MICRODUPLICATION SYNDROME	0.001086973	0.0407790423680014
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 3; CDCBM3	0.001086973	0.0407790423680014
MENTAL RETARDATION, AUTOSOMAL DOMINANT 45; MRD45	0.001086973	0.0407790423680014
MENTAL RETARDATION, AUTOSOMAL DOMINANT 46; MRD46	0.001086973	0.0407790423680014
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 31	0.001086973	0.0407790423680014
WEBB-DATTANI SYNDROME; WEDAS	0.001086973	0.0407790423680014
MUSCULAR DYSTROPHY, CONGENITAL, WITH CATARACTS AND INTELLECTUAL DISABILITY	0.001086973	0.0407790423680014
NEURODEVELOPMENTAL DISORDER WITH CENTRAL AND PERIPHERAL MOTOR DYSFUNCTION; NEDCPMD	0.001086973	0.0407790423680014
HEREDITARY CRYOHYDROCYTOSIS WITH REDUCED STOMATIN	0.001086973	0.0407790423680014
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 72; EIEE72	0.001086973	0.0407790423680014
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND HYPOMYELINATION; NEDMEHM	0.001086973	0.0407790423680014
CHROMOSOME 19Q13.11 DELETION SYNDROME, PROXIMAL	0.001086973	0.0407790423680014
MICRO SYNDROME	0.001086973	0.0407790423680014
PERIVENTRICULAR NODULAR HETEROTOPIA 7; PVNH7	0.001086973	0.0407790423680014
BRAIN SMALL VESSEL DISEASE 3; BSVD3	0.001086973	0.0407790423680014
CLASSIC PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION	0.001086973	0.0407790423680014
EPILEPSY, EARLY-ONSET, VITAMIN B6-DEPENDENT; EPVB6D	0.001086973	0.0407790423680014
CANAVAN DISEASE	0.001086973	0.0407790423680014
LEUKODYSTROPHY, HYPOMYELINATING, 18; HLD18	0.001086973	0.0407790423680014
AICARDI-GOUTIERES SYNDROME 7	0.001086973	0.0407790423680014
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY TYPE 1	0.001086973	0.0407790423680014
LISSENCEPHALY 8; LIS8	0.001086973	0.0407790423680014
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 4; CDCBM4	0.001086973	0.0407790423680014
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 20	0.001086973	0.0407790423680014
PONTOCEREBELLAR HYPOPLASIA, TYPE 2E; PCH2E	0.001086973	0.0407790423680014
INFANTILE LIVER FAILURE SYNDROME 1	0.001086973	0.0407790423680014
NEPHROTIC SYNDROME, TYPE 14; NPHS14	0.001086973	0.0407790423680014
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 11; GPIBD11	0.001086973	0.0407790423680014
MULTIPLE CARBOXYLASE DEFICIENCY	0.001086973	0.0407790423680014
METABOLIC CRISES, RECURRENT, WITH VARIABLE ENCEPHALOMYOPATHIC FEATURES AND NEUROLOGIC REGRESSION; MECREN	0.001086973	0.0407790423680014
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY TYPE 3	0.001086973	0.0407790423680014
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 67	0.000545554	0.020467085824608926
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 69	0.000545554	0.020467085824608926
SPINOCEREBELLAR ATAXIA TYPE 7	0.000545554	0.020467085824608926
JOUBERT SYNDROME WITH JEUNE ASPHYXIATING THORACIC DYSTROPHY	0.000545554	0.020467085824608926
SPECIFIC GRANULE DEFICIENCY 2; SGD2	0.000545554	0.020467085824608926
275595 TRIGONOBRACHYCEPHALY, BULBOUS BIFID NOSE, MICROGNATHIA, AND ABNORMALITIESOF THE HANDS AND FEET	0.000545554	0.020467085824608926
SPONDYLOMETAEPIPHYSEAL DYSPLASIA, SHORT LIMB-HAND TYPE	0.000545554	0.020467085824608926
THUMB, HYPOPLASTIC, WITH CHOROID COLOBOMA, POORLY DEVELOPED ANTIHELIX,AND DEAFNESS	0.000545554	0.020467085824608926
SPECTRIN-ASSOCIATED AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA	0.000545554	0.020467085824608926
TARP SYNDROME; TARPS	0.000545554	0.020467085824608926
ATAXIA, SPASTIC, CHILDHOOD-ONSET, AUTOSOMAL RECESSIVE, WITH OPTIC ATROPHY AND MENTAL RETARDATION	0.000545554	0.020467085824608926
SPINOCEREBELLAR ATAXIA TYPE 29	0.000545554	0.020467085824608926
PROXIMAL MYOPATHY WITH EXTRAPYRAMIDAL SIGNS	0.000545554	0.020467085824608926
GERODERMA OSTEODYSPLASTICA	0.000545554	0.020467085824608926
273730 THORACIC DYSPLASIA-HYDROCEPHALUS SYNDROME	0.000545554	0.020467085824608926
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 60	0.000545554	0.020467085824608926
SPINOCEREBELLAR ATAXIA WITH DYSMORPHISM	0.000545554	0.020467085824608926
DYSKERATOSIS CONGENITA, X-LINKED; DKCX	0.000545554	0.020467085824608926
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 2; NSLH2	0.000545554	0.020467085824608926
RETINITIS PIGMENTOSA 80; RP80	0.000545554	0.020467085824608926
BRAIN DOPAMINE-SEROTONIN VESICULAR TRANSPORT DISEASE	0.000545554	0.020467085824608926
TONNE-KALSCHEUER SYNDROME; TOKAS	0.000545554	0.020467085824608926
SWEENEY-COX SYNDROME; SWCOS	0.000545554	0.020467085824608926
GALLOWAY-MOWAT SYNDROME 5; GAMOS5	0.000545554	0.020467085824608926
MECKEL SYNDROME 13; MKS13	0.000545554	0.020467085824608926
OROFACIODIGITAL SYNDROME XVI; OFD16	0.000545554	0.020467085824608926
MENTAL RETARDATION, X-LINKED 106; MRX106	0.000545554	0.020467085824608926
OROFACIODIGITAL SYNDROME VIII; OFD8	0.000545554	0.020467085824608926
ATAXIA-INTELLECTUAL DISABILITY-OCULOMOTOR APRAXIA-CEREBELLAR CYSTS SYNDROME	0.000545554	0.020467085824608926
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-PYRAMIDAL SIGNS-NYSTAGMUS-OCULOMOTOR APRAXIA SYNDROME	0.000545554	0.020467085824608926
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 25; SCAR25	0.000545554	0.020467085824608926
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY	0.000545554	0.020467085824608926
MICROCEPHALY 19, PRIMARY, AUTOSOMAL RECESSIVE; MCPH19	0.000545554	0.020467085824608926
OBESITY DUE TO SIM1 DEFICIENCY	0.000545554	0.020467085824608926
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH MULTIPLE DISLOCATIONS	0.000545554	0.020467085824608926
JOUBERT SYNDROME 10	0.000545554	0.020467085824608926
MENTAL RETARDATION, X-LINKED 99	0.000545554	0.020467085824608926
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 71	0.000545554	0.020467085824608926
CLEFT PALATE-LARGE EARS-SMALL HEAD SYNDROME	0.000545554	0.020467085824608926
%300858 MENTAL RETARDATION, X-LINKED, SYNDROMIC 17; MRXS17;;MENTAL RETARDATION, X-LINKED, WITH ALACRIMA AND ACHALASIA	0.000545554	0.020467085824608926
CONGENITAL ANOMALIES OF KIDNEY AND URINARY TRACT SYNDROME WITH OR WITHOUT HEARING LOSS, ABNORMAL EARS, OR DEVELOPMENTAL DELAY; CAKUTHED	0.000545554	0.020467085824608926
MICROPHTHALMIA, SYNDROMIC 13; MCOPS13	0.000545554	0.020467085824608926
NEURODEVELOPMENTAL DISORDER, X-LINKED, WITH CRANIOFACIAL ABNORMALITIES; NEDXCF	0.000545554	0.020467085824608926
JOUBERT SYNDROME 32; JBTS32	0.000545554	0.020467085824608926
OCCIPITAL HORN SYNDROME	0.000545554	0.020467085824608926
INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 108; MRX108	0.000545554	0.020467085824608926
OROFACIODIGITAL SYNDROME VI	0.000545554	0.020467085824608926
ALPHA-MANNOSIDOSIS	0.000545554	0.020467085824608926
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLF TYPE	0.000545554	0.020467085824608926
POMT2-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R14	0.000545554	0.020467085824608926
277465 VITILIGO, PROGRESSIVE, WITH MENTAL RETARDATION AND URETHRAL DUPLICATION	0.000545554	0.020467085824608926
ALDH18A1-RELATED DE BARSY SYNDROME	0.000545554	0.020467085824608926
CEREBELLAR ATAXIA, CAYMAN TYPE	0.000545554	0.020467085824608926
OPITZ GBBB SYNDROME, TYPE I; GBBB1	0.000545554	0.020467085824608926
CHONDRODYSPLASIA PUNCTATA 1, X-LINKED RECESSIVE	0.000545554	0.020467085824608926
MENTAL RETARDATION, AUTOSOMAL DOMINANT 50; MRD50	0.000545554	0.020467085824608926
CHROMOSOME XQ27.3-Q28 DUPLICATION SYNDROME	0.000545554	0.020467085824608926
ARTHROGRYPOSIS, ECTODERMAL DYSPLASIA, CLEFT LIP/PALATE, AND DEVELOPMENTAL DELAY	0.000545554	0.020467085824608926
CONGENITAL MUSCULAR DYSTROPHY WITH INTELLECTUAL DISABILITY	0.000545554	0.020467085824608926
JOUBERT SYNDROME 33; JBTS33	0.000545554	0.020467085824608926
RAHMAN SYNDROME	0.000545554	0.020467085824608926
GAZE PALSY, FAMILIAL HORIZONTAL, WITH PROGRESSIVE SCOLIOSIS 2, WITH IMPAIRED INTELLECTUAL DEVELOPMENT; HGPPS2	0.000545554	0.020467085824608926
JOUBERT SYNDROME 31; JBTS31	0.000545554	0.020467085824608926
HOLMES-GANG SYNDROME	0.000545554	0.020467085824608926
COLE-CARPENTER SYNDROME	0.000545554	0.020467085824608926
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 70	0.000545554	0.020467085824608926
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 14	0.000545554	0.020467085824608926
TOLUENE EMBRYOPATHY	0.000545554	0.020467085824608926
ROBIN SEQUENCE WITH CLEFT MANDIBLE AND LIMB ANOMALIES	0.000545554	0.020467085824608926
SEPTOOPTIC DYSPLASIA	0.000545554	0.020467085824608926
OCULOSKELETODENTAL SYNDROME; OCSKD	0.000545554	0.020467085824608926
TERATOCARCINOMA-DERIVED GROWTH FACTOR 1; TDGF1	0.000545554	0.020467085824608926
THUMBS, STIFF, WITH BRACHYDACTYLY TYPE A1 AND DEVELOPMENTAL DELAY	0.000545554	0.020467085824608926
SYNAPTIC CONGENITAL MYASTHENIC SYNDROMES	0.000545554	0.020467085824608926
TRANSKETOLASE DEFICIENCY	0.000545554	0.020467085824608926
NEUTRAL LIPID STORAGE DISEASE WITH ICHTHYOSIS	0.000545554	0.020467085824608926
ALSTROM SYNDROME; ALMS	0.000545554	0.020467085824608926
DUCHENNE MUSCULAR DYSTROPHY	0.000545554	0.020467085824608926
2-AMINOADIPIC 2-OXOADIPIC ACIDURIA; AMOXAD	0.000545554	0.020467085824608926
CONGENITAL CATARACTS-FACIAL DYSMORPHISM-NEUROPATHY SYNDROME	0.000545554	0.020467085824608926
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 39; COXPD39	0.000545554	0.020467085824608926
MICROPHTHALMIA, SYNDROMIC 3	0.000545554	0.020467085824608926
GLOBAL DEVELOPMENTAL DELAY-VISUAL ANOMALIES-PROGRESSIVE CEREBELLAR ATROPHY-TRUNCAL HYPOTONIA SYNDROME	0.000545554	0.020467085824608926
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 69; MRT69	0.000545554	0.020467085824608926
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 38; COXPD38	0.000545554	0.020467085824608926
AUSTRALIA ANTIGEN	0.000545554	0.020467085824608926
BARDET-BIEDL SYNDROME 1; BBS1	0.000545554	0.020467085824608926
PMP22-RAI1 CONTIGUOUS GENE DUPLICATION SYNDROME	0.000545554	0.020467085824608926
SHORT STATURE, AMELOGENESIS IMPERFECTA, AND SKELETAL DYSPLASIA WITH SCOLIOSIS; SSASKS	0.000545554	0.020467085824608926
CEREBELLAR HYPOPLASIA WITH ENDOSTEAL SCLEROSIS	0.000545554	0.020467085824608926
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 2; SCAR2	0.000545554	0.020467085824608926
MICROCEPHALY 25, PRIMARY, AUTOSOMAL RECESSIVE; MCPH25	0.000545554	0.020467085824608926
CHROMOSOMAL INSTABILITY WITH TISSUE-SPECIFIC RADIOSENSITIVITY	0.000545554	0.020467085824608926
GALLOWAY-MOWAT SYNDROME 7; GAMOS7	0.000545554	0.020467085824608926
ACUTE INFANTILE LIVER FAILURE-CEREBELLAR ATAXIA-PERIPHERAL SENSORY MOTOR NEUROPATHY SYNDROME	0.000545554	0.020467085824608926
CORTICAL BLINDNESS, RETARDATION, AND POSTAXIAL POLYDACTYLY	0.000545554	0.020467085824608926
CRANIOTELENCEPHALIC DYSPLASIA	0.000545554	0.020467085824608926
CHAR SYNDROME	0.000545554	0.020467085824608926
SILVER-RUSSELL SYNDROME; SRS	0.000545554	0.020467085824608926
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE AND VARIABLE SKELETAL ANOMALIES; IDDSSA	0.000545554	0.020467085824608926
CEREBELLAR ATROPHY WITH SEIZURES AND VARIABLE DEVELOPMENTAL DELAY; CASVDD	0.000545554	0.020467085824608926
LIPODYSTROPHY-INTELLECTUAL DISABILITY-DEAFNESS SYNDROME	0.000545554	0.020467085824608926
CINCA SYNDROME	0.000545554	0.020467085824608926
CODAS SYNDROME	0.000545554	0.020467085824608926
CONTRACTURES-ECTODERMAL DYSPLASIA-CLEFT LIP/PALATE SYNDROME	0.000545554	0.020467085824608926
LEUKOENCEPHALOPATHY WITH BILATERAL ANTERIOR TEMPORAL LOBE CYSTS	0.000545554	0.020467085824608926
AURICULOCONDYLAR SYNDROME	0.000545554	0.020467085824608926
ARTHROGRYPOSIS, DISTAL, TYPE 3; DA3	0.000545554	0.020467085824608926
PEDIATRIC-ONSET GRAVES DISEASE	0.000545554	0.020467085824608926
DYSTONIA-PARKINSONISM-HYPERMANGANESEMIA SYNDROME	0.000545554	0.020467085824608926
GALACTOSE EPIMERASE DEFICIENCY	0.000545554	0.020467085824608926
MARINESCO-SJÖGREN SYNDROME	0.000545554	0.020467085824608926
ALG6-CDG	0.000545554	0.020467085824608926
EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 1; EDSSPD1	0.000545554	0.020467085824608926
HOLOPROSENCEPHALY 3; HPE3	0.000545554	0.020467085824608926
SPINOCEREBELLAR ATAXIA-DYSMORPHISM SYNDROME	0.000545554	0.020467085824608926
NOONAN SYNDROME WITH MULTIPLE LENTIGINES	0.000545554	0.020467085824608926
CHROMOSOME 18P DELETION SYNDROME	0.000545554	0.020467085824608926
ATELOSTEOGENESIS TYPE III	0.000545554	0.020467085824608926
MONOSOMY 18P	0.000545554	0.020467085824608926
CONGENITAL UNILATERAL HYPOPLASIA OF DEPRESSOR ANGULI ORIS	0.000545554	0.020467085824608926
48,XYYY SYNDROME	0.000545554	0.020467085824608926
HYDROXYKYNURENINURIA	0.000545554	0.020467085824608926
ARACHNODACTYLY-ABNORMAL OSSIFICATION-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.020467085824608926
SPONDYLOEPIPHYSEAL DYSPLASIA, NISHIMURA TYPE	0.000545554	0.020467085824608926
ANIRIDIA-CEREBELLAR ATAXIA-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.020467085824608926
SPINAL MUSCULAR ATROPHY, LOWER EXTREMITY-PREDOMINANT, 1, AUTOSOMAL DOMINANT; SMALED1	0.000545554	0.020467085824608926
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 21	0.000545554	0.020467085824608926
TALL STATURE-INTELLECTUAL DISABILITY-RENAL ANOMALIES SYNDROME	0.000545554	0.020467085824608926
ROBINOW SYNDROME, AUTOSOMAL RECESSIVE 2; RRS2	0.000545554	0.020467085824608926
GALLOWAY-MOWAT SYNDROME 6; GAMOS6	0.000545554	0.020467085824608926
17P11.2 MICRODUPLICATION SYNDROME	0.000545554	0.020467085824608926
GLOBAL DEVELOPMENTAL DELAY WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT; GDDI	0.000545554	0.020467085824608926
INSENSITIVITY TO PAIN, CONGENITAL, WITH ANHIDROSIS; CIPA	0.000545554	0.020467085824608926
PCNA-RELATED PROGRESSIVE NEURODEGENERATIVE PHOTOSENSITIVITY SYNDROME	0.000545554	0.020467085824608926
SNIJDERS BLOK-CAMPEAU SYNDROME; SNIBCPS	0.000545554	0.020467085824608926
METHEMOGLOBINEMIA DUE TO DEFICIENCY OF METHEMOGLOBIN REDUCTASE	0.000545554	0.020467085824608926
3-@METHYLGLUTACONIC ACIDURIA, TYPE IV	0.000545554	0.020467085824608926
METHYLMALONIC ACIDURIA DUE TO METHYLMALONYL-COA MUTASE DEFICIENCY	0.000545554	0.020467085824608926
METHYLMALONIC ACIDURIA, CBLB TYPE	0.000545554	0.020467085824608926
JAWAD SYNDROME	0.000545554	0.020467085824608926
SAUL-WILSON SYNDROME; SWILS	0.000545554	0.020467085824608926
BONE MARROW FAILURE SYNDROME 4; BMFS4	0.000545554	0.020467085824608926
CAREY-FINEMAN-ZITER SYNDROME; CFZS	0.000545554	0.020467085824608926
MICROCEPHALY, GROWTH RESTRICTION, AND INCREASED SISTER CHROMATID EXCHANGE 2; MGRISCE2	0.000545554	0.020467085824608926
DEVELOPMENTAL MALFORMATIONS-DEAFNESS-DYSTONIA SYNDROME	0.000545554	0.020467085824608926
FAMILIAL HYPERTHYROIDISM DUE TO MUTATIONS IN TSH RECEPTOR	0.000545554	0.020467085824608926
NAVAJO NEUROHEPATOPATHY	0.000545554	0.020467085824608926
MARINESCO-SJOGREN SYNDROME; MSS	0.000545554	0.020467085824608926
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME OF PREUS	0.000545554	0.020467085824608926
PARKINSONISM-DYSTONIA, INFANTILE, 2; PKDYS2	0.000545554	0.020467085824608926
OROFACIODIGITAL SYNDROME IX; OFD9	0.000545554	0.020467085824608926
SHWACHMAN-DIAMOND SYNDROME 1; SDS1	0.000545554	0.020467085824608926
PELLAGRA-LIKE SYNDROME	0.000545554	0.020467085824608926
FETAL HYDANTOIN SYNDROME	0.000545554	0.020467085824608926
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 36; COXPD36	0.000545554	0.020467085824608926
PINEAL HYPERPLASIA, INSULIN-RESISTANT DIABETES MELLITUS, AND SOMATIC ABNORMALITIES	0.000545554	0.020467085824608926
SHWACHMAN-DIAMOND SYNDROME 2; SDS2	0.000545554	0.020467085824608926
RADIOULNAR SYNOSTOSIS, UNILATERAL, WITH DEVELOPMENTAL RETARDATIONAND HYPOTONIA	0.000545554	0.020467085824608926
PEROXISOME BIOGENESIS DISORDER 3B	0.000545554	0.020467085824608926
PHENOBARBITAL EMBRYOPATHY	0.000545554	0.020467085824608926
REVESZ SYNDROME	0.000545554	0.020467085824608926
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 66; MRT66	0.000545554	0.020467085824608926
ISOLATED PLAGIOCEPHALY	0.000545554	0.020467085824608926
DISTAL TRISOMY 18Q	0.000545554	0.020467085824608926
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 25; MC1DN25	0.000545554	0.020467085824608926
6Q16 MICRODELETION SYNDROME	0.000545554	0.020467085824608926
NEURODEVELOPMENTAL DISORDER WITH IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND ATAXIA; NEDIDHA	0.000545554	0.020467085824608926
DISTAL TRISOMY 6P	0.000545554	0.020467085824608926
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 75	0.000545554	0.020467085824608926
RIGID SPINE SYNDROME	0.000545554	0.020467085824608926
ZEBRA BODY MYOPATHY	0.000545554	0.020467085824608926
GALACTOSE EPIMERASE DEFICIENCY	0.000545554	0.020467085824608926
NEURODEGENERATION, CHILDHOOD-ONSET, WITH CEREBELLAR ATROPHY; CONDCA	0.000545554	0.020467085824608926
GROWTH RETARDATION, SMALL AND PUFFY HANDS AND FEET, AND ECZEMA	0.000545554	0.020467085824608926
GLOBAL DEVELOPMENTAL DELAY, LUNG CYSTS, OVERGROWTH, AND WILMS TUMOR; GLOW	0.000545554	0.020467085824608926
TRICHOTHIODYSTROPHY 4, NONPHOTOSENSITIVE; TTD4	0.000545554	0.020467085824608926
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 28; MC1DN28	0.000545554	0.020467085824608926
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 27; MC1DN27	0.000545554	0.020467085824608926
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 22; MC1DN22	0.000545554	0.020467085824608926
MACROCEPHALY/MEGALENCEPHALY SYNDROME, AUTOSOMAL RECESSIVE	0.000545554	0.020467085824608926
HYDROXYKYNURENINURIA	0.000545554	0.020467085824608926
HYPERTELORISM, MICROTIA, FACIAL CLEFTING SYNDROME	0.000545554	0.020467085824608926
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 5	0.000545554	0.020467085824608926
TEMTAMY SYNDROME	0.000545554	0.020467085824608926
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 9	0.000545554	0.020467085824608926
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 2	0.000545554	0.020467085824608926
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 9B	0.000545554	0.020467085824608926
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 11; MC1DN11	0.000545554	0.020467085824608926
ARIMA SYNDROME	0.000545554	0.020467085824608926
20Q11.2 MICRODELETION SYNDROME	0.000545554	0.020467085824608926
KERATOCONUS POSTICUS CIRCUMSCRIPTUS	0.000545554	0.020467085824608926
RICHARDS-RUNDLE SYNDROME; RRNS	0.000545554	0.020467085824608926
PYRUVATE DEHYDROGENASE E2 DEFICIENCY; PDHDD	0.000545554	0.020467085824608926
MARFANOID MENTAL RETARDATION SYNDROME, AUTOSOMAL	0.000545554	0.020467085824608926
FANCONI ANEMIA, COMPLEMENTATION GROUP E; FANCE	0.000545554	0.020467085824608926
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 25; COXPD25	0.000545554	0.020467085824608926
SENIOR-LOKEN SYNDROME 9	0.000545554	0.020467085824608926
NOONAN SYNDROME-LIKE DISORDER WITH OR WITHOUT JUVENILE MYELOMONOCYTIC LEUKEMIA	0.000545554	0.020467085824608926
NEPHRONOPHTHISIS 11; NPHP11	0.000545554	0.020467085824608926
CHROMOSOME 4Q21 DELETION SYNDROME	0.000545554	0.020467085824608926
ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 2	0.000545554	0.020467085824608926
LEUKODYSTROPHY, HYPOMYELINATING, 9; HLD9	0.000545554	0.020467085824608926
WARSAW BREAKAGE SYNDROME; WABS	0.000545554	0.020467085824608926
AUTOIMMUNE DISEASE, MULTISYSTEM, WITH FACIAL DYSMORPHISM; ADMFD	0.000545554	0.020467085824608926
SPONDYLOMETAPHYSEAL DYSPLASIA, MEGARBANE-DAGHER-MELKI TYPE; SMDMDM	0.000545554	0.020467085824608926
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 18	0.000545554	0.020467085824608926
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 1; MDDGB1	0.000545554	0.020467085824608926
PSYCHOMOTOR DELAY DUE TO S-ADENOSYLHOMOCYSTEINE HYDROLASE DEFICIENCY	0.000545554	0.020467085824608926
AICARDI-GOUTIERES SYNDROME 5	0.000545554	0.020467085824608926
INTELLECTUAL DISABILITY-ALACRIMA-ACHALASIA SYNDROME	0.000545554	0.020467085824608926
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 48; MRT48	0.000545554	0.020467085824608926
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA TYPE MUT0	0.000545554	0.020467085824608926
CHROMOSOME 16P12.2-P11.2 DELETION SYNDROME, 7.1- TO 8.7-MB	0.000545554	0.020467085824608926
FORSYTHE-WAKELING SYNDROME; FWS	0.000545554	0.020467085824608926
AGENESIS OF THE CORPUS CALLOSUM AND CONGENITAL LYMPHEDEMA	0.000545554	0.020467085824608926
MONOCARBOXYLATE TRANSPORTER 1 DEFICIENCY; MCT1D	0.000545554	0.020467085824608926
X-LINKED SIDEROBLASTIC ANEMIA AND SPINOCEREBELLAR ATAXIA	0.000545554	0.020467085824608926
LEUKOTRIENE C4 SYNTHASE DEFICIENCY	0.000545554	0.020467085824608926
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 2; DKCA2	0.000545554	0.020467085824608926
ACRODYSOSTOSIS WITH MULTIPLE HORMONE RESISTANCE	0.000545554	0.020467085824608926
MENTAL RETARDATION, AUTOSOMAL DOMINANT 30; MRD30	0.000545554	0.020467085824608926
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 9; MDDGC9	0.000545554	0.020467085824608926
UPPER LIMB DEFECT-EYE AND EAR ABNORMALITIES SYNDROME	0.000545554	0.020467085824608926
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 17; SCAR17	0.000545554	0.020467085824608926
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 9	0.000545554	0.020467085824608926
PECTUS EXCAVATUM-MACROCEPHALY-DYSPLASTIC NAILS SYNDROME	0.000545554	0.020467085824608926
RUBINSTEIN-TAYBI SYNDROME 2; RSTS2	0.000545554	0.020467085824608926
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-PSYCHOMOTOR DELAY SYNDROME	0.000545554	0.020467085824608926
MENTAL RETARDATION, ANTERIOR MAXILLARY PROTRUSION, AND STRABISMUS; MRAMS	0.000545554	0.020467085824608926
INFANTILE-ONSET AUTOSOMAL RECESSIVE NONPROGRESSIVE CEREBELLAR ATAXIA	0.000545554	0.020467085824608926
MITOCHONDRIAL SHORT-CHAIN ENOYL-COA HYDRATASE 1 DEFICIENCY; ECHS1D	0.000545554	0.020467085824608926
CEREBRAL CREATINE DEFICIENCY SYNDROME 3	0.000545554	0.020467085824608926
CONGENITAL VARICELLA SYNDROME	0.000545554	0.020467085824608926
JOUBERT SYNDROME 6	0.000545554	0.020467085824608926
LEUKODYSTROPHY, HYPOMYELINATING, 11; HLD11	0.000545554	0.020467085824608926
WOLMAN DISEASE	0.000545554	0.020467085824608926
CEREBROOCULOFACIOSKELETAL SYNDROME 2; COFS2	0.000545554	0.020467085824608926
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, TYPE VIB; HMSN6B	0.000545554	0.020467085824608926
MENTAL RETARDATION, AUTOSOMAL DOMINANT 39	0.000545554	0.020467085824608926
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 26; COXPD26	0.000545554	0.020467085824608926
SHORT STATURE, MICROCEPHALY, AND ENDOCRINE DYSFUNCTION; SSMED	0.000545554	0.020467085824608926
AL-RAQAD SYNDROME; ARS	0.000545554	0.020467085824608926
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 6; DKCA6	0.000545554	0.020467085824608926
CEREBROOCULOFACIOSKELETAL SYNDROME 3; COFS3	0.000545554	0.020467085824608926
CAMPTODACTYLY, TALL STATURE, AND HEARING LOSS SYNDROME	0.000545554	0.020467085824608926
MEVALONIC ACIDURIA; MEVA	0.000545554	0.020467085824608926
USHER SYNDROME TYPE 1	0.000545554	0.020467085824608926
CRANIOSYNOSTOSIS 6; CRS6	0.000545554	0.020467085824608926
JOUBERT SYNDROME 23; JBTS23	0.000545554	0.020467085824608926
HEREDITARY OROTIC ACIDURIA	0.000545554	0.020467085824608926
MYASTHENIC SYNDROME, CONGENITAL, 18; CMS18	0.000545554	0.020467085824608926
BONE FRAGILITY WITH CONTRACTURES, ARTERIAL RUPTURE, AND DEAFNESS	0.000545554	0.020467085824608926
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 3; MCCRP3	0.000545554	0.020467085824608926
PREAXIAL POLYDACTYLY-COLOBOMATA-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.020467085824608926
METHYLMALONIC ACIDEMIA WITHOUT HOMOCYSTINURIA	0.000545554	0.020467085824608926
DIAMOND-BLACKFAN ANEMIA 5	0.000545554	0.020467085824608926
DYGGVE-MELCHIOR-CLAUSEN DISEASE	0.000545554	0.020467085824608926
CHROMOSOME 2P16.1-P15 DELETION SYNDROME	0.000545554	0.020467085824608926
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 6	0.000545554	0.020467085824608926
JOUBERT SYNDROME 7	0.000545554	0.020467085824608926
JOUBERT SYNDROME 8	0.000545554	0.020467085824608926
GLUT1 DEFICIENCY SYNDROME 2; GLUT1DS2	0.000545554	0.020467085824608926
LARSEN-LIKE OSSEOUS DYSPLASIA-SHORT STATURE SYNDROME	0.000545554	0.020467085824608926
TRISOMY 9P	0.000545554	0.020467085824608926
CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE III	0.000545554	0.020467085824608926
BRAIN-LUNG-THYROID SYNDROME	0.000545554	0.020467085824608926
BARDET-BIEDL SYNDROME 17; BBS17	0.000545554	0.020467085824608926
BARDET-BIEDL SYNDROME 16; BBS16	0.000545554	0.020467085824608926
VITAMIN B12-RESPONSIVE METHYLMALONIC ACIDEMIA	0.000545554	0.020467085824608926
MIETENS SYNDROME	0.000545554	0.020467085824608926
MENTAL RETARDATION, AUTOSOMAL DOMINANT 18; MRD18	0.000545554	0.020467085824608926
PARTIAL TRISOMY/TETRASOMY OF THE SHORT ARM OF CHROMOSOME 9	0.000545554	0.020467085824608926
ALAZAMI SYNDROME; ALAZS	0.000545554	0.020467085824608926
IMMUNODEFICIENCY, COMMON VARIABLE, 10; CVID10	0.000545554	0.020467085824608926
SPASTIC PARAPLEGIA 55, AUTOSOMAL RECESSIVE; SPG55	0.000545554	0.020467085824608926
AICARDI-GOUTIERES SYNDROME 6	0.000545554	0.020467085824608926
PONTOCEREBELLAR HYPOPLASIA, TYPE 8	0.000545554	0.020467085824608926
FETAL AND NEONATAL ALLOIMMUNE THROMBOCYTOPENIA	0.000545554	0.020467085824608926
EAR-PATELLA-SHORT STATURE SYNDROME	0.000545554	0.020467085824608926
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 40; MRT40	0.000545554	0.020467085824608926
14Q22Q23 MICRODELETION SYNDROME	0.000545554	0.020467085824608926
JOUBERT SYNDROME 21	0.000545554	0.020467085824608926
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 7	0.000545554	0.020467085824608926
ADAMS-OLIVER SYNDROME 3; AOS3	0.000545554	0.020467085824608926
NEURODEVELOPMENTAL DISORDER WITH SPASTIC DIPLEGIA AND VISUAL DEFECTS; NEDSDV	0.000545554	0.020467085824608926
X-LINKED SPINOCEREBELLAR ATAXIA TYPE 3	0.000545554	0.020467085824608926
SHORT STATURE, ONYCHODYSPLASIA, FACIAL DYSMORPHISM, AND HYPOTRICHOSIS	0.000545554	0.020467085824608926
HARTSFIELD SYNDROME; HRTFDS	0.000545554	0.020467085824608926
ISOLATED COMPLEX I DEFICIENCY	0.000545554	0.020467085824608926
16P11.2P12.2 MICRODELETION SYNDROME	0.000545554	0.020467085824608926
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 14; MDDGA14	0.000545554	0.020467085824608926
EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 2; EDSSPD2	0.000545554	0.020467085824608926
NEUTROPENIA, SEVERE CONGENITAL, 5, AUTOSOMAL RECESSIVE; SCN5	0.000545554	0.020467085824608926
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 17	0.000545554	0.020467085824608926
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 5; DKCB5	0.000545554	0.020467085824608926
MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 9; MCOPCB9	0.000545554	0.020467085824608926
TRIOSEPHOSPHATE ISOMERASE DEFICIENCY	0.000545554	0.020467085824608926
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 4; MC3DN4	0.000545554	0.020467085824608926
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 2; MC3DN2	0.000545554	0.020467085824608926
X-LINKED INTELLECTUAL DISABILITY, SCHIMKE TYPE	0.000545554	0.020467085824608926
STEEL SYNDROME; STLS	0.000545554	0.020467085824608926
XQ27.3Q28 DUPLICATION SYNDROME	0.000545554	0.020467085824608926
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 6; NBIA6	0.000545554	0.020467085824608926
BOSCH-BOONSTRA-SCHAAF OPTIC ATROPHY SYNDROME; BBSOAS	0.000545554	0.020467085824608926
ACETYL-COA ACETYLTRANSFERASE-2 DEFICIENCY	0.000545554	0.020467085824608926
2Q32Q33 MICRODELETION SYNDROME	0.000545554	0.020467085824608926
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 11; SCAR11	0.000545554	0.020467085824608926
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 21	0.000545554	0.020467085824608926
ATAXIA-TELANGIECTASIA-LIKE DISORDER 2; ATLD2	0.000545554	0.020467085824608926
MICROBRACHYCEPHALY-PTOSIS-CLEFT LIP SYNDROME	0.000545554	0.020467085824608926
BARDET-BIEDL SYNDROME 8; BBS8	0.000545554	0.020467085824608926
METHYLMALONATE SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.000545554	0.020467085824608926
OSTEOPATHIA STRIATA-CRANIAL SCLEROSIS SYNDROME	0.000545554	0.020467085824608926
LYSOSOMAL ACID LIPASE DEFICIENCY	0.000545554	0.020467085824608926
HERMANSKY-PUDLAK SYNDROME 6; HPS6	0.000545554	0.020467085824608926
BARDET-BIEDL SYNDROME 13; BBS13	0.000545554	0.020467085824608926
OSTEOPOROSIS-PSEUDOGLIOMA SYNDROME	0.000545554	0.020467085824608926
BARDET-BIEDL SYNDROME 14; BBS14	0.000545554	0.020467085824608926
OTOFACIOCERVICAL SYNDROME	0.000545554	0.020467085824608926
OSSIFICATION ANOMALIES-PSYCHOMOTOR DEVELOPMENTAL DELAY SYNDROME	0.000545554	0.020467085824608926
CULLER-JONES SYNDROME; CJS	0.000545554	0.020467085824608926
CHROMOSOME 15Q25 DELETION SYNDROME	0.000545554	0.020467085824608926
CARBONIC ANHYDRASE VA DEFICIENCY, HYPERAMMONEMIA DUE TO	0.000545554	0.020467085824608926
IMMUNODEFICIENCY 23; IMD23	0.000545554	0.020467085824608926
PLECTIN-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R17	0.000545554	0.020467085824608926
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 6; CDCBM6	0.000545554	0.020467085824608926
JOUBERT SYNDROME 17; JBTS17	0.000545554	0.020467085824608926
OCULO-PALATO-CEREBRAL SYNDROME	0.000545554	0.020467085824608926
ACRODYSOSTOSIS 2 WITH OR WITHOUT HORMONE RESISTANCE	0.000545554	0.020467085824608926
SECKEL SYNDROME 8; SCKL8	0.000545554	0.020467085824608926
MICROCEPHALY-CLEFT PALATE-ABNORMAL RETINAL PIGMENTATION SYNDROME	0.000545554	0.020467085824608926
COGNITIVE IMPAIRMENT WITH OR WITHOUT CEREBELLAR ATAXIA; CIAT	0.000545554	0.020467085824608926
JOUBERT SYNDROME 15	0.000545554	0.020467085824608926
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 43; MRT43	0.000545554	0.020467085824608926
OPHTHALMOPLEGIA-INTELLECTUAL DISABILITY-LINGUA SCROTALIS SYNDROME	0.000545554	0.020467085824608926
OPITZ G/BBB SYNDROME	0.000545554	0.020467085824608926
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 27	0.000545554	0.020467085824608926
OROFACIODIGITAL SYNDROME TYPE 4	0.000545554	0.020467085824608926
CUTIS LAXA, AUTOSOMAL DOMINANT 3; ADCL3	0.000545554	0.020467085824608926
RING CHROMOSOME 12 SYNDROME	0.000545554	0.020467085824608926
ROIFMAN SYNDROME; RFMN	0.000545554	0.020467085824608926
MESOMELIC DYSPLASIA, SAVARIRAYAN TYPE	0.000545554	0.020467085824608926
LANGUAGE DELAY AND ATTENTION DEFICIT-HYPERACTIVITY DISORDER/COGNITIVE IMPAIRMENT WITH OR WITHOUT CARDIAC ARRHYTHMIA; LADCI	0.000545554	0.020467085824608926
ARTHROGRYPOSIS, DISTAL, WITH IMPAIRED PROPRIOCEPTION AND TOUCH; DAIPT	0.000545554	0.020467085824608926
AGAMMAGLOBULINEMIA-MICROCEPHALY-CRANIOSYNOSTOSIS-SEVERE DERMATITIS SYNDROME	0.000545554	0.020467085824608926
JOUBERT SYNDROME 28	0.000545554	0.020467085824608926
JOUBERT SYNDROME 27	0.000545554	0.020467085824608926
THAUVIN-ROBINET-FAIVRE SYNDROME	0.000545554	0.020467085824608926
CONGENITAL CATARACTS, FACIAL DYSMORPHISM, AND NEUROPATHY; CCFDN	0.000545554	0.020467085824608926
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 1; MC5DN1	0.000545554	0.020467085824608926
ABETAL34V AMYLOIDOSIS	0.000545554	0.020467085824608926
HYPERTELORISM-MICROTIA-FACIAL CLEFTING SYNDROME	0.000545554	0.020467085824608926
CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME C OXIDASE DEFICIENCY 1; CEMCOX1	0.000545554	0.020467085824608926
INTELLECTUAL DEVELOPMENTAL DISORDER WITH PERSISTENCE OF FETAL HEMOGLOBIN	0.000545554	0.020467085824608926
SPASTIC PARAPLEGIA 75, AUTOSOMAL RECESSIVE	0.000545554	0.020467085824608926
NOONAN SYNDROME 2; NS2	0.000545554	0.020467085824608926
PURINE NUCLEOSIDE PHOSPHORYLASE DEFICIENCY	0.000545554	0.020467085824608926
MACROCEPHALY/AUTISM SYNDROME	0.000545554	0.020467085824608926
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 1; MMDS1	0.000545554	0.020467085824608926
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 55	0.000545554	0.020467085824608926
CONDUCTIVE DEAFNESS-MALFORMED EXTERNAL EAR SYNDROME	0.000545554	0.020467085824608926
INTELLECTUAL DEVELOPMENTAL DISORDER WITH AUTISM AND SPEECH DELAY; IDDAS	0.000545554	0.020467085824608926
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 56	0.000545554	0.020467085824608926
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE, FACIAL ANOMALIES, AND SPEECH DEFECTS; IDDSFAS	0.000545554	0.020467085824608926
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 45	0.000545554	0.020467085824608926
HYPOTONIA-CYSTINURIA SYNDROME	0.000545554	0.020467085824608926
YOU-HOOVER-FONG SYNDROME; YHFS	0.000545554	0.020467085824608926
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 54	0.000545554	0.020467085824608926
LIG4 SYNDROME	0.000545554	0.020467085824608926
CHOREA, CHILDHOOD-ONSET, WITH PSYCHOMOTOR RETARDATION	0.000545554	0.020467085824608926
17P13.3 MICRODUPLICATION SYNDROME	0.000545554	0.020467085824608926
CONGENITAL CATARACT-PROGRESSIVE MUSCULAR HYPOTONIA-HEARING LOSS-DEVELOPMENTAL DELAY SYNDROME	0.000545554	0.020467085824608926
CREE MENTAL RETARDATION SYNDROME	0.000545554	0.020467085824608926
CONGENITAL HEART DEFECTS AND ECTODERMAL DYSPLASIA	0.000545554	0.020467085824608926
STRIATONIGRAL DEGENERATION, INFANTILE, MITOCHONDRIAL	0.000545554	0.020467085824608926
SPONDYLOEPIPHYSEAL DYSPLASIA TARDA WITH CHARACTERISTIC FACIES	0.000545554	0.020467085824608926
BARDET-BIEDL SYNDROME 3; BBS3	0.000545554	0.020467085824608926
SPINOCEREBELLAR ATAXIA 5; SCA5	0.000545554	0.020467085824608926
INTELLECTUAL DISABILITY-DEVELOPMENTAL DELAY-CONTRACTURES SYNDROME	0.000545554	0.020467085824608926
LOWRY-MACLEAN SYNDROME	0.000545554	0.020467085824608926
HYPERPHENYLALANINEMIA, MILD, NON-BH4-DEFICIENT; HPANBH4	0.000545554	0.020467085824608926
HNF1B-RELATED AUTOSOMAL DOMINANT TUBULOINTERSTITIAL KIDNEY DISEASE	0.000545554	0.020467085824608926
PECTUS EXCAVATUM, MACROCEPHALY, SHORT STATURE, AND DYSPLASTIC NAILS	0.000545554	0.020467085824608926
WEAVER SYNDROME	0.000545554	0.020467085824608926
600460 CLEFT PALATE, CARDIAC DEFECT, GENITAL ANOMALIES, AND ECTRODACTYLY;;CCGE;;ACROCARDIOFACIAL SYNDROME; ACFS	0.000545554	0.020467085824608926
INTRAUTERINE GROWTH RETARDATION WITH INCREASED MITOMYCIN C SENSITIVITY	0.000545554	0.020467085824608926
PEROXISOME BIOGENESIS DISORDER 10B	0.000545554	0.020467085824608926
GLYCOGEN STORAGE DISEASE DUE TO PHOSPHOGLYCERATE KINASE 1 DEFICIENCY	0.000545554	0.020467085824608926
HOYERAAL-HREIDARSSON SYNDROME	0.000545554	0.020467085824608926
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND PTOSIS; IDDDFP	0.000545554	0.020467085824608926
BILE ACID SYNTHESIS DEFECT, CONGENITAL, 6	0.000545554	0.020467085824608926
OPTIC ATROPHY 11; OPA11	0.000545554	0.020467085824608926
GLYCINE ENCEPHALOPATHY WITH NORMAL SERUM GLYCINE	0.000545554	0.020467085824608926
SPASTIC PARAPLEGIA, INTELLECTUAL DISABILITY, NYSTAGMUS, AND OBESITY; SINO	0.000545554	0.020467085824608926
CEREBELLAR ATAXIA, CAYMAN TYPE; ATCAY	0.000545554	0.020467085824608926
NEUROFIBROMATOSIS-NOONAN SYNDROME; NFNS	0.000545554	0.020467085824608926
DYSTONIA 28, CHILDHOOD-ONSET	0.000545554	0.020467085824608926
GLUTAMATE-CYSTEINE LIGASE DEFICIENCY	0.000545554	0.020467085824608926
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 58; MRT58	0.000545554	0.020467085824608926
ARTERIAL TORTUOSITY SYNDROME	0.000545554	0.020467085824608926
FARBER DISEASE	0.000545554	0.020467085824608926
CURRY-JONES SYNDROME	0.000545554	0.020467085824608926
ULNA HYPOPLASIA-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.020467085824608926
HEREDITARY SENSORY AND AUTONOMIC NEUROPATHY TYPE 4	0.000545554	0.020467085824608926
DIAPHANOSPONDYLODYSOSTOSIS	0.000545554	0.020467085824608926
MICROPHTHALMIA, SYNDROMIC 6; MCOPS6	0.000545554	0.020467085824608926
HYPOMYELINATION-CONGENITAL CATARACT SYNDROME	0.000545554	0.020467085824608926
SENIOR-LOKEN SYNDROME	0.000545554	0.020467085824608926
PONTOCEREBELLAR HYPOPLASIA, TYPE 1A; PCH1A	0.000545554	0.020467085824608926
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 51	0.000545554	0.020467085824608926
CHROMOSOME 22Q11.2 DUPLICATION SYNDROME	0.000545554	0.020467085824608926
608279 CRANIOSYNOSTOSIS WITH OCULAR ABNORMALITIES AND HALLUCAL DEFECTS	0.000545554	0.020467085824608926
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 2	0.000545554	0.020467085824608926
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 1; SMABF1	0.000545554	0.020467085824608926
CEREBROFACIOARTICULAR SYNDROME	0.000545554	0.020467085824608926
JOUBERT SYNDROME 26	0.000545554	0.020467085824608926
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 6	0.000545554	0.020467085824608926
MYOPATHY, AUTOPHAGIC VACUOLAR, INFANTILE-ONSET	0.000545554	0.020467085824608926
SYNDROMIC MULTISYSTEM AUTOIMMUNE DISEASE DUE TO ITCH DEFICIENCY	0.000545554	0.020467085824608926
DUPLICATION OF THE PITUITARY GLAND	0.000545554	0.020467085824608926
NEPHROGENIC DIABETES INSIPIDUS-INTRACRANIAL CALCIFICATION SYNDROME	0.000545554	0.020467085824608926
MICROCEPHALY, CONGENITAL CATARACT, AND PSORIASIFORM DERMATITIS	0.000545554	0.020467085824608926
MITOCHONDRIAL TRIFUNCTIONAL PROTEIN DEFICIENCY; MTPD	0.000545554	0.020467085824608926
NEPHROTIC SYNDROME, TYPE 11; NPHS11	0.000545554	0.020467085824608926
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIP	0.000545554	0.020467085824608926
7P22.1 MICRODUPLICATION SYNDROME	0.000545554	0.020467085824608926
CHARCOT-MARIE-TOOTH DISEASE-DEAFNESS-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.020467085824608926
FANCONI ANEMIA, COMPLEMENTATION GROUP I; FANCI	0.000545554	0.020467085824608926
NATURAL KILLER CELL AND GLUCOCORTICOID DEFICIENCY WITH DNA REPAIR DEFECT	0.000545554	0.020467085824608926
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IG; CDG1G	0.000545554	0.020467085824608926
THUMB DEFORMITY-ALOPECIA-PIGMENTATION ANOMALY SYNDROME	0.000545554	0.020467085824608926
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 4; ICF4	0.000545554	0.020467085824608926
LAMB-SHAFFER SYNDROME	0.000545554	0.020467085824608926
MICROVILLUS INCLUSION DISEASE	0.000545554	0.020467085824608926
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 28	0.000545554	0.020467085824608926
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IID	0.000545554	0.020467085824608926
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION; IHPMR	0.000545554	0.020467085824608926
BRACHYDACTYLY, COLOBOMA, AND ANTERIOR SEGMENT DYSGENESIS	0.000545554	0.020467085824608926
DIHYDROPTERIDINE REDUCTASE DEFICIENCY	0.000545554	0.020467085824608926
FRIAS SYNDROME	0.000545554	0.020467085824608926
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 3; ICF3	0.000545554	0.020467085824608926
ROBERTS SYNDROME	0.000545554	0.020467085824608926
JOUBERT SYNDROME 25	0.000545554	0.020467085824608926
LARSEN-LIKE SYNDROME	0.000545554	0.020467085824608926
LASSA FEVER	0.000541419	0.02031195654339248
MITOCHONDRIAL TRIFUNCTIONAL PROTEIN DEFICIENCY	0.000541419	0.02031195654339248
ALG2-CDG	0.000541419	0.02031195654339248
HEREDITARY HEMORRHAGIC TELANGIECTASIA	0.000541419	0.02031195654339248
DERMOTRICHIC SYNDROME	0.000541419	0.02031195654339248
DPM1-CDG	0.000541419	0.02031195654339248
MPDU1-CDG	0.000541419	0.02031195654339248
ANGELMAN SYNDROME	0.000541419	0.02031195654339248
RABIES	0.000541419	0.02031195654339248
HADDAD SYNDROME	0.000541419	0.02031195654339248
MYASTHENIA GRAVIS	0.000541419	0.02031195654339248
MUTILATING PALMOPLANTAR KERATODERMA WITH PERIORIFICIAL KERATOTIC PLAQUES	0.000541419	0.02031195654339248
X-LINKED EPILEPSY-LEARNING DISABILITIES-BEHAVIOR DISORDERS SYNDROME	0.000541419	0.02031195654339248
FAMILIAL THROMBOCYTOSIS	0.000541419	0.02031195654339248
X-LINKED INTELLECTUAL DISABILITY, STOCCO DOS SANTOS TYPE	0.000541419	0.02031195654339248
SCRUB TYPHUS	0.000541419	0.02031195654339248
PFEIFFER SYNDROME TYPE 3	0.000541419	0.02031195654339248
SECONDARY SYRINGOMYELIA	0.000541419	0.02031195654339248
RAPID-ONSET DYSTONIA-PARKINSONISM	0.000541419	0.02031195654339248
INFANTILE NEURONAL CEROID LIPOFUSCINOSIS	0.000541419	0.02031195654339248
SNEDDON SYNDROME	0.000541419	0.02031195654339248
X-LINKED INTELLECTUAL DISABILITY, WILSON TYPE	0.000541419	0.02031195654339248
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA TYPE CBLF	0.000541419	0.02031195654339248
X-LINKED INTELLECTUAL DISABILITY, SHASHI TYPE	0.000541419	0.02031195654339248
CRIGLER-NAJJAR SYNDROME TYPE 1	0.000541419	0.02031195654339248
ONDINE SYNDROME	0.000541419	0.02031195654339248
DILATED CARDIOMYOPATHY WITH ATAXIA	0.000541419	0.02031195654339248
HEREDITARY METHEMOGLOBINEMIA	0.000541419	0.02031195654339248
SHIGA TOXIN-ASSOCIATED HEMOLYTIC UREMIC SYNDROME	0.000541419	0.02031195654339248
NIPAH VIRUS DISEASE	0.000541419	0.02031195654339248
SANDHOFF DISEASE	0.000541419	0.02031195654339248
HOLOCARBOXYLASE SYNTHETASE DEFICIENCY	0.000541419	0.02031195654339248
HYPERINSULINISM DUE TO GLUCOKINASE DEFICIENCY	0.000541419	0.02031195654339248
L-2-HYDROXYGLUTARIC ACIDURIA	0.000541419	0.02031195654339248
AUTOSOMAL DOMINANT DEAFNESS-ONYCHODYSTROPHY SYNDROME	0.000541419	0.02031195654339248
ALG9-CDG	0.000541419	0.02031195654339248
PROTEUS SYNDROME	0.000541419	0.02031195654339248
MOGS-CDG	0.000541419	0.02031195654339248
SYNDROMIC X-LINKED INTELLECTUAL DISABILITY DUE TO JARID1C MUTATION	0.000541419	0.02031195654339248
CEREBROTENDINOUS XANTHOMATOSIS	0.000541419	0.02031195654339248
FRAGILE X SYNDROME	0.000541419	0.02031195654339248
COG8-CDG	0.000541419	0.02031195654339248
HEREDITARY CONTINUOUS MUSCLE FIBER ACTIVITY	0.000541419	0.02031195654339248
PRIMARY INTESTINAL LYMPHANGIECTASIA	0.000541419	0.02031195654339248
SMITH-FINEMAN-MYERS SYNDROME	0.000541419	0.02031195654339248
RENIER-GABREELS-JASPER SYNDROME	0.000541419	0.02031195654339248
SJÖGREN-LARSSON SYNDROME	0.000541419	0.02031195654339248
MIXED CONNECTIVE TISSUE DISEASE	0.000541419	0.02031195654339248
ACQUIRED PARTIAL LIPODYSTROPHY	0.000541419	0.02031195654339248
CONGENITAL BILE ACID SYNTHESIS DEFECT TYPE 4	0.000541419	0.02031195654339248
EPISODIC ATAXIA TYPE 3	0.000541419	0.02031195654339248
X-LINKED INTELLECTUAL DISABILITY, CANTAGREL TYPE	0.000541419	0.02031195654339248
JERVELL AND LANGE-NIELSEN SYNDROME	0.000541419	0.02031195654339248
ADRENOMYODYSTROPHY	0.000541419	0.02031195654339248
SPINOCEREBELLAR ATAXIA WITH AXONAL NEUROPATHY TYPE 1	0.000541419	0.02031195654339248
POSTENCEPHALITIC PARKINSONISM	0.000541419	0.02031195654339248
MALIGNANT ATROPHIC PAPULOSIS	0.000541419	0.02031195654339248
FETAL GAUCHER DISEASE	0.000541419	0.02031195654339248
CONGENITAL MYASTHENIC SYNDROME	0.000541419	0.02031195654339248
INSULINOMA	0.000541419	0.02031195654339248
NORRIE DISEASE	0.000541419	0.02031195654339248
DEND SYNDROME	0.000541419	0.02031195654339248
X-LINKED INTELLECTUAL DISABILITY-CUBITUS VALGUS-DYSMORPHISM SYNDROME	0.000541419	0.02031195654339248
FAMILIAL MULTIPLE NEVI FLAMMEI	0.000541419	0.02031195654339248
PRIMARY CUTIS VERTICIS GYRATA	0.000541419	0.02031195654339248
X-LINKED INTELLECTUAL DISABILITY, SEEMANOVA TYPE	0.000541419	0.02031195654339248
IMMUNOGLOBULIN A VASCULITIS	0.000541419	0.02031195654339248
GRISCELLI SYNDROME TYPE 2	0.000541419	0.02031195654339248
SAETHRE-CHOTZEN SYNDROME	0.000541419	0.02031195654339248
POSTERIOR COLUMN ATAXIA-RETINITIS PIGMENTOSA SYNDROME	0.000541419	0.02031195654339248
MEHMO SYNDROME	0.000541419	0.02031195654339248
RECURRENT ACUTE PANCREATITIS	0.000541419	0.02031195654339248
CAMOS SYNDROME	0.000541419	0.02031195654339248
PITUITARY DEFICIENCY DUE TO EMPTY SELLA TURCICA SYNDROME	0.000541419	0.02031195654339248
PITUITARY DERMOID AND EPIDERMOID CYSTS	0.000541419	0.02031195654339248
NON-FUNCTIONING PITUITARY ADENOMA	0.000541419	0.02031195654339248
XERODERMA PIGMENTOSUM	0.000541419	0.02031195654339248
SCLERODERMA	0.000541419	0.02031195654339248
SENSORY ATAXIC NEUROPATHY-DYSARTHRIA-OPHTHALMOPARESIS SYNDROME	0.000541419	0.02031195654339248
TSH-SECRETING PITUITARY ADENOMA	0.000541419	0.02031195654339248
DOPA-RESPONSIVE DYSTONIA DUE TO SEPIAPTERIN REDUCTASE DEFICIENCY	0.000541419	0.02031195654339248
SYSTEMIC SCLEROSIS	0.000541419	0.02031195654339248
X-LINKED INTELLECTUAL DISABILITY-ATAXIA-APRAXIA SYNDROME	0.000541419	0.02031195654339248
PEDIATRIC SYSTEMIC LUPUS ERYTHEMATOSUS	0.000541419	0.02031195654339248
PRESYNAPTIC CONGENITAL MYASTHENIC SYNDROMES	0.000541419	0.02031195654339248
3-HYDROXYISOBUTYRIC ACIDURIA	0.000541419	0.02031195654339248
RETT SYNDROME	0.000541419	0.02031195654339248
ENCEPHALOPATHY DUE TO SULFITE OXIDASE DEFICIENCY	0.000541419	0.02031195654339248
WOLF-HIRSCHHORN SYNDROME	0.000541419	0.02031195654339248
THROMBOTIC THROMBOCYTOPENIC PURPURA	0.000541419	0.02031195654339248
600302 FRYNS MACROCEPHALY;;MACROCEPHALY WITH SPASTIC PARAPLEGIA AND DISTINCTIVE CRANIOFACIALAPPEARANCE	0.000541419	0.02031195654339248
CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, INFANTILE	0.000541419	0.02031195654339248
GURRIERI SYNDROME	0.000541419	0.02031195654339248
HYPOCALCEMIA, AUTOSOMAL DOMINANT 1	0.000541419	0.02031195654339248
MENTAL RETARDATION, MICROCEPHALY, EPILEPSY, AND COARSE FACE	0.000541419	0.02031195654339248
CEROID LIPOFUSCINOSIS, NEURONAL, 6	0.000541419	0.02031195654339248
PHOSPHOGLYCERATE DEHYDROGENASE DEFICIENCY	0.000541419	0.02031195654339248
GOMEZ-LOPEZ-HERNANDEZ SYNDROME; GLHS	0.000541419	0.02031195654339248
HYPOMAGNESEMIA 1, INTESTINAL; HOMG1	0.000541419	0.02031195654339248
MIGRAINE, FAMILIAL HEMIPLEGIC, 2; FHM2	0.000541419	0.02031195654339248
SKELETAL DYSPLASIA AND PROGRESSIVE CENTRAL NERVOUS SYSTEM DEGENERATION, LETHAL	0.000541419	0.02031195654339248
CEREBRAL CAVERNOUS MALFORMATIONS 2	0.000541419	0.02031195654339248
ACROMELIC FRONTONASAL DYSOSTOSIS; AFND	0.000541419	0.02031195654339248
ENCEPHALOPATHY, FAMILIAL, WITH NEUROSERPIN INCLUSION BODIES; FENIB	0.000541419	0.02031195654339248
BLEPHAROPHIMOSIS WITH FACIAL AND GENITAL ANOMALIES AND MENTAL RETARDATION	0.000541419	0.02031195654339248
CRANIOSYNOSTOSIS 2	0.000541419	0.02031195654339248
VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 1, WITH OR WITHOUT ATRIAL DYSFUNCTION AND/OR DILATED CARDIOMYOPATHY; CPVT1	0.000541419	0.02031195654339248
ALZHEIMER DISEASE, FAMILIAL EARLY-ONSET, WITH COEXISTING AMYLOID AND PRION PATHOLOGY	0.000541419	0.02031195654339248
GLYCINE ENCEPHALOPATHY; GCE	0.000541419	0.02031195654339248
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE, WITH AXONAL NEUROPATHY 1; SCAN1	0.000541419	0.02031195654339248
LATHOSTEROLOSIS	0.000541419	0.02031195654339248
AUTISM, SUSCEPTIBILITY TO, 8; AUTS8	0.000541419	0.02031195654339248
COENZYME Q10 DEFICIENCY, PRIMARY, 1; COQ10D1	0.000541419	0.02031195654339248
SENSORY ATAXIC NEUROPATHY, DYSARTHRIA, AND OPHTHALMOPARESIS; SANDO	0.000541419	0.02031195654339248
GRISCELLI SYNDROME, TYPE 2; GS2	0.000541419	0.02031195654339248
MUSCULAR DYSTROPHY, CONGENITAL MEROSIN-DEFICIENT, 1A; MDC1A	0.000541419	0.02031195654339248
GAUCHER DISEASE, PERINATAL LETHAL	0.000541419	0.02031195654339248
AUTISM, SUSCEPTIBILITY TO, 3; AUTS3	0.000541419	0.02031195654339248
TELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 2; HHT2	0.000541419	0.02031195654339248
CEROID LIPOFUSCINOSIS, NEURONAL, 8	0.000541419	0.02031195654339248
CHROMOSOME 15Q11-Q13 DUPLICATION SYNDROME	0.000541419	0.02031195654339248
WOLFRAM SYNDROME, MITOCHONDRIAL FORM	0.000541419	0.02031195654339248
MENTAL RETARDATION, X-LINKED 82	0.000541419	0.02031195654339248
NEPHROGENIC SYNDROME OF INAPPROPRIATE ANTIDIURESIS; NSIAD	0.000541419	0.02031195654339248
CLARK-BARAITSER SYNDROME	0.000541419	0.02031195654339248
%300612 BROOKS-WISNIEWSKI-BROWN SYNDROME;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, BROOKS-WISNIEWSKI-BROWN TYPE;MRXSBWB	0.000541419	0.02031195654339248
FRAGILE X MENTAL RETARDATION SYNDROME	0.000541419	0.02031195654339248
MENTAL RETARDATION, X-LINKED, SYNDROMIC, WU TYPE; MRXSW	0.000541419	0.02031195654339248
MENTAL RETARDATION, X-LINKED 96; MRX96	0.000541419	0.02031195654339248
AUTISM, SUSCEPTIBILITY TO, X-LINKED 6	0.000541419	0.02031195654339248
MENTAL RETARDATION, X-LINKED 100	0.000541419	0.02031195654339248
LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 3; LSDMCA3	0.000541419	0.02031195654339248
MENTAL RETARDATION, X-LINKED 102	0.000541419	0.02031195654339248
IMMUNODEFICIENCY 47	0.000541419	0.02031195654339248
FABRY DISEASE	0.000541419	0.02031195654339248
HHHH SYNDROME	0.000541419	0.02031195654339248
HYPOPARATHYROIDISM, X-LINKED	0.000541419	0.02031195654339248
ICHTHYOSIS AND MALE HYPOGONADISM	0.000541419	0.02031195654339248
INCONTINENTIA PIGMENTI; IP	0.000541419	0.02031195654339248
MENTAL RETARDATION ASSOCIATED WITH PSORIASIS	0.000541419	0.02031195654339248
MENTAL RETARDATION, X-LINKED 1	0.000541419	0.02031195654339248
METHYLMALONIC ACIDEMIA AND HOMOCYSTEINEMIA, CBLX TYPE	0.000541419	0.02031195654339248
%309545 MENTAL RETARDATION, X-LINKED, SYNDROMIC 12; MRXS12	0.000541419	0.02031195654339248
MENTAL RETARDATION WITH OPTIC ATROPHY, DEAFNESS, AND SEIZURES	0.000541419	0.02031195654339248
MENTAL RETARDATION, X-LINKED, SYNDROMIC, SNYDER-ROBINSON TYPE	0.000541419	0.02031195654339248
MICROPHTHALMIA, SYNDROMIC 1	0.000541419	0.02031195654339248
311450 PALLISTER W SYNDROME;;W SYNDROME	0.000541419	0.02031195654339248
CYCLIC VOMITING SYNDROME	0.000541419	0.02031195654339248
KEARNS-SAYRE SYNDROME; KSS	0.000541419	0.02031195654339248
LIPODYSTROPHY, GENERALIZED, WITH MENTAL RETARDATION, DEAFNESS, SHORT STATURE, AND SLENDER BONES	0.000541419	0.02031195654339248
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IE	0.000541419	0.02031195654339248
AUTISM, SUSCEPTIBILITY TO, X-LINKED 2; AUTSX2	0.000541419	0.02031195654339248
MECKEL SYNDROME, TYPE 10; MKS10	0.000541419	0.02031195654339248
WARBURG MICRO SYNDROME 3; WARBM3	0.000541419	0.02031195654339248
MICROCEPHALY-CAPILLARY MALFORMATION SYNDROME	0.000541419	0.02031195654339248
EPILEPSY, FAMILIAL TEMPORAL LOBE, 5	0.000541419	0.02031195654339248
HYPERGLYCINEMIA, LACTIC ACIDOSIS, AND SEIZURES	0.000541419	0.02031195654339248
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 34, WITH VARIANT LISSENCEPHALY; MRT34	0.000541419	0.02031195654339248
INFANTILE CEREBELLAR-RETINAL DEGENERATION	0.000541419	0.02031195654339248
GLUCOCORTICOID DEFICIENCY 4 WITH OR WITHOUT MINERALOCORTICOID DEFICIENCY; GCCD4	0.000541419	0.02031195654339248
MICROCEPHALY, SHORT STATURE, AND POLYMICROGYRIA WITH OR WITHOUT SEIZURES; MSSP	0.000541419	0.02031195654339248
SECKEL SYNDROME 7; SCKL7	0.000541419	0.02031195654339248
PEROXISOME BIOGENESIS DISORDER 3A (ZELLWEGER); PBD3A	0.000541419	0.02031195654339248
PEROXISOME BIOGENESIS DISORDER 6A (ZELLWEGER); PBD6A	0.000541419	0.02031195654339248
PEROXISOME BIOGENESIS DISORDER 7A (ZELLWEGER); PBD7A	0.000541419	0.02031195654339248
PEROXISOME BIOGENESIS DISORDER 8A (ZELLWEGER); PBD8A	0.000541419	0.02031195654339248
PEROXISOME BIOGENESIS DISORDER 10A (ZELLWEGER); PBD10A	0.000541419	0.02031195654339248
PEROXISOME BIOGENESIS DISORDER 13A (ZELLWEGER)	0.000541419	0.02031195654339248
COWDEN SYNDROME 5; CWS5	0.000541419	0.02031195654339248
COWDEN SYNDROME 6; CWS6	0.000541419	0.02031195654339248
HYDROCEPHALUS, CONGENITAL, 2, WITH OR WITHOUT BRAIN OR EYE ANOMALIES; HYC2	0.000541419	0.02031195654339248
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 4; MC5DN4	0.000541419	0.02031195654339248
NEPHROTIC SYNDROME, TYPE 8; NPHS8	0.000541419	0.02031195654339248
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 14; MDDGC14	0.000541419	0.02031195654339248
CEROID LIPOFUSCINOSIS, NEURONAL, 13; CLN13	0.000541419	0.02031195654339248
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 37	0.000541419	0.02031195654339248
PARKINSON DISEASE 19A, JUVENILE-ONSET	0.000541419	0.02031195654339248
ASPARAGINE SYNTHETASE DEFICIENCY; ASNSD	0.000541419	0.02031195654339248
MOYAMOYA DISEASE 6 WITH ACHALASIA	0.000541419	0.02031195654339248
ENCEPHALOPATHY, PROGRESSIVE, WITH OR WITHOUT LIPODYSTROPHY; PELD	0.000541419	0.02031195654339248
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 4; IIAE4	0.000541419	0.02031195654339248
PERRAULT SYNDROME 3	0.000541419	0.02031195654339248
CEROID LIPOFUSCINOSIS, NEURONAL, 9	0.000541419	0.02031195654339248
MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS 2A; MLC2A	0.000541419	0.02031195654339248
PANCREATIC AND CEREBELLAR AGENESIS; PACA	0.000541419	0.02031195654339248
MITOCHONDRIAL DNA DEPLETION SYNDROME 2 (MYOPATHIC TYPE)	0.000541419	0.02031195654339248
MIGRAINE, FAMILIAL HEMIPLEGIC, 3	0.000541419	0.02031195654339248
GLUTAMINE DEFICIENCY, CONGENITAL	0.000541419	0.02031195654339248
PONTOCEREBELLAR HYPOPLASIA, TYPE 5; PCH5	0.000541419	0.02031195654339248
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2B; NBIA2B	0.000541419	0.02031195654339248
PACHYGYRIA, FRONTOTEMPORAL	0.000541419	0.02031195654339248
EPILEPSY, NOCTURNAL FRONTAL LOBE, 4; ENFL4	0.000541419	0.02031195654339248
HYPOGONADOTROPIC HYPOGONADISM 4 WITH OR WITHOUT ANOSMIA; HH4	0.000541419	0.02031195654339248
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 10	0.000541419	0.02031195654339248
PAROXYSMAL NONKINESIGENIC DYSKINESIA 2	0.000541419	0.02031195654339248
LISSENCEPHALY 3; LIS3	0.000541419	0.02031195654339248
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 5; COXPD5	0.000541419	0.02031195654339248
CONGENITAL ARTHROGRYPOSIS WITH ANTERIOR HORN CELL DISEASE; CAAHD	0.000541419	0.02031195654339248
VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 2; CPVT2	0.000541419	0.02031195654339248
MITOCHONDRIAL DNA DEPLETION SYNDROME 8A (ENCEPHALOMYOPATHIC TYPE WITH RENAL TUBULOPATHY)	0.000541419	0.02031195654339248
EPISODIC ATAXIA, TYPE 6	0.000541419	0.02031195654339248
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 2; IIAE2	0.000541419	0.02031195654339248
NEURODEGENERATION DUE TO CEREBRAL FOLATE TRANSPORT DEFICIENCY	0.000541419	0.02031195654339248
NEPHRONOPHTHISIS-LIKE NEPHROPATHY 1	0.000541419	0.02031195654339248
MICROCEPHALY, SEIZURES, AND DEVELOPMENTAL DELAY	0.000541419	0.02031195654339248
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 5	0.000541419	0.02031195654339248
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIJ; CDG2J	0.000541419	0.02031195654339248
RAJAB INTERSTITIAL LUNG DISEASE WITH BRAIN CALCIFICATIONS; RILDBC	0.000541419	0.02031195654339248
INFECTIONS, RECURRENT, WITH ENCEPHALOPATHY, HEPATIC DYSFUNCTION, AND CARDIOVASCULAR MALFORMATIONS	0.000541419	0.02031195654339248
RETINITIS PIGMENTOSA 59; RP59	0.000541419	0.02031195654339248
OBESITY, HYPERPHAGIA, AND DEVELOPMENTAL DELAY; OBHD	0.000541419	0.02031195654339248
AUTISM, SUSCEPTIBILITY TO, X-LINKED 3; AUTSX3	0.000541419	0.02031195654339248
CUBITUS VALGUS WITH MENTAL RETARDATION AND UNUSUAL FACIES	0.000541419	0.02031195654339248
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 22	0.000541419	0.02031195654339248
SNEDDON SYNDROME	0.000541419	0.02031195654339248
STURGE-WEBER SYNDROME	0.000541419	0.02031195654339248
SUPRABULBAR PARESIS, CONGENITAL	0.000541419	0.02031195654339248
PREECLAMPSIA/ECLAMPSIA 1	0.000541419	0.02031195654339248
ACTH DEFICIENCY, ISOLATED; IAD	0.000541419	0.02031195654339248
PEROXISOME BIOGENESIS DISORDER 2B; PBD2B	0.000541419	0.02031195654339248
203600 ALOPECIA-EPILEPSY-OLIGOPHRENIA SYNDROME OF MOYNAHAN;;MOYNAHAN ALOPECIA SYNDROME	0.000541419	0.02031195654339248
CEROID LIPOFUSCINOSIS, NEURONAL, 3; CLN3	0.000541419	0.02031195654339248
CEROID LIPOFUSCINOSIS, NEURONAL, 4A, AUTOSOMAL RECESSIVE	0.000541419	0.02031195654339248
CEROID LIPOFUSCINOSIS, NEURONAL, 2	0.000541419	0.02031195654339248
ANGIOMATOSIS, DIFFUSE CORTICOMENINGEAL, OF DIVRY AND VAN BOGAERT	0.000541419	0.02031195654339248
ASPARTYLGLUCOSAMINURIA; AGU	0.000541419	0.02031195654339248
AUTISM	0.000541419	0.02031195654339248
SECKEL SYNDROME 1; SCKL1	0.000541419	0.02031195654339248
BANGSTAD SYNDROME	0.000541419	0.02031195654339248
BRACHYDACTYLY, TYPE A2, WITH MICROCEPHALY	0.000541419	0.02031195654339248
CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY	0.000541419	0.02031195654339248
CELIAC DISEASE, SUSCEPTIBILITY TO, 1; CELIAC1	0.000541419	0.02031195654339248
CEREBELLOPARENCHYMAL DISORDER II	0.000541419	0.02031195654339248
CEREBROTENDINOUS XANTHOMATOSIS; CTX	0.000541419	0.02031195654339248
CEREBROOCULOFACIOSKELETAL SYNDROME 1	0.000541419	0.02031195654339248
215480 CHOROID PLEXUS CALCIFICATION AND MENTAL RETARDATION	0.000541419	0.02031195654339248
CONVULSIVE DISORDER, FAMILIAL, WITH PRENATAL OR EARLY ONSET	0.000541419	0.02031195654339248
CRANIOSYNOSTOSIS-MENTAL RETARDATION-CLEFTING SYNDROME	0.000541419	0.02031195654339248
CROME SYNDROME	0.000541419	0.02031195654339248
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIA; ARCL2A	0.000541419	0.02031195654339248
DEAFNESS, ONYCHODYSTROPHY, OSTEODYSTROPHY, MENTAL RETARDATION, AND SEIZURES SYNDROME; DOORS	0.000541419	0.02031195654339248
DIAMINOPENTANURIA	0.000541419	0.02031195654339248
182610 SPASTIC PARAPLEGIA, EPILEPSY, AND MENTAL RETARDATION; SPEMR	0.000541419	0.02031195654339248
PATTERSON PSEUDOLEPRECHAUNISM SYNDROME	0.000541419	0.02031195654339248
DYSOSTEOSCLEROSIS	0.000541419	0.02031195654339248
PARIETAL FORAMINA	0.000541419	0.02031195654339248
1P36 MICRODELETION SYNDROME	0.000541419	0.02031195654339248
ANGELMAN SYNDROME (TYPE 1)	0.000541419	0.02031195654339248
2Q33.1 DELETION SYNDROME	0.000541419	0.02031195654339248
ANGELMAN SYNDROME (TYPE 2)	0.000541419	0.02031195654339248
NEUROFIBROMATOSIS, TYPE II	0.000541419	0.02031195654339248
%104130 ALOPECIA, PSYCHOMOTOR EPILEPSY, PYORRHEA, AND MENTAL SUBNORMALITY;;SHOKEIR SYNDROME	0.000541419	0.02031195654339248
ARTERITIS, FAMILIAL GRANULOMATOUS, WITH JUVENILE POLYARTHRITIS	0.000541419	0.02031195654339248
PAPILLORENAL SYNDROME	0.000541419	0.02031195654339248
COPPER DEFICIENCY, FAMILIAL BENIGN	0.000541419	0.02031195654339248
DARIER-WHITE DISEASE; DAR	0.000541419	0.02031195654339248
DENTATORUBRAL-PALLIDOLUYSIAN ATROPHY NAITO-OYANAGI DISEASE HAW RIVER SYNDROME ATAXIA, CHOREA, SEIZURES, AND DEMENTIA	0.000541419	0.02031195654339248
KENNY-CAFFEY SYNDROME, TYPE 2; KCS2	0.000541419	0.02031195654339248
EPILEPSY, BENIGN OCCIPITAL	0.000541419	0.02031195654339248
EPILEPSY, READING	0.000541419	0.02031195654339248
FLYNN-AIRD SYNDROME	0.000541419	0.02031195654339248
MENTAL RETARDATION, FRA12A TYPE	0.000541419	0.02031195654339248
HEMIFACIAL ATROPHY, PROGRESSIVE; HFA	0.000541419	0.02031195654339248
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, CHROMOSOME 16-RELATED	0.000541419	0.02031195654339248
HUNTINGTON DISEASE; HD	0.000541419	0.02031195654339248
HYPOPARATHYROIDISM, FAMILIAL ISOLATED; FIH	0.000541419	0.02031195654339248
%149000 KLIPPEL-TRENAUNAY-WEBER SYNDROME;;KTW SYNDROME;;KLIPPEL-TRENAUNAY SYNDROME; KTS;;ANGIOOSTEOHYPERTROPHY SYNDROME	0.000541419	0.02031195654339248
SYSTEMIC LUPUS ERYTHEMATOSUS; SLE	0.000541419	0.02031195654339248
BANNAYAN-RILEY-RUVALCABA SYNDROME	0.000541419	0.02031195654339248
HYPOMAGNESEMIA 2, RENAL	0.000541419	0.02031195654339248
CEROID LIPOFUSCINOSIS, NEURONAL, 4B, AUTOSOMAL DOMINANT; CLN4B	0.000541419	0.02031195654339248
SCHIMMELPENNING-FEUERSTEIN-MIMS SYNDROME; SFM	0.000541419	0.02031195654339248
OCULOCEREBROCUTANEOUS SYNDROME	0.000541419	0.02031195654339248
224250 DYSMYELINATION WITH JAUNDICE	0.000541419	0.02031195654339248
PONTOCEREBELLAR HYPOPLASIA, TYPE 4; PCH4	0.000541419	0.02031195654339248
ATKIN-FLAITZ SYNDROME	0.000541419	0.02031195654339248
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP B; MOCODB	0.000541419	0.02031195654339248
CARNITINE PALMITOYLTRANSFERASE I DEFICIENCY	0.000541419	0.02031195654339248
PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 1; PRAAS1	0.000541419	0.02031195654339248
NEURAMINIDASE DEFICIENCY WITH BETA-GALACTOSIDASE DEFICIENCY	0.000541419	0.02031195654339248
NEURAMINIDASE DEFICIENCY	0.000541419	0.02031195654339248
PHENYLKETONURIA	0.000541419	0.02031195654339248
GLYCOGEN STORAGE DISEASE OF HEART, LETHAL CONGENITAL	0.000541419	0.02031195654339248
GLUTATHIONE SYNTHETASE DEFICIENCY	0.000541419	0.02031195654339248
RAMON SYNDROME	0.000541419	0.02031195654339248
RETINAL DEGENERATION AND EPILEPSY	0.000541419	0.02031195654339248
KNOBLOCH SYNDROME 1; KNO1	0.000541419	0.02031195654339248
AUTOIMMUNE POLYENDOCRINE SYNDROME, TYPE II	0.000541419	0.02031195654339248
SJOGREN-LARSSON SYNDROME; SLS	0.000541419	0.02031195654339248
CRISPONI/COLD-INDUCED SWEATING SYNDROME 1; CISS1	0.000541419	0.02031195654339248
TAY-SACHS DISEASE; TSD	0.000541419	0.02031195654339248
THREONINEMIA	0.000541419	0.02031195654339248
THYROCEREBRORETINAL SYNDROME	0.000541419	0.02031195654339248
DIHYDROPYRIMIDINE DEHYDROGENASE DEFICIENCY	0.000541419	0.02031195654339248
XYLOSIDASE DEFICIENCY	0.000541419	0.02031195654339248
ZUNICH NEUROECTODERMAL SYNDROME	0.000541419	0.02031195654339248
INTESTINAL PSEUDOOBSTRUCTION, NEURONAL, CHRONIC IDIOPATHIC, X-LINKED	0.000541419	0.02031195654339248
MENTAL RETARDATION, X-LINKED 14	0.000541419	0.02031195654339248
LISSENCEPHALY, X-LINKED, 1; LISX1	0.000541419	0.02031195654339248
LISSENCEPHALY, X-LINKED, 2	0.000541419	0.02031195654339248
%300261 ARMFIELD X-LINKED MENTAL RETARDATION SYNDROME; MRXSA;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, ARMFIELD TYPE	0.000541419	0.02031195654339248
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CABEZAS TYPE; MRXSC	0.000541419	0.02031195654339248
MENTAL RETARDATION, X-LINKED, WITH OR WITHOUT SEIZURES, ARX-RELATED	0.000541419	0.02031195654339248
AUTISM, SUSCEPTIBILITY TO, X-LINKED 1; AUTSX1	0.000541419	0.02031195654339248
MUSCULAR DYSTROPHY, ADULT-ONSET, WITH LEUKOENCEPHALOPATHY	0.000541419	0.02031195654339248
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP A; MOCODA	0.000541419	0.02031195654339248
VISCERAL STEATOSIS, CONGENITAL	0.000541419	0.02031195654339248
MITOCHONDRIAL DNA DEPLETION SYNDROME 3 (HEPATOCEREBRAL TYPE)	0.000541419	0.02031195654339248
FOUNTAIN SYNDROME	0.000541419	0.02031195654339248
FRUCTOSE AND GALACTOSE INTOLERANCE	0.000541419	0.02031195654339248
FRUCTOSE-1,6-BISPHOSPHATASE DEFICIENCY	0.000541419	0.02031195654339248
BERNARD-SOULIER SYNDROME	0.000541419	0.02031195654339248
GLUTARIC ACIDEMIA I; GA1	0.000541419	0.02031195654339248
234250 HALL-RIGGS MENTAL RETARDATION SYNDROME	0.000541419	0.02031195654339248
N-ACETYLGLUTAMATE SYNTHASE DEFICIENCY	0.000541419	0.02031195654339248
HYPER-BETA-ALANINEMIA	0.000541419	0.02031195654339248
HYPERLEUCINE-ISOLEUCINEMIA	0.000541419	0.02031195654339248
HYPERLYSINEMIA, TYPE I	0.000541419	0.02031195654339248
HYPERPHOSPHATEMIA, POLYURIA, AND SEIZURES	0.000541419	0.02031195654339248
HYPERPROLINEMIA, TYPE II	0.000541419	0.02031195654339248
HYPOADRENOCORTICISM, FAMILIAL	0.000541419	0.02031195654339248
GLYCOGEN STORAGE DISEASE 0, LIVER	0.000541419	0.02031195654339248
HYPOGLYCEMIA, LEUCINE-INDUCED; LIH	0.000541419	0.02031195654339248
HYPOPHOSPHATASIA, CHILDHOOD	0.000541419	0.02031195654339248
HYPOGONADOTROPIC HYPOGONADISM 3 WITH OR WITHOUT ANOSMIA; HH3	0.000541419	0.02031195654339248
KEUTEL SYNDROME; KTLS	0.000541419	0.02031195654339248
KIFAFA SEIZURE DISORDER	0.000541419	0.02031195654339248
LIPOID PROTEINOSIS OF URBACH AND WIETHE	0.000541419	0.02031195654339248
MANNOSIDOSIS, BETA A, LYSOSOMAL	0.000541419	0.02031195654339248
MAPLE SYRUP URINE DISEASE; MSUD	0.000541419	0.02031195654339248
MARDEN-WALKER SYNDROME	0.000541419	0.02031195654339248
MEGALOCORNEA-MENTAL RETARDATION SYNDROME	0.000541419	0.02031195654339248
MENTAL RETARDATION SYNDROME, BELGIAN TYPE	0.000541419	0.02031195654339248
%250900 METHIONINE MALABSORPTION SYNDROME;;SMITH-STRANG DISEASE;;OASTHOUSE URINE DISEASE	0.000541419	0.02031195654339248
MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 1	0.000541419	0.02031195654339248
MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 1; MSSGM1	0.000541419	0.02031195654339248
MICROCEPHALY 13, PRIMARY, AUTOSOMAL RECESSIVE; MCPH13	0.000541419	0.02031195654339248
9Q21.13 MICRODELETION SYNDROME	0.000541419	0.02031195654339248
MOYNAHAN SYNDROME	0.000541419	0.02031195654339248
MYOPATHY-GROWTH DELAY-INTELLECTUAL DISABILITY-HYPOSPADIAS SYNDROME	0.000541419	0.02031195654339248
LINEAR VERRUCOUS NEVUS SYNDROME	0.000541419	0.02031195654339248
14Q12 MICRODELETION SYNDROME	0.000541419	0.02031195654339248
LINEAR NEVUS SEBACEUS SYNDROME	0.000541419	0.02031195654339248
HYPERINSULINISM DUE TO HNF4A DEFICIENCY	0.000541419	0.02031195654339248
HYPERINSULINISM DUE TO INSR DEFICIENCY	0.000541419	0.02031195654339248
MULTIPLE ACYL-COA DEHYDROGENASE DEFICIENCY	0.000541419	0.02031195654339248
OLIVOPONTOCEREBELLAR ATROPHY-DEAFNESS SYNDROME	0.000541419	0.02031195654339248
HORIZONTAL GAZE PALSY WITH PROGRESSIVE SCOLIOSIS	0.000541419	0.02031195654339248
OROFACIODIGITAL SYNDROME TYPE 1	0.000541419	0.02031195654339248
ADULT-ONSET NON-INSULINOMA PERSISTENT HYPERINSULINEMIC HYPOGLYCEMIA	0.000541419	0.02031195654339248
SYMPTOMATIC FORM OF COFFIN-LOWRY SYNDROME IN FEMALE CARRIERS	0.000541419	0.02031195654339248
OSTEOGENESIS IMPERFECTA-RETINOPATHY-SEIZURES-INTELLECTUAL DISABILITY SYNDROME	0.000541419	0.02031195654339248
MICROFORM HOLOPROSENCEPHALY	0.000541419	0.02031195654339248
INHERITED CREUTZFELDT-JAKOB DISEASE	0.000541419	0.02031195654339248
TYROSINEMIA TYPE 2	0.000541419	0.02031195654339248
PHAKOMATOSIS PIGMENTOVASCULARIS	0.000541419	0.02031195654339248
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, VERLOES TYPE	0.000541419	0.02031195654339248
PORENCEPHALY	0.000541419	0.02031195654339248
PROLACTINOMA	0.000541419	0.02031195654339248
LEUKOCYTE ADHESION DEFICIENCY	0.000541419	0.02031195654339248
QAZI-MARKOUIZOS SYNDROME	0.000541419	0.02031195654339248
RAMON SYNDROME	0.000541419	0.02031195654339248
ISOLATED BILIARY ATRESIA	0.000541419	0.02031195654339248
X-LINKED INTELLECTUAL DISABILITY-SEIZURES-PSORIASIS SYNDROME	0.000541419	0.02031195654339248
BENIGN FAMILIAL INFANTILE EPILEPSY	0.000541419	0.02031195654339248
FADD-RELATED IMMUNODEFICIENCY	0.000541419	0.02031195654339248
MITOCHONDRIAL MYOPATHY-LACTIC ACIDOSIS-DEAFNESS SYNDROME	0.000541419	0.02031195654339248
MOYAMOYA DISEASE	0.000541419	0.02031195654339248
SEVERE X-LINKED INTELLECTUAL DISABILITY, GUSTAVSON TYPE	0.000541419	0.02031195654339248
MOMO SYNDROME	0.000541419	0.02031195654339248
NEURONAL CEROID LIPOFUSCINOSIS	0.000541419	0.02031195654339248
MICRODUPLICATION XP11.22P11.23 SYNDROME	0.000541419	0.02031195654339248
FAMILIAL CEREBRAL CAVERNOUS MALFORMATION	0.000541419	0.02031195654339248
PITT-HOPKINS-LIKE SYNDROME	0.000541419	0.02031195654339248
MATERNAL HYPERTHERMIA-INDUCED BIRTH DEFECTS	0.000541419	0.02031195654339248
FAMILIAL ISOLATED HYPOPARATHYROIDISM	0.000541419	0.02031195654339248
CARNITINE PALMITOYL TRANSFERASE II DEFICIENCY, SEVERE INFANTILE FORM	0.000541419	0.02031195654339248
CARNITINE PALMITOYL TRANSFERASE II DEFICIENCY, NEONATAL FORM	0.000541419	0.02031195654339248
5Q35 MICRODUPLICATION SYNDROME	0.000541419	0.02031195654339248
NEURONAL INTRANUCLEAR INCLUSION DISEASE	0.000541419	0.02031195654339248
FAMILIAL CEREBRAL SACCULAR ANEURYSM	0.000541419	0.02031195654339248
SANJAD-SAKATI SYNDROME	0.000541419	0.02031195654339248
OSTEOPENIA-INTELLECTUAL DISABILITY-SPARSE HAIR SYNDROME	0.000541419	0.02031195654339248
ANGIOOSTEOHYPERTROPHIC SYNDROME	0.000541419	0.02031195654339248
EARLY-ONSET PARKINSONISM-INTELLECTUAL DISABILITY SYNDROME	0.000541419	0.02031195654339248
PYRUVATE DEHYDROGENASE E3 DEFICIENCY	0.000541419	0.02031195654339248
CITRULLINEMIA TYPE I	0.000541419	0.02031195654339248
RETINAL VASCULOPATHY WITH CEREBRAL LEUKOENCEPHALOPATHY AND SYSTEMIC MANIFESTATIONS	0.000541419	0.02031195654339248
NEUROCUTANEOUS MELANOCYTOSIS	0.000541419	0.02031195654339248
CORPUS CALLOSUM AGENESIS-ABNORMAL GENITALIA SYNDROME	0.000541419	0.02031195654339248
AICA-RIBOSIDURIA	0.000541419	0.02031195654339248
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 1	0.000541419	0.02031195654339248
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 1	0.000541419	0.02031195654339248
MICROCEPHALY-CARDIOMYOPATHY SYNDROME	0.000541419	0.02031195654339248
PINEOBLASTOMA	0.000541419	0.02031195654339248
LETHAL INFANTILE MITOCHONDRIAL MYOPATHY	0.000541419	0.02031195654339248
MICROSPORIDIOSIS	0.000541419	0.02031195654339248
X-LINKED INTELLECTUAL DISABILITY-PSYCHOSIS-MACROORCHIDISM SYNDROME	0.000541419	0.02031195654339248
GM2 GANGLIOSIDOSIS, AB VARIANT	0.000541419	0.02031195654339248
NODULAR NEURONAL HETEROTOPIA	0.000541419	0.02031195654339248
HYPOCOMPLEMENTEMIC URTICARIAL VASCULITIS	0.000541419	0.02031195654339248
ATYPICAL JUVENILE PARKINSONISM	0.000541419	0.02031195654339248
CLASSIC HOMOCYSTINURIA	0.000541419	0.02031195654339248
MACROCEPHALY-DEVELOPMENTAL DELAY SYNDROME	0.000541419	0.02031195654339248
PERIPHERAL NEUROPATHY-MYOPATHY-HOARSENESS-HEARING LOSS SYNDROME	0.000541419	0.02031195654339248
SEVERE INTELLECTUAL DISABILITY-PROGRESSIVE SPASTIC DIPLEGIA SYNDROME	0.000541419	0.02031195654339248
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-EPILEPSY-INTELLECTUAL DISABILITY SYNDROME DUE TO TUD DEFICIENCY	0.000541419	0.02031195654339248
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-EPILEPSY-INTELLECTUAL DISABILITY SYNDROME DUE TO RUBCN DEFICIENCY	0.000541419	0.02031195654339248
HYPERPROLINEMIA TYPE 1	0.000541419	0.02031195654339248
MALAN OVERGROWTH SYNDROME	0.000541419	0.02031195654339248
CONO-SPONDYLAR DYSPLASIA	0.000541419	0.02031195654339248
KEPPEN-LUBINSKY SYNDROME	0.000541419	0.02031195654339248
X-LINKED MICROCEPHALY-GROWTH RETARDATION-PROGNATHISM-CRYPTORCHIDISM SYNDROME	0.000541419	0.02031195654339248
HYPOPHOSPHATASIA	0.000541419	0.02031195654339248
INTELLECTUAL DISABILITY-EXPRESSIVE APHASIA-FACIAL DYSMORPHISM SYNDROME	0.000541419	0.02031195654339248
PGM3-CDG	0.000541419	0.02031195654339248
3-METHYLGLUTACONIC ACIDURIA TYPE 7	0.000541419	0.02031195654339248
ADENYLOSUCCINATE LYASE DEFICIENCY	0.000541419	0.02031195654339248
ACQUIRED METHEMOGLOBINEMIA	0.000541419	0.02031195654339248
SLC39A8-CDG	0.000541419	0.02031195654339248
LEIGH SYNDROME	0.000541419	0.02031195654339248
AUTOSOMAL RECESSIVE COMPLEX SPASTIC PARAPLEGIA DUE TO KENNEDY PATHWAY DYSFUNCTION	0.000541419	0.02031195654339248
ETHYLMALONIC ENCEPHALOPATHY	0.000541419	0.02031195654339248
WHIM SYNDROME	0.000541419	0.02031195654339248
ACUTE BILIRUBIN ENCEPHALOPATHY	0.000541419	0.02031195654339248
CHRONIC BILIRUBIN ENCEPHALOPATHY	0.000541419	0.02031195654339248
LIPOID PROTEINOSIS	0.000541419	0.02031195654339248
MILLER-DIEKER SYNDROME	0.000541419	0.02031195654339248
PERIPHERAL PRIMITIVE NEUROECTODERMAL TUMOR	0.000541419	0.02031195654339248
GLYCOGEN STORAGE DISEASE DUE TO GLUCOSE-6-PHOSPHATASE DEFICIENCY	0.000541419	0.02031195654339248
ATYPICAL RETT SYNDROME	0.000541419	0.02031195654339248
X-LINKED PARKINSONISM-SPASTICITY SYNDROME	0.000541419	0.02031195654339248
NOCARDIOSIS	0.000541419	0.02031195654339248
DEVELOPMENTAL AND SPEECH DELAY DUE TO SOX5 DEFICIENCY	0.000541419	0.02031195654339248
INFANTILE SPASMS-BROAD THUMBS SYNDROME	0.000541419	0.02031195654339248
LUJO HEMORRHAGIC FEVER	0.000541419	0.02031195654339248
EBOLA HEMORRHAGIC FEVER	0.000541419	0.02031195654339248
RIFT VALLEY FEVER	0.000541419	0.02031195654339248
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 44	0.000541419	0.02031195654339248
COCHLEOSACCULAR DEGENERATION-CATARACT SYNDROME	0.000541419	0.02031195654339248
CENTRAL NERVOUS SYSTEM CALCIFICATION-DEAFNESS-TUBULAR ACIDOSIS-ANEMIA SYNDROME	0.000541419	0.02031195654339248
AUTOSOMAL RECESSIVE CONGENITAL CEREBELLAR ATAXIA DUE TO MGLUR1 DEFICIENCY	0.000541419	0.02031195654339248
EARLY-ONSET LAFORA BODY DISEASE	0.000541419	0.02031195654339248
HYPERINSULINISM DUE TO HNF1A DEFICIENCY	0.000541419	0.02031195654339248
ABETA AMYLOIDOSIS, ITALIAN TYPE	0.000541419	0.02031195654339248
IDIOPATHIC HYPEREOSINOPHILIC SYNDROME	0.000541419	0.02031195654339248
AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME	0.000541419	0.02031195654339248
TAKAYASU ARTERITIS	0.000541419	0.02031195654339248
THYROCEREBRORENAL SYNDROME	0.000541419	0.02031195654339248
FIBRODYSPLASIA OSSIFICANS PROGRESSIVA	0.000541419	0.02031195654339248
VIRAL HEMORRHAGIC FEVER	0.000541419	0.02031195654339248
FAMILIAL PRIMARY HYPOMAGNESEMIA WITH NORMOCALCIURIA AND NORMOCALCEMIA	0.000541419	0.02031195654339248
WORSTER-DROUGHT SYNDROME	0.000541419	0.02031195654339248
FRUCTOSE-1,6-BISPHOSPHATASE DEFICIENCY	0.000541419	0.02031195654339248
GALACTOSIALIDOSIS	0.000541419	0.02031195654339248
GM1 GANGLIOSIDOSIS	0.000541419	0.02031195654339248
ANK3-RELATED INTELLECTUAL DISABILITY-SLEEP DISTURBANCE SYNDROME	0.000541419	0.02031195654339248
3-HYDROXY-3-METHYLGLUTARYL-COA SYNTHASE DEFICIENCY	0.000541419	0.02031195654339248
GLIOBLASTOMA	0.000541419	0.02031195654339248
HIRSCHSPRUNG DISEASE-GANGLIONEUROBLASTOMA SYNDROME	0.000541419	0.02031195654339248
LISSENCEPHALY TYPE 1 DUE TO DOUBLECORTIN GENE MUTATION	0.000541419	0.02031195654339248
IMMUNODEFICIENCY 37; IMD37	0.000541419	0.02031195654339248
COMBINED IMMUNODEFICIENCY AND MEGALOBLASTIC ANEMIA WITH OR WITHOUT HYPERHOMOCYSTEINEMIA; CIMAH	0.000541419	0.02031195654339248
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 8; IIAE8	0.000541419	0.02031195654339248
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 59; EIEE59	0.000541419	0.02031195654339248
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, CATARACTS, AND RENAL ABNORMALITIES; NEDMCR	0.000541419	0.02031195654339248
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 60; EIEE60	0.000541419	0.02031195654339248
SPINOCEREBELLAR ATAXIA 47; SCA47	0.000541419	0.02031195654339248
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 61; EIEE61	0.000541419	0.02031195654339248
LEUKODYSTROPHY, HYPOMYELINATING, 16; HLD16	0.000541419	0.02031195654339248
LEUKODYSTROPHY, HYPOMYELINATING, 17; HLD17	0.000541419	0.02031195654339248
ENCEPHALITIS/ENCEPHALOPATHY, MILD, WITH REVERSIBLE MYELIN VACUOLIZATION; MMERV	0.000541419	0.02031195654339248
NEURODEGENERATION, CHILDHOOD-ONSET, STRESS-INDUCED, WITH VARIABLE ATAXIA AND SEIZURES; CONDSIAS	0.000541419	0.02031195654339248
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 9; CDCBM9	0.000541419	0.02031195654339248
PERIVENTRICULAR NODULAR HETEROTOPIA 8; PVNH8	0.000541419	0.02031195654339248
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 3; MC1DN3	0.000541419	0.02031195654339248
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 9; MC1DN9	0.000541419	0.02031195654339248
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 14; MC1DN14	0.000541419	0.02031195654339248
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 15; MC1DN15	0.000541419	0.02031195654339248
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 32; MC1DN32	0.000541419	0.02031195654339248
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 67; MRT67	0.000541419	0.02031195654339248
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 71; EIEE71	0.000541419	0.02031195654339248
INTRAUTERINE GROWTH RETARDATION, METAPHYSEAL DYSPLASIA, ADRENAL HYPOPLASIA CONGENITA, GENITAL ANOMALIES, AND IMMUNODEFICIENCY; IMAGEI	0.000541419	0.02031195654339248
POLYMICROGYRIA WITH OR WITHOUT VASCULAR-TYPE EHLERS-DANLOS SYNDROME; PMGEDSV	0.000541419	0.02031195654339248
MICROCEPHALY, GROWTH DEFICIENCY, SEIZURES, AND BRAIN MALFORMATIONS; MIGSB	0.000541419	0.02031195654339248
ABETA AMYLOIDOSIS, DUTCH TYPE	0.000541419	0.02031195654339248
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 4	0.000541419	0.02031195654339248
DENTATORUBRAL PALLIDOLUYSIAN ATROPHY	0.000541419	0.02031195654339248
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 23	0.000541419	0.02031195654339248
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 29	0.000541419	0.02031195654339248
LEUKODYSTROPHY, HYPOMYELINATING, 14; HLD14	0.000541419	0.02031195654339248
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND SPASTICITY; PEBAS	0.000541419	0.02031195654339248
EARLY-ONSET AUTOSOMAL DOMINANT ALZHEIMER DISEASE	0.000541419	0.02031195654339248
ENCEPHALOPATHY, NEONATAL SEVERE, WITH LACTIC ACIDOSIS AND BRAIN ABNORMALITIES; NELABA	0.000541419	0.02031195654339248
IMMUNODEFICIENCY 38 WITH BASAL GANGLIA CALCIFICATION; IMD38	0.000541419	0.02031195654339248
PERRAULT SYNDROME 5; PRLTS5	0.000541419	0.02031195654339248
EPILEPSY, PROGRESSIVE MYOCLONIC 7; EPM7	0.000541419	0.02031195654339248
COENZYME Q10 DEFICIENCY, PRIMARY, 7; COQ10D7	0.000541419	0.02031195654339248
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 32; EIEE32	0.000541419	0.02031195654339248
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 6; IBGC6	0.000541419	0.02031195654339248
INFANTILE LIVER FAILURE SYNDROME 2	0.000541419	0.02031195654339248
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 7; IIAE7	0.000541419	0.02031195654339248
SEIZURES, CORTICAL BLINDNESS, AND MICROCEPHALY SYNDROME	0.000541419	0.02031195654339248
MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 2	0.000541419	0.02031195654339248
DYSKINESIA, LIMB AND OROFACIAL, INFANTILE-ONSET; IOLOD	0.000541419	0.02031195654339248
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 23; SCAR23	0.000541419	0.02031195654339248
HYDROPS, LACTIC ACIDOSIS, AND SIDEROBLASTIC ANEMIA; HLASA	0.000541419	0.02031195654339248
PONTOCEREBELLAR HYPOPLASIA, TYPE 2F	0.000541419	0.02031195654339248
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 40	0.000541419	0.02031195654339248
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 2; FFEVF2	0.000541419	0.02031195654339248
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 3; FFEVF3	0.000541419	0.02031195654339248
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 44	0.000541419	0.02031195654339248
SHORT STATURE, RHIZOMELIC, WITH MICROCEPHALY, MICROGNATHIA, AND DEVELOPMENTAL DELAY; SRMMD	0.000541419	0.02031195654339248
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 1; PEBEL1	0.000541419	0.02031195654339248
SUDDEN CARDIAC FAILURE, INFANTILE	0.000541419	0.02031195654339248
MYOCLONUS, INTRACTABLE, NEONATAL; NEIMY	0.000541419	0.02031195654339248
3-METHYLGLUTACONIC ACIDURIA, TYPE VIII; MGCA8	0.000541419	0.02031195654339248
PSEUDO-TORCH SYNDROME 2	0.000541419	0.02031195654339248
IMMUNOSKELETAL DYSPLASIA WITH NEURODEVELOPMENTAL ABNORMALITIES; ISDNA	0.000541419	0.02031195654339248
ARTHROGRYPOSIS MULTIPLEX CONGENITA, NEUROGENIC, WITH MYELIN DEFECT	0.000541419	0.02031195654339248
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, HYPOTONIA, AND VARIABLE BRAIN ANOMALIES; NMIHBA	0.000541419	0.02031195654339248
ROMANO-WARD SYNDROME	0.000541419	0.02031195654339248
HEREDITARY NEUROCUTANEOUS MALFORMATION	0.000541419	0.02031195654339248
HENNEKAM SYNDROME	0.000541419	0.02031195654339248
CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY	0.000541419	0.02031195654339248
ROSAÏ-DORFMAN DISEASE	0.000541419	0.02031195654339248
2Q24 MICRODELETION SYNDROME	0.000541419	0.02031195654339248
PONTOCEREBELLAR HYPOPLASIA TYPE 4	0.000541419	0.02031195654339248
CONGENITAL NEURONAL CEROID LIPOFUSCINOSIS	0.000541419	0.02031195654339248
LATE INFANTILE NEURONAL CEROID LIPOFUSCINOSIS	0.000541419	0.02031195654339248
DISTAL TRISOMY 15Q	0.000541419	0.02031195654339248
CENTRAL DIABETES INSIPIDUS	0.000541419	0.02031195654339248
EPIPHYSEAL DYSPLASIA-HEARING LOSS-DYSMORPHISM SYNDROME	0.000541419	0.02031195654339248
SKELETAL DYSPLASIA-EPILEPSY-SHORT STATURE SYNDROME	0.000541419	0.02031195654339248
COCKAYNE SYNDROME	0.000541419	0.02031195654339248
EPILEPSY-MICROCEPHALY-SKELETAL DYSPLASIA SYNDROME	0.000541419	0.02031195654339248
BENIGN FAMILIAL NEONATAL EPILEPSY	0.000541419	0.02031195654339248
EPILEPSY-TELANGIECTASIA SYNDROME	0.000541419	0.02031195654339248
BILATERAL STRIOPALLIDODENTATE CALCINOSIS	0.000541419	0.02031195654339248
FAMILIAL MULTIPLE LIPOMATOSIS	0.000541419	0.02031195654339248
3-HYDROXY-3-METHYLGLUTARIC ACIDURIA	0.000541419	0.02031195654339248
ENDOCARDIAL FIBROELASTOSIS	0.000541419	0.02031195654339248
PULMONARY ARTERIOVENOUS MALFORMATION	0.000541419	0.02031195654339248
CRIGLER-NAJJAR SYNDROME	0.000541419	0.02031195654339248
FRYNS SYNDROME	0.000541419	0.02031195654339248
SPLENOGONADAL FUSION-LIMB DEFECTS-MICROGNATHIA SYNDROME	0.000541419	0.02031195654339248
X-LINKED INTELLECTUAL DISABILITY-EPILEPSY SYNDROME	0.000541419	0.02031195654339248
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 18	0.000541419	0.02031195654339248
EPISODIC ATAXIA TYPE 6	0.000541419	0.02031195654339248
HALL-RIGGS SYNDROME	0.000541419	0.02031195654339248
HARROD SYNDROME	0.000541419	0.02031195654339248
CYSTATHIONINURIA	0.000541419	0.02031195654339248
HUNTINGTON DISEASE-LIKE 1	0.000541419	0.02031195654339248
CARNITINE PALMITOYL TRANSFERASE 1A DEFICIENCY	0.000541419	0.02031195654339248
BANNAYAN-RILEY-RUVALCABA SYNDROME	0.000541419	0.02031195654339248
CUTIS MARMORATA TELANGIECTATICA CONGENITA	0.000541419	0.02031195654339248
ARTHROGRYPOSIS MULTIPLEX CONGENITA-WHISTLING FACE SYNDROME	0.000541419	0.02031195654339248
CEREBELLAR ATAXIA-AREFLEXIA-PES CAVUS-OPTIC ATROPHY-SENSORINEURAL HEARING LOSS SYNDROME	0.000541419	0.02031195654339248
BETA-MANNOSIDOSIS	0.000541419	0.02031195654339248
SPASTIC ATAXIA WITH CONGENITAL MIOSIS	0.000541419	0.02031195654339248
TMEM70-RELATED MITOCHONDRIAL ENCEPHALO-CARDIO-MYOPATHY	0.000541419	0.02031195654339248
PROGRESSIVE HEMIFACIAL ATROPHY	0.000541419	0.02031195654339248
CONGENITAL INTRAUTERINE INFECTION-LIKE SYNDROME	0.000541419	0.02031195654339248
SEVERE MICROBRACHYCEPHALY-INTELLECTUAL DISABILITY-ATHETOID CEREBRAL PALSY SYNDROME	0.000541419	0.02031195654339248
BOWEN-CONRADI SYNDROME	0.000541419	0.02031195654339248
INFANTILE CHOROIDOCEREBRAL CALCIFICATION SYNDROME	0.000541419	0.02031195654339248
SYMMETRICAL THALAMIC CALCIFICATIONS	0.000541419	0.02031195654339248
CHRONIC MUCOCUTANEOUS CANDIDIASIS	0.000541419	0.02031195654339248
BETA-KETOTHIOLASE DEFICIENCY	0.000541419	0.02031195654339248
LEUKOENCEPHALOPATHY WITH BRAIN STEM AND SPINAL CORD INVOLVEMENT-HIGH LACTATE SYNDROME	0.000541419	0.02031195654339248
CATARACT-NEPHROPATHY-ENCEPHALOPATHY SYNDROME	0.000541419	0.02031195654339248
AUTOSOMAL RECESSIVE ATAXIA DUE TO UBIQUINONE DEFICIENCY	0.000541419	0.02031195654339248
ISOLATED CEREBELLAR AGENESIS	0.000541419	0.02031195654339248
SYNDACTYLY-TELECANTHUS-ANOGENITAL AND RENAL MALFORMATIONS SYNDROME	0.000541419	0.02031195654339248
PRIMARY ANGIITIS OF THE CENTRAL NERVOUS SYSTEM	0.000541419	0.02031195654339248
FAMILIAL CALCIUM PYROPHOSPHATE DEPOSITION	0.000541419	0.02031195654339248
RING CHROMOSOME 10 SYNDROME	0.000541419	0.02031195654339248
CARBAMOYL-PHOSPHATE SYNTHETASE 1 DEFICIENCY	0.000541419	0.02031195654339248
INTELLECTUAL DISABILITY-HYPOPLASTIC CORPUS CALLOSUM-PREAURICULAR TAG SYNDROME	0.000541419	0.02031195654339248
X-LINKED COMPLICATED CORPUS CALLOSUM DYSGENESIS	0.000541419	0.02031195654339248
CRANIOSYNOSTOSIS-FIBULAR APLASIA SYNDROME	0.000541419	0.02031195654339248
CRISPONI SYNDROME	0.000541419	0.02031195654339248
FAMILIAL BENIGN COPPER DEFICIENCY	0.000541419	0.02031195654339248
MICROCEPHALY 22, PRIMARY, AUTOSOMAL RECESSIVE; MCPH22	0.000541419	0.02031195654339248
